Duloxetine should be considered for the treatment of patients with diabetic neuropathic pain if other first or second line pharmacological <e1>therapies</e1> have <e2>failed</e2> .	actor-of(e1,e2)
In patients with peripheral arthritis and an <e1>inadequate</e1> <e2>response</e2> to at least one csDMARD , therapy with a bDMARD , usually a TNF inhibitor , should be commenced .	modifier(e1,e2)
Offer parathyroid surgery to <e1>women</e1> who <e2>have</e2> primary hyperparathyroidism and are considering pregnancy .	actor-of(e1,e2)
Patients with heart failure with reduced ejection fraction , NYHA class 2-4 , who are <e1>intolerant</e1> of angiotensin converting enzyme <e2>inhibitors</e2> should be given an angiotensin receptor blocker .	modifier(e1,e2)
If HbA1c rises to 48 mmol/mol ( 6.5 % ) on lifestyle interventions , consider a DPP-4i , pioglitazone , an SU , an SGLT-2i , and <e1>support</e1> the <e2>person</e2> to aim for an HbA1c level of 48 mmol/mol ( 6.5 % ) for people on a DPP-4i , SGLT-2i or pioglitazone or 53 mmol/mol ( 7 % ) for people on an SU .	acts-on(e1,e2)
CVD risk assessment is recommended for all patients with RA , <e1>AS</e1> or <e2>PsA</e2> at least once every 5 years and should be reconsidered following major changes in antirheumatic therapy .	choice
In patients with active enthesitis and/or <e1>dactylitis</e1> and insufficient <e2>response</e2> to NSAIDs or local glucocorticoid injections , therapy with a bDMARD should be considered , which according to current practice is a TNF inhibitor .	joint
<e1>Offer</e1> contrast-enhanced brain MRI for <e2>people</e2> with stage 3 NSCLC who are having treatment with curative intent .	receiver(e2,e1)
Consider second-line palliative chemotherapy for <e1>people</e1> with oesophago-gastric <e2>cancer</e2> .	owner(e1,e2)
<e1>Measure</e1> N-terminal pro-B-type natriuretic peptide in <e2>people</e2> with suspected heart failure .	receiver(e2,e1)
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider triple therapy with metformin and a DPP-4i and an SU , metformin and pioglitazone and an SU , metformin and pioglitazone and an SGLT-2i , metformin and an SU and an SGLT-2i , insulin-based treatment , and support the person to <e1>aim</e1> for an HbA1c <e2>level</e2> of 53 mmol/mol ( 7 % ) .	acts-on(e1,e2)
Consider a maintenance dosage higher than 20 mg/kg daily if therapeutic efficacy is not achieved , while ensuring that a safe plasma <e1>level</e1> is <e2>maintained</e2> .	modifier(e2,e1)
Review <e1>intravenous</e1> <e2>antibiotics</e2> by 48 hours and consider stepping down to oral antibiotics where possible .	modifier(e1,e2)
Human papillomavirus vaccination should be considered in <e1>selected</e1> <e2>patients</e2> with AIIRD .	modifier(e1,e2)
Olaparib monotherapy should be considered for maintenance treatment after response to platinum for <e1>patients</e1> with relapsed platinum sensitive BRCA mutated ovarian <e2>cancer</e2> .	owner(e1,e2)
Review antibiotic treatment after 14 days and either stop the antibiotic or continue for a further 14 days if needed , based on an assessment of the person's <e1>history</e1> , <e2>symptoms</e2> , clinical examination , urine and blood tests .	joint
Do not offer dedicated brain imaging to people with clinical stage 1 NSCLC who have no neurological symptoms and are having <e1>treatment</e1> with curative <e2>intent</e2> .	other
Patients with hepatitis C virus and concurrent <e1>operable</e1> hepatocellular <e2>carcinoma</e2> should be offered liver transplantation .	modifier(e1,e2)
<e1>Perform</e1> transthoracic echocardiography to exclude important valve disease , <e2>assess</e2> the systolic function of the ventricle , and detect intracardiac shunts .	other
Provide an accessible resource to promote <e1>best</e1> <e2>practice</e2> in the management of patients using medium/high-dose GCs to general practitioners .	modifier(e1,e2)
Anthracycline taxane based chemotherapy combinations should be considered for all <e1>patients</e1> <e2>receiving</e2> neoadjuvant chemotherapy .	actor-of(e1,e2)
If clinical evaluation or lung function testing indicates an inadequate response to rhDNase , consider both rhDNase and hypertonic sodium <e1>chloride</e1> or hypertonic sodium <e2>chloride</e2> alone .	choice
If HbA1c rises to 48 mmol/mol ( 6.5 % ) on lifestyle interventions , <e1>offer</e1> metformin and <e2>support</e2> the person to aim for an HbA1c level of 48 mmol/mol ( 6.5 % ) .	other
A combination of digoxin with either a beta-blocker or <e1>diltiazem</e1> should be <e2>considered</e2> to control heart rate in patients with atrial fibrillation .	modifier(e2,e1)
For people who cannot <e1>tolerate</e1> <e2>aminosalicylates</e2> , consider a time-limited course of a topical or an oral corticosteroid .	acts-on(e1,e2)
All patients with stable angina due to atherosclerotic disease should receive long <e1>term</e1> standard <e2>aspirin</e2> and statin therapy .	modifier(e1,e2)
<e1>Beta-blockers</e1> should be <e2>used</e2> as first line therapy for the relief of symptoms of stable angina .	acts-on(e2,e1)
If dipstick <e1>screening</e1> is <e2>positive</e2> , use albumin:creatinine ratio or protein:creatinine ratio to quantify proteinuria in pregnant women .	modifier(e2,e1)
Patients with AIIRD who plan to travel are recommended to <e1>receive</e1> their <e2>vaccinations</e2> according to general rules , except for live attenuated vaccines which should be avoided whenever possible in immunosuppressed patients with AIIRD .	acts-on(e1,e2)
Support adults with type 1 diabetes to aim for a target HbA1c <e1>level</e1> of <e2>48</e2> mmol/mol ( 6.5 % ) or lower .	modifier(e2,e1)
If the person is aged under 80 years with stage 1 hypertension and has renal disease , <e1>offer</e1> antihypertensive drug <e2>treatment</e2> .	acts-on(e1,e2)
Adjuvant trastuzumab should be considered in all patients with HER 2 positive breast cancer who receive <e1>adjuvant</e1> <e2>chemotherapy</e2> .	modifier(e1,e2)
All <e1>patients</e1> <e2>co-infected</e2> with HIV and HCV genotype 1 should be considered for treatment with a regimen which includes an HCV protease inhibitor .	actor-of(e1,e2)
Monitor for neutropenia in people taking azathioprine or mercaptopurine even if <e1>they</e1> <e2>have</e2> normal TPMT activity .	actor-of(e1,e2)
CVD risk prediction models should be adapted for patients with <e1>RA</e1> by a 1.5 multiplication factor , if <e2>this</e2> is not already included in the model .	other
If the patient is already on an ACE inhibitor , the ACE inhibitor should be stopped for 36 hours before initiating <e1>sacubitril</e1> / <e2>valsartan</e2> to minimise the risk of angioedema .	choice
CVD risk <e1>management</e1> should be <e2>carried</e2> out according to national guidelines in RA , AS or PsA .	acts-on(e2,e1)
<e1>Evaluate</e1> <e2>PET-CT-positive</e2> or enlarged intrathoracic nodes using a systematic approach with EBUS-TBNA and/or EUS-FNA if nodal status would affect the treatment plan .	acts-on(e1,e2)
For <e1>prolonged</e1> <e2>treatment</e2> , the glucocorticoid dosage should be kept to a minimum and a glucocorticoid taper should be attempted in case of remission or low disease activity .	modifier(e1,e2)
If the <e1>person</e1> is aged under 80 years with stage 1 hypertension and <e2>has</e2> 10 year cardiovascular risk , offer antihypertensive drug treatment .	actor-of(e1,e2)
If <e1>conventional</e1> <e2>radiography</e2> is negative , CT should be performed .	modifier(e1,e2)
If an <e1>adult</e1> with type 2 diabetes is symptomatically <e2>hyperglycaemic</e2> , consider insulin or an SU .	modifier(e2,e1)
Consider measuring albumin-adjusted serum calcium for people with chronic <e1>non-differentiated</e1> <e2>symptoms</e2> .	modifier(e1,e2)
<e1>Women</e1> with platinum resistant ovarian cancer should be <e2>considered</e2> for treatment with paclitaxel or single agent pegylated liposomal doxorubicin hydrochloride .	receiver(e1,e2)
In <e1>surgery</e1> for advanced ovarian cancer , the <e2>aim</e2> should be to achieve complete cytoreduction .	other
<e1>Offer</e1> contrast-enhanced brain CT to <e2>people</e2> with clinical stage 2 NSCLC who are having treatment with curative intent .	receiver(e2,e1)
<e1>Offer</e1> antihypertensive drug treatment for an annual <e2>vaccination</e2> against influenza .	other
If an adult with type 2 diabetes is symptomatically hyperglycaemic , <e1>consider</e1> <e2>insulin</e2> or an SU .	acts-on(e1,e2)
Patients with chronic hepatitis B and C co-infection should be considered for treatment with pegylated <e1>IFN</e1> and weight based <e2>ribavirin</e2> .	joint
For <e1>people</e1> who cannot <e2>tolerate</e2> aminosalicylates , consider a time-limited course of a topical or an oral corticosteroid .	actor-of(e1,e2)
Carboplatin AUC 6 and paclitaxel 80 mg/m2 may be <e1>considered</e1> for the <e2>treatment</e2> of first line ovarian cancer .	acts-on(e1,e2)
Offer image-guided biopsy to people with peripheral lung lesions when <e1>treatment</e1> can be <e2>planned</e2> on the basis of this test .	acts-on(e2,e1)
<e1>Consider</e1> thoracic radiotherapy with prophylactic cranial irradiation for <e2>people</e2> with extensive-stage disease SCLC .	receiver(e2,e1)
Consider dual therapy with ACE <e1>inhibitor</e1> and <e2>metformin</e2> if the person is aged under 80 years .	joint
Patients with genotype 1 infection who <e1>fail</e1> to <e2>achieve</e2> an EVR at 12 weeks should be considered for cessation of treatment .	other
<e1>Consider</e1> oral sodium bicarbonate <e2>concentration</e2> of less than 20 mmol/litre .	acts-on(e1,e2)
<e1>Consider</e1> ovarian function <e2>suppression</e2> in addition to endocrine therapy for premenopausal women with ER-positive invasive breast cancer .	acts-on(e1,e2)
Prescribe metformin with caution for those at risk of a sudden deterioration in kidney function and those at risk of eGFR <e1>falling</e1> below 45 <e2>ml/minute/1.73m2</e2> .	modifier(e2,e1)
If the <e1>diagnosis</e1> is still <e2>unclear</e2> , offer CT and EUS with EUS-guided tissue sampling .	modifier(e2,e1)
Erythropoietin is not recommended for patients with heart failure with <e1>reduced</e1> ejection <e2>fraction</e2> and iron deficiency .	modifier(e1,e2)
If further treatment is needed , stop topical treatments and offer an oral aminosalicylate and a time-limited <e1>course</e1> of an oral <e2>corticosteroid</e2> .	other
In patients who have <e1>recovered</e1> from an episode of sustained ventricular <e2>tachycardia</e2> who are not candidates for an ICD , amiodarone or sotalol should be considered .	acts-on(e1,e2)
All patients with stable <e1>angina</e1> due to atherosclerotic <e2>disease</e2> should receive long term standard aspirin and statin therapy .	other
Exclude hypoglycaemia in people with sudden <e1>onset</e1> of neurological <e2>symptoms</e2> as the cause of these symptoms .	other
All patients <e1>co-infected</e1> with HIV and <e2>HCV</e2> genotype 1 should be considered for treatment with a regimen which includes an HCV protease inhibitor .	acts-on(e1,e2)
Do not <e1>routinely</e1> <e2>use</e2> 24-hour urine collection to quantify proteinuria in pregnant women .	modifier(e1,e2)
Offer PET-CT , followed by EBUS-TBNA and/or EUS-FNA , to people with suspected lung cancer who have enlarged intrathoracic lymph nodes and who could potentially have <e1>treatment</e1> with curative <e2>intent</e2> .	other
Conventional radiography of the SI joints and/or spine may be used for long-term monitoring of structural damage , particularly new bone formation , in <e1>axial</e1> <e2>SpA</e2> .	modifier(e1,e2)
Maintain blood <e1>pressure</e1> below 140/90 <e2>mmHg</e2> for people who have symptoms of stage 1 hypertension .	modifier(e2,e1)
<e1>Women</e1> with platinum sensitive relapsed ovarian cancer should be <e2>offered</e2> treatment with carboplatin combined with either paclitaxel or pegylated liposomal doxorubicin hydrochloride .	receiver(e1,e2)
In general , STIR <e1>sequences</e1> are sufficient to detect inflammation and the use of contrast <e2>medium</e2> is not needed .	joint
For <e1>people</e1> who have had pancreatoduodenectomy and who have a functioning gut , <e2>offer</e2> early enteral nutrition rather than parenteral nutrition .	receiver(e1,e2)
Provide an <e1>accessible</e1> <e2>resource</e2> to promote best practice in the management of patients using medium/high-dose GCs to general practitioners .	modifier(e1,e2)
Consider adding azathioprine or <e1>mercaptopurine</e1> to a conventional <e2>glucocorticosteroid</e2> or budesonide to induce remission of Crohn's disease if there are 2 or more inflammatory exacerbations in a 12 month period or the glucocorticosteroid dose cannot be tapered .	other
To induce remission in <e1>people</e1> with a mild-to-moderate first <e2>presentation</e2> or inflammatory exacerbation of extensive ulcerative colitis , offer a topical aminosalicylate and a high-dose oral aminosalicylate as first-line treatment .	owner(e1,e2)
BCG vaccination is not recommended in <e1>patients</e1> with <e2>AIIRD</e2> .	owner(e1,e2)
Perform transthoracic echocardiography to exclude important valve disease , <e1>assess</e1> the systolic <e2>function</e2> of the ventricle , and detect intracardiac shunts .	acts-on(e1,e2)
If remission is not achieved within 4 weeks , consider adding a high-dose <e1>oral</e1> <e2>aminosalicylate</e2> to the topical aminosalicylate or switching to a high-dose oral aminosalicylate and a time-limited course of a topical corticosteroid .	modifier(e1,e2)
<e1>Support</e1> <e2>adults</e2> with type 1 diabetes to aim for a target HbA1c level of 48 mmol/mol ( 6.5 % ) or lower .	acts-on(e1,e2)
Consider budesonide for a first presentation or a single inflammatory exacerbation in a 12-month period for people who <e1>have</e1> one or more of distal <e2>ileal</e2> , ileocaecal or right-sided colonic disease and if conventional glucocorticosteroids are contraindicated , or if the person declines or cannot tolerate them .	acts-on(e1,e2)
If the <e1>person</e1> is aged under 80 years with stage 1 hypertension and has renal disease , <e2>offer</e2> antihypertensive drug treatment .	receiver(e1,e2)
For adults with sudden onset <e1>acute</e1> vestibular <e2>syndrome</e2> , a HINTS test should be performed if a healthcare professional with training and experience in the use of this test is available .	modifier(e1,e2)
Do not offer nitrosoureas concurrently with radiotherapy to people with newly <e1>diagnosed</e1> grade 3 <e2>glioma</e2> .	modifier(e1,e2)
Consider oral sodium bicarbonate supplementation for <e1>people</e1> with both a <e2>GFR</e2> less than 30 ml/min/1.73m2 and a serum bicarbonate concentration of less than 20 mmol/litre .	owner(e1,e2)
When adequate <e1>control</e1> of anginal symptoms is not <e2>achieved</e2> with beta blockade , addition of a calcium channel blocker should be considered .	modifier(e2,e1)
Routine <e1>initiation</e1> of perioperative beta-blocker <e2>therapy</e2> to reduce perioperative myocardial infarction in patients undergoing non cardiac surgery is not recommended .	other
In patients with ankylosing spondylitis , <e1>initial</e1> conventional <e2>radiography</e2> of the lumbar and cervical spine is recommended to detect syndesmophytes , which are predictive of development of new syndesmophytes .	modifier(e1,e2)
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider <e1>dual</e1> <e2>therapy</e2> with metformin and a DPP-4i , metformin and pioglitazone , metformin and an SU , metformin and an SGLT-2i , and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	modifier(e1,e2)
<e1>Patients</e1> with <e2>AIIRD</e2> who plan to travel are recommended to receive their vaccinations according to general rules , except for live attenuated vaccines which should be avoided whenever possible in immunosuppressed patients with AIIRD .	owner(e1,e2)
If the <e1>person</e1> is aged under 80 years with stage 1 <e2>hypertension</e2> and has 10 year cardiovascular risk , offer antihypertensive drug treatment .	owner(e1,e2)
Select the appropriate starting dose to <e1>achieve</e1> therapeutic <e2>response</e2> , taking into account the risk of undertreatment .	acts-on(e1,e2)
Offer contrast-enhanced brain CT to <e1>people</e1> with clinical stage 2 NSCLC who are <e2>having</e2> treatment with curative intent .	actor-of(e1,e2)
Maintain a blood glucose concentration between 4 and 11 mmol/litre in <e1>people</e1> with acute <e2>stroke</e2> .	owner(e1,e2)
Monitor for neutropenia in people <e1>taking</e1> <e2>azathioprine</e2> or mercaptopurine even if they have normal TPMT activity .	acts-on(e1,e2)
Offer an MRA , in addition to an ACE <e1>inhibitor</e1> ( or <e2>ARB</e2> ) and beta-blocker , to people who have heart failure with reduced ejection fraction if they continue to have symptoms of heart failure .	choice
Optimised antidepressant therapy should be considered for the <e1>treatment</e1> of <e2>patients</e2> with chronic pain with moderate depression .	other
<e1>Consider</e1> dual therapy with ACE inhibitor and metformin if the <e2>person</e2> is aged under 80 years .	receiver(e2,e1)
Do not routinely use MRI to assess the stage of the primary tumour (T-stage) in <e1>non-small-cell</e1> lung <e2>cancer</e2> .	modifier(e1,e2)
Offer to carry out a blood test for rheumatoid factor in adults with <e1>suspected</e1> rheumatoid <e2>arthritis</e2> who are found to have synovitis on clinical examination .	modifier(e1,e2)
<e1>Patients</e1> with early stage peripheral lung cancers who are not <e2>suitable</e2> for surgery should be considered for stereotactic ablative radiotherapy .	modifier(e2,e1)
Do not <e1>use</e1> anticoagulation <e2>treatment</e2> routinely for the treatment of acute stroke .	acts-on(e1,e2)
Disease activity should be controlled optimally in order to lower CVD risk in all patients with <e1>RA</e1> , <e2>AS</e2> or PsA .	choice
<e1>Systemic</e1> <e2>glucocorticoids</e2> may be used with caution at the lowest effective dose .	modifier(e1,e2)
For people with an acute cough who are identified at a <e1>face-to-face</e1> clinical <e2>examination</e2> as at higher risk of complications , consider an immediate antibiotic prescription or a back-up antibiotic prescription .	modifier(e1,e2)
To induce remission in people with a mild-to-moderate first presentation or inflammatory exacerbation of <e1>extensive</e1> ulcerative <e2>colitis</e2> , offer a topical aminosalicylate and a high-dose oral aminosalicylate as first-line treatment .	modifier(e1,e2)
In <e1>hyposplenic/asplenic</e1> <e2>patients</e2> with AIIRD influenza , pneumococcal , Haemophilus influenzae b and meningococcal C , vaccinations are recommended .	modifier(e1,e2)
For people who cannot tolerate aminosalicylates , consider a time-limited course of a topical or an <e1>oral</e1> <e2>corticosteroid</e2> .	modifier(e1,e2)
The decision on when to repeat MRI depends on the <e1>clinical</e1> <e2>circumstances</e2> .	modifier(e1,e2)
For women with a cerebrovascular malformation at low risk of intracranial bleeding , base decisions on the mode of birth on the <e1>woman's</e1> <e2>preference</e2> and obstetric indications .	modifier(e1,e2)
Consider alpha blockers for adults , <e1>children</e1> and young <e2>people</e2> with distal ureteric stones less than 10 mm .	joint
In patients being considered for active therapy , pleural effusion should be investigated with <e1>pleural</e1> <e2>aspiration</e2> and/or pleural biopsy using image-guided or thoracoscopic biopsy .	modifier(e1,e2)
Olaparib <e1>monotherapy</e1> should be <e2>considered</e2> for maintenance treatment after response to platinum for patients with relapsed platinum sensitive BRCA mutated ovarian cancer .	acts-on(e2,e1)
Do not <e1>use</e1> first morning urine <e2>void</e2> to quantify proteinuria in pregnant women .	acts-on(e1,e2)
Offer bisphosphonates as adjuvant therapy to postmenopausal <e1>women</e1> with node-positive invasive breast <e2>cancer</e2> .	owner(e1,e2)
Erythropoietin is not <e1>recommended</e1> for <e2>patients</e2> with heart failure with reduced ejection fraction and iron deficiency .	receiver(e2,e1)
Consider adding intravenous ciclosporin to intravenous corticosteroids or consider surgery for people who <e1>have</e1> little or no <e2>improvement</e2> within 72 hours of starting intravenous corticosteroids or whose symptoms worsen at any time despite corticosteroid treatment .	acts-on(e1,e2)
Offer systemic combination chemotherapy to people with locally advanced pancreatic cancer who are well enough to <e1>tolerate</e1> <e2>it</e2> .	acts-on(e1,e2)
Offer systemic combination chemotherapy to people with locally <e1>advanced</e1> pancreatic <e2>cancer</e2> who are well enough to tolerate it .	modifier(e1,e2)
<e1>Assess</e1> the HER2 status of all invasive breast cancers using standardised and quality-assured techniques , and <e2>report</e2> the results quantitatively .	other
<e1>Antihypertensives</e1> and <e2>statins</e2> may be used as in the general population .	joint
Patients with AF who remain severely <e1>symptomatic</e1> despite adequate rate <e2>control</e2> should be considered for rhythm control or for stricter rate control if their heart rate remains 80-110 bpm at rest .	other
Pregabalin is recommended for the treatment of <e1>patients</e1> with <e2>fibromyalgia</e2> .	owner(e1,e2)
If <e1>SABR</e1> is <e2>contraindicated</e2> , offer either conventional or hyperfractionated radiotherapy .	modifier(e2,e1)
<e1>Carbamazepine</e1> should be <e2>considered</e2> for the treatment of patients with neuropathic pain .	acts-on(e2,e1)
All <e1>women</e1> with high grade early stage ovarian cancer should be <e2>considered</e2> for adjuvant chemotherapy .	receiver(e1,e2)
If HbA1c <e1>rises</e1> to <e2>58</e2> mmol/mol ( 7.5 % ) , consider insulin-based treatment and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	modifier(e2,e1)
<e1>Use</e1> nasal cannula or incubator oxygen for preterm <e2>babies</e2> who need supplemental oxygen .	receiver(e2,e1)
Consider thoracic radiotherapy with prophylactic cranial irradiation for <e1>people</e1> with extensive-stage disease <e2>SCLC</e2> .	owner(e1,e2)
Amiodarone may be used when <e1>prophylaxis</e1> for atrial fibrillation and ventricular <e2>arrhythmias</e2> is indicated following CABG surgery .	modifier(e2,e1)
Consider adding intravenous ciclosporin to intravenous corticosteroids or consider surgery for people who have little or no improvement within 72 hours of starting intravenous corticosteroids or whose <e1>symptoms</e1> <e2>worsen</e2> at any time despite corticosteroid treatment .	modifier(e2,e1)
Do not offer a mucolytic to treat an acute cough associated with an upper respiratory tract infection or <e1>acute</e1> <e2>bronchitis</e2> .	modifier(e1,e2)
If the <e1>person</e1> is aged under 80 years with stage 1 <e2>hypertension</e2> and has diabetes , offer antihypertensive drug treatment .	owner(e1,e2)
For people with an acute cough who are identified at a face-to-face clinical examination as at higher risk of complications , <e1>consider</e1> an immediate antibiotic prescription or a back-up antibiotic <e2>prescription</e2> .	acts-on(e1,e2)
Consider ovarian function suppression in addition to endocrine therapy for premenopausal women with ER-positive <e1>invasive</e1> breast <e2>cancer</e2> .	modifier(e1,e2)
Consider prostaglandin E1 or prostaglandin E2 as options for inducing <e1>labour</e1> in <e2>women</e2> with asthma because there is no evidence that they worsen asthma .	owner(e2,e1)
<e1>Patients</e1> with , or at risk of , GC-induced osteoporosis should <e2>receive</e2> appropriate preventive/therapeutic interventions .	receiver(e1,e2)
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider dual therapy with a DPP-4i and pioglitazone , a DPP-4i and an SU , pioglitazone and an SU , and support the person to <e1>aim</e1> for an HbA1c <e2>level</e2> of 53 mmol/mol ( 7 % ) .	acts-on(e1,e2)
<e1>Consider</e1> prostaglandin <e2>E1</e2> as an option for treating postpartum haemorrhage in women with asthma because there is no evidence it worsens asthma .	acts-on(e1,e2)
In patients with stable angina requiring percutaneous coronary intervention for in stent restenosis , a drug eluting <e1>balloon</e1> or a <e2>second</e2> or third generation drug eluting stent should be considered .	choice
If remission is not achieved within 4 weeks , stop the topical aminosalicylate and offer a high-dose <e1>oral</e1> <e2>aminosalicylate</e2> with a time-limited course of an oral corticosteroid .	modifier(e1,e2)
<e1>Offer</e1> to carry out a blood test for rheumatoid factor in <e2>adults</e2> with suspected rheumatoid arthritis who are found to have synovitis on clinical examination .	receiver(e2,e1)
Offer urgent ultrasound as first-line imaging for children and <e1>young</e1> <e2>people</e2> with suspected renal colic .	modifier(e1,e2)
When adequate control of anginal symptoms is not <e1>achieved</e1> with beta <e2>blockade</e2> , addition of a calcium channel blocker should be considered .	other
<e1>Women</e1> with platinum resistant relapsed ovarian cancer should be <e2>offered</e2> bevacizumab in combination with paclitaxel .	receiver(e1,e2)
The <e1>decision</e1> on when to repeat US/MRI <e2>depends</e2> on the clinical circumstances .	actor-of(e1,e2)
The decision on when to repeat US/MRI <e1>depends</e1> on the clinical <e2>circumstances</e2> .	acts-on(e1,e2)
Measure serum calcium for people who <e1>develop</e1> a pancreatic cancer <e2>resection</e2> .	acts-on(e1,e2)
For <e1>people</e1> with an acute cough who are identified at a face-to-face clinical examination as at higher risk of complications , <e2>consider</e2> an immediate antibiotic prescription or a back-up antibiotic prescription .	receiver(e1,e2)
Offer bisphosphonates as adjuvant therapy to <e1>postmenopausal</e1> <e2>women</e2> with node-positive invasive breast cancer .	modifier(e1,e2)
<e1>Patients</e1> with larger tumours may be <e2>considered</e2> for oncoplastic surgery instead of mastectomy .	receiver(e1,e2)
If the person is symptomatically hyperglycaemic , <e1>consider</e1> <e2>insulin</e2> or an SU .	acts-on(e1,e2)
Erythropoietin is not recommended for <e1>patients</e1> with heart failure with reduced ejection <e2>fraction</e2> and iron deficiency .	owner(e1,e2)
Gabapentin should be considered for the <e1>treatment</e1> of <e2>patients</e2> with neuropathic pain .	other
A chest X-ray should be <e1>performed</e1> on all <e2>patients</e2> being investigated for the possibility of lung cancer .	receiver(e2,e1)
Consider an <e1>ARB</e1> licensed for heart <e2>failure</e2> as an alternative to an ACE inhibitor for people who have heart failure with reduced ejection fraction and intolerable side effects with ACE inhibitors .	other
Maintain blood <e1>pressure</e1> <e2>below</e2> 130/80 mmHg by addition of other anti-hypertensive drugs if necessary .	modifier(e2,e1)
When peripheral SpA is suspected , US or <e1>MRI</e1> may be <e2>used</e2> to detect peripheral enthesitis , which may support the diagnosis of SpA .	modifier(e2,e1)
Furthermore , US or MRI might be used to detect peripheral <e1>arthritis</e1> , <e2>tenosynovitis</e2> and bursitis .	joint
Do not <e1>offer</e1> <e2>azathioprine</e2> , mercaptopurine or methotrexate as monotherapy to induce remission .	acts-on(e1,e2)
TC and HDLc should be used in CVD risk assessment in RA , AS and PsA and lipids should ideally be measured when disease <e1>activity</e1> is <e2>stable</e2> or in remission .	modifier(e2,e1)
Consider aminosalicylate treatment for a <e1>first</e1> <e2>presentation</e2> or a single inflammatory exacerbation in a 12-month period if conventional glucocorticosteroids are contraindicated , or if the person declines or cannot tolerate them .	modifier(e1,e2)
<e1>Offer</e1> enteric-coated pancreatin to <e2>people</e2> with unresectable pancreatic cancer .	receiver(e2,e1)
Do not offer budesonide or aminosalicylate <e1>treatment</e1> for severe <e2>presentations</e2> or exacerbations .	other
If the clinic blood pressure is 140/90 mmHg or higher , <e1>offer</e1> ABPM to <e2>confirm</e2> the diagnosis of hypertension .	other
Screening for asymptomatic atherosclerotic plaques by use of carotid ultrasound may be considered as part of the CVD risk evaluation in <e1>patients</e1> with <e2>RA</e2> .	owner(e1,e2)
Keep the requirement for continuing GC treatment under constant review , and titrate the dose against therapeutic <e1>response</e1> , <e2>risk</e2> of undertreatment and development of AEs .	joint
The <e1>routine</e1> <e2>use</e2> of aspirin to reduce perioperative cardiac events in patients undergoing non cardiac surgery , including those with known stable CAD , is not recommended .	modifier(e1,e2)
In patients with peripheral arthritis and an inadequate response to at least one csDMARD , in whom TNF <e1>inhibitors</e1> are not <e2>appropriate</e2> , bDMARDs targeting IL12/23 or IL17 pathways may be considered .	modifier(e2,e1)
<e1>Pregabalin</e1> is <e2>recommended</e2> for the treatment of patients with neuropathic pain if other first and second line pharmacological treatments have failed .	modifier(e2,e1)
All patients should have <e1>appropriate</e1> <e2>monitoring</e2> for clinically significant AEs .	modifier(e1,e2)
All <e1>patients</e1> with chronic HCV <e2>infection</e2> should be considered for antiviral therapy .	owner(e1,e2)
<e1>Consider</e1> dual <e2>therapy</e2> with ACE inhibitor and metformin if the person is aged under 80 years .	acts-on(e1,e2)
<e1>Consider</e1> bisphosphonates as adjuvant therapy for postmenopausal <e2>women</e2> with node-negative invasive breast cancer and a high risk of recurrence .	receiver(e2,e1)
If SABR is contraindicated , <e1>offer</e1> either conventional or hyperfractionated <e2>radiotherapy</e2> .	acts-on(e1,e2)
If the person is with CKD and an ACR of 70 mg/mmol or more , offer a low-cost <e1>renin-angiotensin-aldosterone</e1> system <e2>antagonist</e2> .	modifier(e1,e2)
Short-term GC should be considered when initiating or changing csDMARDs , in different dose regimens and routes of administration , but should be <e1>tapered</e1> as <e2>rapidly</e2> as clinically feasible .	modifier(e2,e1)
Patients with an ST segment elevation acute coronary syndrome should be treated immediately with <e1>primary</e1> percutaneous coronary <e2>intervention</e2> .	modifier(e1,e2)
If the person is with <e1>CKD</e1> and <e2>diabetes</e2> and an ACR of 3 mg/mmol or more , offer a low-cost renin-angiotensin-aldosterone system antagonist .	joint
Select the appropriate starting dose to achieve therapeutic response , <e1>taking</e1> into account the <e2>risk</e2> of undertreatment .	acts-on(e1,e2)
If remission is not achieved within 4 weeks , stop the topical aminosalicylate and offer a high-dose oral <e1>aminosalicylate</e1> with a time-limited <e2>course</e2> of an oral corticosteroid .	other
Offer intravenous paracetamol to adults , <e1>children</e1> and young <e2>people</e2> with suspected renal colic if NSAIDs are contraindicated or are not giving sufficient pain relief .	joint
<e1>Offer</e1> a non-steroidal anti-inflammatory drug by any route as first-line treatment for <e2>adults</e2> , children and young people with suspected renal colic .	receiver(e2,e1)
<e1>Consider</e1> adding intravenous <e2>ciclosporin</e2> to intravenous corticosteroids or consider surgery for people who have little or no improvement within 72 hours of starting intravenous corticosteroids or whose symptoms worsen at any time despite corticosteroid treatment .	acts-on(e1,e2)
Do not <e1>offer</e1> azathioprine , mercaptopurine or <e2>methotrexate</e2> as monotherapy to induce remission .	acts-on(e1,e2)
<e1>Maintain</e1> a blood glucose <e2>concentration</e2> between 4 and 11 mmol/litre in people with acute stroke .	acts-on(e1,e2)
Second line systemic anticancer therapy with single agent docetaxel or erlotinib should be considered for <e1>patients</e1> with performance status 0-2 recurrent <e2>NSCLC</e2> who have been previously treated with first line SACT for advanced disease .	owner(e1,e2)
If <e1>remission</e1> is not <e2>achieved</e2> within 4 weeks , consider adding an oral aminosalicylate .	modifier(e2,e1)
If the <e1>clinic</e1> blood <e2>pressure</e2> is below 150/90 mmHg , offer other anti-hypertensive drugs .	modifier(e1,e2)
Do not use fish oils as a nutritional intervention to manage weight loss in <e1>people</e1> with unresectable pancreatic <e2>cancer</e2> .	owner(e1,e2)
TC and HDLc should be used in CVD risk <e1>assessment</e1> in <e2>RA</e2> , AS and PsA and lipids should ideally be measured when disease activity is stable or in remission .	other
Women with platinum sensitive relapsed ovarian cancer should be offered treatment with <e1>carboplatin</e1> combined with either <e2>paclitaxel</e2> or pegylated liposomal doxorubicin hydrochloride .	other
If a bDMARD or <e1>tsDMARD</e1> has <e2>failed</e2> , treatment with another bDMARD or a tsDMARD should be considered .	modifier(e2,e1)
All women with non-mucinous ovarian or fallopian tube cancer should be offered <e1>BRCA1</e1> and BRCA2 mutation <e2>testing</e2> .	joint
Consider <e1>azathioprine</e1> or <e2>mercaptopurine</e2> at a lower dose if TPMT activity is below normal but not deficient .	choice
Consider an ARB licensed for heart failure as an <e1>alternative</e1> to an ACE <e2>inhibitor</e2> for people who have heart failure with reduced ejection fraction and intolerable side effects with ACE inhibitors .	other
<e1>Offer</e1> <e2>radiotherapy</e2> using 40 Gy in 15 fractions with concomitant and up to 12 cycles of adjuvant temozolomide for people aged around 70 or over .	acts-on(e1,e2)
Herpes zoster vaccination may be <e1>considered</e1> in <e2>patients</e2> with AIIRD .	receiver(e2,e1)
Beta-blockers should be <e1>used</e1> as first line <e2>therapy</e2> for the relief of symptoms of stable angina .	other
All <e1>patients</e1> with stable <e2>angina</e2> should be considered for treatment with angiotensin converting enzyme inhibitors .	owner(e1,e2)
Offer PET-CT , followed by <e1>EBUS-TBNA</e1> and/or <e2>EUS-FNA</e2> , to people with suspected lung cancer who have enlarged intrathoracic lymph nodes and who could potentially have treatment with curative intent .	joint
If the person is with CKD and <e1>diabetes</e1> and an <e2>ACR</e2> of 3 mg/mmol or more , offer a low-cost renin-angiotensin-aldosterone system antagonist .	joint
Routine initiation of perioperative beta-blocker therapy to reduce perioperative myocardial infarction in patients <e1>undergoing</e1> non cardiac <e2>surgery</e2> is not recommended .	acts-on(e1,e2)
Do not use synchronised pressure-limited ventilation such as assist control , synchronised intermittent positive pressure <e1>ventilation</e1> , patient-triggered <e2>ventilation</e2> , pressure support ventilation or synchronised time-cycled pressure-limited ventilation .	choice
Vaccination in patients with AIIRD can be administered during the use of disease-modifying antirheumatic drugs and tumour necrosis <e1>factor</e1> alpha blocking <e2>agents</e2> but should ideally be administered before starting B cell depleting biological therapy .	modifier(e1,e2)
Offer PET-CT as the preferred first test after CT with a <e1>low</e1> <e2>probability</e2> of nodal malignancy , for people with lung cancer who could potentially have treatment with curative intent .	modifier(e1,e2)
<e1>Measure</e1> serum calcium for <e2>adults</e2> with ureteric or renal stones .	receiver(e2,e1)
Keep the requirement for continuing GC treatment under constant review , and titrate the dose against therapeutic response , risk of undertreatment and <e1>development</e1> of <e2>AEs</e2> .	other
In patients with peripheral arthritis and an inadequate <e1>response</e1> to at least one <e2>csDMARD</e2> , in whom TNF inhibitors are not appropriate , bDMARDs targeting IL12/23 or IL17 pathways may be considered .	other
Consider opioids for adults , children and young people with <e1>suspected</e1> renal <e2>colic</e2> if both NSAIDs and intravenous paracetamol are contraindicated or are not giving sufficient pain relief .	modifier(e1,e2)
If a patient is in persistent remission after having <e1>tapered</e1> <e2>GC</e2> , one can consider tapering bDMARDs , especially if this treatment is combined with a csDMARD .	modifier(e1,e2)
<e1>Patients</e1> with heart failure and clinical signs or symptoms of fluid overload or congestion should be <e2>considered</e2> for diuretic therapy .	modifier(e2,e1)
Start ACE inhibitor therapy at a low dose and titrate upwards at short intervals until the target or maximum <e1>tolerated</e1> <e2>dose</e2> is reached .	modifier(e1,e2)
For preterm <e1>babies</e1> who <e2>need</e2> invasive ventilation , use volume-targeted ventilation in combination with synchronised ventilation as the primary mode of respiratory support .	actor-of(e1,e2)
In case of <e1>major</e1> and/or <e2>contaminated</e2> wounds in patients who received rituximab within the last 24 weeks , passive immunisation with tetanus immunoglobulins should be administered .	joint
<e1>Measure</e1> N-terminal pro-B-type natriuretic <e2>peptide</e2> in people with suspected heart failure .	acts-on(e1,e2)
<e1>Patients</e1> with NSCLC stage 1 and 2 who are medically <e2>inoperable</e2> or who do not consent to surgery should be offered radical radiotherapy .	modifier(e2,e1)
Patients with AIIRD who plan to travel are recommended to receive their vaccinations according to <e1>general</e1> <e2>rules</e2> , except for live attenuated vaccines which should be avoided whenever possible in immunosuppressed patients with AIIRD .	modifier(e1,e2)
If HbA1c rises to 48 mmol/mol ( 6.5 % ) on lifestyle interventions , <e1>consider</e1> a <e2>DPP-4i</e2> , pioglitazone , an SU , an SGLT-2i , and support the person to aim for an HbA1c level of 48 mmol/mol ( 6.5 % ) for people on a DPP-4i , SGLT-2i or pioglitazone or 53 mmol/mol ( 7 % ) for people on an SU .	acts-on(e1,e2)
Ensure that <e1>people</e1> with disabling ischaemic <e2>stroke</e2> who are in atrial fibrillation are treated with aspirin 300 mg for the first 2 weeks before anticoagulation treatment is considered .	owner(e1,e2)
If a <e1>woman</e1> is pregnant , <e2>offer</e2> ultrasound instead of CT .	receiver(e1,e2)
Offer a non-steroidal anti-inflammatory drug by any route as <e1>first-line</e1> <e2>treatment</e2> for adults , children and young people with suspected renal colic .	modifier(e1,e2)
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , <e1>consider</e1> dual <e2>therapy</e2> with metformin and a DPP-4i , metformin and pioglitazone , metformin and an SU , metformin and an SGLT-2i , and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	acts-on(e1,e2)
Offer staging laparoscopy to all people with potentially <e1>curable</e1> gastric <e2>cancer</e2> .	modifier(e1,e2)
Patients with <e1>AIIRD</e1> who plan to <e2>travel</e2> are recommended to receive their vaccinations according to general rules , except for live attenuated vaccines which should be avoided whenever possible in immunosuppressed patients with AIIRD .	actor-of(e1,e2)
If the patient is already on an ACE inhibitor , the ACE inhibitor should be stopped for 36 hours before initiating sacubitril / valsartan to <e1>minimise</e1> the <e2>risk</e2> of angioedema .	acts-on(e1,e2)
If the person is symptomatically hyperglycaemic , offer antispasmodics to have HbA1c <e1>level</e1> of <e2>53</e2> mmol/mol ( 7.5 % ) .	modifier(e2,e1)
Do not offer cinacalcet to pregnant women with <e1>primary</e1> <e2>hyperparathyroidism</e2> .	modifier(e1,e2)
<e1>Patients</e1> with heart failure with reduced ejection fraction , NYHA class 2-4 , who are intolerant of angiotensin converting enzyme inhibitors should be <e2>given</e2> an angiotensin receptor blocker .	receiver(e1,e2)
<e1>Patients</e1> with <e2>stage</e2> 1 and 2 NSCLC should be considered for curative surgery whenever possible .	owner(e1,e2)
<e1>Patients</e1> with heart failure with reduced ejection fraction , NYHA class 2-4 , who are <e2>intolerant</e2> of angiotensin converting enzyme inhibitors should be given an angiotensin receptor blocker .	modifier(e2,e1)
In <e1>patients</e1> with peripheral arthritis and an inadequate <e2>response</e2> to at least one csDMARD , in whom TNF inhibitors are not appropriate , bDMARDs targeting IL12/23 or IL17 pathways may be considered .	owner(e1,e2)
In patients with predominantly axial disease that is active and <e1>has</e1> insufficient <e2>response</e2> to NSAIDs , therapy with a bDMARD should be considered , which according to current practice is a TNF inhibitor .	acts-on(e1,e2)
If the <e1>person</e1> is symptomatically hyperglycaemic , <e2>consider</e2> insulin or an SU .	receiver(e1,e2)
Aim for a target clinic blood <e1>pressure</e1> <e2>below</e2> 140/90 mmHg in people aged under 80 years with treated hypertension .	modifier(e2,e1)
Do not offer <e1>platinum-based</e1> combination <e2>chemotherapy</e2> to obtain a serum calcium for people with extensive-stage disease SCLC if they are fit enough .	modifier(e1,e2)
CVD risk assessment is recommended for all patients with RA , AS or PsA at least once every 5 years and should be reconsidered following major <e1>changes</e1> in antirheumatic <e2>therapy</e2> .	other
If HbA1c rises to 58 mmol/mol ( 7 % ) , <e1>consider</e1> <e2>HBPM</e2> if the person has diabetes .	acts-on(e1,e2)
<e1>Patients</e1> with genotype 1 <e2>infection</e2> who fail to achieve an EVR at 12 weeks should be considered for cessation of treatment .	owner(e1,e2)
CVD risk management should be carried out according to national guidelines in <e1>RA</e1> , <e2>AS</e2> or PsA .	choice
Short-term GC should be considered when initiating or changing csDMARDs , in different dose regimens and routes of administration , but should be tapered as <e1>rapidly</e1> as clinically <e2>feasible</e2> .	other
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider insulin-based treatment and support the <e1>person</e1> to <e2>aim</e2> for an HbA1c level of 53 mmol/mol ( 7 % ) .	actor-of(e1,e2)
The routine <e1>use</e1> of <e2>aspirin</e2> to reduce perioperative cardiac events in patients undergoing non cardiac surgery , including those with known stable CAD , is not recommended .	other
Fluoxetine should be <e1>considered</e1> for the <e2>treatment</e2> of patients with fibromyalgia .	other
Patients with early stage peripheral lung cancers who are not suitable for surgery should be <e1>considered</e1> for stereotactic ablative <e2>radiotherapy</e2> .	other
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider triple therapy with metformin and a DPP-4i and an SU , <e1>metformin</e1> and <e2>pioglitazone</e2> and an SU , metformin and pioglitazone and an SGLT-2i , metformin and an SU and an SGLT-2i , insulin-based treatment , and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	joint
All <e1>patients</e1> with invasive breast cancer who are <e2>operable</e2> should have axillary surgery .	modifier(e2,e1)
Women with stage 4 ovarian cancer should be offered bevacizumab in combination with <e1>carboplatin</e1> and <e2>paclitaxel</e2> .	joint
<e1>Consider</e1> measuring anti-CCP <e2>antibodies</e2> in adults with suspected RA if they are negative for rheumatoid factor .	acts-on(e1,e2)
Consider adjuvant <e1>therapy</e1> after <e2>surgery</e2> for people with invasive breast cancer , and ensure that recommendations are recorded at the multidisciplinary team meeting .	other
MRI of the SI joints and/or the spine may be used to assess and monitor disease activity in axial SpA , providing additional information on top of <e1>clinical</e1> and <e2>biochemical</e2> assessments .	joint
Duloxetine should be considered for the treatment of patients with <e1>fibromyalgia</e1> or <e2>osteoarthritis</e2> .	choice
Offer standard structural MRI as the initial diagnostic test for <e1>suspected</e1> <e2>glioma</e2> , unless MRI is contraindicated .	modifier(e1,e2)
In patients with peripheral arthritis , particularly in those with many swollen joints , structural damage in the presence of inflammation , high ESR/CRP and/or clinically relevant extra-articular manifestations , csDMARDs should be considered at an early stage , with methotrexate preferred in those with <e1>relevant</e1> skin <e2>involvement</e2> .	modifier(e1,e2)
<e1>Assess</e1> the ER <e2>status</e2> of all invasive breast cancers using standardised and quality-assured immunohistochemical techniques , and report the results quantitatively .	acts-on(e1,e2)
Do not offer budesonide or aminosalicylate treatment for severe <e1>presentations</e1> or <e2>exacerbations</e2> .	choice
Patients with , or at risk of , <e1>GC-induced</e1> <e2>osteoporosis</e2> should receive appropriate preventive/therapeutic interventions .	modifier(e1,e2)
Second line systemic anticancer therapy with single agent docetaxel or erlotinib should be <e1>considered</e1> for <e2>patients</e2> with performance status 0-2 recurrent NSCLC who have been previously treated with first line SACT for advanced disease .	receiver(e2,e1)
To induce remission in people with a mild-to-moderate first <e1>presentation</e1> or inflammatory <e2>exacerbation</e2> of proctosigmoiditis or left-sided ulcerative colitis , offer a topical aminosalicylate as first-line treatment .	choice
<e1>Offer</e1> <e2>people</e2> who present with superior vena cava obstruction chemotherapy and radiotherapy according to the stage of disease and performance status .	acts-on(e1,e2)
Patients with lung cancer who <e1>have</e1> symptomatic bone <e2>metastases</e2> should be considered for treatment with a bisphosphonate .	acts-on(e1,e2)
Consider <e1>radiotherapy</e1> <e2>using</e2> 40 Gy in 15 fractions with concomitant and up to 12 cycles of adjuvant temozolomide for people aged around 70 or over .	actor-of(e1,e2)
<e1>Offer</e1> contrast-enhanced brain <e2>CT</e2> to people with clinical stage 2 NSCLC who are having treatment with curative intent .	acts-on(e1,e2)
Long term <e1>beta-blockers</e1> are <e2>recommended</e2> for routine use in patients following ACS without contraindications .	acts-on(e2,e1)
Treatment should be aimed at reaching the target of remission or , alternatively , <e1>minimal/low</e1> disease <e2>activity</e2> , by regular monitoring and appropriate adjustment of therapy .	modifier(e1,e2)
Consider oral sodium bicarbonate supplementation for people with both a GFR <e1>less</e1> than <e2>30</e2> ml/min/1.73m2 and a serum bicarbonate concentration of less than 20 mmol/litre .	modifier(e1,e2)
Women with stage 4 ovarian cancer should be offered <e1>bevacizumab</e1> in combination with <e2>carboplatin</e2> and paclitaxel .	joint
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , <e1>consider</e1> dual <e2>therapy</e2> with a DPP-4i and pioglitazone , a DPP-4i and an SU , pioglitazone and an SU , and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	acts-on(e1,e2)
Do not offer <e1>antihypertensive</e1> drug <e2>treatment</e2> if the person is with type 1 diabetes .	modifier(e1,e2)
Optimised antidepressant <e1>therapy</e1> should be <e2>considered</e2> for the treatment of patients with chronic pain with moderate depression .	acts-on(e2,e1)
If the <e1>person</e1> is aged under 80 years with stage 1 hypertension and has established cardiovascular disease , <e2>offer</e2> antihypertensive drug treatment .	receiver(e1,e2)
Start a <e1>trial</e1> of a renin-angiotensin system blocking <e2>drug</e2> as first-line therapy for hypertension in adults with type 1 diabetes .	other
Perform transthoracic echocardiography to exclude important valve disease , assess the systolic <e1>function</e1> of the <e2>ventricle</e2> , and detect intracardiac shunts .	other
<e1>Consider</e1> prostaglandin E1 or prostaglandin <e2>E2</e2> as options for inducing labour in women with asthma because there is no evidence that they worsen asthma .	acts-on(e1,e2)
Patients with AF who remain severely symptomatic despite adequate rate control should be <e1>considered</e1> for rhythm <e2>control</e2> or for stricter rate control if their heart rate remains 80-110 bpm at rest .	acts-on(e1,e2)
If the treatment target is not achieved with the first csDMARD strategy , in the absence of <e1>poor</e1> prognostic <e2>factors</e2> , other csDMARDs should be considered .	modifier(e1,e2)
Offer enteric-coated pancreatin to people with <e1>unresectable</e1> pancreatic <e2>cancer</e2> .	modifier(e1,e2)
Provide an accessible resource to promote best practice in the management of patients using <e1>medium/high-dose</e1> <e2>GCs</e2> to general practitioners .	modifier(e1,e2)
For <e1>people</e1> with an acute <e2>cough</e2> who are identified at a face-to-face clinical examination as systemically very unwell , offer an immediate antibiotic prescription .	owner(e1,e2)
In patients with peripheral arthritis , particularly in those with many swollen joints , <e1>structural</e1> <e2>damage</e2> in the presence of inflammation , high ESR/CRP and/or clinically relevant extra-articular manifestations , csDMARDs should be considered at an early stage , with methotrexate preferred in those with relevant skin involvement .	modifier(e1,e2)
<e1>Avoid</e1> <e2>verapamil</e2> , diltiazem and short-acting dihydropyridine agents in people who have heart failure with reduced ejection fraction .	acts-on(e1,e2)
Use caffeine citrate routinely in <e1>preterm</e1> <e2>babies</e2> born at or before 30 weeks , starting it as early as possible and ideally before 3 days of age .	modifier(e1,e2)
<e1>Offer</e1> an MRA , in addition to an ACE inhibitor ( or ARB ) and beta-blocker , to <e2>people</e2> who have heart failure with reduced ejection fraction if they continue to have symptoms of heart failure .	receiver(e2,e1)
For <e1>women</e1> with a cerebrovascular malformation at low risk of intracranial bleeding , <e2>manage</e2> the second stage of labour based on the woman's preference and obstetric indications .	receiver(e1,e2)
Offer a proton pump inhibitor , in addition to aspirin , to <e1>anyone</e1> with acute ischaemic <e2>stroke</e2> for whom previous dyspepsia associated with aspirin is reported .	owner(e1,e2)
Consider azathioprine or mercaptopurine at a <e1>lower</e1> <e2>dose</e2> if TPMT activity is below normal but not deficient .	modifier(e1,e2)
For people with stage 1-2A NSCLC who <e1>decline</e1> <e2>surgery</e2> or in whom any surgery is contraindicated , offer SABR .	acts-on(e1,e2)
If the treatment target is not achieved with the first csDMARD strategy , in the absence of poor prognostic factors , <e1>other</e1> <e2>csDMARDs</e2> should be considered .	modifier(e1,e2)
Patients with HCV <e1>associated</e1> chronic liver <e2>failure</e2> should be considered for assessment for liver transplantation .	modifier(e1,e2)
Duloxetine should be <e1>considered</e1> for the <e2>treatment</e2> of patients with diabetic neuropathic pain if other first or second line pharmacological therapies have failed .	other
For preterm <e1>babies</e1> who need invasive ventilation but VTV and HFOV are not available or not suitable , <e2>consider</e2> synchronised intermittent mandatory ventilation .	receiver(e1,e2)
Perform transthoracic echocardiography to exclude important valve disease , assess the systolic function of the ventricle , and detect <e1>intracardiac</e1> <e2>shunts</e2> .	modifier(e1,e2)
<e1>Offer</e1> <e2>bisphosphonates</e2> as adjuvant therapy to postmenopausal women with node-positive invasive breast cancer .	acts-on(e1,e2)
Do not offer bisphosphonates for chronic hypercalcaemia of <e1>primary</e1> <e2>hyperparathyroidism</e2> .	modifier(e1,e2)
If cytological or histological samples are needed , offer EUS with <e1>EUS-guided</e1> tissue <e2>sampling</e2> .	modifier(e1,e2)
In general , STIR <e1>sequences</e1> are <e2>sufficient</e2> to detect inflammation and the use of contrast medium is not needed .	modifier(e2,e1)
CVD risk estimation for patients with RA , AS or PsA should be performed according to national guidelines and the SCORE CVD risk prediction model should be used if no national <e1>guideline</e1> is <e2>available</e2> .	modifier(e2,e1)
Do not offer an antibiotic to treat an acute cough associated with an upper respiratory tract infection in people who are not systemically very unwell or at <e1>higher</e1> <e2>risk</e2> of complications .	modifier(e1,e2)
<e1>Exclude</e1> <e2>hypoglycaemia</e2> in people with sudden onset of neurological symptoms as the cause of these symptoms .	acts-on(e1,e2)
Start a trial of a renin-angiotensin system blocking drug as first-line <e1>therapy</e1> for <e2>hypertension</e2> in adults with type 1 diabetes .	other
Offer chemotherapy <e1>before</e1> and <e2>after</e2> surgery to people with gastric cancer who are having radical surgical resection .	joint
Pregabalin is recommended for the treatment of patients with neuropathic pain if other <e1>first</e1> and second <e2>line</e2> pharmacological treatments have failed .	joint
If the treatment target is not <e1>achieved</e1> with the first csDMARD <e2>strategy</e2> , in the absence of poor prognostic factors , other csDMARDs should be considered .	other
Give oral antibiotics first line if the person can take <e1>oral</e1> <e2>medicines</e2> , and the severity of their condition does not require intravenous antibiotics .	modifier(e1,e2)
Patients with suspected <e1>T3</e1> or T4 <e2>disease</e2> who are otherwise fit for surgery should not be denied surgical exploration on the basis of a CT scan alone .	choice
For people who cannot tolerate aminosalicylates , consider a time-limited <e1>course</e1> of a topical or an oral <e2>corticosteroid</e2> .	other
Consider budesonide for a first presentation or a single inflammatory exacerbation in a 12-month period for people who have one or more of distal ileal , ileocaecal or right-sided colonic disease and if conventional glucocorticosteroids are contraindicated , or if the person declines or cannot <e1>tolerate</e1> <e2>them</e2> .	acts-on(e1,e2)
To induce remission in people with a mild-to-moderate <e1>first</e1> <e2>presentation</e2> or inflammatory exacerbation of proctitis , offer a topical aminosalicylate as first-line treatment .	modifier(e1,e2)
If the person is aged under 80 years with stage 1 hypertension and has diabetes , <e1>offer</e1> antihypertensive drug <e2>treatment</e2> .	acts-on(e1,e2)
If clinical evaluation or lung function testing indicates an inadequate response to rhDNase , consider both rhDNase and hypertonic sodium chloride or <e1>hypertonic</e1> sodium <e2>chloride</e2> alone .	modifier(e1,e2)
Maintain blood pressure below 130/80 mmHg or lower for people who <e1>have</e1> heart <e2>failure</e2> with stage 2 diabetes .	acts-on(e1,e2)
Short-term GC should be considered when initiating or changing csDMARDs , in different dose <e1>regimens</e1> and <e2>routes</e2> of administration , but should be tapered as rapidly as clinically feasible .	joint
For <e1>patients</e1> with HCV genotype 1 infection and HIV , who do not <e2>achieve</e2> an EVR , treatment should be stopped .	actor-of(e1,e2)
In personalised asthma action plans for adults , consider advising <e1>quadrupling</e1> <e2>ICS</e2> at the onset of an asthma attack and for up to 14 days in order to reduce the risk of needing oral steroids .	modifier(e1,e2)
For patients receiving a protease <e1>inhibitor</e1> in combination with pegylated <e2>IFN</e2> and ribavirin therapy , consider ribavirin dose reduction as an alternative to the addition of EPO for controlling anaemia .	other
When spinal <e1>fracture</e1> in axial SpA is <e2>suspected</e2> , conventional radiography is the recommended initial imaging method .	modifier(e2,e1)
For <e1>people</e1> with an acute cough who are identified at a face-to-face clinical examination as systemically very unwell , <e2>offer</e2> an immediate antibiotic prescription .	receiver(e1,e2)
A combination of digoxin with either a <e1>beta-blocker</e1> or <e2>diltiazem</e2> should be considered to control heart rate in patients with atrial fibrillation .	choice
Offer <e1>image-guided</e1> <e2>biopsy</e2> to people with peripheral lung lesions when treatment can be planned on the basis of this test .	modifier(e1,e2)
Select the appropriate starting dose to achieve <e1>therapeutic</e1> <e2>response</e2> , taking into account the risk of undertreatment .	modifier(e1,e2)
Offer <e1>antihypertensive</e1> drug <e2>treatment</e2> for an annual vaccination against influenza .	modifier(e1,e2)
If the patient is already on an ACE inhibitor , the ACE inhibitor should be stopped for 36 hours before <e1>initiating</e1> <e2>sacubitril</e2> / valsartan to minimise the risk of angioedema .	acts-on(e1,e2)
<e1>Screening</e1> for asymptomatic atherosclerotic plaques by use of carotid ultrasound may be <e2>considered</e2> as part of the CVD risk evaluation in patients with RA .	modifier(e2,e1)
If HbA1c rises to 48 mmol/mol ( 6.5 % ) on lifestyle interventions , consider a DPP-4i , pioglitazone , an SU , an SGLT-2i , and support the person to aim for an HbA1c level of 48 mmol/mol ( 6.5 % ) for people on a <e1>DPP-4i</e1> , <e2>SGLT-2i</e2> or pioglitazone or 53 mmol/mol ( 7 % ) for people on an SU .	choice
If the person is aged under 80 years with stage 1 hypertension and has target organ damage , offer <e1>antihypertensive</e1> drug <e2>treatment</e2> .	modifier(e1,e2)
<e1>Duloxetine</e1> should be <e2>considered</e2> for the treatment of patients with diabetic neuropathic pain if other first or second line pharmacological therapies have failed .	acts-on(e2,e1)
If <e1>HbA1c</e1> <e2>rises</e2> to 58 mmol/mol ( 7.5 % ) , consider insulin-based treatment and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	actor-of(e1,e2)
Request the oestrogen receptor , progesterone receptor and human epidermal growth receptor 2 status of all <e1>invasive</e1> breast <e2>cancers</e2> simultaneously at the time of initial histopathological diagnosis .	modifier(e1,e2)
All patients with stable angina should be <e1>considered</e1> for <e2>treatment</e2> with angiotensin converting enzyme inhibitors .	acts-on(e1,e2)
<e1>Gabapentin</e1> should be <e2>considered</e2> for the treatment of patients with neuropathic pain .	modifier(e2,e1)
For children who are <e1>allergic</e1> to <e2>penicillins</e2> , consider an alternative oral anti-Staphylococcus aureus agent .	other
<e1>TC</e1> and <e2>HDLc</e2> should be used in CVD risk assessment in RA , AS and PsA and lipids should ideally be measured when disease activity is stable or in remission .	joint
Assess the ER status of all invasive breast cancers using standardised and quality-assured immunohistochemical techniques , and <e1>report</e1> the <e2>results</e2> quantitatively .	acts-on(e1,e2)
In patients with peripheral arthritis and an inadequate <e1>response</e1> to at least one <e2>csDMARD</e2> , therapy with a bDMARD , usually a TNF inhibitor , should be commenced .	other
If the clinic blood pressure is <e1>140/90</e1> mmHg or <e2>higher</e2> , offer ABPM to confirm the diagnosis of hypertension .	modifier(e2,e1)
Offer platinum-based combination chemotherapy to people with <e1>extensive-stage</e1> disease <e2>SCLC</e2> if they are fit enough .	modifier(e1,e2)
If the <e1>person</e1> is with <e2>CKD</e2> and vitamin D supplementation is indicated , offer colecalciferol or ergocalciferol .	owner(e1,e2)
Consider cinacalcet for people with primary hyperparathyroidism if surgery has been unsuccessful , is unsuitable or has been declined , and if their albumin-adjusted serum calcium <e1>level</e1> is either : <e2>2.85</e2> mmol/litre or above with symptoms of hypercalcaemia or 3 mmol/litre or above with or without symptoms of hypercalcaemia .	modifier(e2,e1)
Routine initiation of perioperative beta-blocker therapy to reduce perioperative myocardial infarction in <e1>patients</e1> <e2>undergoing</e2> non cardiac surgery is not recommended .	actor-of(e1,e2)
All patients co-infected with HIV and HCV genotype 1 should be considered for <e1>treatment</e1> with a regimen which <e2>includes</e2> an HCV protease inhibitor .	actor-of(e1,e2)
In patients with <e1>peripheral</e1> <e2>arthritis</e2> and an inadequate response to at least one csDMARD , in whom bDMARDs are not appropriate , a targeted synthetic DMARD such as a PDE4-inhibitor may be considered .	modifier(e1,e2)
CVD risk <e1>estimation</e1> for <e2>patients</e2> with RA , AS or PsA should be performed according to national guidelines and the SCORE CVD risk prediction model should be used if no national guideline is available .	receiver(e2,e1)
<e1>Consider</e1> an ARB licensed for heart failure as an alternative to an ACE inhibitor for <e2>people</e2> who have heart failure with reduced ejection fraction and intolerable side effects with ACE inhibitors .	receiver(e2,e1)
Intravenous amiodarone should be considered in the management of <e1>patients</e1> with haemodynamically stable sustained monomorphic <e2>VT</e2> .	owner(e1,e2)
All <e1>patients</e1> with stable angina due to atherosclerotic disease should <e2>receive</e2> long term standard aspirin and statin therapy .	receiver(e1,e2)
Use caffeine citrate routinely in preterm babies born at or before 30 weeks , <e1>starting</e1> <e2>it</e2> as early as possible and ideally before 3 days of age .	acts-on(e1,e2)
<e1>Offer</e1> endoscopic mucosal resection for staging to <e2>people</e2> with suspected T1 oesophageal cancer .	receiver(e2,e1)
All patients should <e1>have</e1> appropriate <e2>monitoring</e2> for clinically significant AEs .	acts-on(e1,e2)
Conventional radiography of the SI joints and/or spine may be used for <e1>long-term</e1> <e2>monitoring</e2> of structural damage , particularly new bone formation , in axial SpA .	modifier(e1,e2)
For early stage disease , maintenance cytotoxic <e1>chemotherapy</e1> should not be <e2>given</e2> .	modifier(e2,e1)
In patients with syndesmophytes in the lumbar spine on <e1>conventional</e1> <e2>radiography</e2> , osteoporosis should be assessed by hip DXA , supplemented by either spine DXA in lateral projection or possibly QCT of the spine .	modifier(e1,e2)
Consider alpha blockers for adults , children and young <e1>people</e1> with distal ureteric <e2>stones</e2> less than 10 mm .	owner(e1,e2)
A <e1>regimen</e1> <e2>containing</e2> a platinum agent and etoposide is recommended for first line treatment of patients with SCLC .	actor-of(e1,e2)
Do not offer antispasmodics to adults , children and young people with <e1>suspected</e1> renal <e2>colic</e2> .	modifier(e1,e2)
Consider opioids for adults , children and young people with suspected renal colic if both NSAIDs and intravenous <e1>paracetamol</e1> are <e2>contraindicated</e2> or are not giving sufficient pain relief .	modifier(e2,e1)
Consider dual <e1>therapy</e1> with ACE <e2>inhibitor</e2> and metformin if the person is aged under 80 years .	other
<e1>Consider</e1> a maintenance <e2>dosage</e2> higher than 20 mg/kg daily if therapeutic efficacy is not achieved , while ensuring that a safe plasma level is maintained .	acts-on(e1,e2)
In <e1>patients</e1> with predominantly axial disease that is active and has insufficient response to NSAIDs , therapy with a bDMARD should be <e2>considered</e2> , which according to current practice is a TNF inhibitor .	receiver(e1,e2)
Consider adjuvant radiotherapy for <e1>patients</e1> with completely resected stage <e2>3B</e2> or 3C melanoma after discussion of the risk of local recurrence and the benefits and risks of radiotherapy including risk of significant adverse effects .	owner(e1,e2)
Maintain blood pressure below 130/80 mmHg or lower for <e1>people</e1> who <e2>have</e2> heart failure with stage 2 diabetes .	actor-of(e1,e2)
In <e1>peripheral</e1> <e2>SpA</e2> , if the clinical scenario requires monitoring of structural damage , then conventional radiography is recommended .	modifier(e1,e2)
Patients with early stage peripheral lung cancers who are not suitable for surgery should be considered for stereotactic <e1>ablative</e1> <e2>radiotherapy</e2> .	modifier(e1,e2)
Offer contrast-enhanced brain CT to people with <e1>clinical</e1> stage 2 <e2>NSCLC</e2> who are having treatment with curative intent .	modifier(e1,e2)
Do not <e1>offer</e1> cinacalcet to pregnant <e2>women</e2> with primary hyperparathyroidism .	receiver(e2,e1)
Tricyclic <e1>antidepressants</e1> should not be <e2>used</e2> for the management of pain in patients with chronic low back pain .	acts-on(e2,e1)
Niraparib monotherapy should be considered for maintenance treatment after response to platinum for patients with relapsed platinum sensitive non <e1>germline</e1> BRCA mutated ovarian <e2>cancer</e2> .	modifier(e1,e2)
Do not offer dedicated brain imaging to <e1>people</e1> with clinical stage 1 NSCLC who <e2>have</e2> no neurological symptoms and are having treatment with curative intent .	actor-of(e1,e2)
<e1>MRI</e1> of the SI <e2>joints</e2> and/or the spine may be used to assess and monitor disease activity in axial SpA , providing additional information on top of clinical and biochemical assessments .	other
Do not <e1>use</e1> synchronised pressure-limited <e2>ventilation</e2> such as assist control , synchronised intermittent positive pressure ventilation , patient-triggered ventilation , pressure support ventilation or synchronised time-cycled pressure-limited ventilation .	acts-on(e1,e2)
<e1>Adjuvant</e1> <e2>chemotherapy</e2> should be considered for all patients with breast cancer where benefit outweighs risk .	modifier(e1,e2)
<e1>Prescribe</e1> <e2>metformin</e2> with caution for those at risk of a sudden deterioration in kidney function and those at risk of eGFR falling below 45 ml/minute/1.73m2 .	acts-on(e1,e2)
In patients <e1>undergoing</e1> multiple coronary artery bypass <e2>grafting</e2> , use of both internal mammary arteries should be considered .	acts-on(e1,e2)
Do not <e1>offer</e1> <e2>cinacalcet</e2> to pregnant women with primary hyperparathyroidism .	acts-on(e1,e2)
In patients with a contraindication to MTX , leflunomide or <e1>sulfasalazine</e1> should be <e2>considered</e2> as part of the treatment strategy .	acts-on(e2,e1)
<e1>Patients</e1> with suspected <e2>T3</e2> or T4 disease who are otherwise fit for surgery should not be denied surgical exploration on the basis of a CT scan alone .	owner(e1,e2)
<e1>Patients</e1> with suspected T3 or T4 disease who are otherwise fit for surgery should not be <e2>denied</e2> surgical exploration on the basis of a CT scan alone .	modifier(e2,e1)
Offer people who present with superior vena cava obstruction <e1>chemotherapy</e1> and <e2>radiotherapy</e2> according to the stage of disease and performance status .	joint
Consider adding intravenous ciclosporin to intravenous corticosteroids or consider surgery for people who have little or no improvement within 72 hours of <e1>starting</e1> intravenous <e2>corticosteroids</e2> or whose symptoms worsen at any time despite corticosteroid treatment .	acts-on(e1,e2)
Do not use synchronised pressure-limited <e1>ventilation</e1> such as assist <e2>control</e2> , synchronised intermittent positive pressure ventilation , patient-triggered ventilation , pressure support ventilation or synchronised time-cycled pressure-limited ventilation .	other
Consider cinacalcet for people with <e1>primary</e1> <e2>hyperparathyroidism</e2> if surgery has been unsuccessful , is unsuitable or has been declined , and if their albumin-adjusted serum calcium level is either : 2.85 mmol/litre or above with symptoms of hypercalcaemia or 3 mmol/litre or above with or without symptoms of hypercalcaemia .	modifier(e1,e2)
Offer an ACE inhibitor and a beta-blocker licensed for heart failure to <e1>people</e1> who <e2>have</e2> heart failure with reduced ejection fraction .	actor-of(e1,e2)
Patients and the patients' treatment teams should receive appropriate , practical advice on how to manage with <e1>GC-induced</e1> hypothalamic-pituitary-adrenal axis <e2>suppression</e2> .	modifier(e1,e2)
For people who cannot tolerate aminosalicylates , consider a time-limited <e1>course</e1> of an oral <e2>corticosteroid</e2> .	other
All <e1>patients</e1> should <e2>have</e2> appropriate monitoring for clinically significant AEs .	actor-of(e1,e2)
<e1>People</e1> with a <e2>history</e2> of fragility fractures over the age of 50 should be offered DXA scanning to evaluate the need for antiosteoporosis therapy .	owner(e1,e2)
For people with an acute cough who are identified at a face-to-face clinical <e1>examination</e1> as systemically very <e2>unwell</e2> , offer an immediate antibiotic prescription .	modifier(e2,e1)
To <e1>induce</e1> <e2>remission</e2> in people with a mild-to-moderate first presentation or inflammatory exacerbation of proctitis , offer a topical aminosalicylate as first-line treatment .	acts-on(e1,e2)
TC and HDLc should be used in CVD risk assessment in RA , <e1>AS</e1> and <e2>PsA</e2> and lipids should ideally be measured when disease activity is stable or in remission .	joint
If a bDMARD or tsDMARD has failed , treatment with another <e1>bDMARD</e1> or a <e2>tsDMARD</e2> should be considered .	choice
Patients with AIIRD should <e1>receive</e1> tetanus toxoid <e2>vaccination</e2> in accordance to recommendations for the general population .	acts-on(e1,e2)
For people who <e1>have</e1> had pancreatoduodenectomy and who <e2>have</e2> a functioning gut , offer early enteral nutrition rather than parenteral nutrition .	joint
The routine use of aspirin to reduce perioperative cardiac events in patients <e1>undergoing</e1> non cardiac <e2>surgery</e2> , including those with known stable CAD , is not recommended .	acts-on(e1,e2)
For people with an acute cough who are identified at a face-to-face clinical examination as systemically very unwell , offer an <e1>immediate</e1> antibiotic <e2>prescription</e2> .	modifier(e1,e2)
In patients with peripheral arthritis , particularly in those with many swollen joints , structural damage in the presence of inflammation , high ESR/CRP and/or clinically relevant extra-articular manifestations , <e1>csDMARDs</e1> should be <e2>considered</e2> at an early stage , with methotrexate preferred in those with relevant skin involvement .	modifier(e2,e1)
Blood pressure reduction to 185/110 mmHg or lower should be <e1>considered</e1> in <e2>people</e2> who are candidates for intravenous thrombolysis .	receiver(e2,e1)
Offer an MRA , in addition to an ACE inhibitor ( or ARB ) and beta-blocker , to people who have heart failure with reduced ejection fraction if <e1>they</e1> <e2>continue</e2> to have symptoms of heart failure .	actor-of(e1,e2)
Adjuvant trastuzumab should be considered in all patients with HER 2 positive breast cancer who <e1>receive</e1> adjuvant <e2>chemotherapy</e2> .	acts-on(e1,e2)
Do not offer <e1>azathioprine</e1> or <e2>mercaptopurine</e2> if TPMT activity is deficient .	choice
Consider cinacalcet for people with primary hyperparathyroidism if surgery has been unsuccessful , is unsuitable or has been declined , and if their albumin-adjusted serum calcium level is either : <e1>2.85</e1> mmol/litre or <e2>above</e2> with symptoms of hypercalcaemia or 3 mmol/litre or above with or without symptoms of hypercalcaemia .	modifier(e2,e1)
Do not <e1>offer</e1> antihypertensive drug treatment if the <e2>person</e2> is with type 1 diabetes .	receiver(e2,e1)
Offer endocrine therapy after breast-conserving surgery for women with <e1>ER-positive</e1> <e2>DCIS</e2> if radiotherapy is recommended but not received .	modifier(e1,e2)
Offer an MRA , in addition to an ACE inhibitor ( or ARB ) and beta-blocker , to <e1>people</e1> who <e2>have</e2> heart failure with reduced ejection fraction if they continue to have symptoms of heart failure .	actor-of(e1,e2)
For <e1>people</e1> who <e2>have</e2> had pancreatoduodenectomy and who have a functioning gut , offer early enteral nutrition rather than parenteral nutrition .	actor-of(e1,e2)
MRI of the SI <e1>joints</e1> and/or the <e2>spine</e2> may be used to assess and monitor disease activity in axial SpA , providing additional information on top of clinical and biochemical assessments .	joint
Patients with heart failure and clinical signs or symptoms of fluid <e1>overload</e1> or <e2>congestion</e2> should be considered for diuretic therapy .	choice
Patients with NSCLC stage <e1>1</e1> and <e2>2</e2> who are medically inoperable or who do not consent to surgery should be offered radical radiotherapy .	joint
Review intravenous antibiotics by 48 hours and <e1>consider</e1> stepping down to oral <e2>antibiotics</e2> where possible .	acts-on(e1,e2)
Aromatase inhibitor is recommended for ER positive postmenopausal women <e1>receiving</e1> neoadjuvant endocrine <e2>therapy</e2> .	acts-on(e1,e2)
If the clinic blood pressure is 140/90 mmHg or higher , offer ABPM to <e1>confirm</e1> the <e2>diagnosis</e2> of hypertension .	acts-on(e1,e2)
Treatment should be aimed at reaching a target of sustained remission or <e1>low</e1> disease <e2>activity</e2> in every patient .	modifier(e1,e2)
Aim for a target clinic blood pressure below 150/90 mmHg in <e1>people</e1> aged 80 years and over with treated <e2>hypertension</e2> .	owner(e1,e2)
For eligible people with stage 3B NSCLC who cannot tolerate or who decline chemoradiotherapy , consider <e1>radical</e1> <e2>radiotherapy</e2> .	modifier(e1,e2)
Request the oestrogen receptor , progesterone receptor and human epidermal growth receptor 2 <e1>status</e1> of all invasive breast <e2>cancers</e2> simultaneously at the time of initial histopathological diagnosis .	other
Acute <e1>withdrawal</e1> of beta-blockers in the postoperative period is not <e2>recommended</e2> .	acts-on(e2,e1)
To induce remission in people with a mild-to-moderate first presentation or inflammatory exacerbation of extensive ulcerative colitis , offer a topical <e1>aminosalicylate</e1> and a high-dose oral <e2>aminosalicylate</e2> as first-line treatment .	joint
Offer <e1>monotherapy</e1> with a conventional <e2>glucocorticosteroid</e2> to induce remission in people with a first presentation or a single inflammatory exacerbation of Crohn's disease in a 12-month period .	other
If the <e1>person</e1> is aged under 80 <e2>years</e2> with stage 1 hypertension and has renal disease , offer antihypertensive drug treatment .	modifier(e2,e1)
Consider adding methotrexate to a conventional glucocorticosteroid or budesonide to induce remission in people who cannot tolerate <e1>azathioprine</e1> or <e2>mercaptopurine</e2> .	choice
Low dose pegylated IFN maintenance monotherapy should not be used in <e1>patients</e1> with compensated <e2>cirrhosis</e2> .	owner(e1,e2)
US with high-frequency colour or power Doppler is sufficient to <e1>detect</e1> <e2>inflammation</e2> and the use of US contrast medium is not needed .	acts-on(e1,e2)
Use <e1>MRI</e1> when necessary to <e2>assess</e2> the extent of disease , for people with superior sulcus tumours .	actor-of(e1,e2)
<e1>Patients</e1> with genotype 1 infection should be <e2>tested</e2> for an EVR at 12 weeks .	receiver(e1,e2)
Consider adjuvant therapy after surgery for people with <e1>invasive</e1> breast <e2>cancer</e2> , and ensure that recommendations are recorded at the multidisciplinary team meeting .	modifier(e1,e2)
Maintain blood pressure below 45 ml/minute/1.73m2 if the <e1>person</e1> is aged under <e2>80</e2> years with type 1 diabetes .	owner(e1,e2)
In patients who fail to <e1>respond</e1> <e2>adequately</e2> to a bDMARD , switching to another bDMARD should be considered , including switching between TNF inhibitors .	modifier(e2,e1)
<e1>Offer</e1> an <e2>MRA</e2> , in addition to an ACE inhibitor ( or ARB ) and beta-blocker , to people who have heart failure with reduced ejection fraction if they continue to have symptoms of heart failure .	acts-on(e1,e2)
If the person is aged under 80 years with stage 1 hypertension and has target organ damage , <e1>offer</e1> antihypertensive drug <e2>treatment</e2> .	acts-on(e1,e2)
To <e1>induce</e1> remission in <e2>people</e2> with a mild-to-moderate first presentation or inflammatory exacerbation of extensive ulcerative colitis , offer a topical aminosalicylate and a high-dose oral aminosalicylate as first-line treatment .	receiver(e2,e1)
In patients with PsA , NSAIDs may be <e1>used</e1> to <e2>relieve</e2> musculoskeletal signs and symptoms .	other
<e1>Request</e1> the oestrogen receptor , progesterone receptor and human epidermal growth receptor 2 status of all invasive breast cancers <e2>simultaneously</e2> at the time of initial histopathological diagnosis .	modifier(e2,e1)
23-valent polysaccharide pneumococcal vaccination (23-PPV) should be strongly <e1>considered</e1> for <e2>patients</e2> with AIIRD .	receiver(e2,e1)
If HbA1c <e1>rises</e1> to <e2>58</e2> mmol/mol ( 7.5 % ) , consider dual therapy with a DPP-4i and pioglitazone , a DPP-4i and an SU , pioglitazone and an SU , and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	modifier(e2,e1)
To induce remission in people with a mild-to-moderate first <e1>presentation</e1> or inflammatory <e2>exacerbation</e2> of extensive ulcerative colitis , offer a topical aminosalicylate and a high-dose oral aminosalicylate as first-line treatment .	choice
<e1>Perform</e1> transthoracic echocardiography to exclude important valve disease , assess the systolic function of the ventricle , and <e2>detect</e2> intracardiac shunts .	other
Maintain blood pressure <e1>below</e1> 130/80 mmHg or <e2>lower</e2> for people who have heart failure with stage 2 diabetes .	choice
Evaluate PET-CT-positive or enlarged intrathoracic nodes using a <e1>systematic</e1> <e2>approach</e2> with EBUS-TBNA and/or EUS-FNA if nodal status would affect the treatment plan .	modifier(e1,e2)
If cytological or histological samples are needed , offer <e1>EUS</e1> with EUS-guided tissue <e2>sampling</e2> .	other
All patients with stable angina due to atherosclerotic disease should receive long term standard <e1>aspirin</e1> and statin <e2>therapy</e2> .	joint
Consider <e1>adjuvant</e1> <e2>therapy</e2> after surgery for people with invasive breast cancer , and ensure that recommendations are recorded at the multidisciplinary team meeting .	modifier(e1,e2)
Offer PET-CT , followed by EBUS-TBNA and/or EUS-FNA , to people with suspected lung cancer who <e1>have</e1> enlarged intrathoracic lymph <e2>nodes</e2> and who could potentially have treatment with curative intent .	acts-on(e1,e2)
Do not <e1>offer</e1> <e2>antispasmodics</e2> to adults , children and young people with suspected renal colic .	acts-on(e1,e2)
If dipstick screening is positive , use albumin:creatinine <e1>ratio</e1> or protein:creatinine <e2>ratio</e2> to quantify proteinuria in pregnant women .	choice
Patients with AF who remain severely symptomatic despite adequate rate control should be considered for rhythm control or for stricter rate control if their heart <e1>rate</e1> <e2>remains</e2> 80-110 bpm at rest .	actor-of(e1,e2)
Adjuvant trastuzumab should be considered in all <e1>patients</e1> with HER 2 positive breast <e2>cancer</e2> who receive adjuvant chemotherapy .	owner(e1,e2)
If there is no improvement by at most 3 months after the start of <e1>treatment</e1> or the <e2>target</e2> has not been reached by 6 months , therapy should be adjusted .	choice
For people who have had pancreatoduodenectomy and who <e1>have</e1> a functioning <e2>gut</e2> , offer early enteral nutrition rather than parenteral nutrition .	acts-on(e1,e2)
If the clinic blood pressure is below 150/90 mmHg , <e1>offer</e1> other anti-hypertensive <e2>drugs</e2> .	acts-on(e1,e2)
Short-term GC should be considered when <e1>initiating</e1> or <e2>changing</e2> csDMARDs , in different dose regimens and routes of administration , but should be tapered as rapidly as clinically feasible .	choice
Do not offer ACE inhibitor therapy if there is a clinical <e1>suspicion</e1> of haemodynamically significant valve <e2>disease</e2> until the valve disease has been assessed by a specialist .	other
<e1>Consider</e1> surgical mediastinal <e2>staging</e2> for people with a negative EBUS-TBNA or EUS-FNA if clinical suspicion of nodal malignancy is high and nodal status would affect their treatment plan .	acts-on(e1,e2)
In patients with active enthesitis and/or dactylitis and insufficient response to NSAIDs or local glucocorticoid injections , <e1>therapy</e1> with a <e2>bDMARD</e2> should be considered , which according to current practice is a TNF inhibitor .	other
Patients with HCV associated chronic liver failure should be considered for <e1>assessment</e1> for liver <e2>transplantation</e2> .	other
Start ACE inhibitor <e1>therapy</e1> at a low <e2>dose</e2> and titrate upwards at short intervals until the target or maximum tolerated dose is reached .	other
Sublingual glyceryl trinitrate tablets or <e1>spray</e1> should be <e2>used</e2> for the immediate relief of angina and before performing activities that are known to bring on angina .	acts-on(e2,e1)
If remission is not achieved within 4 weeks , <e1>stop</e1> the topical <e2>aminosalicylate</e2> and offer a high-dose oral aminosalicylate with a time-limited course of an oral corticosteroid .	acts-on(e1,e2)
CVD risk prediction <e1>models</e1> should be <e2>adapted</e2> for patients with RA by a 1.5 multiplication factor , if this is not already included in the model .	acts-on(e2,e1)
<e1>Measure</e1> serum <e2>calcium</e2> for people who develop a pancreatic cancer resection .	acts-on(e1,e2)
<e1>Consider</e1> adding <e2>azathioprine</e2> or mercaptopurine to a conventional glucocorticosteroid or budesonide to induce remission of Crohn's disease if there are 2 or more inflammatory exacerbations in a 12 month period or the glucocorticosteroid dose cannot be tapered .	acts-on(e1,e2)
All patients with stable angina due to atherosclerotic disease should <e1>receive</e1> long term standard <e2>aspirin</e2> and statin therapy .	acts-on(e1,e2)
For people who cannot tolerate aminosalicylates , consider a <e1>time-limited</e1> <e2>course</e2> of an oral corticosteroid .	modifier(e1,e2)
In surgery for <e1>advanced</e1> ovarian <e2>cancer</e2> , the aim should be to achieve complete cytoreduction .	modifier(e1,e2)
Evaluate PET-CT-positive or enlarged intrathoracic nodes using a systematic <e1>approach</e1> with <e2>EBUS-TBNA</e2> and/or EUS-FNA if nodal status would affect the treatment plan .	other
If the treatment target is not achieved with the <e1>first</e1> csDMARD <e2>strategy</e2> , in the absence of poor prognostic factors , other csDMARDs should be considered .	modifier(e1,e2)
All patients with heart <e1>failure</e1> with reduced ejection <e2>fraction</e2> , NYHA class 2-4 should be started on beta-blocker therapy as soon as their condition is stable .	other
Offer flexible bronchoscopy to people with central lesions on CT if nodal staging does not <e1>influence</e1> <e2>treatment</e2> .	acts-on(e1,e2)
Select the appropriate starting <e1>dose</e1> to <e2>achieve</e2> therapeutic response , taking into account the risk of undertreatment .	actor-of(e1,e2)
Patients with AF who <e1>remain</e1> severely <e2>symptomatic</e2> despite adequate rate control should be considered for rhythm control or for stricter rate control if their heart rate remains 80-110 bpm at rest .	modifier(e2,e1)
Do not offer an antibiotic to treat an acute cough associated with an upper respiratory tract infection in <e1>people</e1> who are not systemically very <e2>unwell</e2> or at higher risk of complications .	modifier(e2,e1)
In peripheral SpA , if the clinical <e1>scenario</e1> <e2>requires</e2> monitoring of structural damage , then conventional radiography is recommended .	actor-of(e1,e2)
Consider adding <e1>azathioprine</e1> or <e2>mercaptopurine</e2> to a conventional glucocorticosteroid or budesonide to induce remission of Crohn's disease if there are 2 or more inflammatory exacerbations in a 12 month period or the glucocorticosteroid dose cannot be tapered .	choice
Offer systemic combination chemotherapy to <e1>people</e1> with locally advanced pancreatic cancer who are <e2>well</e2> enough to tolerate it .	modifier(e2,e1)
Human papillomavirus <e1>vaccination</e1> should be <e2>considered</e2> in selected patients with AIIRD .	modifier(e2,e1)
Consider prostaglandin E1 or prostaglandin E2 as options for inducing labour in women with asthma because there is no evidence that <e1>they</e1> <e2>worsen</e2> asthma .	actor-of(e1,e2)
If an <e1>adult</e1> with type 2 <e2>diabetes</e2> is symptomatically hyperglycaemic , consider insulin or an SU .	owner(e1,e2)
<e1>Duloxetine</e1> should be <e2>considered</e2> for the treatment of patients with fibromyalgia or osteoarthritis .	acts-on(e2,e1)
In patients with stable angina requiring percutaneous coronary intervention for in stent restenosis , a drug eluting balloon or a second or third generation drug eluting <e1>stent</e1> should be <e2>considered</e2> .	modifier(e2,e1)
Lifestyle recommendations should <e1>emphasise</e1> the <e2>benefits</e2> of a healthy diet , regular exercise and smoking cessation for all patients .	acts-on(e1,e2)
Offer radical resection to people with T1bN0 oesophageal adenocarcinoma if they are fit enough to <e1>have</e1> <e2>surgery</e2> .	acts-on(e1,e2)
Consider alpha blockers for adults , children and young people with <e1>distal</e1> ureteric <e2>stones</e2> less than 10 mm .	modifier(e1,e2)
Offer PET-CT as the preferred <e1>first</e1> <e2>test</e2> after CT with a low probability of nodal malignancy , for people with lung cancer who could potentially have treatment with curative intent .	modifier(e1,e2)
Offer nutritional assessment and tailored specialist dietetic support to people with oesophago-gastric cancer before , during and <e1>after</e1> radical <e2>treatments</e2> .	modifier(e1,e2)
<e1>Avoid</e1> <e2>surgery</e2> within 30 days of myocardial infarction .	acts-on(e1,e2)
Provide an accessible <e1>resource</e1> to <e2>promote</e2> best practice in the management of patients using medium/high-dose GCs to general practitioners .	actor-of(e1,e2)
Offer monotherapy with a conventional glucocorticosteroid to induce remission in people with a first presentation or a single <e1>inflammatory</e1> <e2>exacerbation</e2> of Crohn's disease in a 12-month period .	modifier(e1,e2)
To induce remission in people with a mild-to-moderate first presentation or inflammatory <e1>exacerbation</e1> of proctosigmoiditis or left-sided ulcerative <e2>colitis</e2> , offer a topical aminosalicylate as first-line treatment .	choice
Offer radiotherapy using 40 Gy in 15 fractions with concomitant and up to 12 cycles of adjuvant temozolomide for <e1>people</e1> aged around <e2>70</e2> or over .	modifier(e2,e1)
If the <e1>person</e1> is with stage 2 diabetes and symptomatically <e2>hyperglycaemic</e2> , offer SGLT-2i , pioglitazone or ergocalciferol .	modifier(e2,e1)
Keep the <e1>requirement</e1> for <e2>continuing</e2> GC treatment under constant review , and titrate the dose against therapeutic response , risk of undertreatment and development of AEs .	actor-of(e1,e2)
<e1>Patients</e1> with hepatitis C <e2>virus</e2> and concurrent operable hepatocellular carcinoma should be offered liver transplantation .	owner(e1,e2)
Advise pregnant women with more than 1 moderate risk factor for pre-eclampsia to take <e1>75-150</e1> mg of <e2>aspirin</e2> daily from 12 weeks until the birth of the baby .	modifier(e1,e2)
If a <e1>woman</e1> is <e2>pregnant</e2> , offer ultrasound instead of CT .	modifier(e2,e1)
For women with a cerebrovascular malformation at low risk of intracranial bleeding , <e1>manage</e1> the second stage of labour based on the woman's <e2>preference</e2> and obstetric indications .	modifier(e2,e1)
If dipstick screening is positive , use albumin:creatinine <e1>ratio</e1> or protein:creatinine ratio to <e2>quantify</e2> proteinuria in pregnant women .	actor-of(e1,e2)
For <e1>children</e1> who are <e2>allergic</e2> to penicillins , consider an alternative oral anti-Staphylococcus aureus agent .	modifier(e2,e1)
bDMARDs and <e1>tsDMARDs</e1> should be combined with a <e2>csDMARD</e2> .	joint
<e1>Consider</e1> an <e2>ARB</e2> licensed for heart failure as an alternative to an ACE inhibitor for people who have heart failure with reduced ejection fraction and intolerable side effects with ACE inhibitors .	acts-on(e1,e2)
For people with stage 1-2A NSCLC who decline surgery or in whom any surgery is contraindicated , <e1>offer</e1> <e2>SABR</e2> .	acts-on(e1,e2)
All patients <e1>co-infected</e1> with <e2>HIV</e2> and HCV genotype 1 should be considered for treatment with a regimen which includes an HCV protease inhibitor .	acts-on(e1,e2)
If the person is aged under 80 years with stage 1 hypertension and <e1>has</e1> <e2>diabetes</e2> , offer antihypertensive drug treatment .	acts-on(e1,e2)
If further treatment is needed , stop topical treatments and offer an oral aminosalicylate and a <e1>time-limited</e1> <e2>course</e2> of an oral corticosteroid .	modifier(e1,e2)
Offer chemotherapy before and <e1>after</e1> <e2>surgery</e2> to people with gastric cancer who are having radical surgical resection .	modifier(e1,e2)
If HbA1c rises to 48 mmol/mol ( 6.5 % ) on lifestyle interventions , consider a DPP-4i , pioglitazone , an <e1>SU</e1> , an <e2>SGLT-2i</e2> , and support the person to aim for an HbA1c level of 48 mmol/mol ( 6.5 % ) for people on a DPP-4i , SGLT-2i or pioglitazone or 53 mmol/mol ( 7 % ) for people on an SU .	joint
Consider oral sodium bicarbonate <e1>concentration</e1> of less than <e2>20</e2> mmol/litre .	other
<e1>Monitor</e1> the <e2>response</e2> to titration of medicines closely in people who have heart failure with reduced ejection fraction and chronic kidney disease .	acts-on(e1,e2)
For people who cannot tolerate aminosalicylates , consider a time-limited course of a <e1>topical</e1> or an <e2>oral</e2> corticosteroid .	choice
For prolonged treatment , the glucocorticoid dosage should be kept to a minimum and a glucocorticoid taper should be attempted in case of <e1>remission</e1> or low disease <e2>activity</e2> .	choice
Patients who are <e1>unfit</e1> for combination <e2>therapy</e2> should be offered single agent carboplatin .	other
Do not use fish oils as a <e1>nutritional</e1> <e2>intervention</e2> to manage weight loss in people with unresectable pancreatic cancer .	modifier(e1,e2)
Start ACE inhibitor therapy at a low dose and titrate upwards at short intervals until the target or maximum tolerated <e1>dose</e1> is <e2>reached</e2> .	acts-on(e2,e1)
If remission is not achieved within 4 weeks , consider adding an <e1>oral</e1> <e2>aminosalicylate</e2> .	modifier(e1,e2)
Offer bisphosphonates if indicated for the prevention and treatment of osteoporosis in people with a GFR of 30 <e1>ml/min/1.73m2</e1> or <e2>more</e2> .	modifier(e2,e1)
Offer metformin as the <e1>initial</e1> drug <e2>treatment</e2> for adults with type 2 diabetes .	modifier(e1,e2)
If further treatment is needed , stop topical treatments and <e1>offer</e1> an oral <e2>aminosalicylate</e2> and a time-limited course of an oral corticosteroid .	acts-on(e1,e2)
Human papillomavirus vaccination should be considered in selected <e1>patients</e1> with <e2>AIIRD</e2> .	owner(e1,e2)
Maintain blood <e1>pressure</e1> <e2>below</e2> 130/80 mmHg for people with advanced pancreatic cancer .	modifier(e2,e1)
In <e1>patients</e1> with active <e2>enthesitis</e2> and/or dactylitis and insufficient response to NSAIDs or local glucocorticoid injections , therapy with a bDMARD should be considered , which according to current practice is a TNF inhibitor .	owner(e1,e2)
Do not offer an antibiotic to treat an <e1>acute</e1> <e2>cough</e2> associated with an upper respiratory tract infection in people who are not systemically very unwell or at higher risk of complications .	modifier(e1,e2)
Vaccination in patients with AIIRD can be administered during the use of disease-modifying antirheumatic drugs and tumour necrosis factor alpha blocking agents but should ideally be administered before <e1>starting</e1> B cell depleting biological <e2>therapy</e2> .	acts-on(e1,e2)
If remission is not achieved within 4 weeks , <e1>consider</e1> adding a high-dose oral aminosalicylate to the topical aminosalicylate or switching to a high-dose oral <e2>aminosalicylate</e2> and a time-limited course of a topical corticosteroid .	acts-on(e1,e2)
For <e1>women</e1> with a cerebrovascular <e2>malformation</e2> at low risk of intracranial bleeding , base decisions on the mode of birth on the woman's preference and obstetric indications .	owner(e1,e2)
All women with non-mucinous <e1>ovarian</e1> or fallopian tube <e2>cancer</e2> should be offered BRCA1 and BRCA2 mutation testing .	choice
If surgical resection is not appropriate , consider <e1>biopsy</e1> to <e2>obtain</e2> a histological and molecular diagnosis .	actor-of(e1,e2)
<e1>Consider</e1> prostaglandin <e2>E1</e2> or prostaglandin E2 as options for inducing labour in women with asthma because there is no evidence that they worsen asthma .	acts-on(e1,e2)
Consider enteric-coated <e1>pancreatin</e1> before and after pancreatic cancer <e2>resection</e2> .	other
Carbamazepine should be <e1>considered</e1> for the treatment of <e2>patients</e2> with neuropathic pain .	receiver(e2,e1)
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider dual therapy with metformin and a DPP-4i , metformin and pioglitazone , metformin and an SU , metformin and an SGLT-2i , and <e1>support</e1> the person to <e2>aim</e2> for an HbA1c level of 53 mmol/mol ( 7 % ) .	other
Consider prostaglandin <e1>E1</e1> or prostaglandin E2 as options for <e2>inducing</e2> labour in women with asthma because there is no evidence that they worsen asthma .	actor-of(e1,e2)
In patients with peripheral arthritis and an inadequate response to at least one csDMARD , in whom <e1>bDMARDs</e1> are not <e2>appropriate</e2> , a targeted synthetic DMARD such as a PDE4-inhibitor may be considered .	modifier(e2,e1)
The routine use of aspirin to reduce perioperative cardiac events in <e1>patients</e1> <e2>undergoing</e2> non cardiac surgery , including those with known stable CAD , is not recommended .	actor-of(e1,e2)
Evaluate PET-CT-positive or enlarged intrathoracic nodes <e1>using</e1> a systematic <e2>approach</e2> with EBUS-TBNA and/or EUS-FNA if nodal status would affect the treatment plan .	acts-on(e1,e2)
Offer antihypertensive drug treatment for an annual <e1>vaccination</e1> against <e2>influenza</e2> .	other
If the person is with CKD and vitamin D supplementation is indicated , <e1>offer</e1> <e2>colecalciferol</e2> or ergocalciferol .	acts-on(e1,e2)
Offer an ACE inhibitor and a <e1>beta-blocker</e1> licensed for heart <e2>failure</e2> to people who have heart failure with reduced ejection fraction .	other
Local <e1>injections</e1> of <e2>glucocorticoids</e2> should be considered as adjunctive therapy in PsA .	other
For people with cystic fibrosis who develop a Haemophilus influenzae infection but do not have clinical evidence of pulmonary infection , treat with an appropriate <e1>oral</e1> <e2>antibiotic</e2> .	modifier(e1,e2)
All <e1>patients</e1> co-infected with <e2>HCV</e2> and HIV should be considered for HCV treatment .	owner(e1,e2)
Give oral antibiotics first line if the person can take oral medicines , and the severity of their condition does not <e1>require</e1> intravenous <e2>antibiotics</e2> .	acts-on(e1,e2)
Optimised antidepressant therapy should be considered for the treatment of <e1>patients</e1> with chronic <e2>pain</e2> with moderate depression .	owner(e1,e2)
For <e1>people</e1> with an acute cough who are <e2>identified</e2> at a face-to-face clinical examination as at higher risk of complications , consider an immediate antibiotic prescription or a back-up antibiotic prescription .	modifier(e2,e1)
Treatment should be aimed at reaching the target of remission or , alternatively , minimal/low disease activity , by regular monitoring and appropriate <e1>adjustment</e1> of <e2>therapy</e2> .	other
Patients with stage 1 and 2 NSCLC should be considered for <e1>curative</e1> <e2>surgery</e2> whenever possible .	modifier(e1,e2)
Patients with heart failure and clinical signs or <e1>symptoms</e1> of fluid <e2>overload</e2> or congestion should be considered for diuretic therapy .	other
In peripheral SpA , if the clinical scenario <e1>requires</e1> <e2>monitoring</e2> of structural damage , then conventional radiography is recommended .	acts-on(e1,e2)
<e1>Assess</e1> the PR <e2>status</e2> of all invasive breast cancers using standardised and quality-assured immunohistochemical techniques , and report the results quantitatively .	acts-on(e1,e2)
If the person is with <e1>CKD</e1> and <e2>beta-blocker</e2> , consider starting antihypertensive drug .	joint
<e1>Measure</e1> parathyroid hormone for <e2>people</e2> whose albumin-adjusted serum calcium level is either 2.6 mmol/litre or above on at least 2 separate occasions or 2.5 mmol/litre or above on at least 2 separate occasions and primary hyperparathyroidism is suspected .	receiver(e2,e1)
When peripheral SpA is suspected , US or MRI may be used to detect peripheral enthesitis , which may support the <e1>diagnosis</e1> of <e2>SpA</e2> .	other
<e1>Patients</e1> with AF who remain severely symptomatic despite adequate rate control should be <e2>considered</e2> for rhythm control or for stricter rate control if their heart rate remains 80-110 bpm at rest .	receiver(e1,e2)
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider triple therapy with metformin and a DPP-4i and an SU , metformin and pioglitazone and an SU , metformin and pioglitazone and an SGLT-2i , metformin and an <e1>SU</e1> and an <e2>SGLT-2i</e2> , insulin-based treatment , and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	joint
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider dual <e1>therapy</e1> with metformin and a DPP-4i , <e2>metformin</e2> and pioglitazone , metformin and an SU , metformin and an SGLT-2i , and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	other
Patients with lung cancer who have symptomatic bone metastases should be <e1>considered</e1> for <e2>treatment</e2> with a bisphosphonate .	acts-on(e1,e2)
Patients with AIIRD should receive tetanus toxoid vaccination in accordance to recommendations for the <e1>general</e1> <e2>population</e2> .	modifier(e1,e2)
Offer either <e1>anticoagulants</e1> or antiplatelet <e2>agents</e2> to people who have stroke secondary to acute arterial dissection .	choice
Patients with , or at risk of , GC-induced osteoporosis should <e1>receive</e1> appropriate preventive/therapeutic <e2>interventions</e2> .	acts-on(e1,e2)
Low dose pegylated IFN maintenance <e1>monotherapy</e1> should not be <e2>used</e2> in patients with compensated cirrhosis .	modifier(e2,e1)
CVD risk prediction models should be adapted for patients with RA by a 1.5 multiplication factor , if this is not already <e1>included</e1> in the <e2>model</e2> .	other
If the person has severe hypertension , <e1>consider</e1> starting antihypertensive drug treatment <e2>immediately</e2> , without waiting for the results of ABPM or HBPM .	modifier(e2,e1)
Therapy with DMARDs should be started as soon as the <e1>diagnosis</e1> of <e2>RA</e2> is made .	other
Assess the ER status of all invasive breast cancers using <e1>standardised</e1> and <e2>quality-assured</e2> immunohistochemical techniques , and report the results quantitatively .	joint
Beta-blockers should be used as first line therapy for the relief of symptoms of <e1>stable</e1> <e2>angina</e2> .	modifier(e1,e2)
Give oral antibiotics first line if the person can take oral medicines , and the <e1>severity</e1> of their <e2>condition</e2> does not require intravenous antibiotics .	other
Use an automated reagent-strip reading <e1>device</e1> for dipstick <e2>screening</e2> for proteinuria in pregnant women in secondary care settings .	other
Assess the HER2 status of all invasive breast cancers using standardised and quality-assured techniques , and report the <e1>results</e1> <e2>quantitatively</e2> .	modifier(e2,e1)
Patients with early stage peripheral lung cancers who are not <e1>suitable</e1> for <e2>surgery</e2> should be considered for stereotactic ablative radiotherapy .	modifier(e1,e2)
Erythropoietin is not recommended for <e1>patients</e1> with heart <e2>failure</e2> with reduced ejection fraction and iron deficiency .	owner(e1,e2)
Pregabalin is <e1>recommended</e1> for the <e2>treatment</e2> of patients with fibromyalgia .	other
Consider adding intravenous ciclosporin to intravenous corticosteroids or consider surgery for <e1>people</e1> who <e2>have</e2> little or no improvement within 72 hours of starting intravenous corticosteroids or whose symptoms worsen at any time despite corticosteroid treatment .	actor-of(e1,e2)
Do not offer ACE inhibitor therapy if there is a <e1>clinical</e1> <e2>suspicion</e2> of haemodynamically significant valve disease until the valve disease has been assessed by a specialist .	modifier(e1,e2)
Offer platinum-based combination chemotherapy to <e1>people</e1> with extensive-stage disease SCLC if <e2>they</e2> are fit enough .	other
<e1>Low</e1> dose pegylated IFN maintenance <e2>monotherapy</e2> should not be used in patients with compensated cirrhosis .	modifier(e1,e2)
Consider adding azathioprine or mercaptopurine to a conventional glucocorticosteroid or <e1>budesonide</e1> to <e2>induce</e2> remission of Crohn's disease if there are 2 or more inflammatory exacerbations in a 12 month period or the glucocorticosteroid dose cannot be tapered .	actor-of(e1,e2)
For people who cannot tolerate aminosalicylates , consider a time-limited course of a <e1>topical</e1> or an <e2>oral</e2> corticosteroid .	choice
<e1>Offer</e1> a proton pump inhibitor , in addition to aspirin , to <e2>anyone</e2> with acute ischaemic stroke for whom previous dyspepsia associated with aspirin is reported .	receiver(e2,e1)
Do not use first morning urine void to quantify proteinuria in <e1>pregnant</e1> <e2>women</e2> .	modifier(e1,e2)
Sublingual glyceryl trinitrate tablets or spray should be <e1>used</e1> for the immediate <e2>relief</e2> of angina and before performing activities that are known to bring on angina .	other
If the clinic blood <e1>pressure</e1> is <e2>below</e2> 150/90 mmHg , offer other anti-hypertensive drugs .	modifier(e2,e1)
Offer radiotherapy using 40 Gy in 15 fractions with concomitant and up to 12 cycles of adjuvant temozolomide for people aged around <e1>70</e1> or <e2>over</e2> .	modifier(e2,e1)
Tricyclic antidepressants should not be used for the management of pain in <e1>patients</e1> with chronic low back <e2>pain</e2> .	owner(e1,e2)
Do not offer pre-treatment stenting to adults having <e1>shockwave</e1> <e2>lithotripsy</e2> for ureteric or renal stones .	modifier(e1,e2)
MRI of the SI joints and/or the spine may be used to assess and monitor disease <e1>activity</e1> in axial <e2>SpA</e2> , providing additional information on top of clinical and biochemical assessments .	other
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider <e1>dual</e1> <e2>therapy</e2> with a DPP-4i and pioglitazone , a DPP-4i and an SU , pioglitazone and an SU , and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	modifier(e1,e2)
Offer <e1>endoscopic</e1> mucosal <e2>resection</e2> for staging to people with suspected T1 oesophageal cancer .	modifier(e1,e2)
If HbA1c rises to 58 mmol/mol ( 7 % ) , consider HBPM if the <e1>person</e1> <e2>has</e2> diabetes .	actor-of(e1,e2)
If cytological or <e1>histological</e1> <e2>samples</e2> are needed , offer EUS with EUS-guided tissue sampling .	modifier(e1,e2)
Offer urgent ultrasound as <e1>first-line</e1> <e2>imaging</e2> for children and young people with suspected renal colic .	modifier(e1,e2)
Women with platinum sensitive relapsed ovarian cancer should be offered <e1>treatment</e1> with <e2>carboplatin</e2> combined with either paclitaxel or pegylated liposomal doxorubicin hydrochloride .	other
People with a history of fragility fractures over the age of 50 should be <e1>offered</e1> DXA <e2>scanning</e2> to evaluate the need for antiosteoporosis therapy .	acts-on(e1,e2)
A <e1>resting</e1> <e2>ECG</e2> should be performed in patients with suspected cardiac chest pain .	modifier(e1,e2)
Consider a bisphosphonate to reduce fracture risk for people with primary hyperparathyroidism and <e1>increased</e1> fracture <e2>risk</e2> .	modifier(e1,e2)
<e1>Exclude</e1> hypoglycaemia in <e2>people</e2> with sudden onset of neurological symptoms as the cause of these symptoms .	receiver(e2,e1)
Consider adding intravenous <e1>ciclosporin</e1> to intravenous <e2>corticosteroids</e2> or consider surgery for people who have little or no improvement within 72 hours of starting intravenous corticosteroids or whose symptoms worsen at any time despite corticosteroid treatment .	other
If the <e1>person</e1> is aged under <e2>80</e2> years with stage 1 hypertension and has established cardiovascular disease , offer antihypertensive drug treatment .	modifier(e2,e1)
Live attenuated vaccines should be avoided whenever possible in immunosuppressed <e1>patients</e1> with <e2>AIIRD</e2> .	owner(e1,e2)
If one TNF-inhibitor therapy has failed , <e1>patients</e1> may <e2>receive</e2> another TNF-inhibitor or an agent with another mode of action .	actor-of(e1,e2)
Do not offer antispasmodics to adults , <e1>children</e1> and young <e2>people</e2> with suspected renal colic .	joint
If CT shows suspected brain metastases , <e1>offer</e1> contrast-enhanced brain <e2>MRI</e2> .	acts-on(e1,e2)
To <e1>induce</e1> remission in <e2>people</e2> with a mild-to-moderate first presentation or inflammatory exacerbation of proctitis , offer a topical aminosalicylate as first-line treatment .	receiver(e2,e1)
<e1>Patients</e1> with CHC who are on a drug treatment programme should be <e2>considered</e2> for treatment .	receiver(e1,e2)
A regimen containing a platinum agent and etoposide is recommended for first line treatment of <e1>patients</e1> with <e2>SCLC</e2> .	owner(e1,e2)
If a patient is in <e1>persistent</e1> <e2>remission</e2> , tapering the csDMARD could be considered .	modifier(e1,e2)
Consider prostaglandin <e1>E1</e1> or prostaglandin E2 as <e2>options</e2> for inducing labour in women with asthma because there is no evidence that they worsen asthma .	modifier(e2,e1)
For <e1>eligible</e1> <e2>people</e2> with stage 3A NSCLC who cannot tolerate or who decline chemoradiotherapy , consider radical radiotherapy .	modifier(e1,e2)
If <e1>HbA1c</e1> <e2>rises</e2> to 58 mmol/mol ( 7.5 % ) , consider dual therapy with a DPP-4i and pioglitazone , a DPP-4i and an SU , pioglitazone and an SU , and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	actor-of(e1,e2)
Low dose pegylated IFN maintenance monotherapy should not be <e1>used</e1> in <e2>patients</e2> with compensated cirrhosis .	receiver(e2,e1)
If there is no improvement by at most 3 months after the start of treatment or the target has not been reached by 6 months , <e1>therapy</e1> should be <e2>adjusted</e2> .	modifier(e2,e1)
<e1>Assess</e1> the HER2 <e2>status</e2> of all invasive breast cancers using standardised and quality-assured techniques , and report the results quantitatively .	acts-on(e1,e2)
If the person is aged under 80 years with stage 1 hypertension and has 10 year cardiovascular risk , offer <e1>antihypertensive</e1> drug <e2>treatment</e2> .	modifier(e1,e2)
Aim for a target clinic blood pressure below 140/90 mmHg in <e1>people</e1> aged under 80 years with treated <e2>hypertension</e2> .	owner(e1,e2)
If a person is <e1>unable</e1> to <e2>tolerate</e2> ABPM , HBPM is a suitable alternative to confirm the diagnosis of hypertension .	modifier(e1,e2)
MRI of the SI joints and/or the spine may be used to assess and monitor disease activity in axial SpA , providing additional information on top of clinical and <e1>biochemical</e1> <e2>assessments</e2> .	modifier(e1,e2)
Offer PET-CT , followed by EBUS-TBNA and/or EUS-FNA , to <e1>people</e1> with suspected lung cancer who <e2>have</e2> enlarged intrathoracic lymph nodes and who could potentially have treatment with curative intent .	actor-of(e1,e2)
Transmyocardial laser <e1>revascularisation</e1> is not <e2>recommended</e2> for the treatment of stable angina .	acts-on(e2,e1)
<e1>Offer</e1> image-guided biopsy to <e2>people</e2> with peripheral lung lesions when treatment can be planned on the basis of this test .	receiver(e2,e1)
Offer monotherapy with a conventional glucocorticosteroid to induce remission in people with a <e1>first</e1> <e2>presentation</e2> or a single inflammatory exacerbation of Crohn's disease in a 12-month period .	modifier(e1,e2)
<e1>Consider</e1> radiotherapy using 40 Gy in 15 fractions with concomitant and up to 12 cycles of adjuvant temozolomide for <e2>people</e2> aged around 70 or over .	receiver(e2,e1)
Consider adding methotrexate to a conventional <e1>glucocorticosteroid</e1> or <e2>budesonide</e2> to induce remission in people who cannot tolerate azathioprine or mercaptopurine .	choice
Conventional radiography of the SI joints and/or spine may be <e1>used</e1> for long-term <e2>monitoring</e2> of structural damage , particularly new bone formation , in axial SpA .	other
Maintain blood pressure below 45 ml/minute/1.73m2 if the person is aged <e1>under</e1> <e2>80</e2> years with type 1 diabetes .	modifier(e1,e2)
<e1>Offer</e1> nutritional <e2>assessment</e2> and tailored specialist dietetic support to people with oesophago-gastric cancer before , during and after radical treatments .	acts-on(e1,e2)
In patients with permanent AF or persistent AF following a rate control strategy and a resting heart rate > 110 bpm , appropriate rate control <e1>therapy</e1> should be <e2>instituted</e2> with an initial target of resting heart rate .	modifier(e2,e1)
For people with an acute cough who are identified at a <e1>face-to-face</e1> clinical <e2>examination</e2> as systemically very unwell , offer an immediate antibiotic prescription .	modifier(e1,e2)
<e1>Patients</e1> with AIIRD should receive tetanus toxoid vaccination in accordance to <e2>recommendations</e2> for the general population .	other
For <e1>people</e1> who cannot tolerate aminosalicylates , <e2>consider</e2> a time-limited course of a topical or an oral corticosteroid .	receiver(e1,e2)
For patients with HCV genotype 1 <e1>infection</e1> and <e2>HIV</e2> , who do not achieve an EVR , treatment should be stopped .	joint
Inactivated influenza <e1>vaccination</e1> should be strongly <e2>considered</e2> for patients with AIIRD .	acts-on(e2,e1)
Consider cinacalcet for people with primary hyperparathyroidism if surgery has been <e1>unsuccessful</e1> , is <e2>unsuitable</e2> or has been declined , and if their albumin-adjusted serum calcium level is either : 2.85 mmol/litre or above with symptoms of hypercalcaemia or 3 mmol/litre or above with or without symptoms of hypercalcaemia .	choice
<e1>Optimised</e1> antidepressant <e2>therapy</e2> should be considered for the treatment of patients with chronic pain with moderate depression .	modifier(e1,e2)
To induce remission in people with a mild-to-moderate first presentation or inflammatory exacerbation of extensive ulcerative colitis , offer a topical aminosalicylate and a high-dose oral aminosalicylate as <e1>first-line</e1> <e2>treatment</e2> .	modifier(e1,e2)
For preterm babies who need invasive ventilation , use volume-targeted ventilation in combination with synchronised ventilation as the primary <e1>mode</e1> of respiratory <e2>support</e2> .	other
Do not offer antispasmodics to adults , children and <e1>young</e1> <e2>people</e2> with suspected renal colic .	modifier(e1,e2)
Do not <e1>offer</e1> dedicated brain <e2>imaging</e2> to people with clinical stage 1 NSCLC who have no neurological symptoms and are having treatment with curative intent .	acts-on(e1,e2)
<e1>Pregabalin</e1> is <e2>recommended</e2> for the treatment of patients with fibromyalgia .	acts-on(e2,e1)
Treatment should be aimed at reaching the target of remission or , alternatively , minimal/low disease activity , by <e1>regular</e1> <e2>monitoring</e2> and appropriate adjustment of therapy .	modifier(e1,e2)
<e1>Consider</e1> ovarian function suppression in addition to endocrine therapy for premenopausal <e2>women</e2> with ER-positive invasive breast cancer .	receiver(e2,e1)
Do not use anticoagulation treatment routinely for the <e1>treatment</e1> of acute <e2>stroke</e2> .	other
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider dual therapy with <e1>metformin</e1> and a <e2>DPP-4i</e2> , metformin and pioglitazone , metformin and an SU , metformin and an SGLT-2i , and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	joint
Do not offer <e1>aspirin</e1> for the primary <e2>prevention</e2> of cardiovascular disease to adults with type 1 diabetes .	other
CVD risk assessment is <e1>recommended</e1> for all <e2>patients</e2> with RA , AS or PsA at least once every 5 years and should be reconsidered following major changes in antirheumatic therapy .	receiver(e2,e1)
<e1>Offer</e1> <e2>people</e2> diagnosed with cerebral venous sinus thrombosis full-dose anticoagulation treatment unless there are comorbidities that preclude its use .	receiver(e2,e1)
Pregabalin is <e1>recommended</e1> for the <e2>treatment</e2> of patients with neuropathic pain if other first and second line pharmacological treatments have failed .	acts-on(e1,e2)
If an adult with type 2 diabetes is symptomatically hyperglycaemic , consider <e1>insulin</e1> or an <e2>SU</e2> .	choice
Offer chemotherapy before and after surgery to people with gastric cancer who are <e1>having</e1> radical surgical <e2>resection</e2> .	acts-on(e1,e2)
<e1>Offer</e1> radical resection to <e2>people</e2> with T1bN0 oesophageal adenocarcinoma if they are fit enough to have surgery .	receiver(e2,e1)
Offer parathyroid surgery to women who <e1>have</e1> primary <e2>hyperparathyroidism</e2> and are considering pregnancy .	acts-on(e1,e2)
<e1>Patients</e1> with early stage peripheral lung <e2>cancers</e2> who are not suitable for surgery should be considered for stereotactic ablative radiotherapy .	owner(e1,e2)
If the person is aged under 80 years with stage 1 hypertension and <e1>has</e1> 10 year cardiovascular <e2>risk</e2> , offer antihypertensive drug treatment .	acts-on(e1,e2)
If long-term <e1>medium/high-dose</e1> GC <e2>therapy</e2> is anticipated to be necessary , actively consider GC-sparing therapy .	modifier(e1,e2)
Offer urgent low-dose <e1>non-contrast</e1> <e2>CT</e2> to adults with suspected renal colic .	modifier(e1,e2)
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider insulin-based treatment and support the person to aim for an HbA1c <e1>level</e1> of <e2>53</e2> mmol/mol ( 7 % ) .	modifier(e2,e1)
<e1>Offer</e1> people with heart failure an annual <e2>vaccination</e2> against influenza .	acts-on(e1,e2)
In patients with axial SpA without syndesmophytes in the lumbar spine on conventional radiography , osteoporosis should be assessed by hip <e1>DXA</e1> and AP-spine <e2>DXA</e2> .	joint
Avoid verapamil , diltiazem and short-acting dihydropyridine agents in people who have heart <e1>failure</e1> with reduced ejection <e2>fraction</e2> .	other
If the <e1>person</e1> is aged under 80 years with stage 1 <e2>hypertension</e2> , prescribe metformin and a DPP-4i and support for a target HbA1c level of 48 mmol/mol ( 6.5 % ) .	owner(e1,e2)
For <e1>patients</e1> receiving a protease inhibitor in combination with pegylated IFN and ribavirin therapy , <e2>consider</e2> ribavirin dose reduction as an alternative to the addition of EPO for controlling anaemia .	receiver(e1,e2)
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider dual <e1>therapy</e1> with a DPP-4i and pioglitazone , a <e2>DPP-4i</e2> and an SU , pioglitazone and an SU , and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	other
Consider adding <e1>intravenous</e1> <e2>ciclosporin</e2> to intravenous corticosteroids or consider surgery for people who have little or no improvement within 72 hours of starting intravenous corticosteroids or whose symptoms worsen at any time despite corticosteroid treatment .	modifier(e1,e2)
Patients with AIIRD who plan to travel are <e1>recommended</e1> to <e2>receive</e2> their vaccinations according to general rules , except for live attenuated vaccines which should be avoided whenever possible in immunosuppressed patients with AIIRD .	other
Offer an MRA , in addition to an ACE inhibitor ( or ARB ) and beta-blocker , to people who have heart failure with reduced ejection fraction if they continue to <e1>have</e1> <e2>symptoms</e2> of heart failure .	acts-on(e1,e2)
Monitor the effects of azathioprine , <e1>mercaptopurine</e1> and <e2>methotrexate</e2> as advised in the British National Formulary or British National Formulary for Children .	joint
Offer to carry out a blood test for rheumatoid factor in <e1>adults</e1> with suspected rheumatoid arthritis who are found to <e2>have</e2> synovitis on clinical examination .	actor-of(e1,e2)
In patients with predominantly axial <e1>disease</e1> that is <e2>active</e2> and has insufficient response to NSAIDs , therapy with a bDMARD should be considered , which according to current practice is a TNF inhibitor .	modifier(e2,e1)
Offer radiotherapy using 40 Gy in 15 fractions with concomitant and up to 12 cycles of adjuvant temozolomide for people aged <e1>around</e1> <e2>70</e2> or over .	modifier(e1,e2)
In patients with peripheral arthritis and an inadequate response to at least one csDMARD , in whom TNF inhibitors are not appropriate , bDMARDs targeting <e1>IL12/23</e1> or IL17 pathways may be <e2>considered</e2> .	modifier(e2,e1)
Consider adding <e1>methotrexate</e1> to a conventional <e2>glucocorticosteroid</e2> or budesonide to induce remission in people who cannot tolerate azathioprine or mercaptopurine .	other
Patients and the patients' treatment teams should receive appropriate , practical advice on how to <e1>manage</e1> with GC-induced hypothalamic-pituitary-adrenal axis <e2>suppression</e2> .	acts-on(e1,e2)
Amiodarone may be used when <e1>prophylaxis</e1> for atrial <e2>fibrillation</e2> and ventricular arrhythmias is indicated following CABG surgery .	other
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , <e1>consider</e1> insulin-based <e2>treatment</e2> and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	acts-on(e1,e2)
If dipstick screening is positive , use albumin:creatinine ratio or protein:creatinine ratio to quantify proteinuria in <e1>pregnant</e1> <e2>women</e2> .	modifier(e1,e2)
Aim for a target <e1>clinic</e1> blood <e2>pressure</e2> below 150/90 mmHg in people aged 80 years and over with treated hypertension .	modifier(e1,e2)
Consider opioids for adults , children and young people with suspected renal colic if both NSAIDs and <e1>intravenous</e1> <e2>paracetamol</e2> are contraindicated or are not giving sufficient pain relief .	modifier(e1,e2)
Repeat the albumin-adjusted serum calcium measurement at least once if the first measurement is either 2.6 mmol/litre or above or 2.5 mmol/litre or above and <e1>features</e1> of primary hyperparathyroidism are <e2>present</e2> .	modifier(e2,e1)
If the person is symptomatically hyperglycaemic , consider <e1>insulin</e1> or an <e2>SU</e2> .	choice
In patients with peripheral <e1>arthritis</e1> and an inadequate <e2>response</e2> to at least one csDMARD , in whom TNF inhibitors are not appropriate , bDMARDs targeting IL12/23 or IL17 pathways may be considered .	joint
<e1>Patients</e1> with heart failure with reduced ejection <e2>fraction</e2> of all NYHA functional classes , should be given angiotensin converting enzyme inhibitors .	owner(e1,e2)
Consider an ARB licensed for heart failure as an alternative to an ACE inhibitor for people who <e1>have</e1> heart <e2>failure</e2> with reduced ejection fraction and intolerable side effects with ACE inhibitors .	acts-on(e1,e2)
If the treatment target is not achieved with the <e1>first</e1> csDMARD <e2>strategy</e2> , when poor prognostic factors are present , addition of a bDMARD or a tsDMARD should be considered .	modifier(e1,e2)
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider triple therapy with metformin and a DPP-4i and an SU , metformin and pioglitazone and an SU , metformin and pioglitazone and an SGLT-2i , metformin and an SU and an SGLT-2i , insulin-based treatment , and <e1>support</e1> the <e2>person</e2> to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	acts-on(e1,e2)
Keep the requirement for continuing GC treatment under constant review , and titrate the dose against therapeutic response , <e1>risk</e1> of undertreatment and <e2>development</e2> of AEs .	joint
Offer intravenous paracetamol to <e1>adults</e1> , <e2>children</e2> and young people with suspected renal colic if NSAIDs are contraindicated or are not giving sufficient pain relief .	joint
Disease activity should be controlled optimally in order to lower CVD risk in all <e1>patients</e1> with <e2>RA</e2> , AS or PsA .	owner(e1,e2)
If remission is not achieved within 4 weeks , stop the topical aminosalicylate and offer a high-dose oral aminosalicylate with a <e1>time-limited</e1> <e2>course</e2> of an oral corticosteroid .	modifier(e1,e2)
For women with a cerebrovascular malformation at low risk of intracranial bleeding , manage the second stage of labour based on the woman's <e1>preference</e1> and obstetric <e2>indications</e2> .	joint
<e1>Routine</e1> <e2>initiation</e2> of perioperative beta-blocker therapy to reduce perioperative myocardial infarction in patients undergoing non cardiac surgery is not recommended .	modifier(e1,e2)
Offer flexible bronchoscopy to people with <e1>central</e1> <e2>lesions</e2> on CT if nodal staging does not influence treatment .	modifier(e1,e2)
If further treatment is needed , consider adding a time-limited <e1>course</e1> of a topical or an oral <e2>corticosteroid</e2> .	other
<e1>Amiodarone</e1> may be <e2>used</e2> when prophylaxis for atrial fibrillation and ventricular arrhythmias is indicated following CABG surgery .	modifier(e2,e1)
When peripheral SpA is suspected , US or MRI may be used to <e1>detect</e1> peripheral <e2>enthesitis</e2> , which may support the diagnosis of SpA .	acts-on(e1,e2)
Offer a <e1>pancreatic</e1> protocol CT <e2>scan</e2> to people with pancreatic abnormalities but no jaundice .	modifier(e1,e2)
<e1>Offer</e1> a non-steroidal anti-inflammatory <e2>drug</e2> by any route as first-line treatment for adults , children and young people with suspected renal colic .	acts-on(e1,e2)
The vaccination status should be <e1>assessed</e1> in the initial <e2>work-up</e2> of patients with AIIRD .	other
Offer <e1>flexible</e1> <e2>bronchoscopy</e2> to people with central lesions on CT if nodal staging does not influence treatment .	modifier(e1,e2)
Class 1 antiarrhythmic drugs should not be used for treatment of premature ventricular <e1>beats</e1> or non sustained <e2>VT</e2> in patients with previous MI .	choice
If remission is not achieved within 4 weeks , <e1>consider</e1> adding an oral <e2>aminosalicylate</e2> .	acts-on(e1,e2)
Second line systemic anticancer therapy with single agent docetaxel or erlotinib should be considered for patients with performance status 0-2 recurrent NSCLC who have been previously <e1>treated</e1> with first line <e2>SACT</e2> for advanced disease .	acts-on(e1,e2)
When peripheral SpA is suspected , US or MRI may be used to detect peripheral <e1>enthesitis</e1> , which may <e2>support</e2> the diagnosis of SpA .	actor-of(e1,e2)
To induce remission in <e1>people</e1> with a mild-to-moderate first <e2>presentation</e2> or inflammatory exacerbation of proctitis , offer a topical aminosalicylate as first-line treatment .	owner(e1,e2)
Niraparib <e1>monotherapy</e1> should be <e2>considered</e2> for maintenance treatment after response to platinum for patients with relapsed platinum sensitive non germline BRCA mutated ovarian cancer .	acts-on(e2,e1)
Intravenous amiodarone should be considered in the management of patients with haemodynamically <e1>stable</e1> sustained monomorphic <e2>VT</e2> .	modifier(e1,e2)
In <e1>patients</e1> with suspected stable <e2>angina</e2> , the exercise tolerance test should not be used routinely as a first line diagnostic tool .	owner(e1,e2)
If an <e1>adult</e1> with type 2 diabetes is symptomatically hyperglycaemic , <e2>consider</e2> insulin or an SU .	receiver(e1,e2)
Aromatase inhibitor is recommended for ER positive postmenopausal women receiving <e1>neoadjuvant</e1> endocrine <e2>therapy</e2> .	modifier(e1,e2)
In patients with <e1>permanent</e1> <e2>AF</e2> or persistent AF following a rate control strategy and a resting heart rate > 110 bpm , appropriate rate control therapy should be instituted with an initial target of resting heart rate .	modifier(e1,e2)
For eligible people with stage 3A NSCLC who cannot <e1>tolerate</e1> or who <e2>decline</e2> chemoradiotherapy , consider radical radiotherapy .	choice
Offer a proton pump inhibitor , in addition to aspirin , to anyone with acute ischaemic stroke for whom previous <e1>dyspepsia</e1> associated with aspirin is <e2>reported</e2> .	acts-on(e2,e1)
Offer PET-CT , followed by EBUS-TBNA and/or EUS-FNA , to people with suspected lung cancer who have <e1>enlarged</e1> intrathoracic lymph <e2>nodes</e2> and who could potentially have treatment with curative intent .	modifier(e1,e2)
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider dual therapy with metformin and a DPP-4i , metformin and pioglitazone , metformin and an SU , metformin and an SGLT-2i , and support the <e1>person</e1> to <e2>aim</e2> for an HbA1c level of 53 mmol/mol ( 7 % ) .	actor-of(e1,e2)
Offer parathyroid surgery to <e1>women</e1> who have primary hyperparathyroidism and are <e2>considering</e2> pregnancy .	actor-of(e1,e2)
In <e1>patients</e1> who cannot <e2>use</e2> csDMARDs as comedication , IL-6 pathway inhibitors and tsDMARDs may have some advantages compared with other bDMARDs .	actor-of(e1,e2)
If the diagnosis is still unclear , <e1>offer</e1> <e2>CT</e2> and EUS with EUS-guided tissue sampling .	acts-on(e1,e2)
MRI of the SI joints and/or the spine may be used to assess and monitor disease activity in axial SpA , providing additional information on top of <e1>clinical</e1> and biochemical <e2>assessments</e2> .	modifier(e1,e2)
<e1>Local</e1> <e2>injections</e2> of glucocorticoids should be considered as adjunctive therapy in PsA .	modifier(e1,e2)
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider dual therapy with metformin and a DPP-4i , metformin and pioglitazone , metformin and an SU , metformin and an SGLT-2i , and support the person to <e1>aim</e1> for an HbA1c <e2>level</e2> of 53 mmol/mol ( 7 % ) .	acts-on(e1,e2)
Ensure that people with <e1>disabling</e1> ischaemic <e2>stroke</e2> who are in atrial fibrillation are treated with aspirin 300 mg for the first 2 weeks before anticoagulation treatment is considered .	modifier(e1,e2)
Anthracycline taxane based chemotherapy combinations should be considered for all patients <e1>receiving</e1> neoadjuvant <e2>chemotherapy</e2> .	acts-on(e1,e2)
Before starting <e1>medium/high-dose</e1> GC <e2>treatment</e2> , consider comorbidities predisposing to AEs .	modifier(e1,e2)
Offer urgent ultrasound as first-line imaging for children and young people with <e1>suspected</e1> renal <e2>colic</e2> .	modifier(e1,e2)
<e1>Assess</e1> thiopurine methyltransferase <e2>activity</e2> before offering azathioprine or mercaptopurine .	acts-on(e1,e2)
Class 1 antiarrhythmic drugs should not be used for <e1>treatment</e1> of premature ventricular <e2>beats</e2> or non sustained VT in patients with previous MI .	other
In patients with peripheral arthritis and an <e1>inadequate</e1> <e2>response</e2> to at least one csDMARD , in whom bDMARDs are not appropriate , a targeted synthetic DMARD such as a PDE4-inhibitor may be considered .	modifier(e1,e2)
Consider an ARB licensed for heart failure as an alternative to an ACE inhibitor for people who have heart failure with reduced ejection fraction and <e1>intolerable</e1> side <e2>effects</e2> with ACE inhibitors .	modifier(e1,e2)
All women with <e1>non-mucinous</e1> <e2>ovarian</e2> or fallopian tube cancer should be offered BRCA1 and BRCA2 mutation testing .	modifier(e1,e2)
If HbA1c rises to 48 mmol/mol ( 6.5 % ) on lifestyle interventions , <e1>consider</e1> a DPP-4i , pioglitazone , an SU , an SGLT-2i , and <e2>support</e2> the person to aim for an HbA1c level of 48 mmol/mol ( 6.5 % ) for people on a DPP-4i , SGLT-2i or pioglitazone or 53 mmol/mol ( 7 % ) for people on an SU .	other
If the diagnosis is still unclear , offer <e1>CT</e1> and <e2>EUS</e2> with EUS-guided tissue sampling .	joint
In patients with permanent AF or persistent AF following a rate control strategy and a resting heart rate > 110 bpm , appropriate rate control therapy should be instituted with an <e1>initial</e1> <e2>target</e2> of resting heart rate .	modifier(e1,e2)
All <e1>patients</e1> co-infected with HIV and HCV genotype 1 should be <e2>considered</e2> for treatment with a regimen which includes an HCV protease inhibitor .	modifier(e2,e1)
<e1>Patients</e1> with chronic hepatitis B and C co-infection should be <e2>considered</e2> for treatment with pegylated IFN and weight based ribavirin .	receiver(e1,e2)
Review antibiotic treatment after 14 days and either stop the antibiotic or continue for a further 14 days if needed , based on an assessment of the person's history , symptoms , clinical examination , <e1>urine</e1> and blood <e2>tests</e2> .	joint
Do not <e1>offer</e1> a bisphosphonate to pregnant <e2>women</e2> with primary hyperparathyroidism .	receiver(e2,e1)
In peripheral SpA , if the <e1>clinical</e1> <e2>scenario</e2> requires monitoring of structural damage , then conventional radiography is recommended .	modifier(e1,e2)
A regimen containing a platinum agent and etoposide is recommended for first <e1>line</e1> <e2>treatment</e2> of patients with SCLC .	modifier(e1,e2)
To induce remission in people with a mild-to-moderate <e1>first</e1> <e2>presentation</e2> or inflammatory exacerbation of proctosigmoiditis or left-sided ulcerative colitis , offer a topical aminosalicylate as first-line treatment .	modifier(e1,e2)
Offer PET-CT as the preferred first test after CT with a low probability of nodal malignancy , for <e1>people</e1> with lung <e2>cancer</e2> who could potentially have treatment with curative intent .	owner(e1,e2)
In patients who cannot <e1>use</e1> <e2>csDMARDs</e2> as comedication , IL-6 pathway inhibitors and tsDMARDs may have some advantages compared with other bDMARDs .	acts-on(e1,e2)
Advise pregnant <e1>women</e1> at high risk of pre-eclampsia to <e2>take</e2> 75-150 mg of aspirin daily from 12 weeks until the birth of the baby .	actor-of(e1,e2)
Offer <e1>antihypertensive</e1> drug <e2>treatment</e2> for heart failure with treated hypertension .	modifier(e1,e2)
Offer <e1>systemic</e1> combination <e2>chemotherapy</e2> to people with locally advanced pancreatic cancer who are well enough to tolerate it .	modifier(e1,e2)
If the <e1>person</e1> is aged under 80 years with stage 1 <e2>hypertension</e2> and has established cardiovascular disease , offer antihypertensive drug treatment .	owner(e1,e2)
Consider ovarian function suppression in addition to endocrine therapy for <e1>premenopausal</e1> <e2>women</e2> with ER-positive invasive breast cancer .	modifier(e1,e2)
Offer <e1>PET-CT</e1> , followed by <e2>EBUS-TBNA</e2> and/or EUS-FNA , to people with suspected lung cancer who have enlarged intrathoracic lymph nodes and who could potentially have treatment with curative intent .	joint
Lifestyle recommendations should emphasise the benefits of a <e1>healthy</e1> <e2>diet</e2> , regular exercise and smoking cessation for all patients .	modifier(e1,e2)
BCG <e1>vaccination</e1> is not <e2>recommended</e2> in patients with AIIRD .	acts-on(e2,e1)
Consider aminosalicylate treatment for a first presentation or a single inflammatory exacerbation in a 12-month period if <e1>conventional</e1> <e2>glucocorticosteroids</e2> are contraindicated , or if the person declines or cannot tolerate them .	modifier(e1,e2)
Do not <e1>offer</e1> nitrosoureas concurrently with radiotherapy to <e2>people</e2> with newly diagnosed grade 3 glioma .	receiver(e2,e1)
To induce remission in people with a mild-to-moderate first presentation or inflammatory exacerbation of extensive ulcerative colitis , offer a <e1>topical</e1> <e2>aminosalicylate</e2> and a high-dose oral aminosalicylate as first-line treatment .	modifier(e1,e2)
Amiodarone therapy is not recommended for <e1>patients</e1> following ACS or <e2>patients</e2> with congestive heart failure who do not have sustained ventricular arrhythmias or atrial fibrillation .	choice
Conventional radiography of the SI <e1>joints</e1> and/or <e2>spine</e2> may be used for long-term monitoring of structural damage , particularly new bone formation , in axial SpA .	joint
Consider adjuvant radiotherapy for patients with completely resected stage <e1>3B</e1> or 3C <e2>melanoma</e2> after discussion of the risk of local recurrence and the benefits and risks of radiotherapy including risk of significant adverse effects .	choice
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider dual <e1>therapy</e1> with <e2>metformin</e2> and a DPP-4i , metformin and pioglitazone , metformin and an SU , metformin and an SGLT-2i , and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	other
In patients with stable angina requiring percutaneous coronary <e1>intervention</e1> for in stent <e2>restenosis</e2> , a drug eluting balloon or a second or third generation drug eluting stent should be considered .	other
When spinal <e1>fracture</e1> in axial <e2>SpA</e2> is suspected , conventional radiography is the recommended initial imaging method .	other
If further treatment is needed , stop topical treatments and offer an oral <e1>aminosalicylate</e1> and a time-limited <e2>course</e2> of an oral corticosteroid .	joint
<e1>Offer</e1> a pancreatic protocol CT <e2>scan</e2> to people with pancreatic abnormalities but no jaundice .	acts-on(e1,e2)
In patients being considered for active therapy , pleural effusion should be <e1>investigated</e1> with pleural aspiration and/or pleural biopsy <e2>using</e2> image-guided or thoracoscopic biopsy .	other
If the person is with CKD and diabetes and an <e1>ACR</e1> of 3 <e2>mg/mmol</e2> or more , offer a low-cost renin-angiotensin-aldosterone system antagonist .	modifier(e2,e1)
<e1>Consider</e1> stone analysis for <e2>adults</e2> with ureteric or renal stones .	receiver(e2,e1)
Amiodarone therapy is not recommended for <e1>patients</e1> <e2>following</e2> ACS or patients with congestive heart failure who do not have sustained ventricular arrhythmias or atrial fibrillation .	actor-of(e1,e2)
If the person is with CKD and an <e1>ACR</e1> of <e2>70</e2> mg/mmol or more , offer a low-cost renin-angiotensin-aldosterone system antagonist .	modifier(e2,e1)
In peripheral SpA , if the clinical scenario requires monitoring of structural damage , then conventional <e1>radiography</e1> is <e2>recommended</e2> .	acts-on(e2,e1)
For preterm babies who need invasive ventilation , use volume-targeted ventilation in combination with synchronised ventilation as the <e1>primary</e1> <e2>mode</e2> of respiratory support .	modifier(e1,e2)
TC and HDLc should be used in CVD risk assessment in RA , AS and PsA and lipids should ideally be measured when disease activity is <e1>stable</e1> or in <e2>remission</e2> .	choice
Do not offer nitrosoureas concurrently with radiotherapy to <e1>people</e1> with newly diagnosed grade 3 <e2>glioma</e2> .	owner(e1,e2)
Consider aminosalicylate treatment for a first <e1>presentation</e1> or a single inflammatory <e2>exacerbation</e2> in a 12-month period if conventional glucocorticosteroids are contraindicated , or if the person declines or cannot tolerate them .	choice
A regimen containing a platinum agent and etoposide is recommended for first line <e1>treatment</e1> of <e2>patients</e2> with SCLC .	other
If a <e1>patient</e1> is in persistent <e2>remission</e2> , tapering the csDMARD could be considered .	owner(e1,e2)
Do not offer <e1>budesonide</e1> or aminosalicylate <e2>treatment</e2> for severe presentations or exacerbations .	choice
Routine <e1>initiation</e1> of perioperative beta-blocker therapy to <e2>reduce</e2> perioperative myocardial infarction in patients undergoing non cardiac surgery is not recommended .	actor-of(e1,e2)
Treatment should be aimed at <e1>reaching</e1> a <e2>target</e2> of sustained remission or low disease activity in every patient .	acts-on(e1,e2)
Consider adding intravenous ciclosporin to intravenous corticosteroids or consider surgery for people who have little or no improvement within 72 hours of starting <e1>intravenous</e1> <e2>corticosteroids</e2> or whose symptoms worsen at any time despite corticosteroid treatment .	modifier(e1,e2)
Where appropriate , functional tests , including the exercise tolerance test , should be considered to aid in the risk stratification of <e1>patients</e1> with known <e2>CAD</e2> .	owner(e1,e2)
Evaluate PET-CT-positive or enlarged intrathoracic nodes using a systematic approach with <e1>EBUS-TBNA</e1> and/or <e2>EUS-FNA</e2> if nodal status would affect the treatment plan .	joint
<e1>Consider</e1> adjuvant therapy after surgery for <e2>people</e2> with invasive breast cancer , and ensure that recommendations are recorded at the multidisciplinary team meeting .	receiver(e2,e1)
Patients with an ST segment elevation acute coronary syndrome should be <e1>treated</e1> immediately with primary percutaneous coronary <e2>intervention</e2> .	other
<e1>Offer</e1> parathyroid <e2>surgery</e2> to women who have primary hyperparathyroidism and are considering pregnancy .	acts-on(e1,e2)
Consider surgical mediastinal staging for people with a negative EBUS-TBNA or EUS-FNA if clinical suspicion of nodal malignancy is high and nodal <e1>status</e1> would <e2>affect</e2> their treatment plan .	actor-of(e1,e2)
For people with an acute <e1>cough</e1> who are <e2>identified</e2> at a face-to-face clinical examination as systemically very unwell , offer an immediate antibiotic prescription .	modifier(e2,e1)
To induce remission in people with a mild-to-moderate first presentation or inflammatory <e1>exacerbation</e1> of <e2>proctosigmoiditis</e2> or left-sided ulcerative colitis , offer a topical aminosalicylate as first-line treatment .	other
If the person is aged under 80 years with reduced ejection fraction , maintain blood <e1>pressure</e1> below <e2>150/90</e2> mmHg .	modifier(e2,e1)
<e1>Measure</e1> blood <e2>pressure</e2> after each dose increment of an ARB .	acts-on(e1,e2)
CVD risk estimation for <e1>patients</e1> with <e2>RA</e2> , AS or PsA should be performed according to national guidelines and the SCORE CVD risk prediction model should be used if no national guideline is available .	owner(e1,e2)
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider dual therapy with a DPP-4i and pioglitazone , a DPP-4i and an SU , pioglitazone and an SU , and support the person to aim for an HbA1c <e1>level</e1> of <e2>53</e2> mmol/mol ( 7 % ) .	modifier(e2,e1)
If the person is aged <e1>under</e1> 80 <e2>years</e2> with stage 1 hypertension and has target organ damage , offer antihypertensive drug treatment .	modifier(e1,e2)
Consider enteric-coated pancreatin <e1>before</e1> and <e2>after</e2> pancreatic cancer resection .	joint
Do not use synchronised pressure-limited ventilation such as assist control , synchronised intermittent positive pressure ventilation , <e1>patient-triggered</e1> <e2>ventilation</e2> , pressure support ventilation or synchronised time-cycled pressure-limited ventilation .	modifier(e1,e2)
Consider prostaglandin E1 as an option for treating postpartum haemorrhage in <e1>women</e1> with <e2>asthma</e2> because there is no evidence it worsens asthma .	owner(e1,e2)
Offer an alternative antiplatelet agent to <e1>anyone</e1> with acute ischaemic <e2>stroke</e2> who is allergic to or genuinely intolerant of aspirin .	owner(e1,e2)
For adults with sudden onset acute vestibular syndrome , a HINTS <e1>test</e1> should be <e2>performed</e2> if a healthcare professional with training and experience in the use of this test is available .	acts-on(e2,e1)
<e1>Vaccination</e1> in <e2>patients</e2> with AIIRD should ideally be administered during stable disease .	other
If the person is aged under 80 years with stage 1 hypertension and has diabetes , offer <e1>antihypertensive</e1> drug <e2>treatment</e2> .	modifier(e1,e2)
Offer a pancreatic protocol CT scan to <e1>people</e1> with pancreatic <e2>abnormalities</e2> but no jaundice .	owner(e1,e2)
If one TNF-inhibitor <e1>therapy</e1> has <e2>failed</e2> , patients may receive another TNF-inhibitor or an agent with another mode of action .	actor-of(e1,e2)
If HbA1c rises to 48 mmol/mol ( 6.5 % ) on lifestyle interventions , consider a DPP-4i , pioglitazone , an SU , an SGLT-2i , and support the person to aim for an HbA1c level of 48 mmol/mol ( 6.5 % ) for <e1>people</e1> on a <e2>DPP-4i</e2> , SGLT-2i or pioglitazone or 53 mmol/mol ( 7 % ) for people on an SU .	owner(e1,e2)
In patients with predominantly axial disease that is active and has <e1>insufficient</e1> <e2>response</e2> to NSAIDs , therapy with a bDMARD should be considered , which according to current practice is a TNF inhibitor .	modifier(e1,e2)
Measure serum calcium for <e1>people</e1> who <e2>develop</e2> a pancreatic cancer resection .	actor-of(e1,e2)
<e1>Patients</e1> with compensated <e2>cirrhosis</e2> should be considered for therapy , unless contraindicated .	owner(e1,e2)
Gabapentin should be <e1>considered</e1> for the <e2>treatment</e2> of patients with neuropathic pain .	acts-on(e1,e2)
If further <e1>treatment</e1> is <e2>needed</e2> , consider adding a time-limited course of a topical or an oral corticosteroid .	modifier(e2,e1)
To induce remission in people with a mild-to-moderate first presentation or inflammatory <e1>exacerbation</e1> of <e2>proctitis</e2> , offer a topical aminosalicylate as first-line treatment .	other
Patients with genotype 1 infection should be <e1>tested</e1> for an <e2>EVR</e2> at 12 weeks .	other
Provide an accessible resource to <e1>promote</e1> best <e2>practice</e2> in the management of patients using medium/high-dose GCs to general practitioners .	acts-on(e1,e2)
If a person is unable to tolerate <e1>ABPM</e1> , <e2>HBPM</e2> is a suitable alternative to confirm the diagnosis of hypertension .	other
<e1>Measure</e1> parathyroid <e2>hormone</e2> for people whose albumin-adjusted serum calcium level is either 2.6 mmol/litre or above on at least 2 separate occasions or 2.5 mmol/litre or above on at least 2 separate occasions and primary hyperparathyroidism is suspected .	acts-on(e1,e2)
Patients with left main stem stenosis and/or multivessel disease should be considered for <e1>revascularisation</e1> to <e2>improve</e2> prognosis .	actor-of(e1,e2)
In hyposplenic/asplenic patients with AIIRD <e1>influenza</e1> , <e2>pneumococcal</e2> , Haemophilus influenzae b and meningococcal C , vaccinations are recommended .	joint
In patients with peripheral arthritis , particularly in those with many swollen joints , structural damage in the presence of inflammation , high <e1>ESR/CRP</e1> and/or clinically relevant extra-articular <e2>manifestations</e2> , csDMARDs should be considered at an early stage , with methotrexate preferred in those with relevant skin involvement .	joint
<e1>Maintain</e1> blood <e2>pressure</e2> below 130/80 mmHg or lower for people who have heart failure with stage 2 diabetes .	acts-on(e1,e2)
For children who are allergic to penicillins , consider an alternative <e1>oral</e1> anti-Staphylococcus aureus <e2>agent</e2> .	modifier(e1,e2)
For <e1>preterm</e1> <e2>babies</e2> who need invasive ventilation , use volume-targeted ventilation in combination with synchronised ventilation as the primary mode of respiratory support .	modifier(e1,e2)
<e1>Consider</e1> cinacalcet for <e2>people</e2> with primary hyperparathyroidism if surgery has been unsuccessful , is unsuitable or has been declined , and if their albumin-adjusted serum calcium level is either : 2.85 mmol/litre or above with symptoms of hypercalcaemia or 3 mmol/litre or above with or without symptoms of hypercalcaemia .	receiver(e2,e1)
<e1>Patients</e1> with stage 1 and 2 NSCLC should be <e2>considered</e2> for curative surgery whenever possible .	receiver(e1,e2)
Do not <e1>use</e1> fish <e2>oils</e2> as a nutritional intervention to manage weight loss in people with unresectable pancreatic cancer .	acts-on(e1,e2)
In patients with active enthesitis and/or dactylitis and insufficient response to NSAIDs or local glucocorticoid injections , <e1>therapy</e1> with a bDMARD should be <e2>considered</e2> , which according to current practice is a TNF inhibitor .	modifier(e2,e1)
Consider measuring anti-CCP antibodies in adults with suspected RA if <e1>they</e1> are <e2>negative</e2> for rheumatoid factor .	modifier(e2,e1)
Provide an accessible resource to promote best practice in the <e1>management</e1> of <e2>patients</e2> using medium/high-dose GCs to general practitioners .	other
If remission is not achieved within 4 weeks , consider adding a high-dose oral aminosalicylate to the topical aminosalicylate or switching to a high-dose oral aminosalicylate and a time-limited course of a <e1>topical</e1> <e2>corticosteroid</e2> .	modifier(e1,e2)
Digoxin should not be used for prophylaxis of atrial <e1>fibrillation</e1> <e2>following</e2> CABG surgery .	actor-of(e1,e2)
For women with a cerebrovascular malformation at low risk of intracranial bleeding , base decisions on the mode of birth on the woman's <e1>preference</e1> and obstetric <e2>indications</e2> .	joint
<e1>Offer</e1> nutritional assessment and tailored specialist dietetic support to <e2>people</e2> with oesophago-gastric cancer before , during and after radical treatments .	receiver(e2,e1)
Patients with advanced liver disease should be given nutritional support to <e1>minimise</e1> <e2>malnutrition</e2> .	acts-on(e1,e2)
Patients with acute coronary syndrome should have <e1>continuous</e1> cardiac rhythm <e2>monitoring</e2> .	modifier(e1,e2)
Monitor the response to titration of medicines closely in people who have heart failure with <e1>reduced</e1> ejection <e2>fraction</e2> and chronic kidney disease .	modifier(e1,e2)
For preterm <e1>babies</e1> who <e2>need</e2> invasive ventilation but VTV and HFOV are not available or not suitable , consider synchronised intermittent mandatory ventilation .	actor-of(e1,e2)
Assess thiopurine methyltransferase activity before offering <e1>azathioprine</e1> or <e2>mercaptopurine</e2> .	choice
If <e1>HbA1c</e1> <e2>rises</e2> to 48 mmol/mol ( 6.5 % ) on lifestyle interventions , offer metformin and support the person to aim for an HbA1c level of 48 mmol/mol ( 6.5 % ) .	actor-of(e1,e2)
Patients with <e1>acute</e1> coronary <e2>syndrome</e2> should have continuous cardiac rhythm monitoring .	modifier(e1,e2)
Calcium channel blocker therapy is not recommended for reduction in sudden <e1>death</e1> or all cause <e2>mortality</e2> in patients following ACS .	choice
Assess the ER <e1>status</e1> of all invasive breast <e2>cancers</e2> using standardised and quality-assured immunohistochemical techniques , and report the results quantitatively .	other
For <e1>patients</e1> <e2>receiving</e2> a protease inhibitor in combination with pegylated IFN and ribavirin therapy , consider ribavirin dose reduction as an alternative to the addition of EPO for controlling anaemia .	actor-of(e1,e2)
<e1>Patients</e1> with HCV associated chronic liver <e2>failure</e2> should be considered for assessment for liver transplantation .	owner(e1,e2)
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , <e1>consider</e1> triple <e2>therapy</e2> with metformin and a DPP-4i and an SU , metformin and pioglitazone and an SU , metformin and pioglitazone and an SGLT-2i , metformin and an SU and an SGLT-2i , insulin-based treatment , and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	acts-on(e1,e2)
<e1>Offer</e1> radiotherapy using 40 Gy in 15 fractions with concomitant and up to 12 cycles of adjuvant temozolomide for <e2>people</e2> aged around 70 or over .	receiver(e2,e1)
If the person is with stage 2 diabetes and symptomatically hyperglycaemic , offer SGLT-2i , <e1>pioglitazone</e1> or <e2>ergocalciferol</e2> .	choice
For <e1>people</e1> who cannot tolerate aminosalicylates , <e2>consider</e2> a time-limited course of an oral corticosteroid .	receiver(e1,e2)
For <e1>people</e1> with cystic fibrosis who <e2>develop</e2> a Haemophilus influenzae infection but do not have clinical evidence of pulmonary infection , treat with an appropriate oral antibiotic .	actor-of(e1,e2)
Offer standard structural MRI as the initial diagnostic <e1>test</e1> for suspected <e2>glioma</e2> , unless MRI is contraindicated .	other
Offer an alternative antiplatelet agent to <e1>anyone</e1> with acute ischaemic stroke who is <e2>allergic</e2> to or genuinely intolerant of aspirin .	modifier(e2,e1)
All <e1>patients</e1> with chronic HCV infection should be <e2>considered</e2> for antiviral therapy .	receiver(e1,e2)
Consider adding intravenous ciclosporin to <e1>intravenous</e1> <e2>corticosteroids</e2> or consider surgery for people who have little or no improvement within 72 hours of starting intravenous corticosteroids or whose symptoms worsen at any time despite corticosteroid treatment .	modifier(e1,e2)
To induce remission in <e1>people</e1> with a mild-to-moderate first <e2>presentation</e2> or inflammatory exacerbation of proctosigmoiditis or left-sided ulcerative colitis , offer a topical aminosalicylate as first-line treatment .	owner(e1,e2)
Calcium channel blocker therapy is not <e1>recommended</e1> for reduction in sudden death or all cause mortality in <e2>patients</e2> following ACS .	receiver(e2,e1)
Do not use synchronised pressure-limited ventilation such as assist control , synchronised intermittent positive pressure ventilation , patient-triggered ventilation , pressure <e1>support</e1> <e2>ventilation</e2> or synchronised time-cycled pressure-limited ventilation .	modifier(e1,e2)
In patients with stable angina requiring percutaneous coronary intervention for in stent restenosis , a drug eluting balloon or a <e1>second</e1> or <e2>third</e2> generation drug eluting stent should be considered .	choice
If the person is with CKD and diabetes and an ACR of 3 mg/mmol or more , offer a <e1>low-cost</e1> renin-angiotensin-aldosterone system <e2>antagonist</e2> .	modifier(e1,e2)
The decision on when to repeat US/MRI depends on the <e1>clinical</e1> <e2>circumstances</e2> .	modifier(e1,e2)
Where appropriate , functional tests , including the exercise tolerance test , should be considered to <e1>aid</e1> in the risk <e2>stratification</e2> of patients with known CAD .	acts-on(e1,e2)
Offer a mucoactive agent to people with cystic fibrosis who <e1>have</e1> clinical <e2>evidence</e2> of lung disease .	acts-on(e1,e2)
Consider prostaglandin E1 as an option for treating postpartum haemorrhage in women with asthma because there is no evidence it <e1>worsens</e1> <e2>asthma</e2> .	acts-on(e1,e2)
If the person is aged under 80 years with reduced ejection fraction , <e1>maintain</e1> blood <e2>pressure</e2> below 150/90 mmHg .	acts-on(e1,e2)
Do not offer <e1>azathioprine</e1> , <e2>mercaptopurine</e2> or methotrexate as monotherapy to induce remission .	choice
Do not <e1>routinely</e1> <e2>repeat</e2> PTH measurement in primary care .	modifier(e1,e2)
Patients with acute coronary syndrome should <e1>have</e1> continuous cardiac rhythm <e2>monitoring</e2> .	acts-on(e1,e2)
Adjuvant <e1>trastuzumab</e1> should be <e2>considered</e2> in all patients with HER 2 positive breast cancer who receive adjuvant chemotherapy .	acts-on(e2,e1)
Women with platinum <e1>resistant</e1> ovarian <e2>cancer</e2> should be considered for treatment with paclitaxel or single agent pegylated liposomal doxorubicin hydrochloride .	modifier(e1,e2)
For women with a cerebrovascular malformation at low <e1>risk</e1> of intracranial <e2>bleeding</e2> , manage the second stage of labour based on the woman's preference and obstetric indications .	other
For patients with HCV genotype 1 infection and HIV , who do not achieve an EVR , <e1>treatment</e1> should be <e2>stopped</e2> .	acts-on(e2,e1)
Offer a mucoactive agent to <e1>people</e1> with cystic fibrosis who <e2>have</e2> clinical evidence of lung disease .	actor-of(e1,e2)
Request the oestrogen receptor , progesterone <e1>receptor</e1> and human epidermal growth receptor 2 <e2>status</e2> of all invasive breast cancers simultaneously at the time of initial histopathological diagnosis .	joint
CVD risk management should be carried out according to national guidelines in RA , <e1>AS</e1> or <e2>PsA</e2> .	choice
<e1>Maintain</e1> blood pressure below 130/80 mmHg for <e2>people</e2> with advanced pancreatic cancer .	receiver(e2,e1)
Consider adding intravenous ciclosporin to intravenous corticosteroids or <e1>consider</e1> <e2>surgery</e2> for people who have little or no improvement within 72 hours of starting intravenous corticosteroids or whose symptoms worsen at any time despite corticosteroid treatment .	acts-on(e1,e2)
In patients with peripheral arthritis , particularly in those with many swollen joints , structural damage in the presence of inflammation , high ESR/CRP and/or clinically relevant extra-articular manifestations , csDMARDs should be considered at an <e1>early</e1> <e2>stage</e2> , with methotrexate preferred in those with relevant skin involvement .	modifier(e1,e2)
If the person is with stage 2 diabetes and symptomatically hyperglycaemic , offer <e1>SGLT-2i</e1> , <e2>pioglitazone</e2> or ergocalciferol .	choice
For <e1>women</e1> with a cerebrovascular <e2>malformation</e2> at low risk of intracranial bleeding , manage the second stage of labour based on the woman's preference and obstetric indications .	owner(e1,e2)
In patients with permanent AF or persistent AF following a rate control strategy and a resting heart rate > 110 bpm , appropriate rate control therapy should be instituted with an initial <e1>target</e1> of resting heart <e2>rate</e2> .	other
Offer <e1>monotherapy</e1> with a conventional glucocorticosteroid to <e2>induce</e2> remission in people with a first presentation or a single inflammatory exacerbation of Crohn's disease in a 12-month period .	actor-of(e1,e2)
<e1>Consider</e1> oral sodium bicarbonate <e2>supplementation</e2> for people with both a GFR less than 30 ml/min/1.73m2 and a serum bicarbonate concentration of less than 20 mmol/litre .	acts-on(e1,e2)
For people with an acute cough who are identified at a face-to-face clinical examination as at higher risk of complications , consider an immediate antibiotic <e1>prescription</e1> or a back-up antibiotic <e2>prescription</e2> .	choice
In patients with <e1>axial</e1> <e2>SpA</e2> without syndesmophytes in the lumbar spine on conventional radiography , osteoporosis should be assessed by hip DXA and AP-spine DXA .	modifier(e1,e2)
<e1>Offer</e1> bisphosphonates if indicated for the prevention and treatment of osteoporosis in <e2>people</e2> with a GFR of 30 ml/min/1.73m2 or more .	receiver(e2,e1)
Maintain blood pressure below 140/90 mmHg for people who <e1>have</e1> <e2>symptoms</e2> of stage 1 hypertension .	acts-on(e1,e2)
In general , STIR sequences are sufficient to detect inflammation and the use of contrast <e1>medium</e1> is not <e2>needed</e2> .	modifier(e2,e1)
Consider bisphosphonates as <e1>adjuvant</e1> <e2>therapy</e2> for postmenopausal women with node-negative invasive breast cancer and a high risk of recurrence .	modifier(e1,e2)
CVD risk management should be carried out according to national <e1>guidelines</e1> in <e2>RA</e2> , AS or PsA .	other
Consider bisphosphonates as adjuvant therapy for <e1>postmenopausal</e1> <e2>women</e2> with node-negative invasive breast cancer and a high risk of recurrence .	modifier(e1,e2)
<e1>Fluoxetine</e1> should be <e2>considered</e2> for the treatment of patients with fibromyalgia .	acts-on(e2,e1)
Advise pregnant <e1>women</e1> at high <e2>risk</e2> of pre-eclampsia to take 75-150 mg of aspirin daily from 12 weeks until the birth of the baby .	owner(e1,e2)
If the person is aged under 80 years with stage 1 hypertension and has established cardiovascular disease , <e1>offer</e1> antihypertensive drug <e2>treatment</e2> .	acts-on(e1,e2)
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider triple therapy with metformin and a DPP-4i and an SU , metformin and pioglitazone and an SU , metformin and <e1>pioglitazone</e1> and an <e2>SGLT-2i</e2> , metformin and an SU and an SGLT-2i , insulin-based treatment , and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	joint
<e1>Assess</e1> thiopurine methyltransferase activity before <e2>offering</e2> azathioprine or mercaptopurine .	other
If the person is with CKD and vitamin D <e1>supplementation</e1> is <e2>indicated</e2> , offer colecalciferol or ergocalciferol .	modifier(e2,e1)
MRI of the SI joints and/or the spine may be used to assess and monitor disease activity in axial SpA , providing <e1>additional</e1> <e2>information</e2> on top of clinical and biochemical assessments .	modifier(e1,e2)
All patients should have appropriate <e1>monitoring</e1> for clinically significant <e2>AEs</e2> .	other
For eligible <e1>people</e1> with stage 3B <e2>NSCLC</e2> who cannot tolerate or who decline chemoradiotherapy , consider radical radiotherapy .	owner(e1,e2)
If the diagnosis is still unclear , offer CT and <e1>EUS</e1> with EUS-guided tissue <e2>sampling</e2> .	other
Consider a maintenance dosage higher than 20 mg/kg daily if therapeutic efficacy is not achieved , while ensuring that a <e1>safe</e1> plasma <e2>level</e2> is maintained .	modifier(e1,e2)
Treatment should be <e1>aimed</e1> at <e2>reaching</e2> a target of sustained remission or low disease activity in every patient .	other
<e1>Offer</e1> enteric-coated <e2>pancreatin</e2> to people with unresectable pancreatic cancer .	acts-on(e1,e2)
Measure N-terminal pro-B-type natriuretic peptide in <e1>people</e1> with suspected heart <e2>failure</e2> .	owner(e1,e2)
If the <e1>person</e1> is symptomatically hyperglycaemic , <e2>offer</e2> antispasmodics to have HbA1c level of 53 mmol/mol ( 7.5 % ) .	receiver(e1,e2)
Offer contrast-enhanced brain MRI for people with stage 3 NSCLC who are <e1>having</e1> <e2>treatment</e2> with curative intent .	acts-on(e1,e2)
Treatment should be aimed at <e1>reaching</e1> the <e2>target</e2> of remission or , alternatively , minimal/low disease activity , by regular monitoring and appropriate adjustment of therapy .	acts-on(e1,e2)
Review antibiotic treatment after 14 days and either stop the antibiotic or continue for a further 14 days if needed , based on an assessment of the person's history , symptoms , clinical <e1>examination</e1> , <e2>urine</e2> and blood tests .	joint
Do not offer pre-treatment stenting to adults having shockwave lithotripsy for <e1>ureteric</e1> or renal <e2>stones</e2> .	choice
Offer intravenous paracetamol to adults , children and young people with suspected renal colic if <e1>NSAIDs</e1> are contraindicated or are not <e2>giving</e2> sufficient pain relief .	actor-of(e1,e2)
For preterm babies who need invasive ventilation , use volume-targeted ventilation in combination with synchronised ventilation as the primary mode of <e1>respiratory</e1> <e2>support</e2> .	modifier(e1,e2)
If <e1>remission</e1> is not <e2>achieved</e2> within 4 weeks , consider adding a high-dose oral aminosalicylate to the topical aminosalicylate or switching to a high-dose oral aminosalicylate and a time-limited course of a topical corticosteroid .	modifier(e2,e1)
Patients with genotype 1 infection who fail to <e1>achieve</e1> an <e2>EVR</e2> at 12 weeks should be considered for cessation of treatment .	acts-on(e1,e2)
For <e1>women</e1> with a cerebrovascular malformation at low <e2>risk</e2> of intracranial bleeding , manage the second stage of labour based on the woman's preference and obstetric indications .	owner(e1,e2)
Consider oral sodium bicarbonate supplementation for people with both a GFR less than 30 ml/min/1.73m2 and a serum bicarbonate concentration of <e1>less</e1> than <e2>20</e2> mmol/litre .	modifier(e1,e2)
In patients with active enthesitis and/or dactylitis and insufficient response to NSAIDs or local glucocorticoid injections , therapy with a bDMARD should be considered , which according to current <e1>practice</e1> is a TNF <e2>inhibitor</e2> .	other
Offer monotherapy with a conventional glucocorticosteroid to <e1>induce</e1> <e2>remission</e2> in people with a first presentation or a single inflammatory exacerbation of Crohn's disease in a 12-month period .	acts-on(e1,e2)
<e1>Inactivated</e1> influenza <e2>vaccination</e2> should be strongly considered for patients with AIIRD .	modifier(e1,e2)
Patients with left main stem stenosis and/or <e1>multivessel</e1> <e2>disease</e2> should be considered for revascularisation to improve prognosis .	modifier(e1,e2)
Women with platinum sensitive relapsed ovarian cancer should be offered treatment with carboplatin combined with either <e1>paclitaxel</e1> or pegylated liposomal doxorubicin <e2>hydrochloride</e2> .	choice
Offer PET-CT as the preferred first test after CT with a low probability of nodal malignancy , for <e1>people</e1> with lung cancer who could potentially <e2>have</e2> treatment with curative intent .	actor-of(e1,e2)
Give a loading dose of 20 mg/kg of caffeine citrate , followed 24 hours later by a maintenance dosage of 5 mg/kg once daily , increasing up to 20 mg/kg daily if <e1>episodes</e1> of apnoea <e2>persist</e2> .	actor-of(e1,e2)
A resting ECG should be performed in patients with <e1>suspected</e1> cardiac chest <e2>pain</e2> .	modifier(e1,e2)
Patients with compensated cirrhosis should be <e1>considered</e1> for <e2>therapy</e2> , unless contraindicated .	acts-on(e1,e2)
Consider opioids for adults , children and young people with suspected renal colic if both <e1>NSAIDs</e1> and intravenous <e2>paracetamol</e2> are contraindicated or are not giving sufficient pain relief .	joint
Offer radiotherapy <e1>using</e1> 40 <e2>Gy</e2> in 15 fractions with concomitant and up to 12 cycles of adjuvant temozolomide for people aged around 70 or over .	acts-on(e1,e2)
<e1>Therapy</e1> with DMARDs should be <e2>started</e2> as soon as the diagnosis of RA is made .	acts-on(e2,e1)
<e1>Consider</e1> adding <e2>methotrexate</e2> to a conventional glucocorticosteroid or budesonide to induce remission in people who cannot tolerate azathioprine or mercaptopurine .	acts-on(e1,e2)
Do not offer platinum-based combination chemotherapy to obtain a serum calcium for people with extensive-stage disease SCLC if <e1>they</e1> are <e2>fit</e2> enough .	modifier(e2,e1)
If clinical evaluation or lung function testing indicates an <e1>inadequate</e1> <e2>response</e2> to rhDNase , consider both rhDNase and hypertonic sodium chloride or hypertonic sodium chloride alone .	modifier(e1,e2)
Do not routinely offer an antibiotic to treat an acute <e1>cough</e1> associated with acute <e2>bronchitis</e2> in people who are not systemically very unwell or at higher risk of complications .	other
Consider oral sodium bicarbonate supplementation for people with both a <e1>GFR</e1> less than 30 ml/min/1.73m2 and a serum bicarbonate <e2>concentration</e2> of less than 20 mmol/litre .	joint
Consider a bisphosphonate to reduce fracture risk for people with <e1>primary</e1> <e2>hyperparathyroidism</e2> and increased fracture risk .	modifier(e1,e2)
Use MRI when necessary to <e1>assess</e1> the <e2>extent</e2> of disease , for people with superior sulcus tumours .	acts-on(e1,e2)
Combination <e1>therapies</e1> should be <e2>considered</e2> for patients with neuropathic pain .	modifier(e2,e1)
Offer PET-CT , followed by EBUS-TBNA and/or EUS-FNA , to people with suspected lung cancer who have enlarged intrathoracic lymph nodes and who could potentially have treatment with <e1>curative</e1> <e2>intent</e2> .	modifier(e1,e2)
In patients with ankylosing spondylitis , initial conventional <e1>radiography</e1> of the <e2>lumbar</e2> and cervical spine is recommended to detect syndesmophytes , which are predictive of development of new syndesmophytes .	other
<e1>Patients</e1> with advanced liver disease should be <e2>given</e2> nutritional support to minimise malnutrition .	receiver(e1,e2)
Consider alpha blockers for adults , children and young people with distal ureteric <e1>stones</e1> less than 10 <e2>mm</e2> .	modifier(e2,e1)
Offer PET-CT as the preferred first test after CT with a low <e1>probability</e1> of nodal <e2>malignancy</e2> , for people with lung cancer who could potentially have treatment with curative intent .	other
Local injections of glucocorticoids should be <e1>considered</e1> as adjunctive <e2>therapy</e2> in PsA .	other
A resting <e1>ECG</e1> should be <e2>performed</e2> in patients with suspected cardiac chest pain .	modifier(e2,e1)
In patients with a contraindication to MTX , leflunomide or sulfasalazine should be <e1>considered</e1> as part of the treatment <e2>strategy</e2> .	other
Consider adjuvant therapy after surgery for people with invasive breast cancer , and <e1>ensure</e1> that <e2>recommendations</e2> are recorded at the multidisciplinary team meeting .	acts-on(e1,e2)
In personalised asthma action plans for adults , <e1>consider</e1> advising quadrupling <e2>ICS</e2> at the onset of an asthma attack and for up to 14 days in order to reduce the risk of needing oral steroids .	acts-on(e1,e2)
If the person is with CKD and hypertension and an <e1>ACR</e1> of <e2>30</e2> mg/mmol or more , offer a low-cost renin-angiotensin-aldosterone system antagonist .	modifier(e2,e1)
Offer radical resection to <e1>people</e1> with T1bN0 oesophageal <e2>adenocarcinoma</e2> if they are fit enough to have surgery .	owner(e1,e2)
<e1>Assess</e1> the PR status of all invasive breast cancers <e2>using</e2> standardised and quality-assured immunohistochemical techniques , and report the results quantitatively .	other
If the <e1>patient</e1> is already on an ACE <e2>inhibitor</e2> , the ACE inhibitor should be stopped for 36 hours before initiating sacubitril / valsartan to minimise the risk of angioedema .	owner(e1,e2)
When peripheral SpA is suspected , <e1>US</e1> or MRI may be used to <e2>detect</e2> peripheral enthesitis , which may support the diagnosis of SpA .	actor-of(e1,e2)
In patients being considered for active therapy , pleural effusion should be investigated with pleural aspiration and/or pleural biopsy using image-guided or <e1>thoracoscopic</e1> <e2>biopsy</e2> .	modifier(e1,e2)
Consider oral sodium bicarbonate concentration of <e1>less</e1> than <e2>20</e2> mmol/litre .	modifier(e1,e2)
If the <e1>person</e1> is aged under 80 <e2>years</e2> with stage 1 hypertension and has target organ damage , offer antihypertensive drug treatment .	modifier(e2,e1)
Consider adding azathioprine or mercaptopurine to a conventional glucocorticosteroid or budesonide to <e1>induce</e1> <e2>remission</e2> of Crohn's disease if there are 2 or more inflammatory exacerbations in a 12 month period or the glucocorticosteroid dose cannot be tapered .	acts-on(e1,e2)
Offer bisphosphonates if indicated for the <e1>prevention</e1> and <e2>treatment</e2> of osteoporosis in people with a GFR of 30 ml/min/1.73m2 or more .	joint
The routine <e1>use</e1> of aspirin to reduce perioperative cardiac events in patients undergoing non cardiac surgery , including those with known stable CAD , is not <e2>recommended</e2> .	modifier(e2,e1)
Patients with left main stem stenosis and/or multivessel disease should be <e1>considered</e1> for <e2>revascularisation</e2> to improve prognosis .	other
If surgical <e1>resection</e1> is not <e2>appropriate</e2> , consider biopsy to obtain a histological and molecular diagnosis .	modifier(e2,e1)
Consider opioids for <e1>adults</e1> , <e2>children</e2> and young people with suspected renal colic if both NSAIDs and intravenous paracetamol are contraindicated or are not giving sufficient pain relief .	joint
Offer intravenous paracetamol to adults , children and young people with suspected renal colic if NSAIDs are contraindicated or are not <e1>giving</e1> sufficient pain <e2>relief</e2> .	acts-on(e1,e2)
In patients with axial SpA without syndesmophytes in the lumbar spine on conventional radiography , osteoporosis should be <e1>assessed</e1> by hip <e2>DXA</e2> and AP-spine DXA .	other
In patients with <e1>predominantly</e1> axial <e2>disease</e2> that is active and has insufficient response to NSAIDs , therapy with a bDMARD should be considered , which according to current practice is a TNF inhibitor .	modifier(e1,e2)
In patients with <e1>peripheral</e1> <e2>arthritis</e2> and an inadequate response to at least one csDMARD , therapy with a bDMARD , usually a TNF inhibitor , should be commenced .	modifier(e1,e2)
For <e1>people</e1> who are at low <e2>risk</e2> of developing a diabetic foot problem , continue to carry out annual foot assessments .	owner(e1,e2)
Duloxetine should be <e1>considered</e1> for the <e2>treatment</e2> of patients with fibromyalgia or osteoarthritis .	other
If the <e1>person</e1> is aged under 80 <e2>years</e2> with reduced ejection fraction , maintain blood pressure below 150/90 mmHg .	modifier(e2,e1)
All patients with invasive breast cancer who are operable should <e1>have</e1> axillary <e2>surgery</e2> .	acts-on(e1,e2)
For women with a cerebrovascular malformation at low risk of intracranial bleeding , <e1>manage</e1> the second <e2>stage</e2> of labour based on the woman's preference and obstetric indications .	acts-on(e1,e2)
Optimised antidepressant therapy should be considered for the treatment of patients with <e1>chronic</e1> <e2>pain</e2> with moderate depression .	modifier(e1,e2)
<e1>MRI</e1> of the SI joints and/or the spine may be used to assess and <e2>monitor</e2> disease activity in axial SpA , providing additional information on top of clinical and biochemical assessments .	actor-of(e1,e2)
Offer either anticoagulants or antiplatelet agents to people who have stroke secondary to <e1>acute</e1> arterial <e2>dissection</e2> .	modifier(e1,e2)
Do not offer a bisphosphonate to <e1>pregnant</e1> <e2>women</e2> with primary hyperparathyroidism .	modifier(e1,e2)
Select the appropriate <e1>starting</e1> <e2>dose</e2> to achieve therapeutic response , taking into account the risk of undertreatment .	modifier(e1,e2)
Patients with genotype 1 infection who fail to achieve an EVR at 12 weeks should be considered for <e1>cessation</e1> of <e2>treatment</e2> .	other
Maintain blood pressure below 130/80 mmHg for people with <e1>advanced</e1> pancreatic <e2>cancer</e2> .	modifier(e1,e2)
People with a history of fragility fractures over the age of 50 should be offered DXA <e1>scanning</e1> to <e2>evaluate</e2> the need for antiosteoporosis therapy .	actor-of(e1,e2)
Assess the ER status of all <e1>invasive</e1> breast <e2>cancers</e2> using standardised and quality-assured immunohistochemical techniques , and report the results quantitatively .	modifier(e1,e2)
If the <e1>person</e1> is aged under 80 years with stage 1 hypertension and <e2>has</e2> established cardiovascular disease , offer antihypertensive drug treatment .	actor-of(e1,e2)
Women with platinum <e1>sensitive</e1> relapsed ovarian <e2>cancer</e2> should be offered treatment with carboplatin combined with either paclitaxel or pegylated liposomal doxorubicin hydrochloride .	modifier(e1,e2)
Do not routinely <e1>use</e1> 24-hour urine <e2>collection</e2> to quantify proteinuria in pregnant women .	acts-on(e1,e2)
Offer an MRA , in addition to an ACE inhibitor ( or ARB ) and beta-blocker , to people who have heart <e1>failure</e1> with reduced ejection <e2>fraction</e2> if they continue to have symptoms of heart failure .	other
If the person is aged under 80 years with stage 1 hypertension and <e1>has</e1> established cardiovascular <e2>disease</e2> , offer antihypertensive drug treatment .	acts-on(e1,e2)
<e1>Patients</e1> with <e2>AIIRD</e2> should receive tetanus toxoid vaccination in accordance to recommendations for the general population .	owner(e1,e2)
Request the oestrogen receptor , progesterone receptor and human epidermal growth receptor 2 status of all invasive breast cancers simultaneously at the time of <e1>initial</e1> histopathological <e2>diagnosis</e2> .	modifier(e1,e2)
In patients with active enthesitis and/or dactylitis and insufficient <e1>response</e1> to <e2>NSAIDs</e2> or local glucocorticoid injections , therapy with a bDMARD should be considered , which according to current practice is a TNF inhibitor .	other
For preterm babies who need invasive ventilation but VTV and HFOV are not available or not suitable , consider synchronised intermittent <e1>mandatory</e1> <e2>ventilation</e2> .	modifier(e1,e2)
Consider opioids for adults , children and young people with suspected renal colic if both NSAIDs and intravenous paracetamol are contraindicated or are not <e1>giving</e1> sufficient pain <e2>relief</e2> .	acts-on(e1,e2)
Do not routinely <e1>use</e1> <e2>MRI</e2> to assess the stage of the primary tumour (T-stage) in non-small-cell lung cancer .	acts-on(e1,e2)
Assess the ER status of all invasive breast cancers using standardised and quality-assured immunohistochemical techniques , and report the <e1>results</e1> <e2>quantitatively</e2> .	modifier(e2,e1)
In patients being considered for active therapy , pleural effusion should be investigated with pleural <e1>aspiration</e1> and/or pleural <e2>biopsy</e2> using image-guided or thoracoscopic biopsy .	joint
In general , STIR sequences are sufficient to <e1>detect</e1> <e2>inflammation</e2> and the use of contrast medium is not needed .	acts-on(e1,e2)
Patients with <e1>mild</e1> <e2>CHC</e2> should be considered for treatment .	modifier(e1,e2)
Offer platinum-based combination chemotherapy to <e1>people</e1> with extensive-stage disease <e2>SCLC</e2> if they are fit enough .	owner(e1,e2)
Consider ovarian function suppression in addition to endocrine therapy for premenopausal <e1>women</e1> with ER-positive invasive breast <e2>cancer</e2> .	owner(e1,e2)
If a person is unable to tolerate ABPM , HBPM is a suitable alternative to <e1>confirm</e1> the <e2>diagnosis</e2> of hypertension .	acts-on(e1,e2)
Consider thoracic radiotherapy with prophylactic cranial irradiation for people with <e1>extensive-stage</e1> disease <e2>SCLC</e2> .	modifier(e1,e2)
Consider dual therapy with ACE inhibitor and metformin if the <e1>person</e1> is aged under 80 <e2>years</e2> .	owner(e1,e2)
In patients who <e1>fail</e1> to <e2>respond</e2> adequately to a bDMARD , switching to another bDMARD should be considered , including switching between TNF inhibitors .	other
Consider measuring albumin-adjusted serum calcium for <e1>people</e1> with chronic non-differentiated <e2>symptoms</e2> .	owner(e1,e2)
Assess the ER status of all invasive breast cancers <e1>using</e1> standardised and quality-assured immunohistochemical <e2>techniques</e2> , and report the results quantitatively .	acts-on(e1,e2)
<e1>Short-term</e1> <e2>GC</e2> should be considered when initiating or changing csDMARDs , in different dose regimens and routes of administration , but should be tapered as rapidly as clinically feasible .	modifier(e1,e2)
<e1>Screening</e1> for asymptomatic atherosclerotic <e2>plaques</e2> by use of carotid ultrasound may be considered as part of the CVD risk evaluation in patients with RA .	other
Routine surgery for <e1>limited</e1> <e2>disease</e2> SCLC is not recommended .	modifier(e1,e2)
To induce remission in people with a mild-to-moderate first presentation or <e1>inflammatory</e1> <e2>exacerbation</e2> of proctitis , offer a topical aminosalicylate as first-line treatment .	modifier(e1,e2)
Amitriptyline should be considered for the <e1>treatment</e1> of <e2>patients</e2> with fibromyalgia and neuropathic pain .	other
If a <e1>patient</e1> is in persistent remission after <e2>having</e2> tapered GC , one can consider tapering bDMARDs , especially if this treatment is combined with a csDMARD .	actor-of(e1,e2)
Do not offer dedicated brain imaging to <e1>people</e1> with clinical stage 1 NSCLC who have no neurological symptoms and are <e2>having</e2> treatment with curative intent .	actor-of(e1,e2)
<e1>Erythropoietin</e1> is not <e2>recommended</e2> for patients with heart failure with reduced ejection fraction and iron deficiency .	acts-on(e2,e1)
If the person is symptomatically hyperglycaemic , <e1>offer</e1> <e2>antispasmodics</e2> to have HbA1c level of 53 mmol/mol ( 7.5 % ) .	acts-on(e1,e2)
Amiodarone therapy is not recommended for patients following ACS or patients with congestive heart failure who do not have sustained ventricular <e1>arrhythmias</e1> or atrial <e2>fibrillation</e2> .	choice
Consider insulin regimen if the <e1>person</e1> is <e2>pregnant</e2> .	modifier(e2,e1)
Consider prostaglandin E1 or prostaglandin E2 as options for inducing labour in women with asthma because there is no evidence that they <e1>worsen</e1> <e2>asthma</e2> .	acts-on(e1,e2)
Women with platinum sensitive relapsed ovarian cancer should be <e1>offered</e1> <e2>treatment</e2> with carboplatin combined with either paclitaxel or pegylated liposomal doxorubicin hydrochloride .	acts-on(e1,e2)
<e1>Ensure</e1> that <e2>people</e2> with disabling ischaemic stroke who are in atrial fibrillation are treated with aspirin 300 mg for the first 2 weeks before anticoagulation treatment is considered .	receiver(e2,e1)
If surgical resection is not appropriate , <e1>consider</e1> <e2>biopsy</e2> to obtain a histological and molecular diagnosis .	acts-on(e1,e2)
If a patient is in persistent remission , tapering the <e1>csDMARD</e1> could be <e2>considered</e2> .	modifier(e1,e2)
<e1>Review</e1> intravenous antibiotics by 48 hours and <e2>consider</e2> stepping down to oral antibiotics where possible .	other
All <e1>patients</e1> with stable <e2>angina</e2> due to atherosclerotic disease should receive long term standard aspirin and statin therapy .	owner(e1,e2)
In patients with permanent AF or persistent AF following a rate control strategy and a resting heart rate > 110 bpm , appropriate rate control therapy should be instituted with an initial target of <e1>resting</e1> heart <e2>rate</e2> .	modifier(e1,e2)
Assess the PR status of all invasive breast cancers <e1>using</e1> standardised and quality-assured immunohistochemical <e2>techniques</e2> , and report the results quantitatively .	acts-on(e1,e2)
If the <e1>person</e1> is aged under 80 years with reduced ejection <e2>fraction</e2> , maintain blood pressure below 150/90 mmHg .	owner(e1,e2)
If HbA1c rises to 48 mmol/mol ( 6.5 % ) on lifestyle interventions , consider a DPP-4i , pioglitazone , an SU , an SGLT-2i , and support the person to aim for an HbA1c <e1>level</e1> of <e2>48</e2> mmol/mol ( 6.5 % ) for people on a DPP-4i , SGLT-2i or pioglitazone or 53 mmol/mol ( 7 % ) for people on an SU .	modifier(e2,e1)
In patients with a <e1>contraindication</e1> to <e2>MTX</e2> , leflunomide or sulfasalazine should be considered as part of the treatment strategy .	other
If the <e1>person</e1> is with CKD and an ACR of 70 mg/mmol or more , <e2>offer</e2> a low-cost renin-angiotensin-aldosterone system antagonist .	receiver(e1,e2)
When <e1>adequate</e1> <e2>control</e2> of anginal symptoms is not achieved with beta blockade , addition of a calcium channel blocker should be considered .	modifier(e1,e2)
Do not use synchronised pressure-limited ventilation such as assist control , synchronised intermittent positive pressure ventilation , patient-triggered ventilation , pressure support <e1>ventilation</e1> or synchronised time-cycled pressure-limited <e2>ventilation</e2> .	choice
Consider adding intravenous ciclosporin to intravenous corticosteroids or consider surgery for <e1>people</e1> who have little or no improvement within 72 hours of starting intravenous corticosteroids or whose <e2>symptoms</e2> worsen at any time despite corticosteroid treatment .	owner(e1,e2)
For patients <e1>receiving</e1> a protease <e2>inhibitor</e2> in combination with pegylated IFN and ribavirin therapy , consider ribavirin dose reduction as an alternative to the addition of EPO for controlling anaemia .	acts-on(e1,e2)
When spinal fracture in axial SpA is suspected , <e1>conventional</e1> <e2>radiography</e2> is the recommended initial imaging method .	modifier(e1,e2)
Optimised antidepressant therapy should be considered for the treatment of <e1>patients</e1> with chronic pain with moderate <e2>depression</e2> .	owner(e1,e2)
Consider azathioprine or mercaptopurine at a lower dose if TPMT <e1>activity</e1> is below <e2>normal</e2> but not deficient .	modifier(e2,e1)
Consider surgical mediastinal staging for people with a negative EBUS-TBNA or EUS-FNA if clinical <e1>suspicion</e1> of nodal <e2>malignancy</e2> is high and nodal status would affect their treatment plan .	other
If the diagnosis is still unclear , offer CT and EUS with <e1>EUS-guided</e1> tissue <e2>sampling</e2> .	modifier(e1,e2)
All patients with stable angina should be considered for <e1>treatment</e1> with angiotensin converting enzyme <e2>inhibitors</e2> .	other
If a <e1>patient</e1> is in persistent remission , tapering the csDMARD could be <e2>considered</e2> .	receiver(e1,e2)
Support <e1>adults</e1> with type 1 diabetes to <e2>aim</e2> for a target HbA1c level of 48 mmol/mol ( 6.5 % ) or lower .	actor-of(e1,e2)
Offer <e1>nutritional</e1> <e2>assessment</e2> and tailored specialist dietetic support to people with oesophago-gastric cancer before , during and after radical treatments .	modifier(e1,e2)
Lifestyle recommendations should emphasise the benefits of a healthy <e1>diet</e1> , regular <e2>exercise</e2> and smoking cessation for all patients .	joint
<e1>Patients</e1> who are <e2>unfit</e2> for combination therapy should be offered single agent carboplatin .	modifier(e2,e1)
Offer monotherapy with a conventional glucocorticosteroid to induce remission in <e1>people</e1> with a first <e2>presentation</e2> or a single inflammatory exacerbation of Crohn's disease in a 12-month period .	owner(e1,e2)
<e1>Maintain</e1> blood <e2>pressure</e2> below 45 ml/minute/1.73m2 if the person is aged under 80 years with type 1 diabetes .	acts-on(e1,e2)
In patients who cannot use csDMARDs as comedication , IL-6 pathway inhibitors and <e1>tsDMARDs</e1> may <e2>have</e2> some advantages compared with other bDMARDs .	actor-of(e1,e2)
For eligible people with stage 3B NSCLC who cannot <e1>tolerate</e1> or who <e2>decline</e2> chemoradiotherapy , consider radical radiotherapy .	choice
If remission is not achieved within 4 weeks , stop the topical aminosalicylate and <e1>offer</e1> a high-dose oral <e2>aminosalicylate</e2> with a time-limited course of an oral corticosteroid .	acts-on(e1,e2)
Do not routinely use <e1>24-hour</e1> urine <e2>collection</e2> to quantify proteinuria in pregnant women .	modifier(e1,e2)
Consider endocrine therapy after breast-conserving surgery for women with <e1>ER-positive</e1> <e2>DCIS</e2> if radiotherapy is not recommended .	modifier(e1,e2)
In <e1>patients</e1> with peripheral arthritis and an inadequate response to at least one csDMARD , in whom TNF <e2>inhibitors</e2> are not appropriate , bDMARDs targeting IL12/23 or IL17 pathways may be considered .	owner(e1,e2)
For preterm babies who <e1>need</e1> invasive <e2>ventilation</e2> but VTV and HFOV are not available or not suitable , consider synchronised intermittent mandatory ventilation .	acts-on(e1,e2)
Combination therapies should be considered for <e1>patients</e1> with neuropathic <e2>pain</e2> .	owner(e1,e2)
<e1>Patients</e1> with suspected T3 or T4 disease who are otherwise <e2>fit</e2> for surgery should not be denied surgical exploration on the basis of a CT scan alone .	modifier(e2,e1)
In case of major and/or contaminated wounds in patients who received rituximab within the last 24 weeks , passive <e1>immunisation</e1> with tetanus <e2>immunoglobulins</e2> should be administered .	other
If cytological or histological samples are needed , <e1>offer</e1> <e2>EUS</e2> with EUS-guided tissue sampling .	acts-on(e1,e2)
<e1>Patients</e1> with <e2>AF</e2> who remain severely symptomatic despite adequate rate control should be considered for rhythm control or for stricter rate control if their heart rate remains 80-110 bpm at rest .	owner(e1,e2)
Maintain blood pressure below 130/80 mmHg for <e1>people</e1> with advanced pancreatic <e2>cancer</e2> .	owner(e1,e2)
CVD risk prediction models should be <e1>adapted</e1> for <e2>patients</e2> with RA by a 1.5 multiplication factor , if this is not already included in the model .	receiver(e2,e1)
Consider radiotherapy using 40 Gy in 15 fractions with concomitant and up to 12 cycles of adjuvant temozolomide for <e1>people</e1> aged around <e2>70</e2> or over .	owner(e2,e1)
Repeat the albumin-adjusted serum calcium measurement at least once if the <e1>first</e1> <e2>measurement</e2> is either 2.6 mmol/litre or above or 2.5 mmol/litre or above and features of primary hyperparathyroidism are present .	modifier(e1,e2)
If the person <e1>has</e1> stage 2 <e2>hypertension</e2> , offer antihypertensive drug treatment .	acts-on(e1,e2)
Do not use fish oils as a nutritional intervention to manage weight loss in people with <e1>unresectable</e1> pancreatic <e2>cancer</e2> .	modifier(e1,e2)
<e1>Extensive</e1> MRI inflammatory <e2>activity</e2> , particularly in the spine in patients with ankylosing spondylitis , might be used as a predictor of good clinical response to anti-TNF-alpha treatment in axial SpA .	modifier(e1,e2)
<e1>Patients</e1> with NSCLC stage 1 and 2 who are medically inoperable or who do not <e2>consent</e2> to surgery should be offered radical radiotherapy .	actor-of(e1,e2)
To induce remission in people with a mild-to-moderate first <e1>presentation</e1> or inflammatory <e2>exacerbation</e2> of proctitis , offer a topical aminosalicylate as first-line treatment .	choice
If the person is with CKD and hypertension and an ACR of 30 mg/mmol or more , <e1>offer</e1> a low-cost renin-angiotensin-aldosterone system <e2>antagonist</e2> .	acts-on(e1,e2)
Patients with heart failure with reduced ejection fraction , NYHA class 2-4 , who are intolerant of angiotensin <e1>converting</e1> enzyme <e2>inhibitors</e2> should be given an angiotensin receptor blocker .	modifier(e1,e2)
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider dual therapy with metformin and a DPP-4i , metformin and pioglitazone , metformin and an SU , metformin and an SGLT-2i , and <e1>support</e1> the <e2>person</e2> to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	receiver(e2,e1)
In patients with active enthesitis and/or dactylitis and insufficient response to NSAIDs or <e1>local</e1> glucocorticoid <e2>injections</e2> , therapy with a bDMARD should be considered , which according to current practice is a TNF inhibitor .	modifier(e1,e2)
<e1>Aim</e1> for a target clinic blood pressure below 150/90 mmHg in <e2>people</e2> aged 80 years and over with treated hypertension .	receiver(e2,e1)
<e1>Consider</e1> thoracic <e2>radiotherapy</e2> with prophylactic cranial irradiation for people with extensive-stage disease SCLC .	acts-on(e1,e2)
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider dual therapy with metformin and a DPP-4i , metformin and pioglitazone , <e1>metformin</e1> and an <e2>SU</e2> , metformin and an SGLT-2i , and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	joint
<e1>Patients</e1> undergoing surgical revascularisation of the left anterior descending coronary artery should <e2>receive</e2> an internal mammary artery graft .	actor-of(e1,e2)
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider triple therapy with metformin and a DPP-4i and an SU , metformin and <e1>pioglitazone</e1> and an <e2>SU</e2> , metformin and pioglitazone and an SGLT-2i , metformin and an SU and an SGLT-2i , insulin-based treatment , and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	joint
<e1>bDMARDs</e1> and <e2>tsDMARDs</e2> should be combined with a csDMARD .	joint
When adequate control of <e1>anginal</e1> <e2>symptoms</e2> is not achieved with beta blockade , addition of a calcium channel blocker should be considered .	modifier(e1,e2)
Offer endocrine therapy after breast-conserving surgery for women with ER-positive DCIS if <e1>radiotherapy</e1> is recommended but not <e2>received</e2> .	modifier(e1,e2)
Calcium channel blocker therapy is not recommended for reduction in sudden death or all cause mortality in <e1>patients</e1> <e2>following</e2> ACS .	actor-of(e1,e2)
If the treatment target is not achieved with the first csDMARD strategy , when poor prognostic factors are present , <e1>addition</e1> of a <e2>bDMARD</e2> or a tsDMARD should be considered .	other
Do not routinely use 24-hour urine <e1>collection</e1> to <e2>quantify</e2> proteinuria in pregnant women .	actor-of(e1,e2)
In patients with PsA , NSAIDs may be used to relieve musculoskeletal <e1>signs</e1> and <e2>symptoms</e2> .	joint
<e1>Use</e1> caffeine <e2>citrate</e2> routinely in preterm babies born at or before 30 weeks , starting it as early as possible and ideally before 3 days of age .	acts-on(e1,e2)
Offer contrast-enhanced brain CT if the <e1>person</e1> has <e2>established</e2> cardiovascular disease .	actor-of(e1,e2)
<e1>Consider</e1> second-line palliative chemotherapy for <e2>people</e2> with oesophago-gastric cancer .	receiver(e2,e1)
When spinal fracture in axial SpA is suspected , conventional radiography is the <e1>recommended</e1> initial imaging <e2>method</e2> .	other
Consider stone analysis for <e1>adults</e1> with <e2>ureteric</e2> or renal stones .	owner(e1,e2)
<e1>Offer</e1> <e2>PET-CT</e2> , followed by EBUS-TBNA and/or EUS-FNA , to people with suspected lung cancer who have enlarged intrathoracic lymph nodes and who could potentially have treatment with curative intent .	acts-on(e1,e2)
Offer intravenous paracetamol to adults , children and young people with suspected renal colic if <e1>NSAIDs</e1> are <e2>contraindicated</e2> or are not giving sufficient pain relief .	modifier(e2,e1)
All <e1>patients</e1> with stable angina should be <e2>considered</e2> for treatment with angiotensin converting enzyme inhibitors .	receiver(e1,e2)
If HbA1c rises to 48 mmol/mol ( 6.5 % ) on lifestyle interventions , consider a <e1>DPP-4i</e1> , <e2>pioglitazone</e2> , an SU , an SGLT-2i , and support the person to aim for an HbA1c level of 48 mmol/mol ( 6.5 % ) for people on a DPP-4i , SGLT-2i or pioglitazone or 53 mmol/mol ( 7 % ) for people on an SU .	joint
For women with a cerebrovascular malformation at low <e1>risk</e1> of intracranial <e2>bleeding</e2> , base decisions on the mode of birth on the woman's preference and obstetric indications .	other
Consider budesonide for a first presentation or a single inflammatory exacerbation in a 12-month period for people who have one or more of distal ileal , ileocaecal or right-sided colonic disease and if conventional <e1>glucocorticosteroids</e1> are <e2>contraindicated</e2> , or if the person declines or cannot tolerate them .	modifier(e2,e1)
<e1>Offer</e1> parathyroid surgery to <e2>women</e2> who have primary hyperparathyroidism and are considering pregnancy .	receiver(e2,e1)
<e1>Patients</e1> with hepatitis C virus and concurrent operable hepatocellular carcinoma should be <e2>offered</e2> liver transplantation .	receiver(e1,e2)
Do not offer a mucolytic to treat an <e1>acute</e1> <e2>cough</e2> associated with an upper respiratory tract infection or acute bronchitis .	modifier(e1,e2)
Consider measuring anti-CCP antibodies in <e1>adults</e1> with suspected RA if <e2>they</e2> are negative for rheumatoid factor .	other
If further treatment is needed , <e1>consider</e1> adding a time-limited <e2>course</e2> of a topical or an oral corticosteroid .	acts-on(e1,e2)
Live attenuated <e1>vaccines</e1> should be <e2>avoided</e2> whenever possible in immunosuppressed patients with AIIRD .	acts-on(e2,e1)
Disease activity should be controlled optimally in order to lower CVD risk in all patients with RA , <e1>AS</e1> or <e2>PsA</e2> .	choice
If dipstick screening is positive , use albumin:creatinine ratio or protein:creatinine ratio to <e1>quantify</e1> <e2>proteinuria</e2> in pregnant women .	acts-on(e1,e2)
In peripheral SpA , if the clinical scenario requires <e1>monitoring</e1> of structural <e2>damage</e2> , then conventional radiography is recommended .	other
If the person is with CKD and an ACR of 70 mg/mmol or more , <e1>offer</e1> a low-cost renin-angiotensin-aldosterone system <e2>antagonist</e2> .	acts-on(e1,e2)
Patients with heart failure with <e1>reduced</e1> ejection <e2>fraction</e2> of all NYHA functional classes , should be given angiotensin converting enzyme inhibitors .	modifier(e1,e2)
If the person is aged under 80 years with stage 1 hypertension , <e1>prescribe</e1> metformin and a DPP-4i and <e2>support</e2> for a target HbA1c level of 48 mmol/mol ( 6.5 % ) .	joint
Aim for a target clinic blood pressure below 140/90 mmHg in <e1>people</e1> aged under <e2>80</e2> years with treated hypertension .	owner(e1,e2)
In patients with peripheral <e1>arthritis</e1> and an inadequate <e2>response</e2> to at least one csDMARD , in whom bDMARDs are not appropriate , a targeted synthetic DMARD such as a PDE4-inhibitor may be considered .	joint
If <e1>cytological</e1> or histological <e2>samples</e2> are needed , offer EUS with EUS-guided tissue sampling .	modifier(e1,e2)
Advise pregnant women at high risk of pre-eclampsia to take 75-150 <e1>mg</e1> of <e2>aspirin</e2> daily from 12 weeks until the birth of the baby .	modifier(e1,e2)
<e1>Consider</e1> budesonide for a first <e2>presentation</e2> or a single inflammatory exacerbation in a 12-month period for people who have one or more of distal ileal , ileocaecal or right-sided colonic disease and if conventional glucocorticosteroids are contraindicated , or if the person declines or cannot tolerate them .	other
Offer radiotherapy using 40 Gy in 15 fractions with concomitant and up to 12 cycles of <e1>adjuvant</e1> <e2>temozolomide</e2> for people aged around 70 or over .	modifier(e1,e2)
A chest <e1>X-ray</e1> should be <e2>performed</e2> on all patients being investigated for the possibility of lung cancer .	acts-on(e2,e1)
<e1>Patients</e1> with genotype 1 infection who fail to achieve an EVR at 12 weeks should be <e2>considered</e2> for cessation of treatment .	receiver(e1,e2)
If the <e1>person</e1> is symptomatically <e2>hyperglycaemic</e2> , consider insulin or an SU .	modifier(e2,e1)
Consider adjuvant radiotherapy for patients with completely resected stage 3B or 3C melanoma after discussion of the risk of <e1>local</e1> <e2>recurrence</e2> and the benefits and risks of radiotherapy including risk of significant adverse effects .	modifier(e1,e2)
Extensive MRI inflammatory activity , particularly in the spine in patients with ankylosing spondylitis , might be used as a predictor of good clinical response to <e1>anti-TNF-alpha</e1> <e2>treatment</e2> in axial SpA .	modifier(e1,e2)
<e1>Monitor</e1> the <e2>effects</e2> of azathioprine , mercaptopurine and methotrexate as advised in the British National Formulary or British National Formulary for Children .	acts-on(e1,e2)
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider dual therapy with metformin and a DPP-4i , metformin and pioglitazone , metformin and an SU , metformin and an SGLT-2i , and support the person to aim for an HbA1c <e1>level</e1> of <e2>53</e2> mmol/mol ( 7 % ) .	modifier(e2,e1)
Second line systemic anticancer therapy with single agent docetaxel or erlotinib should be considered for patients with performance status 0-2 recurrent NSCLC who have been previously treated with first line SACT for <e1>advanced</e1> <e2>disease</e2> .	modifier(e1,e2)
<e1>Measure</e1> serum <e2>calcium</e2> for adults with ureteric or renal stones .	acts-on(e1,e2)
For people with cystic fibrosis who develop a Haemophilus influenzae infection but do not have <e1>clinical</e1> <e2>evidence</e2> of pulmonary infection , treat with an appropriate oral antibiotic .	modifier(e1,e2)
Do not offer a <e1>mucolytic</e1> to <e2>treat</e2> an acute cough associated with an upper respiratory tract infection or acute bronchitis .	actor-of(e1,e2)
Patients with hepatitis C <e1>virus</e1> and concurrent operable hepatocellular <e2>carcinoma</e2> should be offered liver transplantation .	joint
In hyposplenic/asplenic <e1>patients</e1> with AIIRD influenza , pneumococcal , Haemophilus influenzae b and meningococcal C , <e2>vaccinations</e2> are recommended .	receiver(e1,e2)
If the person has stage 2 hypertension , <e1>offer</e1> antihypertensive drug <e2>treatment</e2> .	acts-on(e1,e2)
Aim for a target clinic blood <e1>pressure</e1> below 150/90 <e2>mmHg</e2> in people aged 80 years and over with treated hypertension .	modifier(e2,e1)
Review antibiotic treatment after 14 days and either stop the antibiotic or continue for a further 14 days if needed , based on an assessment of the person's history , symptoms , <e1>clinical</e1> <e2>examination</e2> , urine and blood tests .	modifier(e1,e2)
If the <e1>person</e1> is aged under 80 years with reduced ejection fraction , <e2>maintain</e2> blood pressure below 150/90 mmHg .	receiver(e1,e2)
Disease activity should be <e1>controlled</e1> optimally in order to <e2>lower</e2> CVD risk in all patients with RA , AS or PsA .	other
<e1>Consider</e1> surgical mediastinal staging for <e2>people</e2> with a negative EBUS-TBNA or EUS-FNA if clinical suspicion of nodal malignancy is high and nodal status would affect their treatment plan .	receiver(e2,e1)
Offer contrast-enhanced brain CT to people with clinical stage 2 NSCLC who are <e1>having</e1> <e2>treatment</e2> with curative intent .	acts-on(e1,e2)
Aim for a target clinic blood pressure below 150/90 mmHg in people aged 80 <e1>years</e1> and <e2>over</e2> with treated hypertension .	modifier(e2,e1)
Patients with <e1>AIIRD</e1> who plan to travel are <e2>recommended</e2> to receive their vaccinations according to general rules , except for live attenuated vaccines which should be avoided whenever possible in immunosuppressed patients with AIIRD .	receiver(e1,e2)
Offer parathyroid surgery to women who have primary hyperparathyroidism and are <e1>considering</e1> <e2>pregnancy</e2> .	acts-on(e1,e2)
In patients with <e1>syndesmophytes</e1> in the lumbar <e2>spine</e2> on conventional radiography , osteoporosis should be assessed by hip DXA , supplemented by either spine DXA in lateral projection or possibly QCT of the spine .	other
Live attenuated vaccines should be <e1>avoided</e1> whenever possible in immunosuppressed <e2>patients</e2> with AIIRD .	receiver(e2,e1)
In patients with predominantly axial disease that is active and has insufficient response to NSAIDs , <e1>therapy</e1> with a <e2>bDMARD</e2> should be considered , which according to current practice is a TNF inhibitor .	other
In <e1>patients</e1> with permanent <e2>AF</e2> or persistent AF following a rate control strategy and a resting heart rate > 110 bpm , appropriate rate control therapy should be instituted with an initial target of resting heart rate .	owner(e1,e2)
Consider budesonide for a first presentation or a single inflammatory exacerbation in a 12-month period for people who have one or more of distal ileal , ileocaecal or right-sided colonic disease and if conventional glucocorticosteroids are contraindicated , or if the <e1>person</e1> <e2>declines</e2> or cannot tolerate them .	actor-of(e1,e2)
Consider prostaglandin E1 or prostaglandin E2 as options for <e1>inducing</e1> <e2>labour</e2> in women with asthma because there is no evidence that they worsen asthma .	acts-on(e1,e2)
Use MRI when necessary to assess the extent of disease , for <e1>people</e1> with superior sulcus <e2>tumours</e2> .	owner(e1,e2)
If clinical evaluation or lung function testing indicates an inadequate response to rhDNase , <e1>consider</e1> both <e2>rhDNase</e2> and hypertonic sodium chloride or hypertonic sodium chloride alone .	acts-on(e1,e2)
Offer radiotherapy using 60 Gy in 30 fractions with concomitant temozolomide for people aged around <e1>70</e1> or <e2>under</e2> .	modifier(e2,e1)
Furthermore , <e1>US</e1> or <e2>MRI</e2> might be used to detect peripheral arthritis , tenosynovitis and bursitis .	choice
For eligible <e1>people</e1> with stage 3A <e2>NSCLC</e2> who cannot tolerate or who decline chemoradiotherapy , consider radical radiotherapy .	owner(e1,e2)
Offer a non-steroidal <e1>anti-inflammatory</e1> <e2>drug</e2> by any route as first-line treatment for adults , children and young people with suspected renal colic .	modifier(e1,e2)
<e1>Offer</e1> a mucoactive agent to <e2>people</e2> with cystic fibrosis who have clinical evidence of lung disease .	receiver(e2,e1)
<e1>Consider</e1> <e2>budesonide</e2> for a first presentation or a single inflammatory exacerbation in a 12-month period for people who have one or more of distal ileal , ileocaecal or right-sided colonic disease and if conventional glucocorticosteroids are contraindicated , or if the person declines or cannot tolerate them .	acts-on(e1,e2)
If further treatment is needed , <e1>stop</e1> topical <e2>treatments</e2> and offer an oral aminosalicylate and a time-limited course of an oral corticosteroid .	acts-on(e1,e2)
For <e1>people</e1> with cystic fibrosis who develop a Haemophilus influenzae infection but do not <e2>have</e2> clinical evidence of pulmonary infection , treat with an appropriate oral antibiotic .	actor-of(e1,e2)
For people who have had pancreatoduodenectomy and who have a functioning gut , offer early enteral <e1>nutrition</e1> rather than parenteral <e2>nutrition</e2> .	other
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider dual therapy with a DPP-4i and pioglitazone , a DPP-4i and an SU , pioglitazone and an SU , and <e1>support</e1> the <e2>person</e2> to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	receiver(e2,e1)
Do not offer aspirin for the primary prevention of cardiovascular disease to <e1>adults</e1> with type 1 <e2>diabetes</e2> .	owner(e1,e2)
Offer urgent low-dose non-contrast CT to <e1>adults</e1> with suspected renal <e2>colic</e2> .	owner(e1,e2)
Keep the requirement for continuing GC treatment under constant review , and titrate the dose against therapeutic response , <e1>risk</e1> of <e2>undertreatment</e2> and development of AEs .	other
Duloxetine should be considered for the treatment of patients with diabetic neuropathic pain if other <e1>first</e1> or <e2>second</e2> line pharmacological therapies have failed .	choice
Monitor the effects of <e1>azathioprine</e1> , <e2>mercaptopurine</e2> and methotrexate as advised in the British National Formulary or British National Formulary for Children .	joint
Long term beta-blockers are <e1>recommended</e1> for routine <e2>use</e2> in patients following ACS without contraindications .	other
Monitor the response to titration of medicines closely in <e1>people</e1> who <e2>have</e2> heart failure with reduced ejection fraction and chronic kidney disease .	actor-of(e1,e2)
Offer monotherapy with a conventional glucocorticosteroid to induce remission in people with a first presentation or a single inflammatory <e1>exacerbation</e1> of Crohn's <e2>disease</e2> in a 12-month period .	other
If liver function blood tests are abnormal , perform a liver ultrasound scan and <e1>consider</e1> ursodeoxycholic acid <e2>treatment</e2> .	acts-on(e1,e2)
If performed , <e1>it</e1> should not be <e2>repeated</e2> more frequently than every second year .	modifier(e2,e1)
<e1>MRI</e1> of the SI joints and/or the spine may be used to <e2>assess</e2> and monitor disease activity in axial SpA , providing additional information on top of clinical and biochemical assessments .	actor-of(e1,e2)
In patients with active enthesitis and/or dactylitis and insufficient response to <e1>NSAIDs</e1> or local glucocorticoid <e2>injections</e2> , therapy with a bDMARD should be considered , which according to current practice is a TNF inhibitor .	choice
Fluoxetine should be <e1>considered</e1> for the treatment of <e2>patients</e2> with fibromyalgia .	receiver(e2,e1)
Do not offer <e1>nitrosoureas</e1> concurrently with <e2>radiotherapy</e2> to people with newly diagnosed grade 3 glioma .	other
Do not offer dedicated brain imaging to people with clinical stage 1 NSCLC who <e1>have</e1> no neurological <e2>symptoms</e2> and are having treatment with curative intent .	acts-on(e1,e2)
Do not <e1>use</e1> <e2>dexamethasone</e2> with non-steroidal anti-inflammatory drugs .	acts-on(e1,e2)
Patients with early <e1>stage</e1> peripheral lung <e2>cancers</e2> who are not suitable for surgery should be considered for stereotactic ablative radiotherapy .	modifier(e1,e2)
<e1>Request</e1> the oestrogen receptor , progesterone receptor and human epidermal growth receptor 2 <e2>status</e2> of all invasive breast cancers simultaneously at the time of initial histopathological diagnosis .	acts-on(e1,e2)
TC and <e1>HDLc</e1> should be <e2>used</e2> in CVD risk assessment in RA , AS and PsA and lipids should ideally be measured when disease activity is stable or in remission .	acts-on(e2,e1)
<e1>Offer</e1> intravenous paracetamol to <e2>adults</e2> , children and young people with suspected renal colic if NSAIDs are contraindicated or are not giving sufficient pain relief .	receiver(e2,e1)
Offer a non-steroidal anti-inflammatory <e1>drug</e1> by any route as first-line <e2>treatment</e2> for adults , children and young people with suspected renal colic .	other
Do not <e1>offer</e1> platinum-based combination <e2>chemotherapy</e2> to obtain a serum calcium for people with extensive-stage disease SCLC if they are fit enough .	acts-on(e1,e2)
If the person has severe hypertension , consider starting <e1>antihypertensive</e1> drug <e2>treatment</e2> immediately , without waiting for the results of ABPM or HBPM .	modifier(e1,e2)
In patients undergoing <e1>multiple</e1> coronary artery bypass <e2>grafting</e2> , use of both internal mammary arteries should be considered .	modifier(e1,e2)
Offer people who present with superior vena cava obstruction chemotherapy and radiotherapy according to the <e1>stage</e1> of <e2>disease</e2> and performance status .	other
Consider surgical mediastinal staging for people with a negative <e1>EBUS-TBNA</e1> or <e2>EUS-FNA</e2> if clinical suspicion of nodal malignancy is high and nodal status would affect their treatment plan .	choice
Offer <e1>people</e1> with heart <e2>failure</e2> an annual vaccination against influenza .	owner(e1,e2)
If the <e1>person</e1> is with stage 2 diabetes and symptomatically hyperglycaemic , <e2>offer</e2> SGLT-2i , pioglitazone or ergocalciferol .	receiver(e1,e2)
Consider bisphosphonates as adjuvant therapy for postmenopausal <e1>women</e1> with node-negative invasive breast <e2>cancer</e2> and a high risk of recurrence .	owner(e1,e2)
Use an <e1>automated</e1> reagent-strip reading <e2>device</e2> for dipstick screening for proteinuria in pregnant women in secondary care settings .	modifier(e1,e2)
Offer an ACE inhibitor and a beta-blocker licensed for heart failure to people who <e1>have</e1> heart <e2>failure</e2> with reduced ejection fraction .	acts-on(e1,e2)
In patients with permanent AF or persistent AF <e1>following</e1> a rate control <e2>strategy</e2> and a resting heart rate > 110 bpm , appropriate rate control therapy should be instituted with an initial target of resting heart rate .	acts-on(e1,e2)
If the person is symptomatically hyperglycaemic , <e1>offer</e1> antispasmodics to <e2>have</e2> HbA1c level of 53 mmol/mol ( 7.5 % ) .	other
<e1>Consider</e1> <e2>azathioprine</e2> or mercaptopurine at a lower dose if TPMT activity is below normal but not deficient .	acts-on(e1,e2)
Sublingual glyceryl trinitrate tablets or spray should be used for the immediate relief of angina and before <e1>performing</e1> <e2>activities</e2> that are known to bring on angina .	acts-on(e1,e2)
All patients co-infected with HCV and HIV should be <e1>considered</e1> for HCV <e2>treatment</e2> .	acts-on(e1,e2)
For patients receiving a protease inhibitor in combination with pegylated IFN and ribavirin therapy , consider ribavirin dose reduction as an <e1>alternative</e1> to the addition of <e2>EPO</e2> for controlling anaemia .	other
A chest X-ray should be performed on all patients being <e1>investigated</e1> for the <e2>possibility</e2> of lung cancer .	other
Do not routinely use 24-hour urine collection to quantify proteinuria in <e1>pregnant</e1> <e2>women</e2> .	modifier(e1,e2)
The <e1>decision</e1> on when to <e2>repeat</e2> MRI depends on the clinical circumstances .	actor-of(e1,e2)
<e1>Consider</e1> a bisphosphonate to reduce fracture risk for <e2>people</e2> with primary hyperparathyroidism and increased fracture risk .	receiver(e2,e1)
<e1>Offer</e1> endoscopic mucosal <e2>resection</e2> for staging to people with suspected T1 oesophageal cancer .	acts-on(e1,e2)
Class 1 antiarrhythmic drugs should not be <e1>used</e1> for treatment of premature ventricular beats or non sustained VT in <e2>patients</e2> with previous MI .	receiver(e2,e1)
Offer radiotherapy using 60 <e1>Gy</e1> in 30 fractions with concomitant <e2>temozolomide</e2> for people aged around 70 or under .	other
If the <e1>person</e1> is aged under <e2>80</e2> years with stage 1 hypertension , prescribe metformin and a DPP-4i and support for a target HbA1c level of 48 mmol/mol ( 6.5 % ) .	owner(e1,e2)
If HbA1c rises to 48 mmol/mol ( 6.5 % ) on lifestyle interventions , consider a DPP-4i , pioglitazone , an SU , an SGLT-2i , and support the person to aim for an HbA1c level of 48 mmol/mol ( 6.5 % ) for people on a DPP-4i , <e1>SGLT-2i</e1> or <e2>pioglitazone</e2> or 53 mmol/mol ( 7 % ) for people on an SU .	choice
In peripheral SpA , if the clinical scenario requires monitoring of structural damage , then <e1>conventional</e1> <e2>radiography</e2> is recommended .	modifier(e1,e2)
Evaluate PET-CT-positive or enlarged intrathoracic nodes using a systematic approach with EBUS-TBNA and/or EUS-FNA if nodal <e1>status</e1> would <e2>affect</e2> the treatment plan .	actor-of(e1,e2)
Use nasal cannula or incubator oxygen for preterm babies who <e1>need</e1> supplemental <e2>oxygen</e2> .	acts-on(e1,e2)
Offer image-guided biopsy to people with <e1>peripheral</e1> lung <e2>lesions</e2> when treatment can be planned on the basis of this test .	modifier(e1,e2)
Assess the PR status of all invasive breast cancers using standardised and quality-assured immunohistochemical techniques , and report the <e1>results</e1> <e2>quantitatively</e2> .	modifier(e2,e1)
Avoid verapamil , <e1>diltiazem</e1> and short-acting dihydropyridine <e2>agents</e2> in people who have heart failure with reduced ejection fraction .	joint
US and MRI may be <e1>used</e1> to <e2>monitor</e2> disease activity in peripheral SpA , providing additional information on top of clinical and biochemical assessments .	other
Do not <e1>offer</e1> <e2>budesonide</e2> or aminosalicylate treatment for severe presentations or exacerbations .	acts-on(e1,e2)
In <e1>patients</e1> who have <e2>recovered</e2> from an episode of sustained ventricular tachycardia who are not candidates for an ICD , amiodarone or sotalol should be considered .	actor-of(e1,e2)
<e1>Use</e1> nasal cannula or incubator <e2>oxygen</e2> for preterm babies who need supplemental oxygen .	acts-on(e1,e2)
For people who cannot tolerate aminosalicylates , consider a <e1>time-limited</e1> <e2>course</e2> of a topical or an oral corticosteroid .	modifier(e1,e2)
If long-term medium/high-dose GC therapy is anticipated to be necessary , actively consider <e1>GC-sparing</e1> <e2>therapy</e2> .	modifier(e1,e2)
Offer a pancreatic protocol CT scan to people with pancreatic <e1>abnormalities</e1> but no <e2>jaundice</e2> .	other
Patients with <e1>chronic</e1> hepatitis <e2>B</e2> and C co-infection should be considered for treatment with pegylated IFN and weight based ribavirin .	modifier(e1,e2)
To induce remission in people with a mild-to-moderate first presentation or inflammatory exacerbation of proctosigmoiditis or left-sided ulcerative colitis , offer a <e1>topical</e1> <e2>aminosalicylate</e2> as first-line treatment .	modifier(e1,e2)
Consider ovarian function <e1>suppression</e1> in addition to endocrine <e2>therapy</e2> for premenopausal women with ER-positive invasive breast cancer .	other
Offer urgent ultrasound as first-line imaging for <e1>children</e1> and young <e2>people</e2> with suspected renal colic .	joint
<e1>Use</e1> <e2>MRI</e2> when necessary to assess the extent of disease , for people with superior sulcus tumours .	acts-on(e1,e2)
Offer antihypertensive drug <e1>treatment</e1> for heart <e2>failure</e2> with treated hypertension .	other
If HbA1c rises to 48 mmol/mol ( 6.5 % ) on lifestyle interventions , offer metformin and support the person to <e1>aim</e1> for an HbA1c <e2>level</e2> of 48 mmol/mol ( 6.5 % ) .	acts-on(e1,e2)
Patients undergoing surgical revascularisation of the left anterior descending coronary artery should <e1>receive</e1> an internal mammary artery <e2>graft</e2> .	acts-on(e1,e2)
All patients with <e1>invasive</e1> breast <e2>cancer</e2> who are operable should have axillary surgery .	modifier(e1,e2)
All <e1>patients</e1> with heart <e2>failure</e2> with reduced ejection fraction , NYHA class 2-4 should be started on beta-blocker therapy as soon as their condition is stable .	owner(e1,e2)
<e1>Offer</e1> chemotherapy before and after surgery to <e2>people</e2> with gastric cancer who are having radical surgical resection .	receiver(e1,e2)
If the <e1>person</e1> has stage 2 hypertension , <e2>offer</e2> antihypertensive drug treatment .	receiver(e1,e2)
In <e1>patients</e1> with stable angina <e2>requiring</e2> percutaneous coronary intervention for in stent restenosis , a drug eluting balloon or a second or third generation drug eluting stent should be considered .	actor-of(e1,e2)
Women with stage 4 ovarian cancer should be <e1>offered</e1> <e2>bevacizumab</e2> in combination with carboplatin and paclitaxel .	acts-on(e1,e2)
Consider surgical mediastinal staging for <e1>people</e1> with a negative <e2>EBUS-TBNA</e2> or EUS-FNA if clinical suspicion of nodal malignancy is high and nodal status would affect their treatment plan .	owner(e1,e2)
Conventional radiography of the SI joints and/or spine may be used for long-term monitoring of <e1>structural</e1> <e2>damage</e2> , particularly new bone formation , in axial SpA .	modifier(e1,e2)
Do not offer dedicated brain imaging to people with <e1>clinical</e1> stage 1 <e2>NSCLC</e2> who have no neurological symptoms and are having treatment with curative intent .	modifier(e1,e2)
Consider adding azathioprine or mercaptopurine to a <e1>conventional</e1> <e2>glucocorticosteroid</e2> or budesonide to induce remission of Crohn's disease if there are 2 or more inflammatory exacerbations in a 12 month period or the glucocorticosteroid dose cannot be tapered .	modifier(e1,e2)
Patients with NSCLC stage 1 and 2 who are medically inoperable or who do not <e1>consent</e1> to <e2>surgery</e2> should be offered radical radiotherapy .	acts-on(e1,e2)
If the treatment target is not achieved with the first csDMARD strategy , when poor prognostic factors are present , addition of a <e1>bDMARD</e1> or a <e2>tsDMARD</e2> should be considered .	choice
For people who cannot tolerate aminosalicylates , consider a time-limited course of an <e1>oral</e1> <e2>corticosteroid</e2> .	modifier(e1,e2)
Consider <e1>second-line</e1> palliative <e2>chemotherapy</e2> for people with oesophago-gastric cancer .	modifier(e1,e2)
<e1>Review</e1> antibiotic treatment after 14 days and either <e2>stop</e2> the antibiotic or continue for a further 14 days if needed , based on an assessment of the person's history , symptoms , clinical examination , urine and blood tests .	joint
Measure serum calcium for <e1>adults</e1> with ureteric or renal <e2>stones</e2> .	owner(e1,e2)
If the treatment <e1>target</e1> is not <e2>achieved</e2> with the first csDMARD strategy , in the absence of poor prognostic factors , other csDMARDs should be considered .	acts-on(e2,e1)
<e1>Women</e1> with platinum resistant ovarian <e2>cancer</e2> should be considered for treatment with paclitaxel or single agent pegylated liposomal doxorubicin hydrochloride .	owner(e1,e2)
Do not use synchronised pressure-limited ventilation such as assist control , synchronised intermittent positive pressure ventilation , patient-triggered <e1>ventilation</e1> , pressure support <e2>ventilation</e2> or synchronised time-cycled pressure-limited ventilation .	choice
<e1>MRI</e1> may also be used to <e2>predict</e2> development of new radiographic syndesmophytes .	actor-of(e1,e2)
In <e1>patients</e1> with a contraindication to MTX , leflunomide or sulfasalazine should be <e2>considered</e2> as part of the treatment strategy .	receiver(e1,e2)
Herpes zoster <e1>vaccination</e1> may be <e2>considered</e2> in patients with AIIRD .	acts-on(e2,e1)
Provide an accessible resource to promote best practice in the management of <e1>patients</e1> <e2>using</e2> medium/high-dose GCs to general practitioners .	actor-of(e1,e2)
For prolonged treatment , the glucocorticoid <e1>dosage</e1> should be <e2>kept</e2> to a minimum and a glucocorticoid taper should be attempted in case of remission or low disease activity .	acts-on(e2,e1)
For preterm babies who need invasive ventilation , use <e1>volume-targeted</e1> <e2>ventilation</e2> in combination with synchronised ventilation as the primary mode of respiratory support .	modifier(e1,e2)
For <e1>patients</e1> with HCV genotype 1 <e2>infection</e2> and HIV , who do not achieve an EVR , treatment should be stopped .	owner(e1,e2)
For people who cannot tolerate aminosalicylates , consider a time-limited course of a topical or an <e1>oral</e1> <e2>corticosteroid</e2> .	modifier(e1,e2)
Consider a <e1>bisphosphonate</e1> to <e2>reduce</e2> fracture risk for people with primary hyperparathyroidism and increased fracture risk .	actor-of(e1,e2)
Conventional radiography of the SI joints and/or spine may be used for long-term <e1>monitoring</e1> of structural <e2>damage</e2> , particularly new bone formation , in axial SpA .	other
Adjuvant chemotherapy should be considered for all <e1>patients</e1> with breast <e2>cancer</e2> where benefit outweighs risk .	owner(e1,e2)
Aim for a target clinic blood pressure below 150/90 mmHg in <e1>people</e1> aged 80 <e2>years</e2> and over with treated hypertension .	modifier(e2,e1)
Maintain blood pressure below 140/90 mmHg for people who have <e1>symptoms</e1> of stage 1 <e2>hypertension</e2> .	other
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider triple therapy with metformin and a <e1>DPP-4i</e1> and an <e2>SU</e2> , metformin and pioglitazone and an SU , metformin and pioglitazone and an SGLT-2i , metformin and an SU and an SGLT-2i , insulin-based treatment , and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	joint
For eligible people with stage 3A NSCLC who cannot tolerate or who decline chemoradiotherapy , <e1>consider</e1> radical <e2>radiotherapy</e2> .	acts-on(e1,e2)
Do not <e1>offer</e1> aspirin for the primary prevention of cardiovascular disease to <e2>adults</e2> with type 1 diabetes .	receiver(e2,e1)
Do not use synchronised pressure-limited ventilation such as assist <e1>control</e1> , synchronised intermittent positive pressure <e2>ventilation</e2> , patient-triggered ventilation , pressure support ventilation or synchronised time-cycled pressure-limited ventilation .	choice
<e1>Offer</e1> image-guided <e2>biopsy</e2> to people with peripheral lung lesions when treatment can be planned on the basis of this test .	acts-on(e1,e2)
For eligible <e1>people</e1> with stage 3B NSCLC who cannot <e2>tolerate</e2> or who decline chemoradiotherapy , consider radical radiotherapy .	actor-of(e1,e2)
Assess the PR status of all <e1>invasive</e1> breast <e2>cancers</e2> using standardised and quality-assured immunohistochemical techniques , and report the results quantitatively .	modifier(e1,e2)
Amiodarone therapy is not recommended for patients following ACS or patients with <e1>congestive</e1> heart <e2>failure</e2> who do not have sustained ventricular arrhythmias or atrial fibrillation .	modifier(e1,e2)
For <e1>people</e1> with stage 1-2A NSCLC who decline surgery or in whom any surgery is contraindicated , <e2>offer</e2> SABR .	receiver(e1,e2)
If further <e1>treatment</e1> is <e2>needed</e2> , stop topical treatments and offer an oral aminosalicylate and a time-limited course of an oral corticosteroid .	modifier(e2,e1)
Advise pregnant women with more than 1 moderate risk factor for pre-eclampsia to <e1>take</e1> 75-150 mg of <e2>aspirin</e2> daily from 12 weeks until the birth of the baby .	acts-on(e1,e2)
For children who are allergic to penicillins , <e1>consider</e1> an alternative oral anti-Staphylococcus aureus <e2>agent</e2> .	acts-on(e1,e2)
If the person has severe hypertension , consider starting antihypertensive drug treatment immediately , without waiting for the <e1>results</e1> of <e2>ABPM</e2> or HBPM .	other
Before <e1>starting</e1> medium/high-dose GC <e2>treatment</e2> , consider comorbidities predisposing to AEs .	acts-on(e1,e2)
Consider opioids for adults , children and <e1>young</e1> <e2>people</e2> with suspected renal colic if both NSAIDs and intravenous paracetamol are contraindicated or are not giving sufficient pain relief .	modifier(e1,e2)
Offer to carry out a blood test for rheumatoid factor in <e1>adults</e1> with suspected rheumatoid <e2>arthritis</e2> who are found to have synovitis on clinical examination .	owner(e1,e2)
For people with stage 1-2A NSCLC who decline surgery or in whom any <e1>surgery</e1> is <e2>contraindicated</e2> , offer SABR .	modifier(e2,e1)
If HbA1c rises to 48 mmol/mol ( 6.5 % ) on lifestyle interventions , offer metformin and support the <e1>person</e1> to <e2>aim</e2> for an HbA1c level of 48 mmol/mol ( 6.5 % ) .	actor-of(e1,e2)
Offer an ACE <e1>inhibitor</e1> and a <e2>beta-blocker</e2> licensed for heart failure to people who have heart failure with reduced ejection fraction .	joint
<e1>Aim</e1> for a target clinic blood pressure below 140/90 mmHg in <e2>people</e2> aged under 80 years with treated hypertension .	receiver(e2,e1)
Offer an <e1>alternative</e1> antiplatelet <e2>agent</e2> to anyone with acute ischaemic stroke who is allergic to or genuinely intolerant of aspirin .	modifier(e1,e2)
US and MRI may be used to monitor disease activity in peripheral SpA , providing additional information on top of <e1>clinical</e1> and <e2>biochemical</e2> assessments .	joint
Avoid verapamil , diltiazem and <e1>short-acting</e1> dihydropyridine <e2>agents</e2> in people who have heart failure with reduced ejection fraction .	modifier(e1,e2)
Patients with HCV associated chronic liver failure should be <e1>considered</e1> for <e2>assessment</e2> for liver transplantation .	acts-on(e1,e2)
A regimen <e1>containing</e1> a platinum <e2>agent</e2> and etoposide is recommended for first line treatment of patients with SCLC .	acts-on(e1,e2)
All <e1>women</e1> with high grade early stage ovarian <e2>cancer</e2> should be considered for adjuvant chemotherapy .	owner(e1,e2)
<e1>Consider</e1> a clinical trial as an alternative to second-line chemotherapy for <e2>people</e2> with oesophago-gastric cancer .	receiver(e2,e1)
Maintain blood pressure below 45 ml/minute/1.73m2 if the <e1>person</e1> is aged under 80 years with type 1 <e2>diabetes</e2> .	owner(e1,e2)
Monitor the effects of <e1>azathioprine</e1> , mercaptopurine and methotrexate as <e2>advised</e2> in the British National Formulary or British National Formulary for Children .	modifier(e2,e1)
Evaluate PET-CT-positive or <e1>enlarged</e1> intrathoracic <e2>nodes</e2> using a systematic approach with EBUS-TBNA and/or EUS-FNA if nodal status would affect the treatment plan .	modifier(e1,e2)
Give oral antibiotics first line if the person can take oral medicines , and the severity of their <e1>condition</e1> does not <e2>require</e2> intravenous antibiotics .	actor-of(e1,e2)
Keep the requirement for <e1>continuing</e1> GC <e2>treatment</e2> under constant review , and titrate the dose against therapeutic response , risk of undertreatment and development of AEs .	acts-on(e1,e2)
<e1>Patients</e1> with HCV associated chronic liver failure should be <e2>considered</e2> for assessment for liver transplantation .	receiver(e1,e2)
Offer nutritional assessment and tailored specialist dietetic support to people with oesophago-gastric <e1>cancer</e1> <e2>before</e2> , during and after radical treatments .	modifier(e2,e1)
For early <e1>stage</e1> <e2>disease</e2> , maintenance cytotoxic chemotherapy should not be given .	modifier(e1,e2)
Verapamil and diltiazem may be used for <e1>prophylaxis</e1> of atrial <e2>fibrillation</e2> following CABG surgery .	other
Optimised antidepressant therapy should be <e1>considered</e1> for the <e2>treatment</e2> of patients with chronic pain with moderate depression .	other
<e1>Assess</e1> the ER status of all invasive breast cancers using standardised and quality-assured immunohistochemical techniques , and <e2>report</e2> the results quantitatively .	other
If <e1>ACE</e1> inhibitors are not <e2>tolerated</e2> , substitute angiotensin 2 receptor antagonists .	modifier(e2,e1)
For people with cystic fibrosis who develop a Haemophilus influenzae infection but do not <e1>have</e1> clinical <e2>evidence</e2> of pulmonary infection , treat with an appropriate oral antibiotic .	acts-on(e1,e2)
<e1>Offer</e1> an alternative antiplatelet <e2>agent</e2> to anyone with acute ischaemic stroke who is allergic to or genuinely intolerant of aspirin .	acts-on(e1,e2)
When adequate <e1>control</e1> of anginal <e2>symptoms</e2> is not achieved with beta blockade , addition of a calcium channel blocker should be considered .	other
Aromatase inhibitor is recommended for ER <e1>positive</e1> postmenopausal <e2>women</e2> receiving neoadjuvant endocrine therapy .	modifier(e1,e2)
Consider a bisphosphonate to reduce fracture risk for <e1>people</e1> with primary <e2>hyperparathyroidism</e2> and increased fracture risk .	owner(e1,e2)
Do not offer aspirin for the <e1>primary</e1> <e2>prevention</e2> of cardiovascular disease to adults with type 1 diabetes .	modifier(e1,e2)
In patients who cannot use csDMARDs as comedication , IL-6 pathway <e1>inhibitors</e1> and <e2>tsDMARDs</e2> may have some advantages compared with other bDMARDs .	joint
<e1>Offer</e1> contrast-enhanced brain CT if the <e2>person</e2> has established cardiovascular disease .	receiver(e2,e1)
<e1>Consider</e1> <e2>opioids</e2> , such as codeine or morphine , to reduce cough .	acts-on(e1,e2)
All patients with heart failure with <e1>reduced</e1> ejection <e2>fraction</e2> , NYHA class 2-4 should be started on beta-blocker therapy as soon as their condition is stable .	modifier(e1,e2)
Keep the requirement for continuing GC <e1>treatment</e1> under constant <e2>review</e2> , and titrate the dose against therapeutic response , risk of undertreatment and development of AEs .	other
Vaccination in <e1>patients</e1> with <e2>AIIRD</e2> should ideally be administered during stable disease .	owner(e1,e2)
Offer radical resection to people with T1bN0 oesophageal adenocarcinoma if <e1>they</e1> are <e2>fit</e2> enough to have surgery .	modifier(e2,e1)
<e1>Offer</e1> to carry out a blood <e2>test</e2> for rheumatoid factor in adults with suspected rheumatoid arthritis who are found to have synovitis on clinical examination .	acts-on(e1,e2)
Patients with heart failure with reduced ejection fraction of all NYHA functional classes , should be <e1>given</e1> angiotensin converting enzyme <e2>inhibitors</e2> .	acts-on(e1,e2)
Offer intravenous paracetamol to adults , children and young people with suspected renal colic if NSAIDs are contraindicated or are not giving <e1>sufficient</e1> pain <e2>relief</e2> .	modifier(e1,e2)
<e1>Patients</e1> with heart <e2>failure</e2> with reduced ejection fraction , NYHA class 2-4 , who are intolerant of angiotensin converting enzyme inhibitors should be given an angiotensin receptor blocker .	owner(e1,e2)
Calcium channel blocker therapy is not recommended for reduction in sudden death or all cause mortality in patients <e1>following</e1> <e2>ACS</e2> .	acts-on(e1,e2)
If the treatment target is not achieved with the first csDMARD strategy , in the <e1>absence</e1> of poor prognostic <e2>factors</e2> , other csDMARDs should be considered .	other
For <e1>preterm</e1> <e2>babies</e2> who need invasive ventilation but VTV and HFOV are not available or not suitable , consider synchronised intermittent mandatory ventilation .	modifier(e1,e2)
For preterm babies who need invasive ventilation but <e1>VTV</e1> and <e2>HFOV</e2> are not available or not suitable , consider synchronised intermittent mandatory ventilation .	joint
If the person has severe hypertension , consider starting antihypertensive drug treatment immediately , without <e1>waiting</e1> for the <e2>results</e2> of ABPM or HBPM .	acts-on(e1,e2)
If further treatment is needed , consider adding a time-limited course of a <e1>topical</e1> or an <e2>oral</e2> corticosteroid .	choice
Disease activity should be controlled optimally in order to <e1>lower</e1> CVD <e2>risk</e2> in all patients with RA , AS or PsA .	acts-on(e1,e2)
Offer people who present with superior vena cava obstruction chemotherapy and radiotherapy according to the stage of <e1>disease</e1> and performance <e2>status</e2> .	joint
If clinical <e1>evaluation</e1> or lung function <e2>testing</e2> indicates an inadequate response to rhDNase , consider both rhDNase and hypertonic sodium chloride or hypertonic sodium chloride alone .	choice
Patients with heart <e1>failure</e1> and clinical <e2>signs</e2> or symptoms of fluid overload or congestion should be considered for diuretic therapy .	joint
Do not use fish <e1>oils</e1> as a nutritional intervention to <e2>manage</e2> weight loss in people with unresectable pancreatic cancer .	actor-of(e1,e2)
Patients with heart failure with reduced ejection fraction , NYHA class 2-4 , who are intolerant of angiotensin converting enzyme inhibitors should be <e1>given</e1> an angiotensin receptor <e2>blocker</e2> .	acts-on(e1,e2)
Offer standard structural MRI as the initial diagnostic test for suspected glioma , unless <e1>MRI</e1> is <e2>contraindicated</e2> .	modifier(e2,e1)
Do not offer azathioprine , <e1>mercaptopurine</e1> or <e2>methotrexate</e2> as monotherapy to induce remission .	choice
<e1>Consider</e1> measuring anti-CCP antibodies in <e2>adults</e2> with suspected RA if they are negative for rheumatoid factor .	receiver(e2,e1)
Calcium channel blocker therapy is not recommended for reduction in <e1>sudden</e1> <e2>death</e2> or all cause mortality in patients following ACS .	modifier(e1,e2)
<e1>Consider</e1> alpha <e2>blockers</e2> for adults , children and young people with distal ureteric stones less than 10 mm .	acts-on(e1,e2)
Offer an MRA , in addition to an ACE inhibitor ( or ARB ) and beta-blocker , to people who <e1>have</e1> heart <e2>failure</e2> with reduced ejection fraction if they continue to have symptoms of heart failure .	acts-on(e1,e2)
In <e1>patients</e1> with <e2>syndesmophytes</e2> in the lumbar spine on conventional radiography , osteoporosis should be assessed by hip DXA , supplemented by either spine DXA in lateral projection or possibly QCT of the spine .	owner(e1,e2)
<e1>Monitor</e1> for <e2>neutropenia</e2> in people taking azathioprine or mercaptopurine even if they have normal TPMT activity .	acts-on(e1,e2)
For <e1>eligible</e1> <e2>people</e2> with stage 3B NSCLC who cannot tolerate or who decline chemoradiotherapy , consider radical radiotherapy .	modifier(e1,e2)
Furthermore , US or MRI might be used to detect <e1>peripheral</e1> <e2>arthritis</e2> , tenosynovitis and bursitis .	modifier(e1,e2)
Offer an alternative antiplatelet agent to anyone with <e1>acute</e1> ischaemic <e2>stroke</e2> who is allergic to or genuinely intolerant of aspirin .	modifier(e1,e2)
For women with a cerebrovascular malformation at <e1>low</e1> <e2>risk</e2> of intracranial bleeding , manage the second stage of labour based on the woman's preference and obstetric indications .	modifier(e1,e2)
Offer an MRA , in addition to an ACE <e1>inhibitor</e1> ( or ARB ) and <e2>beta-blocker</e2> , to people who have heart failure with reduced ejection fraction if they continue to have symptoms of heart failure .	joint
<e1>Advise</e1> pregnant <e2>women</e2> at high risk of pre-eclampsia to take 75-150 mg of aspirin daily from 12 weeks until the birth of the baby .	receiver(e2,e1)
<e1>Use</e1> an automated reagent-strip reading <e2>device</e2> for dipstick screening for proteinuria in pregnant women in secondary care settings .	acts-on(e1,e2)
A regimen containing a platinum agent and etoposide is <e1>recommended</e1> for first line <e2>treatment</e2> of patients with SCLC .	other
<e1>Avoid</e1> verapamil , diltiazem and short-acting dihydropyridine agents in <e2>people</e2> who have heart failure with reduced ejection fraction .	receiver(e2,e1)
Offer radical resection to people with T1bN0 oesophageal adenocarcinoma if <e1>they</e1> are fit enough to <e2>have</e2> surgery .	actor-of(e1,e2)
Monitor the effects of azathioprine , mercaptopurine and methotrexate as <e1>advised</e1> in the British National Formulary or British National Formulary for <e2>Children</e2> .	modifier(e2,e1)
Calcium channel blocker therapy is not <e1>recommended</e1> for <e2>reduction</e2> in sudden death or all cause mortality in patients following ACS .	modifier(e1,e2)
People with a <e1>history</e1> of fragility <e2>fractures</e2> over the age of 50 should be offered DXA scanning to evaluate the need for antiosteoporosis therapy .	other
In patients being considered for <e1>active</e1> <e2>therapy</e2> , pleural effusion should be investigated with pleural aspiration and/or pleural biopsy using image-guided or thoracoscopic biopsy .	modifier(e1,e2)
For prolonged treatment , the glucocorticoid dosage should be kept to a minimum and a glucocorticoid taper should be attempted in case of remission or <e1>low</e1> disease <e2>activity</e2> .	modifier(e1,e2)
In patients with permanent AF or persistent <e1>AF</e1> <e2>following</e2> a rate control strategy and a resting heart rate > 110 bpm , appropriate rate control therapy should be instituted with an initial target of resting heart rate .	actor-of(e1,e2)
If the <e1>person</e1> is aged under 80 years with stage 1 hypertension and <e2>has</e2> renal disease , offer antihypertensive drug treatment .	actor-of(e1,e2)
Do not offer ACE inhibitor therapy if there is a clinical suspicion of haemodynamically significant valve disease until the valve <e1>disease</e1> has been <e2>assessed</e2> by a specialist .	acts-on(e2,e1)
Consider measuring anti-CCP antibodies in adults with suspected RA if they are <e1>negative</e1> for rheumatoid <e2>factor</e2> .	modifier(e1,e2)
<e1>Patients</e1> with lung cancer who have symptomatic bone metastases should be <e2>considered</e2> for treatment with a bisphosphonate .	receiver(e1,e2)
For patients receiving a protease inhibitor in combination with pegylated <e1>IFN</e1> and ribavirin <e2>therapy</e2> , consider ribavirin dose reduction as an alternative to the addition of EPO for controlling anaemia .	joint
Tricyclic antidepressants should not be used for the management of pain in patients with <e1>chronic</e1> low back <e2>pain</e2> .	modifier(e1,e2)
All women with high grade early stage ovarian cancer should be <e1>considered</e1> for adjuvant <e2>chemotherapy</e2> .	acts-on(e1,e2)
CVD risk assessment is <e1>recommended</e1> for all patients with RA , AS or PsA at least <e2>once</e2> every 5 years and should be reconsidered following major changes in antirheumatic therapy .	modifier(e2,e1)
Conventional <e1>radiography</e1> of the SI joints and/or spine may be <e2>used</e2> for long-term monitoring of structural damage , particularly new bone formation , in axial SpA .	acts-on(e2,e1)
Consider alpha blockers for <e1>adults</e1> , <e2>children</e2> and young people with distal ureteric stones less than 10 mm .	joint
Acute withdrawal of beta-blockers in the <e1>postoperative</e1> <e2>period</e2> is not recommended .	modifier(e1,e2)
If conventional <e1>radiography</e1> is <e2>negative</e2> , CT should be performed .	modifier(e2,e1)
<e1>Offer</e1> <e2>metformin</e2> as the initial drug treatment for adults with type 2 diabetes .	acts-on(e1,e2)
<e1>Patients</e1> <e2>undergoing</e2> surgical revascularisation of the left anterior descending coronary artery should receive an internal mammary artery graft .	actor-of(e1,e2)
Long term beta-blockers are recommended for routine use in <e1>patients</e1> <e2>following</e2> ACS without contraindications .	actor-of(e1,e2)
Measure serum calcium for adults with ureteric or <e1>renal</e1> <e2>stones</e2> .	modifier(e1,e2)
<e1>Assess</e1> the ER status of all invasive breast cancers <e2>using</e2> standardised and quality-assured immunohistochemical techniques , and report the results quantitatively .	other
Maintain blood pressure below 130/80 mmHg or lower for people who have heart <e1>failure</e1> with stage 2 <e2>diabetes</e2> .	other
Ensure that people with disabling ischaemic stroke who are in atrial fibrillation are treated with aspirin 300 mg for the first 2 weeks before anticoagulation <e1>treatment</e1> is <e2>considered</e2> .	modifier(e2,e1)
Monitor the response to titration of medicines closely in people who have heart <e1>failure</e1> with reduced ejection <e2>fraction</e2> and chronic kidney disease .	other
Patients with heart failure and clinical <e1>signs</e1> or <e2>symptoms</e2> of fluid overload or congestion should be considered for diuretic therapy .	choice
If HbA1c rises to 48 mmol/mol ( 6.5 % ) on lifestyle interventions , consider a DPP-4i , pioglitazone , an SU , an SGLT-2i , and support the <e1>person</e1> to <e2>aim</e2> for an HbA1c level of 48 mmol/mol ( 6.5 % ) for people on a DPP-4i , SGLT-2i or pioglitazone or 53 mmol/mol ( 7 % ) for people on an SU .	actor-of(e1,e2)
Lifestyle recommendations should emphasise the benefits of a healthy diet , regular <e1>exercise</e1> and smoking <e2>cessation</e2> for all patients .	joint
Consider azathioprine or mercaptopurine at a lower dose if TPMT <e1>activity</e1> is below normal but not <e2>deficient</e2> .	modifier(e2,e1)
<e1>Monitor</e1> for neutropenia in <e2>people</e2> taking azathioprine or mercaptopurine even if they have normal TPMT activity .	receiver(e2,e1)
For prolonged treatment , the glucocorticoid dosage should be <e1>kept</e1> to a <e2>minimum</e2> and a glucocorticoid taper should be attempted in case of remission or low disease activity .	other
If the <e1>person</e1> is aged under 80 years with stage 1 hypertension , <e2>prescribe</e2> metformin and a DPP-4i and support for a target HbA1c level of 48 mmol/mol ( 6.5 % ) .	receiver(e1,e2)
Amiodarone therapy is not recommended for patients following ACS or patients with congestive heart failure who do not have sustained ventricular arrhythmias or <e1>atrial</e1> <e2>fibrillation</e2> .	modifier(e1,e2)
Offer chemotherapy before and after surgery to <e1>people</e1> with gastric cancer who are <e2>having</e2> radical surgical resection .	actor-of(e1,e2)
Transmyocardial laser revascularisation is not <e1>recommended</e1> for the <e2>treatment</e2> of stable angina .	other
<e1>Patients</e1> with an ST segment elevation acute coronary <e2>syndrome</e2> should be treated immediately with primary percutaneous coronary intervention .	owner(e1,e2)
In patients who fail to <e1>respond</e1> adequately to a <e2>bDMARD</e2> , switching to another bDMARD should be considered , including switching between TNF inhibitors .	acts-on(e1,e2)
<e1>US</e1> and <e2>MRI</e2> may be used to monitor disease activity in peripheral SpA , providing additional information on top of clinical and biochemical assessments .	joint
To <e1>induce</e1> <e2>remission</e2> in people with a mild-to-moderate first presentation or inflammatory exacerbation of extensive ulcerative colitis , offer a topical aminosalicylate and a high-dose oral aminosalicylate as first-line treatment .	acts-on(e1,e2)
<e1>Patients</e1> with mild <e2>CHC</e2> should be considered for treatment .	owner(e1,e2)
Offer <e1>intravenous</e1> <e2>paracetamol</e2> to adults , children and young people with suspected renal colic if NSAIDs are contraindicated or are not giving sufficient pain relief .	modifier(e1,e2)
The <e1>decision</e1> on when to repeat MRI <e2>depends</e2> on the clinical circumstances .	actor-of(e1,e2)
Offer intravenous paracetamol to adults , children and young <e1>people</e1> with suspected renal <e2>colic</e2> if NSAIDs are contraindicated or are not giving sufficient pain relief .	owner(e1,e2)
Amiodarone therapy is not recommended for patients following ACS or <e1>patients</e1> with congestive heart failure who do not <e2>have</e2> sustained ventricular arrhythmias or atrial fibrillation .	actor-of(e1,e2)
Consider endocrine <e1>therapy</e1> after breast-conserving <e2>surgery</e2> for women with ER-positive DCIS if radiotherapy is not recommended .	other
In patients with ankylosing spondylitis , initial conventional radiography of the lumbar and cervical <e1>spine</e1> is <e2>recommended</e2> to detect syndesmophytes , which are predictive of development of new syndesmophytes .	modifier(e2,e1)
Do not routinely use MRI to <e1>assess</e1> the stage of the primary tumour <e2>(T-stage)</e2> in non-small-cell lung cancer .	acts-on(e1,e2)
Consider opioids , such as codeine or morphine , to <e1>reduce</e1> <e2>cough</e2> .	acts-on(e1,e2)
The routine use of aspirin to reduce perioperative cardiac events in patients undergoing non cardiac surgery , including those with known <e1>stable</e1> <e2>CAD</e2> , is not recommended .	modifier(e1,e2)
Do not offer cinacalcet to pregnant <e1>women</e1> with primary <e2>hyperparathyroidism</e2> .	owner(e1,e2)
<e1>US</e1> with high-frequency colour or power <e2>Doppler</e2> is sufficient to detect inflammation and the use of US contrast medium is not needed .	choice
Where appropriate , functional <e1>tests</e1> , including the exercise tolerance test , should be <e2>considered</e2> to aid in the risk stratification of patients with known CAD .	modifier(e2,e1)
Do not offer platinum-based combination <e1>chemotherapy</e1> to <e2>obtain</e2> a serum calcium for people with extensive-stage disease SCLC if they are fit enough .	actor-of(e1,e2)
Offer PET-CT , followed by EBUS-TBNA and/or EUS-FNA , to people with <e1>suspected</e1> lung <e2>cancer</e2> who have enlarged intrathoracic lymph nodes and who could potentially have treatment with curative intent .	modifier(e1,e2)
US and MRI may be used to monitor disease activity in peripheral SpA , providing <e1>additional</e1> <e2>information</e2> on top of clinical and biochemical assessments .	modifier(e1,e2)
In patients with suspected stable angina , the exercise tolerance <e1>test</e1> should not be <e2>used</e2> routinely as a first line diagnostic tool .	modifier(e2,e1)
CVD risk prediction models should be adapted for patients with <e1>RA</e1> by a 1.5 multiplication <e2>factor</e2> , if this is not already included in the model .	other
If the person is with CKD and diabetes and an ACR of 3 <e1>mg/mmol</e1> or <e2>more</e2> , offer a low-cost renin-angiotensin-aldosterone system antagonist .	other
<e1>Offer</e1> <e2>radiotherapy</e2> using 60 Gy in 30 fractions with concomitant temozolomide for people aged around 70 or under .	acts-on(e1,e2)
Use nasal cannula or incubator oxygen for preterm <e1>babies</e1> who <e2>need</e2> supplemental oxygen .	actor-of(e1,e2)
<e1>Perform</e1> transthoracic <e2>echocardiography</e2> to exclude important valve disease , assess the systolic function of the ventricle , and detect intracardiac shunts .	acts-on(e1,e2)
Lifestyle recommendations should emphasise the <e1>benefits</e1> of a healthy <e2>diet</e2> , regular exercise and smoking cessation for all patients .	other
Patients with an ST segment <e1>elevation</e1> acute coronary <e2>syndrome</e2> should be treated immediately with primary percutaneous coronary intervention .	modifier(e1,e2)
Do not offer <e1>pre-treatment</e1> <e2>stenting</e2> to adults having shockwave lithotripsy for ureteric or renal stones .	modifier(e1,e2)
<e1>Offer</e1> contrast-enhanced brain <e2>CT</e2> if the person has established cardiovascular disease .	acts-on(e1,e2)
Patients with , or at risk of , GC-induced osteoporosis should receive appropriate <e1>preventive/therapeutic</e1> <e2>interventions</e2> .	modifier(e1,e2)
If HbA1c rises to 48 mmol/mol ( 6.5 % ) on lifestyle interventions , consider a DPP-4i , <e1>pioglitazone</e1> , an <e2>SU</e2> , an SGLT-2i , and support the person to aim for an HbA1c level of 48 mmol/mol ( 6.5 % ) for people on a DPP-4i , SGLT-2i or pioglitazone or 53 mmol/mol ( 7 % ) for people on an SU .	joint
Do not <e1>offer</e1> a <e2>mucolytic</e2> to treat an acute cough associated with an upper respiratory tract infection or acute bronchitis .	acts-on(e1,e2)
All <e1>women</e1> with non-mucinous <e2>ovarian</e2> or fallopian tube cancer should be offered BRCA1 and BRCA2 mutation testing .	owner(e1,e2)
Where appropriate , functional <e1>tests</e1> , including the exercise tolerance <e2>test</e2> , should be considered to aid in the risk stratification of patients with known CAD .	joint
Do not <e1>offer</e1> an antibiotic to treat an acute cough associated with an upper respiratory tract infection in <e2>people</e2> who are not systemically very unwell or at higher risk of complications .	receiver(e2,e1)
In <e1>patients</e1> with peripheral <e2>arthritis</e2> and an inadequate response to at least one csDMARD , in whom bDMARDs are not appropriate , a targeted synthetic DMARD such as a PDE4-inhibitor may be considered .	owner(e1,e2)
Consider budesonide for a first presentation or a single inflammatory exacerbation in a 12-month period for people who have one or more of distal ileal , ileocaecal or right-sided colonic disease and if conventional glucocorticosteroids are contraindicated , or if the person <e1>declines</e1> or cannot <e2>tolerate</e2> them .	choice
Advise pregnant women at high risk of pre-eclampsia to <e1>take</e1> 75-150 mg of aspirin <e2>daily</e2> from 12 weeks until the birth of the baby .	modifier(e2,e1)
For preterm babies who need invasive ventilation , use volume-targeted <e1>ventilation</e1> in combination with synchronised <e2>ventilation</e2> as the primary mode of respiratory support .	other
In <e1>patients</e1> with peripheral <e2>arthritis</e2> and an inadequate response to at least one csDMARD , in whom TNF inhibitors are not appropriate , bDMARDs targeting IL12/23 or IL17 pathways may be considered .	owner(e1,e2)
Maintain a blood glucose concentration between <e1>4</e1> and <e2>11</e2> mmol/litre in people with acute stroke .	joint
Consider an ARB licensed for heart failure as an alternative to an ACE inhibitor for people who have heart failure with reduced ejection <e1>fraction</e1> and intolerable side <e2>effects</e2> with ACE inhibitors .	joint
<e1>Patients</e1> with NSCLC stage <e2>1</e2> and 2 who are medically inoperable or who do not consent to surgery should be offered radical radiotherapy .	owner(e1,e2)
Digoxin should not be used for prophylaxis of atrial fibrillation <e1>following</e1> CABG <e2>surgery</e2> .	acts-on(e1,e2)
Offer endocrine therapy after breast-conserving surgery for <e1>women</e1> with ER-positive <e2>DCIS</e2> if radiotherapy is recommended but not received .	owner(e1,e2)
Patients with AF who remain severely symptomatic despite adequate rate control should be considered for rhythm control or for stricter rate control if their heart rate <e1>remains</e1> 80-110 <e2>bpm</e2> at rest .	acts-on(e1,e2)
Do not <e1>use</e1> anticoagulation treatment <e2>routinely</e2> for the treatment of acute stroke .	modifier(e2,e1)
MRI may also be used to predict <e1>development</e1> of new radiographic <e2>syndesmophytes</e2> .	other
<e1>Patients</e1> with an ST segment elevation acute coronary syndrome should be <e2>treated</e2> immediately with primary percutaneous coronary intervention .	receiver(e1,e2)
MRI of the SI joints and/or the spine may be used to assess and <e1>monitor</e1> disease <e2>activity</e2> in axial SpA , providing additional information on top of clinical and biochemical assessments .	acts-on(e1,e2)
CVD risk estimation for patients with RA , <e1>AS</e1> or <e2>PsA</e2> should be performed according to national guidelines and the SCORE CVD risk prediction model should be used if no national guideline is available .	choice
<e1>Consider</e1> adjuvant radiotherapy for <e2>patients</e2> with completely resected stage 3B or 3C melanoma after discussion of the risk of local recurrence and the benefits and risks of radiotherapy including risk of significant adverse effects .	receiver(e2,e1)
Furthermore , US or <e1>MRI</e1> might be <e2>used</e2> to detect peripheral arthritis , tenosynovitis and bursitis .	modifier(e2,e1)
<e1>Offer</e1> either <e2>anticoagulants</e2> or antiplatelet agents to people who have stroke secondary to acute arterial dissection .	acts-on(e1,e2)
Do not routinely use <e1>MRI</e1> to <e2>assess</e2> the stage of the primary tumour (T-stage) in non-small-cell lung cancer .	actor-of(e1,e2)
<e1>Offer</e1> <e2>monotherapy</e2> with a conventional glucocorticosteroid to induce remission in people with a first presentation or a single inflammatory exacerbation of Crohn's disease in a 12-month period .	acts-on(e1,e2)
<e1>Offer</e1> chemotherapy <e2>before</e2> and after surgery to people with gastric cancer who are having radical surgical resection .	acts-on(e1,e2)
<e1>Acute</e1> <e2>withdrawal</e2> of beta-blockers in the postoperative period is not recommended .	modifier(e1,e2)
<e1>Amitriptyline</e1> should be <e2>considered</e2> for the treatment of patients with fibromyalgia and neuropathic pain .	modifier(e2,e1)
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider dual therapy with a <e1>DPP-4i</e1> and <e2>pioglitazone</e2> , a DPP-4i and an SU , pioglitazone and an SU , and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	joint
For eligible people with stage 3B NSCLC who cannot tolerate or who decline chemoradiotherapy , <e1>consider</e1> radical <e2>radiotherapy</e2> .	acts-on(e1,e2)
Offer intravenous paracetamol to adults , children and <e1>young</e1> <e2>people</e2> with suspected renal colic if NSAIDs are contraindicated or are not giving sufficient pain relief .	modifier(e1,e2)
CVD risk assessment is recommended for all patients with RA , AS or PsA at least once every 5 years and should be reconsidered following <e1>major</e1> <e2>changes</e2> in antirheumatic therapy .	modifier(e1,e2)
In patients with active <e1>enthesitis</e1> and/or <e2>dactylitis</e2> and insufficient response to NSAIDs or local glucocorticoid injections , therapy with a bDMARD should be considered , which according to current practice is a TNF inhibitor .	joint
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider triple therapy with metformin and a DPP-4i and an SU , metformin and pioglitazone and an SU , metformin and pioglitazone and an SGLT-2i , <e1>metformin</e1> and an <e2>SU</e2> and an SGLT-2i , insulin-based treatment , and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	joint
Assess the HER2 status of all <e1>invasive</e1> breast <e2>cancers</e2> using standardised and quality-assured techniques , and report the results quantitatively .	modifier(e1,e2)
In <e1>patients</e1> with predominantly axial <e2>disease</e2> that is active and has insufficient response to NSAIDs , therapy with a bDMARD should be considered , which according to current practice is a TNF inhibitor .	owner(e1,e2)
Women with platinum resistant ovarian cancer should be considered for <e1>treatment</e1> with <e2>paclitaxel</e2> or single agent pegylated liposomal doxorubicin hydrochloride .	other
Tricyclic antidepressants should not be used for the <e1>management</e1> of <e2>pain</e2> in patients with chronic low back pain .	other
All patients with <e1>chronic</e1> HCV <e2>infection</e2> should be considered for antiviral therapy .	modifier(e1,e2)
<e1>Patients</e1> with acute coronary syndrome should <e2>have</e2> continuous cardiac rhythm monitoring .	actor-of(e1,e2)
Aromatase inhibitor is recommended for ER positive postmenopausal <e1>women</e1> <e2>receiving</e2> neoadjuvant endocrine therapy .	actor-of(e1,e2)
Do not use synchronised pressure-limited ventilation such as assist control , synchronised intermittent <e1>positive</e1> pressure <e2>ventilation</e2> , patient-triggered ventilation , pressure support ventilation or synchronised time-cycled pressure-limited ventilation .	modifier(e1,e2)
Offer people who present with superior vena cava obstruction chemotherapy and radiotherapy according to the stage of disease and <e1>performance</e1> <e2>status</e2> .	modifier(e1,e2)
Offer nutritional assessment and tailored specialist dietetic support to people with oesophago-gastric cancer before , <e1>during</e1> and <e2>after</e2> radical treatments .	joint
If a person is unable to tolerate ABPM , HBPM is a <e1>suitable</e1> <e2>alternative</e2> to confirm the diagnosis of hypertension .	modifier(e1,e2)
In personalised asthma action plans for adults , consider advising quadrupling ICS at the onset of an asthma attack and for up to 14 days in order to reduce the risk of needing <e1>oral</e1> <e2>steroids</e2> .	modifier(e1,e2)
Do not offer an antibiotic to <e1>treat</e1> an acute <e2>cough</e2> associated with an upper respiratory tract infection in people who are not systemically very unwell or at higher risk of complications .	acts-on(e1,e2)
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider dual therapy with metformin and a DPP-4i , <e1>metformin</e1> and <e2>pioglitazone</e2> , metformin and an SU , metformin and an SGLT-2i , and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	joint
Offer PET-CT , followed by EBUS-TBNA and/or EUS-FNA , to people with suspected lung cancer who have enlarged intrathoracic lymph nodes and who could potentially <e1>have</e1> <e2>treatment</e2> with curative intent .	acts-on(e1,e2)
When <e1>peripheral</e1> <e2>SpA</e2> is suspected , US or MRI may be used to detect peripheral enthesitis , which may support the diagnosis of SpA .	modifier(e1,e2)
Treatment should be <e1>aimed</e1> at <e2>reaching</e2> the target of remission or , alternatively , minimal/low disease activity , by regular monitoring and appropriate adjustment of therapy .	modifier(e1,e2)
Patients with <e1>stage</e1> 1 and 2 <e2>NSCLC</e2> should be considered for curative surgery whenever possible .	joint
For preterm babies who need <e1>invasive</e1> <e2>ventilation</e2> but VTV and HFOV are not available or not suitable , consider synchronised intermittent mandatory ventilation .	modifier(e1,e2)
<e1>Offer</e1> systemic combination <e2>chemotherapy</e2> to people with locally advanced pancreatic cancer who are well enough to tolerate it .	acts-on(e1,e2)
Treatment should be aimed at reaching a target of sustained <e1>remission</e1> or low disease <e2>activity</e2> in every patient .	choice
If HbA1c <e1>rises</e1> to <e2>48</e2> mmol/mol ( 6.5 % ) on lifestyle interventions , offer metformin and support the person to aim for an HbA1c level of 48 mmol/mol ( 6.5 % ) .	modifier(e2,e1)
In patients being considered for active therapy , pleural <e1>effusion</e1> should be <e2>investigated</e2> with pleural aspiration and/or pleural biopsy using image-guided or thoracoscopic biopsy .	acts-on(e2,e1)
Do not routinely <e1>offer</e1> an antibiotic to <e2>treat</e2> an acute cough associated with acute bronchitis in people who are not systemically very unwell or at higher risk of complications .	other
For <e1>people</e1> with cystic <e2>fibrosis</e2> who develop a Haemophilus influenzae infection but do not have clinical evidence of pulmonary infection , treat with an appropriate oral antibiotic .	owner(e1,e2)
<e1>Offer</e1> platinum-based combination <e2>chemotherapy</e2> to people with extensive-stage disease SCLC if they are fit enough .	acts-on(e1,e2)
Patients with larger tumours may be considered for oncoplastic <e1>surgery</e1> instead of <e2>mastectomy</e2> .	other
If the treatment target is not <e1>achieved</e1> with the first csDMARD <e2>strategy</e2> , when poor prognostic factors are present , addition of a bDMARD or a tsDMARD should be considered .	other
CVD risk assessment is recommended for all patients with <e1>RA</e1> , <e2>AS</e2> or PsA at least once every 5 years and should be reconsidered following major changes in antirheumatic therapy .	choice
Measure N-terminal pro-B-type natriuretic peptide in people with <e1>suspected</e1> heart <e2>failure</e2> .	modifier(e1,e2)
Offer <e1>contrast-enhanced</e1> brain <e2>CT</e2> to people with clinical stage 2 NSCLC who are having treatment with curative intent .	modifier(e1,e2)
Do not offer a bisphosphonate to pregnant <e1>women</e1> with primary <e2>hyperparathyroidism</e2> .	owner(e1,e2)
If the person is with stage 2 diabetes and symptomatically hyperglycaemic , <e1>offer</e1> <e2>SGLT-2i</e2> , pioglitazone or ergocalciferol .	acts-on(e1,e2)
<e1>Offer</e1> radiotherapy <e2>using</e2> 60 Gy in 30 fractions with concomitant temozolomide for people aged around 70 or under .	other
Do not offer <e1>dedicated</e1> brain <e2>imaging</e2> to people with clinical stage 1 NSCLC who have no neurological symptoms and are having treatment with curative intent .	modifier(e1,e2)
Assess the PR status of all invasive breast cancers using standardised and quality-assured immunohistochemical techniques , and <e1>report</e1> the <e2>results</e2> quantitatively .	acts-on(e1,e2)
Sotalol therapy is not recommended for patients following ACS who do not <e1>have</e1> sustained ventricular <e2>arrhythmias</e2> or atrial fibrillation .	acts-on(e1,e2)
Give <e1>oral</e1> <e2>antibiotics</e2> first line if the person can take oral medicines , and the severity of their condition does not require intravenous antibiotics .	modifier(e1,e2)
<e1>Interpret</e1> proteinuria measurements for pregnant <e2>women</e2> in the context of a full clinical review of symptoms , signs and other investigations for pre-eclampsia .	receiver(e2,e1)
Furthermore , US or MRI might be used to <e1>detect</e1> peripheral <e2>arthritis</e2> , tenosynovitis and bursitis .	acts-on(e1,e2)
Patients with an ST segment elevation acute coronary syndrome should be <e1>treated</e1> <e2>immediately</e2> with primary percutaneous coronary intervention .	modifier(e2,e1)
If the patient is already on an ACE inhibitor , the ACE inhibitor should be stopped for 36 hours before initiating sacubitril / valsartan to minimise the <e1>risk</e1> of <e2>angioedema</e2> .	other
In case of major and/or contaminated wounds in patients who received rituximab within the last 24 weeks , <e1>passive</e1> <e2>immunisation</e2> with tetanus immunoglobulins should be administered .	modifier(e1,e2)
Do not offer pre-treatment stenting to adults having shockwave <e1>lithotripsy</e1> for <e2>ureteric</e2> or renal stones .	other
Give oral antibiotics first line if the <e1>person</e1> can take oral medicines , and the <e2>severity</e2> of their condition does not require intravenous antibiotics .	owner(e1,e2)
If the <e1>person</e1> is with <e2>CKD</e2> and beta-blocker , consider starting antihypertensive drug .	owner(e1,e2)
Provide an accessible resource to promote best practice in the management of patients using medium/high-dose <e1>GCs</e1> to general <e2>practitioners</e2> .	other
Use nasal <e1>cannula</e1> or incubator <e2>oxygen</e2> for preterm babies who need supplemental oxygen .	choice
Offer chemotherapy before and after surgery to <e1>people</e1> with gastric <e2>cancer</e2> who are having radical surgical resection .	owner(e1,e2)
Offer enteric-coated pancreatin to <e1>people</e1> with unresectable pancreatic <e2>cancer</e2> .	owner(e1,e2)
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider triple <e1>therapy</e1> with metformin and a DPP-4i and an SU , metformin and pioglitazone and an SU , <e2>metformin</e2> and pioglitazone and an SGLT-2i , metformin and an SU and an SGLT-2i , insulin-based treatment , and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	other
<e1>Offer</e1> PET-CT , followed by EBUS-TBNA and/or EUS-FNA , to <e2>people</e2> with suspected lung cancer who have enlarged intrathoracic lymph nodes and who could potentially have treatment with curative intent .	receiver(e2,e1)
Start ACE inhibitor therapy at a low dose and <e1>titrate</e1> <e2>upwards</e2> at short intervals until the target or maximum tolerated dose is reached .	modifier(e2,e1)
To induce remission in <e1>people</e1> with a mild-to-moderate first presentation or inflammatory exacerbation of proctosigmoiditis or left-sided ulcerative colitis , <e2>offer</e2> a topical aminosalicylate as first-line treatment .	receiver(e1,e2)
Do not <e1>offer</e1> <e2>bisphosphonates</e2> for chronic hypercalcaemia of primary hyperparathyroidism .	acts-on(e1,e2)
<e1>Offer</e1> an alternative antiplatelet agent to <e2>anyone</e2> with acute ischaemic stroke who is allergic to or genuinely intolerant of aspirin .	receiver(e2,e1)
Combination intravenous SACT should be considered for <e1>patients</e1> with <e2>SCLC</e2> over 70 years of age with performance status 0-2 .	owner(e1,e2)
If clinical evaluation or lung function testing indicates an inadequate response to rhDNase , consider both rhDNase and <e1>hypertonic</e1> sodium <e2>chloride</e2> or hypertonic sodium chloride alone .	modifier(e1,e2)
Avoid <e1>verapamil</e1> , <e2>diltiazem</e2> and short-acting dihydropyridine agents in people who have heart failure with reduced ejection fraction .	joint
Patients with suspected T3 or T4 disease who are otherwise fit for surgery should not be <e1>denied</e1> surgical <e2>exploration</e2> on the basis of a CT scan alone .	acts-on(e1,e2)
Prescribe metformin with caution for those at risk of a sudden <e1>deterioration</e1> in kidney <e2>function</e2> and those at risk of eGFR falling below 45 ml/minute/1.73m2 .	modifier(e1,e2)
In <e1>patients</e1> who have recovered from an episode of sustained ventricular tachycardia who are not candidates for an ICD , amiodarone or sotalol should be <e2>considered</e2> .	receiver(e1,e2)
Evaluate PET-CT-positive or enlarged intrathoracic nodes using a systematic approach with EBUS-TBNA and/or EUS-FNA if nodal status would <e1>affect</e1> the treatment <e2>plan</e2> .	acts-on(e1,e2)
Routine initiation of perioperative beta-blocker therapy to <e1>reduce</e1> perioperative myocardial infarction in <e2>patients</e2> undergoing non cardiac surgery is not recommended .	receiver(e2,e1)
<e1>Advise</e1> pregnant women with more than 1 moderate risk factor for pre-eclampsia to <e2>take</e2> 75-150 mg of aspirin daily from 12 weeks until the birth of the baby .	other
If the <e1>person</e1> <e2>has</e2> severe hypertension , consider starting antihypertensive drug treatment immediately , without waiting for the results of ABPM or HBPM .	actor-of(e1,e2)
Amiodarone <e1>therapy</e1> is not <e2>recommended</e2> for patients following ACS or patients with congestive heart failure who do not have sustained ventricular arrhythmias or atrial fibrillation .	acts-on(e2,e1)
For patients receiving a protease inhibitor in combination with pegylated IFN and ribavirin therapy , consider <e1>ribavirin</e1> dose reduction as an alternative to the addition of EPO for <e2>controlling</e2> anaemia .	actor-of(e1,e2)
The vaccination status should be assessed in the <e1>initial</e1> <e2>work-up</e2> of patients with AIIRD .	modifier(e1,e2)
In patients being considered for active therapy , pleural effusion should be <e1>investigated</e1> with pleural <e2>aspiration</e2> and/or pleural biopsy using image-guided or thoracoscopic biopsy .	other
Offer <e1>contrast-enhanced</e1> brain <e2>MRI</e2> for people with stage 3 NSCLC who are having treatment with curative intent .	modifier(e1,e2)
In <e1>patients</e1> with peripheral <e2>arthritis</e2> and an inadequate response to at least one csDMARD , therapy with a bDMARD , usually a TNF inhibitor , should be commenced .	owner(e1,e2)
<e1>Consider</e1> <e2>radiotherapy</e2> using 40 Gy in 15 fractions with concomitant and up to 12 cycles of adjuvant temozolomide for people aged around 70 or over .	acts-on(e1,e2)
Disease <e1>activity</e1> should be <e2>controlled</e2> optimally in order to lower CVD risk in all patients with RA , AS or PsA .	acts-on(e2,e1)
bDMARDs and <e1>tsDMARDs</e1> should be <e2>combined</e2> with a csDMARD .	acts-on(e2,e1)
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , <e1>consider</e1> insulin-based treatment and <e2>support</e2> the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	joint
Vaccination in <e1>patients</e1> with <e2>AIIRD</e2> can be administered during the use of disease-modifying antirheumatic drugs and tumour necrosis factor alpha blocking agents but should ideally be administered before starting B cell depleting biological therapy .	owner(e1,e2)
For people with an acute cough who are <e1>identified</e1> at a face-to-face clinical <e2>examination</e2> as at higher risk of complications , consider an immediate antibiotic prescription or a back-up antibiotic prescription .	acts-on(e1,e2)
Consider a clinical trial as an alternative to <e1>second-line</e1> <e2>chemotherapy</e2> for people with oesophago-gastric cancer .	modifier(e1,e2)
In patients with predominantly axial disease that is active and has insufficient response to NSAIDs , <e1>therapy</e1> with a bDMARD should be <e2>considered</e2> , which according to current practice is a TNF inhibitor .	acts-on(e2,e1)
<e1>Consider</e1> second-line palliative <e2>chemotherapy</e2> for people with oesophago-gastric cancer .	acts-on(e1,e2)
Consider radiotherapy <e1>using</e1> <e2>40</e2> Gy in 15 fractions with concomitant and up to 12 cycles of adjuvant temozolomide for people aged around 70 or over .	acts-on(e1,e2)
Offer people diagnosed with cerebral <e1>venous</e1> sinus <e2>thrombosis</e2> full-dose anticoagulation treatment unless there are comorbidities that preclude its use .	modifier(e1,e2)
Offer PET-CT , followed by EBUS-TBNA and/or EUS-FNA , to <e1>people</e1> with suspected lung <e2>cancer</e2> who have enlarged intrathoracic lymph nodes and who could potentially have treatment with curative intent .	owner(e1,e2)
<e1>Patients</e1> with mild CHC should be <e2>considered</e2> for treatment .	receiver(e1,e2)
A <e1>regimen</e1> containing a platinum agent and etoposide is <e2>recommended</e2> for first line treatment of patients with SCLC .	acts-on(e2,e1)
Consider surgical mediastinal staging for people with a negative EBUS-TBNA or EUS-FNA if clinical suspicion of nodal malignancy is high and nodal status would <e1>affect</e1> their treatment <e2>plan</e2> .	acts-on(e1,e2)
If <e1>HbA1c</e1> <e2>rises</e2> to 58 mmol/mol ( 7.5 % ) , consider dual therapy with metformin and a DPP-4i , metformin and pioglitazone , metformin and an SU , metformin and an SGLT-2i , and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	actor-of(e1,e2)
Offer people who present with <e1>superior</e1> vena cava obstruction <e2>chemotherapy</e2> and radiotherapy according to the stage of disease and performance status .	modifier(e1,e2)
23-valent polysaccharide pneumococcal vaccination <e1>(23-PPV)</e1> should be strongly <e2>considered</e2> for patients with AIIRD .	acts-on(e2,e1)
US and MRI may be used to monitor disease activity in peripheral SpA , <e1>providing</e1> additional <e2>information</e2> on top of clinical and biochemical assessments .	acts-on(e1,e2)
Use an automated reagent-strip reading device for dipstick screening for proteinuria in <e1>pregnant</e1> <e2>women</e2> in secondary care settings .	modifier(e1,e2)
If CT shows suspected brain metastases , offer <e1>contrast-enhanced</e1> brain <e2>MRI</e2> .	modifier(e1,e2)
Antihypertensives and statins may be used as in the <e1>general</e1> <e2>population</e2> .	modifier(e1,e2)
Before starting medium/high-dose GC treatment , consider comorbidities <e1>predisposing</e1> to <e2>AEs</e2> .	other
Offer bisphosphonates if indicated for the prevention and treatment of osteoporosis in <e1>people</e1> with a <e2>GFR</e2> of 30 ml/min/1.73m2 or more .	owner(e1,e2)
In patients who have recovered from an episode of sustained ventricular tachycardia who are not <e1>candidates</e1> for an <e2>ICD</e2> , amiodarone or sotalol should be considered .	other
If the person is with CKD and hypertension and an ACR of 30 mg/mmol or more , offer a low-cost <e1>renin-angiotensin-aldosterone</e1> system <e2>antagonist</e2> .	modifier(e1,e2)
Treatment should be aimed at reaching a target of <e1>sustained</e1> <e2>remission</e2> or low disease activity in every patient .	modifier(e1,e2)
Combination intravenous SACT should be considered for <e1>patients</e1> with SCLC over 70 years of age with performance <e2>status</e2> 0-2 .	owner(e1,e2)
If there is no improvement by at most 3 months after the <e1>start</e1> of <e2>treatment</e2> or the target has not been reached by 6 months , therapy should be adjusted .	other
Consider opioids for adults , children and young people with suspected renal colic if both NSAIDs and intravenous paracetamol are contraindicated or are not giving <e1>sufficient</e1> pain <e2>relief</e2> .	modifier(e1,e2)
Fluoxetine should be considered for the treatment of <e1>patients</e1> with <e2>fibromyalgia</e2> .	owner(e1,e2)
If surgical resection is not appropriate , consider biopsy to obtain a <e1>histological</e1> and <e2>molecular</e2> diagnosis .	joint
<e1>Patients</e1> with lung <e2>cancer</e2> who have symptomatic bone metastases should be considered for treatment with a bisphosphonate .	owner(e1,e2)
Assess the HER2 status of all invasive breast cancers using standardised and <e1>quality-assured</e1> <e2>techniques</e2> , and report the results quantitatively .	modifier(e1,e2)
For people who cannot tolerate aminosalicylates , <e1>consider</e1> a time-limited <e2>course</e2> of an oral corticosteroid .	acts-on(e1,e2)
If remission is not achieved within 4 weeks , consider adding a high-dose oral <e1>aminosalicylate</e1> to the topical <e2>aminosalicylate</e2> or switching to a high-dose oral aminosalicylate and a time-limited course of a topical corticosteroid .	other
Offer <e1>people</e1> who present with superior vena cava obstruction <e2>chemotherapy</e2> and radiotherapy according to the stage of disease and performance status .	owner(e1,e2)
CVD risk estimation for <e1>patients</e1> with RA , AS or <e2>PsA</e2> should be performed according to national guidelines and the SCORE CVD risk prediction model should be used if no national guideline is available .	owner(e1,e2)
Do not offer a mucolytic to treat an acute <e1>cough</e1> associated with an upper respiratory tract <e2>infection</e2> or acute bronchitis .	other
<e1>Monitor</e1> the response to titration of medicines closely in <e2>people</e2> who have heart failure with reduced ejection fraction and chronic kidney disease .	receiver(e2,e1)
For eligible people with stage 3B NSCLC who cannot tolerate or who <e1>decline</e1> <e2>chemoradiotherapy</e2> , consider radical radiotherapy .	acts-on(e1,e2)
In patients with permanent AF or persistent AF following a rate control strategy and a resting heart rate > 110 bpm , <e1>appropriate</e1> rate control therapy <e2>should</e2> be instituted with an initial target of resting heart rate .	modifier(e1,e2)
For women with a cerebrovascular malformation at low risk of intracranial bleeding , <e1>base</e1> <e2>decisions</e2> on the mode of birth on the woman's preference and obstetric indications .	acts-on(e1,e2)
Assess the PR <e1>status</e1> of all invasive breast <e2>cancers</e2> using standardised and quality-assured immunohistochemical techniques , and report the results quantitatively .	other
<e1>Consider</e1> measuring albumin-adjusted serum <e2>calcium</e2> for people with chronic non-differentiated symptoms .	acts-on(e1,e2)
Do not offer platinum-based combination chemotherapy to obtain a serum calcium for people with <e1>extensive-stage</e1> disease <e2>SCLC</e2> if they are fit enough .	modifier(e1,e2)
Adjuvant chemotherapy should be considered for all patients with breast cancer where benefit <e1>outweighs</e1> <e2>risk</e2> .	acts-on(e1,e2)
Class 1 antiarrhythmic <e1>drugs</e1> should not be <e2>used</e2> for treatment of premature ventricular beats or non sustained VT in patients with previous MI .	acts-on(e2,e1)
Duloxetine should be <e1>considered</e1> for the treatment of <e2>patients</e2> with fibromyalgia or osteoarthritis .	receiver(e2,e1)
Do not offer <e1>bisphosphonates</e1> for chronic <e2>hypercalcaemia</e2> of primary hyperparathyroidism .	other
<e1>Offer</e1> people diagnosed with cerebral venous sinus thrombosis full-dose anticoagulation <e2>treatment</e2> unless there are comorbidities that preclude its use .	acts-on(e2,e1)
Where appropriate , functional tests , including the exercise tolerance test , should be considered to aid in the risk <e1>stratification</e1> of <e2>patients</e2> with known CAD .	other
If the <e1>person</e1> is with CKD and diabetes and an ACR of 3 mg/mmol or more , <e2>offer</e2> a low-cost renin-angiotensin-aldosterone system antagonist .	receiver(e1,e2)
If the <e1>person</e1> is with <e2>CKD</e2> and hypertension and an ACR of 30 mg/mmol or more , offer a low-cost renin-angiotensin-aldosterone system antagonist .	owner(e1,e2)
If liver function blood tests are abnormal , <e1>perform</e1> a liver ultrasound <e2>scan</e2> and consider ursodeoxycholic acid treatment .	acts-on(e1,e2)
Repeat the albumin-adjusted serum calcium measurement at least once if the first measurement is either 2.6 mmol/litre or above or 2.5 mmol/litre or above and features of <e1>primary</e1> <e2>hyperparathyroidism</e2> are present .	modifier(e1,e2)
Offer standard structural MRI as the <e1>initial</e1> diagnostic <e2>test</e2> for suspected glioma , unless MRI is contraindicated .	modifier(e1,e2)
For people who cannot tolerate aminosalicylates , consider a <e1>time-limited</e1> <e2>course</e2> of a topical or an oral corticosteroid .	modifier(e1,e2)
Patients having radical radiotherapy should be <e1>given</e1> <e2>CHART</e2> in preference to 60 Gy in 30 fractions over six weeks .	acts-on(e1,e2)
CVD risk prediction models should be adapted for <e1>patients</e1> with <e2>RA</e2> by a 1.5 multiplication factor , if this is not already included in the model .	owner(e1,e2)
If the person has <e1>severe</e1> <e2>hypertension</e2> , consider starting antihypertensive drug treatment immediately , without waiting for the results of ABPM or HBPM .	modifier(e1,e2)
<e1>Patients</e1> with heart failure with reduced ejection fraction of all NYHA functional classes , should be <e2>given</e2> angiotensin converting enzyme inhibitors .	receiver(e1,e2)
If HbA1c <e1>rises</e1> to <e2>48</e2> mmol/mol ( 6.5 % ) on lifestyle interventions , consider a DPP-4i , pioglitazone , an SU , an SGLT-2i , and support the person to aim for an HbA1c level of 48 mmol/mol ( 6.5 % ) for people on a DPP-4i , SGLT-2i or pioglitazone or 53 mmol/mol ( 7 % ) for people on an SU .	modifier(e2,e1)
All women with non-mucinous ovarian or fallopian tube cancer should be <e1>offered</e1> <e2>BRCA1</e2> and BRCA2 mutation testing .	acts-on(e1,e2)
Adjuvant chemotherapy should be <e1>considered</e1> for all <e2>patients</e2> with breast cancer where benefit outweighs risk .	receiver(e2,e1)
<e1>Request</e1> the oestrogen receptor , progesterone <e2>receptor</e2> and human epidermal growth receptor 2 status of all invasive breast cancers simultaneously at the time of initial histopathological diagnosis .	acts-on(e1,e2)
Give a loading dose of 20 mg/kg of caffeine citrate , <e1>followed</e1> 24 hours later by a maintenance dosage of 5 mg/kg once daily , <e2>increasing</e2> up to 20 mg/kg daily if episodes of apnoea persist .	other
Offer <e1>people</e1> diagnosed with cerebral venous sinus <e2>thrombosis</e2> full-dose anticoagulation treatment unless there are comorbidities that preclude its use .	owner(e2,e1)
The decision on when to <e1>repeat</e1> <e2>MRI</e2> depends on the clinical circumstances .	acts-on(e1,e2)
Offer bisphosphonates as adjuvant therapy to postmenopausal women with node-positive <e1>invasive</e1> breast <e2>cancer</e2> .	modifier(e1,e2)
Pregabalin is recommended for the <e1>treatment</e1> of <e2>patients</e2> with neuropathic pain if other first and second line pharmacological treatments have failed .	other
In patients with peripheral arthritis and an inadequate response to at least one csDMARD , in whom bDMARDs are not appropriate , a targeted synthetic DMARD such as a <e1>PDE4-inhibitor</e1> may be <e2>considered</e2> .	modifier(e2,e1)
In patients with predominantly axial disease that is active and has insufficient <e1>response</e1> to <e2>NSAIDs</e2> , therapy with a bDMARD should be considered , which according to current practice is a TNF inhibitor .	other
Amitriptyline should be considered for the treatment of patients with <e1>fibromyalgia</e1> and neuropathic <e2>pain</e2> .	joint
Offer an MRA , in addition to an ACE inhibitor ( or ARB ) and beta-blocker , to people who have heart failure with reduced ejection fraction if they <e1>continue</e1> to <e2>have</e2> symptoms of heart failure .	other
In patients being considered for active therapy , pleural effusion should be investigated with pleural aspiration and/or <e1>pleural</e1> <e2>biopsy</e2> using image-guided or thoracoscopic biopsy .	modifier(e1,e2)
Perform transthoracic echocardiography to exclude important valve disease , assess the systolic function of the ventricle , and <e1>detect</e1> intracardiac <e2>shunts</e2> .	acts-on(e1,e2)
Lifestyle recommendations should emphasise the benefits of a healthy diet , <e1>regular</e1> <e2>exercise</e2> and smoking cessation for all patients .	modifier(e1,e2)
Consider <e1>opioids</e1> , such as codeine or morphine , to <e2>reduce</e2> cough .	actor-of(e1,e2)
If the treatment target is not achieved with the first csDMARD strategy , when poor prognostic <e1>factors</e1> are <e2>present</e2> , addition of a bDMARD or a tsDMARD should be considered .	modifier(e2,e1)
Offer standard <e1>structural</e1> <e2>MRI</e2> as the initial diagnostic test for suspected glioma , unless MRI is contraindicated .	modifier(e1,e2)
Assess the ER status of all invasive breast cancers using standardised and <e1>quality-assured</e1> immunohistochemical <e2>techniques</e2> , and report the results quantitatively .	modifier(e1,e2)
<e1>Aim</e1> for a target clinic blood <e2>pressure</e2> below 140/90 mmHg in people aged under 80 years with treated hypertension .	acts-on(e1,e2)
Amiodarone therapy is not recommended for patients following ACS or patients with congestive heart failure who do not have <e1>sustained</e1> ventricular <e2>arrhythmias</e2> or atrial fibrillation .	modifier(e1,e2)
<e1>Therapy</e1> with <e2>DMARDs</e2> should be started as soon as the diagnosis of RA is made .	other
Do not offer an antibiotic to treat an acute cough associated with an upper <e1>respiratory</e1> tract <e2>infection</e2> in people who are not systemically very unwell or at higher risk of complications .	modifier(e1,e2)
For people who cannot <e1>tolerate</e1> <e2>aminosalicylates</e2> , consider a time-limited course of a topical or an oral corticosteroid .	acts-on(e1,e2)
If the person <e1>has</e1> severe <e2>hypertension</e2> , consider starting antihypertensive drug treatment immediately , without waiting for the results of ABPM or HBPM .	acts-on(e1,e2)
If clinical evaluation or lung function testing indicates an inadequate <e1>response</e1> to <e2>rhDNase</e2> , consider both rhDNase and hypertonic sodium chloride or hypertonic sodium chloride alone .	other
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , <e1>consider</e1> triple therapy with metformin and a DPP-4i and an SU , metformin and pioglitazone and an SU , metformin and pioglitazone and an SGLT-2i , metformin and an SU and an SGLT-2i , insulin-based treatment , and <e2>support</e2> the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	joint
To induce remission in <e1>people</e1> with a mild-to-moderate first presentation or inflammatory exacerbation of extensive ulcerative colitis , <e2>offer</e2> a topical aminosalicylate and a high-dose oral aminosalicylate as first-line treatment .	receiver(e1,e2)
In patients with syndesmophytes in the lumbar spine on conventional radiography , osteoporosis should be <e1>assessed</e1> by hip <e2>DXA</e2> , supplemented by either spine DXA in lateral projection or possibly QCT of the spine .	modifier(e2,e1)
Do not offer platinum-based combination chemotherapy to obtain a serum calcium for <e1>people</e1> with extensive-stage disease <e2>SCLC</e2> if they are fit enough .	owner(e1,e2)
When spinal fracture in axial SpA is suspected , conventional <e1>radiography</e1> is the <e2>recommended</e2> initial imaging method .	acts-on(e2,e1)
If SABR is contraindicated , offer either <e1>conventional</e1> or <e2>hyperfractionated</e2> radiotherapy .	choice
Consider bisphosphonates as adjuvant therapy for postmenopausal women with node-negative invasive breast cancer and a high <e1>risk</e1> of <e2>recurrence</e2> .	other
If remission is not achieved within 4 weeks , stop the topical aminosalicylate and offer a high-dose oral aminosalicylate with a time-limited course of an <e1>oral</e1> <e2>corticosteroid</e2> .	modifier(e1,e2)
If the <e1>person</e1> is aged under 80 years with stage 1 hypertension and <e2>has</e2> target organ damage , offer antihypertensive drug treatment .	actor-of(e1,e2)
If the person is aged under 80 years with stage 1 hypertension and has <e1>established</e1> cardiovascular <e2>disease</e2> , offer antihypertensive drug treatment .	modifier(e1,e2)
Consider bisphosphonates as adjuvant therapy for postmenopausal <e1>women</e1> with node-negative invasive breast cancer and a high <e2>risk</e2> of recurrence .	owner(e1,e2)
<e1>Offer</e1> a mucoactive <e2>agent</e2> to people with cystic fibrosis who have clinical evidence of lung disease .	acts-on(e1,e2)
In patients with axial SpA without syndesmophytes in the lumbar spine on <e1>conventional</e1> <e2>radiography</e2> , osteoporosis should be assessed by hip DXA and AP-spine DXA .	modifier(e1,e2)
In patients who have recovered from an episode of <e1>sustained</e1> ventricular <e2>tachycardia</e2> who are not candidates for an ICD , amiodarone or sotalol should be considered .	modifier(e1,e2)
Adjuvant <e1>chemotherapy</e1> should be <e2>considered</e2> for all patients with breast cancer where benefit outweighs risk .	modifier(e2,e1)
Start ACE inhibitor therapy at a <e1>low</e1> <e2>dose</e2> and titrate upwards at short intervals until the target or maximum tolerated dose is reached .	modifier(e1,e2)
Review antibiotic treatment after 14 days and either stop the antibiotic or continue for a further 14 days if needed , based on an assessment of the person's history , <e1>symptoms</e1> , clinical <e2>examination</e2> , urine and blood tests .	joint
Systemic <e1>glucocorticoids</e1> may be <e2>used</e2> with caution at the lowest effective dose .	modifier(e2,e1)
<e1>Patients</e1> with lung cancer who <e2>have</e2> symptomatic bone metastases should be considered for treatment with a bisphosphonate .	actor-of(e1,e2)
For preterm babies who <e1>need</e1> invasive <e2>ventilation</e2> , use volume-targeted ventilation in combination with synchronised ventilation as the primary mode of respiratory support .	acts-on(e1,e2)
The vaccination status should be assessed in the initial work-up of <e1>patients</e1> with <e2>AIIRD</e2> .	owner(e1,e2)
Consider an ARB licensed for heart failure as an alternative to an ACE inhibitor for <e1>people</e1> who <e2>have</e2> heart failure with reduced ejection fraction and intolerable side effects with ACE inhibitors .	actor-of(e1,e2)
Offer radiotherapy using 40 <e1>Gy</e1> in 15 fractions with <e2>concomitant</e2> and up to 12 cycles of adjuvant temozolomide for people aged around 70 or over .	other
For preterm babies who need invasive ventilation , <e1>use</e1> volume-targeted <e2>ventilation</e2> in combination with synchronised ventilation as the primary mode of respiratory support .	acts-on(e1,e2)
Do not <e1>offer</e1> platinum-based combination chemotherapy to obtain a serum calcium for <e2>people</e2> with extensive-stage disease SCLC if they are fit enough .	receiver(e2,e1)
<e1>Offer</e1> contrast-enhanced brain <e2>MRI</e2> for people with stage 3 NSCLC who are having treatment with curative intent .	acts-on(e1,e2)
Offer <e1>radiotherapy</e1> <e2>using</e2> 40 Gy in 15 fractions with concomitant and up to 12 cycles of adjuvant temozolomide for people aged around 70 or over .	actor-of(e1,e2)
In patients who cannot use <e1>csDMARDs</e1> as <e2>comedication</e2> , IL-6 pathway inhibitors and tsDMARDs may have some advantages compared with other bDMARDs .	other
Blood pressure <e1>reduction</e1> to 185/110 mmHg or lower should be <e2>considered</e2> in people who are candidates for intravenous thrombolysis .	modifier(e2,e1)
Consider oral sodium bicarbonate supplementation for people with both a GFR less than 30 ml/min/1.73m2 and a serum bicarbonate <e1>concentration</e1> of less than <e2>20</e2> mmol/litre .	modifier(e2,e1)
In case of major and/or contaminated wounds in patients who <e1>received</e1> <e2>rituximab</e2> within the last 24 weeks , passive immunisation with tetanus immunoglobulins should be administered .	acts-on(e1,e2)
Sotalol therapy is not recommended for patients following ACS who do not have <e1>sustained</e1> ventricular <e2>arrhythmias</e2> or atrial fibrillation .	modifier(e1,e2)
Screening for asymptomatic atherosclerotic plaques by use of carotid ultrasound may be <e1>considered</e1> as part of the CVD risk evaluation in <e2>patients</e2> with RA .	receiver(e2,e1)
In hyposplenic/asplenic patients with AIIRD influenza , pneumococcal , Haemophilus influenzae <e1>b</e1> and meningococcal <e2>C</e2> , vaccinations are recommended .	joint
Consider <e1>oral</e1> sodium bicarbonate <e2>concentration</e2> of less than 20 mmol/litre .	modifier(e1,e2)
CVD risk prediction models should be adapted for patients with RA by a 1.5 multiplication factor , if <e1>this</e1> is not already <e2>included</e2> in the model .	modifier(e2,e1)
Do not offer a mucolytic to treat an acute cough associated with an <e1>upper</e1> respiratory tract <e2>infection</e2> or acute bronchitis .	modifier(e1,e2)
<e1>Patients</e1> with AF who <e2>remain</e2> severely symptomatic despite adequate rate control should be considered for rhythm control or for stricter rate control if their heart rate remains 80-110 bpm at rest .	actor-of(e1,e2)
In <e1>patients</e1> who <e2>fail</e2> to respond adequately to a bDMARD , switching to another bDMARD should be considered , including switching between TNF inhibitors .	actor-of(e1,e2)
CVD risk management should be <e1>carried</e1> out according to national <e2>guidelines</e2> in RA , AS or PsA .	other
If the treatment target is not achieved with the first csDMARD strategy , in the absence of poor prognostic factors , other <e1>csDMARDs</e1> should be <e2>considered</e2> .	acts-on(e2,e1)
Routine initiation of perioperative beta-blocker therapy to <e1>reduce</e1> perioperative myocardial <e2>infarction</e2> in patients undergoing non cardiac surgery is not recommended .	acts-on(e1,e2)
Consider prostaglandin E1 or prostaglandin E2 as options for inducing labour in <e1>women</e1> with <e2>asthma</e2> because there is no evidence that they worsen asthma .	owner(e1,e2)
Assess the HER2 status of all invasive breast cancers using <e1>standardised</e1> and <e2>quality-assured</e2> techniques , and report the results quantitatively .	joint
In patients with <e1>stable</e1> <e2>angina</e2> requiring percutaneous coronary intervention for in stent restenosis , a drug eluting balloon or a second or third generation drug eluting stent should be considered .	modifier(e1,e2)
All patients with heart failure with reduced ejection fraction , <e1>NYHA</e1> class 2-4 should be <e2>started</e2> on beta-blocker therapy as soon as their condition is stable .	other
Consider adding azathioprine or mercaptopurine to a conventional glucocorticosteroid or budesonide to induce <e1>remission</e1> of Crohn's <e2>disease</e2> if there are 2 or more inflammatory exacerbations in a 12 month period or the glucocorticosteroid dose cannot be tapered .	other
In patients with peripheral arthritis and an <e1>inadequate</e1> <e2>response</e2> to at least one csDMARD , in whom TNF inhibitors are not appropriate , bDMARDs targeting IL12/23 or IL17 pathways may be considered .	modifier(e1,e2)
<e1>Offer</e1> image-guided biopsy to people with peripheral lung lesions when treatment can be <e2>planned</e2> on the basis of this test .	other
Measure parathyroid hormone for people whose albumin-adjusted serum calcium level is either 2.6 mmol/litre or above on at least 2 separate occasions or 2.5 mmol/litre or above on at least 2 separate occasions and <e1>primary</e1> <e2>hyperparathyroidism</e2> is suspected .	modifier(e1,e2)
For women with a cerebrovascular <e1>malformation</e1> at low <e2>risk</e2> of intracranial bleeding , base decisions on the mode of birth on the woman's preference and obstetric indications .	other
In hyposplenic/asplenic patients with AIIRD influenza , pneumococcal , Haemophilus influenzae b and meningococcal C , <e1>vaccinations</e1> are <e2>recommended</e2> .	modifier(e2,e1)
Acute <e1>withdrawal</e1> of <e2>beta-blockers</e2> in the postoperative period is not recommended .	other
If the <e1>person</e1> <e2>has</e2> stage 2 hypertension , offer antihypertensive drug treatment .	actor-of(e1,e2)
Do not use first morning urine <e1>void</e1> to <e2>quantify</e2> proteinuria in pregnant women .	actor-of(e1,e2)
In patients with peripheral <e1>arthritis</e1> and an inadequate <e2>response</e2> to at least one csDMARD , therapy with a bDMARD , usually a TNF inhibitor , should be commenced .	joint
Offer endoscopic mucosal <e1>resection</e1> for <e2>staging</e2> to people with suspected T1 oesophageal cancer .	other
For people with an <e1>acute</e1> <e2>cough</e2> who are identified at a face-to-face clinical examination as systemically very unwell , offer an immediate antibiotic prescription .	modifier(e1,e2)
If a person is unable to tolerate ABPM , <e1>HBPM</e1> is a suitable <e2>alternative</e2> to confirm the diagnosis of hypertension .	other
<e1>Patients</e1> with NSCLC stage 1 and 2 who are medically inoperable or who do not consent to surgery should be <e2>offered</e2> radical radiotherapy .	receiver(e1,e2)
Do not routinely offer an antibiotic to treat an acute cough associated with acute bronchitis in <e1>people</e1> who are not systemically very <e2>unwell</e2> or at higher risk of complications .	modifier(e2,e1)
<e1>Vaccination</e1> in <e2>patients</e2> with AIIRD can be administered during the use of disease-modifying antirheumatic drugs and tumour necrosis factor alpha blocking agents but should ideally be administered before starting B cell depleting biological therapy .	other
Second line systemic anticancer therapy with single agent docetaxel or erlotinib should be considered for patients with performance status 0-2 recurrent NSCLC who have been previously treated with first line <e1>SACT</e1> for advanced <e2>disease</e2> .	other
Digoxin should not be used for <e1>prophylaxis</e1> of atrial <e2>fibrillation</e2> following CABG surgery .	other
To <e1>induce</e1> <e2>remission</e2> in people with a mild-to-moderate first presentation or inflammatory exacerbation of proctosigmoiditis or left-sided ulcerative colitis , offer a topical aminosalicylate as first-line treatment .	acts-on(e1,e2)
If surgical resection is not appropriate , consider biopsy to <e1>obtain</e1> a histological and molecular <e2>diagnosis</e2> .	acts-on(e1,e2)
Consider opioids for adults , children and young people with suspected renal colic if both NSAIDs and intravenous paracetamol are <e1>contraindicated</e1> or are not <e2>giving</e2> sufficient pain relief .	choice
In <e1>patients</e1> with stable <e2>angina</e2> requiring percutaneous coronary intervention for in stent restenosis , a drug eluting balloon or a second or third generation drug eluting stent should be considered .	owner(e1,e2)
Sublingual glyceryl trinitrate tablets or spray should be used for the immediate relief of angina and before performing activities that are known to <e1>bring</e1> on <e2>angina</e2> .	acts-on(e1,e2)
<e1>Consider</e1> stone <e2>analysis</e2> for adults with ureteric or renal stones .	acts-on(e1,e2)
<e1>Offer</e1> urgent low-dose non-contrast CT to <e2>adults</e2> with suspected renal colic .	receiver(e2,e1)
If HbA1c rises to 48 mmol/mol ( 6.5 % ) on lifestyle interventions , consider a DPP-4i , pioglitazone , an SU , an SGLT-2i , and support the person to aim for an HbA1c level of 48 mmol/mol ( 6.5 % ) for people on a DPP-4i , SGLT-2i or pioglitazone or 53 mmol/mol ( 7 % ) for <e1>people</e1> on an <e2>SU</e2> .	owner(e1,e2)
Offer urgent ultrasound as first-line imaging for children and young <e1>people</e1> with suspected renal <e2>colic</e2> .	owner(e1,e2)
Use nasal cannula or incubator oxygen for preterm babies who need <e1>supplemental</e1> <e2>oxygen</e2> .	modifier(e1,e2)
Patients with mild CHC should be <e1>considered</e1> for <e2>treatment</e2> .	acts-on(e1,e2)
Offer to carry out a blood test for rheumatoid factor in adults with suspected rheumatoid arthritis who are found to <e1>have</e1> <e2>synovitis</e2> on clinical examination .	acts-on(e1,e2)
Patients with lung cancer who have symptomatic bone metastases should be considered for <e1>treatment</e1> with a <e2>bisphosphonate</e2> .	other
Verapamil and diltiazem may be <e1>used</e1> for <e2>prophylaxis</e2> of atrial fibrillation following CABG surgery .	other
Support adults with type 1 diabetes to aim for a target HbA1c level of <e1>48</e1> mmol/mol ( 6.5 % ) or <e2>lower</e2> .	choice
<e1>Consider</e1> adding intravenous ciclosporin to intravenous corticosteroids or <e2>consider</e2> surgery for people who have little or no improvement within 72 hours of starting intravenous corticosteroids or whose symptoms worsen at any time despite corticosteroid treatment .	choice
If the person is aged under 80 years with stage 1 hypertension and has renal disease , offer <e1>antihypertensive</e1> drug <e2>treatment</e2> .	modifier(e1,e2)
In case of major and/or <e1>contaminated</e1> <e2>wounds</e2> in patients who received rituximab within the last 24 weeks , passive immunisation with tetanus immunoglobulins should be administered .	modifier(e1,e2)
<e1>Assess</e1> the HER2 status of all invasive breast cancers <e2>using</e2> standardised and quality-assured techniques , and report the results quantitatively .	other
For eligible <e1>people</e1> with stage 3A NSCLC who cannot tolerate or who <e2>decline</e2> chemoradiotherapy , consider radical radiotherapy .	actor-of(e1,e2)
For people who have had pancreatoduodenectomy and who have a functioning gut , offer early enteral nutrition rather than <e1>parenteral</e1> <e2>nutrition</e2> .	modifier(e1,e2)
Patients with <e1>left</e1> main stem <e2>stenosis</e2> and/or multivessel disease should be considered for revascularisation to improve prognosis .	modifier(e1,e2)
Verapamil and diltiazem may be used for prophylaxis of atrial fibrillation <e1>following</e1> CABG <e2>surgery</e2> .	acts-on(e1,e2)
For early stage <e1>disease</e1> , maintenance cytotoxic <e2>chemotherapy</e2> should not be given .	other
Adjuvant chemotherapy should be considered for all patients with breast cancer where <e1>benefit</e1> <e2>outweighs</e2> risk .	actor-of(e1,e2)
Do not use dexamethasone with non-steroidal <e1>anti-inflammatory</e1> <e2>drugs</e2> .	modifier(e1,e2)
If the treatment target is not achieved with the first csDMARD strategy , when <e1>poor</e1> prognostic <e2>factors</e2> are present , addition of a bDMARD or a tsDMARD should be considered .	modifier(e1,e2)
Patients with <e1>advanced</e1> liver <e2>disease</e2> should be given nutritional support to minimise malnutrition .	modifier(e1,e2)
In case of major and/or contaminated wounds in patients who received rituximab within the last 24 weeks , passive immunisation with tetanus <e1>immunoglobulins</e1> should be <e2>administered</e2> .	acts-on(e2,e1)
To induce remission in people with a mild-to-moderate first presentation or <e1>inflammatory</e1> <e2>exacerbation</e2> of proctosigmoiditis or left-sided ulcerative colitis , offer a topical aminosalicylate as first-line treatment .	modifier(e1,e2)
In patients with <e1>ankylosing</e1> <e2>spondylitis</e2> , initial conventional radiography of the lumbar and cervical spine is recommended to detect syndesmophytes , which are predictive of development of new syndesmophytes .	modifier(e1,e2)
If a person is unable to tolerate ABPM , HBPM is a suitable alternative to confirm the <e1>diagnosis</e1> of <e2>hypertension</e2> .	other
Carbamazepine should be considered for the treatment of <e1>patients</e1> with neuropathic <e2>pain</e2> .	owner(e1,e2)
Women with platinum <e1>resistant</e1> relapsed ovarian <e2>cancer</e2> should be offered bevacizumab in combination with paclitaxel .	modifier(e1,e2)
Advise pregnant women at high <e1>risk</e1> of <e2>pre-eclampsia</e2> to take 75-150 mg of aspirin daily from 12 weeks until the birth of the baby .	other
If the person is with CKD and <e1>hypertension</e1> and an <e2>ACR</e2> of 30 mg/mmol or more , offer a low-cost renin-angiotensin-aldosterone system antagonist .	joint
Use an automated reagent-strip reading device for dipstick <e1>screening</e1> for <e2>proteinuria</e2> in pregnant women in secondary care settings .	other
Start a trial of a renin-angiotensin system blocking drug as <e1>first-line</e1> <e2>therapy</e2> for hypertension in adults with type 1 diabetes .	modifier(e1,e2)
Duloxetine should be considered for the treatment of patients with <e1>diabetic</e1> neuropathic <e2>pain</e2> if other first or second line pharmacological therapies have failed .	modifier(e1,e2)
Optimised antidepressant therapy should be considered for the treatment of patients with chronic pain with <e1>moderate</e1> <e2>depression</e2> .	modifier(e1,e2)
If a <e1>patient</e1> is in persistent <e2>remission</e2> after having tapered GC , one can consider tapering bDMARDs , especially if this treatment is combined with a csDMARD .	owner(e1,e2)
Maintain a blood glucose concentration between 4 and 11 mmol/litre in people with <e1>acute</e1> <e2>stroke</e2> .	modifier(e1,e2)
Patients <e1>having</e1> radical <e2>radiotherapy</e2> should be given CHART in preference to 60 Gy in 30 fractions over six weeks .	acts-on(e1,e2)
A chest X-ray should be performed on all patients being investigated for the <e1>possibility</e1> of lung <e2>cancer</e2> .	other
Consider a bisphosphonate to reduce fracture risk for people with primary <e1>hyperparathyroidism</e1> and increased fracture <e2>risk</e2> .	joint
Do not offer pre-treatment stenting to <e1>adults</e1> <e2>having</e2> shockwave lithotripsy for ureteric or renal stones .	actor-of(e1,e2)
<e1>Patients</e1> with genotype 1 infection who <e2>fail</e2> to achieve an EVR at 12 weeks should be considered for cessation of treatment .	actor-of(e1,e2)
In patients undergoing multiple coronary artery bypass grafting , <e1>use</e1> of both internal mammary <e2>arteries</e2> should be considered .	acts-on(e1,e2)
<e1>Offer</e1> endocrine therapy after breast-conserving surgery for <e2>women</e2> with ER-positive DCIS if radiotherapy is recommended but not received .	receiver(e2,e1)
All patients co-infected with HIV and HCV genotype 1 should be considered for treatment with a regimen which <e1>includes</e1> an HCV protease <e2>inhibitor</e2> .	acts-on(e1,e2)
Patients with chronic hepatitis B and C co-infection should be considered for <e1>treatment</e1> with pegylated <e2>IFN</e2> and weight based ribavirin .	other
In patients who fail to respond adequately to a bDMARD , <e1>switching</e1> to another <e2>bDMARD</e2> should be considered , including switching between TNF inhibitors .	acts-on(e1,e2)
Duloxetine should be considered for the treatment of <e1>patients</e1> with <e2>fibromyalgia</e2> or osteoarthritis .	owner(e1,e2)
Routine initiation of perioperative beta-blocker therapy to reduce <e1>perioperative</e1> myocardial <e2>infarction</e2> in patients undergoing non cardiac surgery is not recommended .	modifier(e1,e2)
Offer endocrine <e1>therapy</e1> after breast-conserving <e2>surgery</e2> for women with ER-positive DCIS if radiotherapy is recommended but not received .	other
In patients with syndesmophytes in the lumbar spine on conventional radiography , <e1>osteoporosis</e1> should be <e2>assessed</e2> by hip DXA , supplemented by either spine DXA in lateral projection or possibly QCT of the spine .	modifier(e2,e1)
Ensure that <e1>people</e1> with disabling ischaemic stroke who are in atrial <e2>fibrillation</e2> are treated with aspirin 300 mg for the first 2 weeks before anticoagulation treatment is considered .	owner(e1,e2)
If HbA1c <e1>rises</e1> to <e2>58</e2> mmol/mol ( 7 % ) , consider HBPM if the person has diabetes .	modifier(e2,e1)
If <e1>CT</e1> <e2>shows</e2> suspected brain metastases , offer contrast-enhanced brain MRI .	actor-of(e1,e2)
CVD risk assessment is recommended for all patients with RA , AS or PsA at least <e1>once</e1> every 5 <e2>years</e2> and should be reconsidered following major changes in antirheumatic therapy .	modifier(e2,e1)
<e1>Patients</e1> with compensated cirrhosis should be <e2>considered</e2> for therapy , unless contraindicated .	receiver(e1,e2)
Support <e1>adults</e1> with type 1 <e2>diabetes</e2> to aim for a target HbA1c level of 48 mmol/mol ( 6.5 % ) or lower .	owner(e1,e2)
Offer chemotherapy before and after surgery to people with gastric cancer who are having <e1>radical</e1> surgical <e2>resection</e2> .	modifier(e1,e2)
Start ACE inhibitor therapy at a low dose and titrate upwards at <e1>short</e1> <e2>intervals</e2> until the target or maximum tolerated dose is reached .	modifier(e1,e2)
Offer endoscopic mucosal resection for staging to <e1>people</e1> with suspected T1 oesophageal <e2>cancer</e2> .	owner(e1,e2)
<e1>Consider</e1> adding methotrexate to a conventional glucocorticosteroid or budesonide to induce remission in <e2>people</e2> who cannot tolerate azathioprine or mercaptopurine .	receiver(e2,e1)
<e1>Offer</e1> <e2>people</e2> with heart failure an annual vaccination against influenza .	receiver(e2,e1)
Consider adjuvant therapy after surgery for <e1>people</e1> with invasive breast <e2>cancer</e2> , and ensure that recommendations are recorded at the multidisciplinary team meeting .	owner(e1,e2)
Monitor the response to titration of medicines closely in people who have heart failure with reduced ejection <e1>fraction</e1> and chronic kidney <e2>disease</e2> .	joint
Intravenous <e1>amiodarone</e1> should be <e2>considered</e2> in the management of patients with haemodynamically stable sustained monomorphic VT .	modifier(e2,e1)
Low dose pegylated IFN maintenance monotherapy should not be used in patients with <e1>compensated</e1> <e2>cirrhosis</e2> .	modifier(e1,e2)
CVD risk estimation for <e1>patients</e1> with RA , <e2>AS</e2> or PsA should be performed according to national guidelines and the SCORE CVD risk prediction model should be used if no national guideline is available .	owner(e1,e2)
If the person is aged under 80 years with stage 1 hypertension and has 10 year cardiovascular risk , <e1>offer</e1> antihypertensive drug <e2>treatment</e2> .	acts-on(e1,e2)
Do not offer <e1>azathioprine</e1> , mercaptopurine or methotrexate as <e2>monotherapy</e2> to induce remission .	other
In patients with PsA , NSAIDs may be used to <e1>relieve</e1> musculoskeletal <e2>signs</e2> and symptoms .	acts-on(e1,e2)
Amiodarone therapy is not recommended for patients following ACS or <e1>patients</e1> with congestive heart <e2>failure</e2> who do not have sustained ventricular arrhythmias or atrial fibrillation .	owner(e1,e2)
In patients being considered for active therapy , pleural effusion should be investigated with pleural aspiration and/or pleural biopsy using <e1>image-guided</e1> or <e2>thoracoscopic</e2> biopsy .	choice
Advise <e1>pregnant</e1> <e2>women</e2> with more than 1 moderate risk factor for pre-eclampsia to take 75-150 mg of aspirin daily from 12 weeks until the birth of the baby .	modifier(e1,e2)
All patients co-infected with HIV and HCV genotype 1 should be considered for <e1>treatment</e1> with a <e2>regimen</e2> which includes an HCV protease inhibitor .	other
If <e1>further</e1> <e2>treatment</e2> is needed , consider adding a time-limited course of a topical or an oral corticosteroid .	modifier(e1,e2)
Do not offer an antibiotic to treat an acute cough associated with an upper respiratory tract infection in <e1>people</e1> who are not systemically very unwell or at higher <e2>risk</e2> of complications .	owner(e1,e2)
Offer image-guided biopsy to <e1>people</e1> with peripheral lung <e2>lesions</e2> when treatment can be planned on the basis of this test .	owner(e1,e2)
<e1>Consider</e1> adding methotrexate to a conventional glucocorticosteroid or budesonide to <e2>induce</e2> remission in people who cannot tolerate azathioprine or mercaptopurine .	other
In <e1>patients</e1> who have recovered from an episode of sustained ventricular tachycardia who are not <e2>candidates</e2> for an ICD , amiodarone or sotalol should be considered .	modifier(e2,e1)
<e1>Start</e1> a <e2>trial</e2> of a renin-angiotensin system blocking drug as first-line therapy for hypertension in adults with type 1 diabetes .	acts-on(e1,e2)
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider triple <e1>therapy</e1> with <e2>metformin</e2> and a DPP-4i and an SU , metformin and pioglitazone and an SU , metformin and pioglitazone and an SGLT-2i , metformin and an SU and an SGLT-2i , insulin-based treatment , and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	other
If further treatment is needed , consider adding a <e1>time-limited</e1> <e2>course</e2> of a topical or an oral corticosteroid .	modifier(e1,e2)
In <e1>personalised</e1> asthma action <e2>plans</e2> for adults , consider advising quadrupling ICS at the onset of an asthma attack and for up to 14 days in order to reduce the risk of needing oral steroids .	modifier(e1,e2)
Aromatase inhibitor is <e1>recommended</e1> for ER positive postmenopausal <e2>women</e2> receiving neoadjuvant endocrine therapy .	receiver(e2,e1)
Sublingual glyceryl trinitrate tablets or spray should be used for the immediate relief of angina and before performing <e1>activities</e1> that are known to <e2>bring</e2> on angina .	actor-of(e1,e2)
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , <e1>consider</e1> dual therapy with a DPP-4i and pioglitazone , a DPP-4i and an SU , pioglitazone and an SU , and <e2>support</e2> the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	joint
All patients with heart failure with reduced ejection fraction , NYHA class 2-4 should be started on beta-blocker therapy as soon as their <e1>condition</e1> is <e2>stable</e2> .	modifier(e2,e1)
Offer a pancreatic protocol CT scan to people with <e1>pancreatic</e1> <e2>abnormalities</e2> but no jaundice .	modifier(e1,e2)
Do not measure <e1>ionised</e1> <e2>calcium</e2> when testing for primary hyperparathyroidism .	modifier(e1,e2)
If the <e1>person</e1> is with CKD and vitamin D supplementation is indicated , <e2>offer</e2> colecalciferol or ergocalciferol .	receiver(e1,e2)
Conventional <e1>radiography</e1> of the SI <e2>joints</e2> and/or spine may be used for long-term monitoring of structural damage , particularly new bone formation , in axial SpA .	other
For people who are at <e1>low</e1> <e2>risk</e2> of developing a diabetic foot problem , continue to carry out annual foot assessments .	modifier(e1,e2)
If remission is not achieved within 4 weeks , <e1>stop</e1> the topical aminosalicylate and <e2>offer</e2> a high-dose oral aminosalicylate with a time-limited course of an oral corticosteroid .	joint
In patients who fail to respond adequately to a bDMARD , switching to another bDMARD should be considered , including <e1>switching</e1> between TNF <e2>inhibitors</e2> .	acts-on(e1,e2)
Maintain blood <e1>pressure</e1> <e2>below</e2> 45 ml/minute/1.73m2 if the person is aged under 80 years with type 1 diabetes .	modifier(e2,e1)
US and MRI may be used to monitor disease activity in peripheral SpA , providing additional information on top of clinical and <e1>biochemical</e1> <e2>assessments</e2> .	modifier(e1,e2)
If remission is not achieved within 4 weeks , stop the topical aminosalicylate and offer a high-dose oral aminosalicylate with a time-limited <e1>course</e1> of an oral <e2>corticosteroid</e2> .	other
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider dual <e1>therapy</e1> with a <e2>DPP-4i</e2> and pioglitazone , a DPP-4i and an SU , pioglitazone and an SU , and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	other
Do not measure ionised calcium when <e1>testing</e1> for primary <e2>hyperparathyroidism</e2> .	acts-on(e1,e2)
Do not offer budesonide or aminosalicylate treatment for <e1>severe</e1> <e2>presentations</e2> or exacerbations .	modifier(e1,e2)
Amiodarone may be <e1>used</e1> when <e2>prophylaxis</e2> for atrial fibrillation and ventricular arrhythmias is indicated following CABG surgery .	modifier(e2,e1)
All <e1>patients</e1> with heart failure with reduced ejection fraction , NYHA class 2-4 should be <e2>started</e2> on beta-blocker therapy as soon as their condition is stable .	receiver(e1,e2)
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider dual <e1>therapy</e1> with metformin and a DPP-4i , metformin and pioglitazone , <e2>metformin</e2> and an SU , metformin and an SGLT-2i , and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	other
Consider enteric-coated pancreatin before and <e1>after</e1> pancreatic cancer <e2>resection</e2> .	modifier(e1,e2)
Consider opioids for adults , children and young <e1>people</e1> with suspected renal <e2>colic</e2> if both NSAIDs and intravenous paracetamol are contraindicated or are not giving sufficient pain relief .	owner(e1,e2)
All women with high grade early stage ovarian cancer should be considered for <e1>adjuvant</e1> <e2>chemotherapy</e2> .	modifier(e1,e2)
Consider adding methotrexate to a conventional glucocorticosteroid or budesonide to induce remission in people who cannot <e1>tolerate</e1> <e2>azathioprine</e2> or mercaptopurine .	acts-on(e1,e2)
CVD risk <e1>assessment</e1> is <e2>recommended</e2> for all patients with RA , AS or PsA at least once every 5 years and should be reconsidered following major changes in antirheumatic therapy .	acts-on(e2,e1)
Long term beta-blockers are recommended for routine use in patients <e1>following</e1> <e2>ACS</e2> without contraindications .	acts-on(e1,e2)
<e1>Patients</e1> <e2>having</e2> radical radiotherapy should be given CHART in preference to 60 Gy in 30 fractions over six weeks .	actor-of(e1,e2)
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider triple therapy with metformin and a DPP-4i and an SU , metformin and pioglitazone and an SU , metformin and pioglitazone and an SGLT-2i , metformin and an SU and an SGLT-2i , insulin-based treatment , and support the <e1>person</e1> to <e2>aim</e2> for an HbA1c level of 53 mmol/mol ( 7 % ) .	actor-of(e1,e2)
Do not use synchronised <e1>pressure-limited</e1> <e2>ventilation</e2> such as assist control , synchronised intermittent positive pressure ventilation , patient-triggered ventilation , pressure support ventilation or synchronised time-cycled pressure-limited ventilation .	modifier(e1,e2)
Anthracycline taxane based chemotherapy combinations should be considered for all patients receiving <e1>neoadjuvant</e1> <e2>chemotherapy</e2> .	modifier(e1,e2)
To induce remission in people with a mild-to-moderate first presentation or inflammatory <e1>exacerbation</e1> of extensive ulcerative <e2>colitis</e2> , offer a topical aminosalicylate and a high-dose oral aminosalicylate as first-line treatment .	other
Amiodarone may be used when prophylaxis for atrial fibrillation and ventricular <e1>arrhythmias</e1> is <e2>indicated</e2> following CABG surgery .	modifier(e2,e1)
Sotalol <e1>therapy</e1> is not <e2>recommended</e2> for patients following ACS who do not have sustained ventricular arrhythmias or atrial fibrillation .	acts-on(e2,e1)
In patients with stable angina requiring <e1>percutaneous</e1> coronary <e2>intervention</e2> for in stent restenosis , a drug eluting balloon or a second or third generation drug eluting stent should be considered .	modifier(e1,e2)
Monitor for neutropenia in people taking azathioprine or mercaptopurine even if they <e1>have</e1> normal TPMT <e2>activity</e2> .	acts-on(e1,e2)
Do not measure ionised calcium when testing for <e1>primary</e1> <e2>hyperparathyroidism</e2> .	modifier(e1,e2)
Consider adding methotrexate to a conventional glucocorticosteroid or budesonide to <e1>induce</e1> <e2>remission</e2> in people who cannot tolerate azathioprine or mercaptopurine .	acts-on(e1,e2)
Patients with heart failure with reduced ejection fraction of all NYHA functional classes , should be given angiotensin <e1>converting</e1> enzyme <e2>inhibitors</e2> .	modifier(e1,e2)
If the person is aged <e1>under</e1> 80 <e2>years</e2> with stage 1 hypertension and has renal disease , offer antihypertensive drug treatment .	modifier(e1,e2)
<e1>Review</e1> intravenous <e2>antibiotics</e2> by 48 hours and consider stepping down to oral antibiotics where possible .	acts-on(e1,e2)
A regimen containing a platinum <e1>agent</e1> and <e2>etoposide</e2> is recommended for first line treatment of patients with SCLC .	joint
A <e1>combination</e1> of <e2>digoxin</e2> with either a beta-blocker or diltiazem should be considered to control heart rate in patients with atrial fibrillation .	other
Monitor the response to titration of medicines closely in people who <e1>have</e1> heart <e2>failure</e2> with reduced ejection fraction and chronic kidney disease .	acts-on(e1,e2)
Consider measuring <e1>anti-CCP</e1> <e2>antibodies</e2> in adults with suspected RA if they are negative for rheumatoid factor .	modifier(e1,e2)
Consider <e1>oral</e1> sodium bicarbonate <e2>supplementation</e2> for people with both a GFR less than 30 ml/min/1.73m2 and a serum bicarbonate concentration of less than 20 mmol/litre .	modifier(e1,e2)
Monitor the <e1>effects</e1> of <e2>azathioprine</e2> , mercaptopurine and methotrexate as advised in the British National Formulary or British National Formulary for Children .	other
In patients being <e1>considered</e1> for active <e2>therapy</e2> , pleural effusion should be investigated with pleural aspiration and/or pleural biopsy using image-guided or thoracoscopic biopsy .	acts-on(e1,e2)
<e1>Offer</e1> urgent ultrasound as first-line imaging for <e2>children</e2> and young people with suspected renal colic .	receiver(e2,e1)
Exclude hypoglycaemia in people with sudden onset of neurological symptoms as the <e1>cause</e1> of these <e2>symptoms</e2> .	other
<e1>Sublingual</e1> glyceryl trinitrate <e2>tablets</e2> or spray should be used for the immediate relief of angina and before performing activities that are known to bring on angina .	modifier(e1,e2)
TC and HDLc should be used in CVD risk assessment in RA , AS and PsA and <e1>lipids</e1> should ideally be <e2>measured</e2> when disease activity is stable or in remission .	acts-on(e2,e1)
<e1>Measure</e1> serum calcium for <e2>people</e2> who develop a pancreatic cancer resection .	receiver(e2,e1)
Duloxetine should be <e1>considered</e1> for the treatment of <e2>patients</e2> with diabetic neuropathic pain if other first or second line pharmacological therapies have failed .	receiver(e1,e2)
In personalised asthma action plans for adults , consider advising quadrupling ICS at the onset of an asthma attack and for up to 14 days in order to <e1>reduce</e1> the risk of needing oral <e2>steroids</e2> .	acts-on(e1,e2)
Pregabalin is recommended for the treatment of <e1>patients</e1> with neuropathic <e2>pain</e2> if other first and second line pharmacological treatments have failed .	owner(e1,e2)
Consider measuring anti-CCP antibodies in <e1>adults</e1> with suspected <e2>RA</e2> if they are negative for rheumatoid factor .	owner(e1,e2)
<e1>Use</e1> nasal <e2>cannula</e2> or incubator oxygen for preterm babies who need supplemental oxygen .	acts-on(e1,e2)
The routine use of aspirin to <e1>reduce</e1> perioperative cardiac <e2>events</e2> in patients undergoing non cardiac surgery , including those with known stable CAD , is not recommended .	acts-on(e1,e2)
<e1>Offer</e1> an ACE <e2>inhibitor</e2> and a beta-blocker licensed for heart failure to people who have heart failure with reduced ejection fraction .	acts-on(e1,e2)
Consider a <e1>clinical</e1> <e2>trial</e2> as an alternative to second-line chemotherapy for people with oesophago-gastric cancer .	modifier(e1,e2)
<e1>Routine</e1> <e2>surgery</e2> for limited disease SCLC is not recommended .	modifier(e1,e2)
For <e1>children</e1> who are allergic to penicillins , <e2>consider</e2> an alternative oral anti-Staphylococcus aureus agent .	receiver(e1,e2)
Measure serum calcium for adults with <e1>ureteric</e1> or <e2>renal</e2> stones .	choice
Offer nutritional <e1>assessment</e1> and tailored specialist dietetic <e2>support</e2> to people with oesophago-gastric cancer before , during and after radical treatments .	joint
Patients with heart <e1>failure</e1> with reduced ejection <e2>fraction</e2> , NYHA class 2-4 , who are intolerant of angiotensin converting enzyme inhibitors should be given an angiotensin receptor blocker .	other
Consider prostaglandin <e1>E1</e1> or prostaglandin <e2>E2</e2> as options for inducing labour in women with asthma because there is no evidence that they worsen asthma .	choice
Consider cinacalcet for people with primary hyperparathyroidism if <e1>surgery</e1> has been <e2>unsuccessful</e2> , is unsuitable or has been declined , and if their albumin-adjusted serum calcium level is either : 2.85 mmol/litre or above with symptoms of hypercalcaemia or 3 mmol/litre or above with or without symptoms of hypercalcaemia .	modifier(e2,e1)
In <e1>patients</e1> being <e2>considered</e2> for active therapy , pleural effusion should be investigated with pleural aspiration and/or pleural biopsy using image-guided or thoracoscopic biopsy .	receiver(e1,e2)
Consider a clinical trial as an <e1>alternative</e1> to second-line <e2>chemotherapy</e2> for people with oesophago-gastric cancer .	other
For people who are at low risk of developing a diabetic foot problem , <e1>continue</e1> to carry out annual foot <e2>assessments</e2> .	acts-on(e1,e2)
Sublingual glyceryl trinitrate tablets or spray should be used for the immediate <e1>relief</e1> of <e2>angina</e2> and before performing activities that are known to bring on angina .	other
Offer <e1>bisphosphonates</e1> as adjuvant <e2>therapy</e2> to postmenopausal women with node-positive invasive breast cancer .	other
Do not <e1>measure</e1> ionised calcium when <e2>testing</e2> for primary hyperparathyroidism .	other
If the person is with CKD and diabetes and an ACR of 3 mg/mmol or more , <e1>offer</e1> a low-cost renin-angiotensin-aldosterone system <e2>antagonist</e2> .	acts-on(e1,e2)
If HbA1c rises to 48 mmol/mol ( 6.5 % ) on lifestyle interventions , consider a DPP-4i , pioglitazone , an SU , an SGLT-2i , and <e1>support</e1> the person to aim for an HbA1c level of 48 mmol/mol ( 6.5 % ) for <e2>people</e2> on a DPP-4i , SGLT-2i or pioglitazone or 53 mmol/mol ( 7 % ) for people on an SU .	receiver(e2,e1)
Offer monotherapy with a <e1>conventional</e1> <e2>glucocorticosteroid</e2> to induce remission in people with a first presentation or a single inflammatory exacerbation of Crohn's disease in a 12-month period .	modifier(e1,e2)
<e1>People</e1> with a history of fragility fractures over the age of 50 should be <e2>offered</e2> DXA scanning to evaluate the need for antiosteoporosis therapy .	receiver(e1,e2)
Consider caffeine citrate for any <e1>preterm</e1> <e2>baby</e2> with apnoea .	modifier(e1,e2)
Consider opioids , such as <e1>codeine</e1> or <e2>morphine</e2> , to reduce cough .	choice
Exclude hypoglycaemia in people with sudden onset of neurological <e1>symptoms</e1> as the <e2>cause</e2> of these symptoms .	other
Patients with stage 1 and 2 NSCLC should be <e1>considered</e1> for curative <e2>surgery</e2> whenever possible .	other
<e1>Consider</e1> insulin <e2>regimen</e2> if the person is pregnant .	acts-on(e1,e2)
Do not use fish <e1>oils</e1> as a nutritional <e2>intervention</e2> to manage weight loss in people with unresectable pancreatic cancer .	other
For people who are at low risk of developing a <e1>diabetic</e1> foot <e2>problem</e2> , continue to carry out annual foot assessments .	modifier(e1,e2)
<e1>Patients</e1> with heart <e2>failure</e2> with reduced ejection fraction of all NYHA functional classes , should be given angiotensin converting enzyme inhibitors .	owner(e1,e2)
To induce remission in people with a mild-to-moderate first presentation or inflammatory exacerbation of proctosigmoiditis or left-sided ulcerative colitis , offer a topical aminosalicylate as <e1>first-line</e1> <e2>treatment</e2> .	modifier(e1,e2)
Consider caffeine citrate for any preterm <e1>baby</e1> with <e2>apnoea</e2> .	owner(e1,e2)
Adjuvant trastuzumab should be considered in all <e1>patients</e1> with HER 2 positive breast cancer who <e2>receive</e2> adjuvant chemotherapy .	actor-of(e1,e2)
Consider opioids for adults , <e1>children</e1> and young <e2>people</e2> with suspected renal colic if both NSAIDs and intravenous paracetamol are contraindicated or are not giving sufficient pain relief .	joint
Inactivated influenza vaccination should be strongly considered for <e1>patients</e1> with <e2>AIIRD</e2> .	owner(e1,e2)
Pregabalin is recommended for the treatment of patients with neuropathic pain if other first and second <e1>line</e1> pharmacological <e2>treatments</e2> have failed .	modifier(e1,e2)
If cytological or histological <e1>samples</e1> are <e2>needed</e2> , offer EUS with EUS-guided tissue sampling .	modifier(e2,e1)
<e1>Ensure</e1> that people with disabling ischaemic stroke who are in atrial fibrillation are <e2>treated</e2> with aspirin 300 mg for the first 2 weeks before anticoagulation treatment is considered .	acts-on(e1,e2)
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider triple <e1>therapy</e1> with metformin and a DPP-4i and an SU , <e2>metformin</e2> and pioglitazone and an SU , metformin and pioglitazone and an SGLT-2i , metformin and an SU and an SGLT-2i , insulin-based treatment , and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	other
Do not offer aspirin for the primary <e1>prevention</e1> of cardiovascular <e2>disease</e2> to adults with type 1 diabetes .	other
Patients undergoing surgical revascularisation of the left anterior descending coronary artery should receive an <e1>internal</e1> mammary artery <e2>graft</e2> .	modifier(e1,e2)
CVD risk estimation for patients with RA , AS or PsA should be <e1>performed</e1> according to national <e2>guidelines</e2> and the SCORE CVD risk prediction model should be used if no national guideline is available .	modifier(e1,e2)
Aim for a target clinic blood pressure below 140/90 mmHg in people aged <e1>under</e1> <e2>80</e2> years with treated hypertension .	modifier(e1,e2)
For preterm babies who need invasive ventilation , use volume-targeted ventilation in combination with <e1>synchronised</e1> <e2>ventilation</e2> as the primary mode of respiratory support .	modifier(e1,e2)
Consider <e1>adjuvant</e1> <e2>radiotherapy</e2> for patients with completely resected stage 3B or 3C melanoma after discussion of the risk of local recurrence and the benefits and risks of radiotherapy including risk of significant adverse effects .	modifier(e1,e2)
Offer an <e1>MRA</e1> , in addition to an ACE <e2>inhibitor</e2> ( or ARB ) and beta-blocker , to people who have heart failure with reduced ejection fraction if they continue to have symptoms of heart failure .	other
Consider budesonide for a first presentation or a single inflammatory exacerbation in a 12-month period for people who have one or more of distal ileal , <e1>ileocaecal</e1> or right-sided colonic <e2>disease</e2> and if conventional glucocorticosteroids are contraindicated , or if the person declines or cannot tolerate them .	choice
Verapamil and diltiazem may be used for prophylaxis of atrial <e1>fibrillation</e1> <e2>following</e2> CABG surgery .	actor-of(e1,e2)
Calcium channel blocker therapy is not recommended for <e1>reduction</e1> in sudden <e2>death</e2> or all cause mortality in patients following ACS .	other
In patients with permanent AF or <e1>persistent</e1> <e2>AF</e2> following a rate control strategy and a resting heart rate > 110 bpm , appropriate rate control therapy should be instituted with an initial target of resting heart rate .	modifier(e1,e2)
For preterm babies who need <e1>invasive</e1> <e2>ventilation</e2> , use volume-targeted ventilation in combination with synchronised ventilation as the primary mode of respiratory support .	modifier(e1,e2)
All <e1>women</e1> with non-mucinous ovarian or fallopian tube cancer should be <e2>offered</e2> BRCA1 and BRCA2 mutation testing .	receiver(e1,e2)
CVD risk <e1>estimation</e1> for patients with RA , AS or PsA should be <e2>performed</e2> according to national guidelines and the SCORE CVD risk prediction model should be used if no national guideline is available .	modifier(e2,e1)
<e1>Aim</e1> for a target clinic blood <e2>pressure</e2> below 150/90 mmHg in people aged 80 years and over with treated hypertension .	acts-on(e1,e2)
Amiodarone may be used when prophylaxis for atrial fibrillation and ventricular <e1>arrhythmias</e1> is indicated <e2>following</e2> CABG surgery .	actor-of(e1,e2)
Furthermore , US or MRI might be used to detect peripheral arthritis , <e1>tenosynovitis</e1> and <e2>bursitis</e2> .	joint
Aim for a target <e1>clinic</e1> blood <e2>pressure</e2> below 140/90 mmHg in people aged under 80 years with treated hypertension .	modifier(e1,e2)
Avoid surgery within 30 <e1>days</e1> of myocardial <e2>infarction</e2> .	other
CVD risk assessment is recommended for all patients with RA , AS or PsA at least once every 5 years and should be reconsidered <e1>following</e1> major <e2>changes</e2> in antirheumatic therapy .	acts-on(e1,e2)
Intravenous amiodarone should be <e1>considered</e1> in the management of <e2>patients</e2> with haemodynamically stable sustained monomorphic VT .	receiver(e2,e1)
If the person is with CKD and an ACR of <e1>70</e1> mg/mmol or <e2>more</e2> , offer a low-cost renin-angiotensin-aldosterone system antagonist .	modifier(e2,e1)
Do not offer a mucolytic to <e1>treat</e1> an acute <e2>cough</e2> associated with an upper respiratory tract infection or acute bronchitis .	acts-on(e1,e2)
Consider adding methotrexate to a <e1>conventional</e1> <e2>glucocorticosteroid</e2> or budesonide to induce remission in people who cannot tolerate azathioprine or mercaptopurine .	modifier(e1,e2)
<e1>Women</e1> with stage 4 ovarian <e2>cancer</e2> should be offered bevacizumab in combination with carboplatin and paclitaxel .	owner(e1,e2)
A combination of digoxin with either a beta-blocker or diltiazem should be considered to <e1>control</e1> heart <e2>rate</e2> in patients with atrial fibrillation .	acts-on(e1,e2)
If the <e1>clinic</e1> blood <e2>pressure</e2> is 140/90 mmHg or higher , offer ABPM to confirm the diagnosis of hypertension .	modifier(e1,e2)
Offer a non-steroidal anti-inflammatory drug by any route as first-line treatment for adults , <e1>children</e1> and young <e2>people</e2> with suspected renal colic .	joint
<e1>Patients</e1> with CHC who are on a drug treatment <e2>programme</e2> should be considered for treatment .	owner(e1,e2)
<e1>Consider</e1> <e2>opioids</e2> for adults , children and young people with suspected renal colic if both NSAIDs and intravenous paracetamol are contraindicated or are not giving sufficient pain relief .	acts-on(e1,e2)
In patients with peripheral arthritis and an inadequate response to at least one csDMARD , <e1>therapy</e1> with a bDMARD , usually a TNF inhibitor , should be <e2>commenced</e2> .	acts-on(e2,e1)
<e1>Evaluate</e1> PET-CT-positive or enlarged intrathoracic nodes <e2>using</e2> a systematic approach with EBUS-TBNA and/or EUS-FNA if nodal status would affect the treatment plan .	other
<e1>Repeat</e1> the albumin-adjusted serum calcium <e2>measurement</e2> at least once if the first measurement is either 2.6 mmol/litre or above or 2.5 mmol/litre or above and features of primary hyperparathyroidism are present .	acts-on(e1,e2)
All <e1>patients</e1> with invasive breast cancer who are operable should <e2>have</e2> axillary surgery .	actor-of(e1,e2)
Do not use first morning urine void to <e1>quantify</e1> <e2>proteinuria</e2> in pregnant women .	acts-on(e1,e2)
Do not use <e1>dexamethasone</e1> with non-steroidal anti-inflammatory <e2>drugs</e2> .	other
If HbA1c rises to 48 mmol/mol ( 6.5 % ) on lifestyle interventions , offer metformin and support the person to aim for an HbA1c <e1>level</e1> of <e2>48</e2> mmol/mol ( 6.5 % ) .	modifier(e2,e1)
If remission is not <e1>achieved</e1> within 4 <e2>weeks</e2> , consider adding an oral aminosalicylate .	modifier(e2,e1)
Herpes zoster vaccination may be considered in <e1>patients</e1> with <e2>AIIRD</e2> .	owner(e1,e2)
Do not <e1>offer</e1> an <e2>antibiotic</e2> to treat an acute cough associated with an upper respiratory tract infection in people who are not systemically very unwell or at higher risk of complications .	acts-on(e1,e2)
Do not routinely use 24-hour urine collection to <e1>quantify</e1> <e2>proteinuria</e2> in pregnant women .	acts-on(e1,e2)
Patients with left main stem <e1>stenosis</e1> and/or multivessel <e2>disease</e2> should be considered for revascularisation to improve prognosis .	joint
If the person has severe hypertension , consider starting antihypertensive drug treatment immediately , without waiting for the results of <e1>ABPM</e1> or <e2>HBPM</e2> .	choice
Do not offer platinum-based combination chemotherapy to obtain a serum calcium for <e1>people</e1> with extensive-stage disease SCLC if <e2>they</e2> are fit enough .	other
In patients with peripheral arthritis and an inadequate response to at least one csDMARD , in whom bDMARDs are not appropriate , a targeted synthetic <e1>DMARD</e1> such as a <e2>PDE4-inhibitor</e2> may be considered .	other
<e1>Offer</e1> a proton pump <e2>inhibitor</e2> , in addition to aspirin , to anyone with acute ischaemic stroke for whom previous dyspepsia associated with aspirin is reported .	acts-on(e1,e2)
Live attenuated vaccines should be avoided whenever possible in <e1>immunosuppressed</e1> <e2>patients</e2> with AIIRD .	modifier(e1,e2)
<e1>Patients</e1> with <e2>CHC</e2> who are on a drug treatment programme should be considered for treatment .	owner(e1,e2)
Consider <e1>opioids</e1> , such as <e2>codeine</e2> or morphine , to reduce cough .	other
<e1>Offer</e1> antihypertensive drug <e2>treatment</e2> for heart failure with treated hypertension .	acts-on(e1,e2)
If <e1>further</e1> <e2>treatment</e2> is needed , stop topical treatments and offer an oral aminosalicylate and a time-limited course of an oral corticosteroid .	modifier(e1,e2)
Offer monotherapy with a conventional glucocorticosteroid to induce remission in people with a first <e1>presentation</e1> or a single inflammatory <e2>exacerbation</e2> of Crohn's disease in a 12-month period .	choice
Second line systemic anticancer therapy with single agent docetaxel or erlotinib should be considered for patients with performance status 0-2 recurrent NSCLC who have been previously treated with first <e1>line</e1> <e2>SACT</e2> for advanced disease .	modifier(e1,e2)
<e1>Patients</e1> who are unfit for combination therapy should be <e2>offered</e2> single agent carboplatin .	receiver(e1,e2)
<e1>Consider</e1> endocrine <e2>therapy</e2> after breast-conserving surgery for women with ER-positive DCIS if radiotherapy is not recommended .	acts-on(e1,e2)
MRI of the SI joints and/or the spine may be used to <e1>assess</e1> and monitor disease <e2>activity</e2> in axial SpA , providing additional information on top of clinical and biochemical assessments .	acts-on(e1,e2)
Patients with AIIRD should receive tetanus toxoid vaccination in accordance to <e1>recommendations</e1> for the general <e2>population</e2> .	other
Offer an ACE inhibitor and a beta-blocker licensed for heart failure to people who have heart failure with <e1>reduced</e1> ejection <e2>fraction</e2> .	modifier(e1,e2)
Start <e1>ACE</e1> inhibitor therapy at a low dose and <e2>titrate</e2> upwards at short intervals until the target or maximum tolerated dose is reached .	actor-of(e1,e2)
Provide an accessible resource to promote best <e1>practice</e1> in the <e2>management</e2> of patients using medium/high-dose GCs to general practitioners .	other
<e1>Verapamil</e1> and <e2>diltiazem</e2> may be used for prophylaxis of atrial fibrillation following CABG surgery .	joint
The decision on when to <e1>repeat</e1> <e2>US/MRI</e2> depends on the clinical circumstances .	acts-on(e1,e2)
<e1>Patients</e1> with heart failure and clinical <e2>signs</e2> or symptoms of fluid overload or congestion should be considered for diuretic therapy .	owner(e1,e2)
If the <e1>person</e1> is aged under 80 years with stage 1 <e2>hypertension</e2> and has target organ damage , offer antihypertensive drug treatment .	owner(e1,e2)
Patients with heart failure with reduced ejection <e1>fraction</e1> , <e2>NYHA</e2> class 2-4 , who are intolerant of angiotensin converting enzyme inhibitors should be given an angiotensin receptor blocker .	joint
All patients co-infected with HIV and HCV genotype 1 should be <e1>considered</e1> for <e2>treatment</e2> with a regimen which includes an HCV protease inhibitor .	acts-on(e1,e2)
Amiodarone therapy is not <e1>recommended</e1> for <e2>patients</e2> following ACS or patients with congestive heart failure who do not have sustained ventricular arrhythmias or atrial fibrillation .	receiver(e2,e1)
In <e1>patients</e1> with predominantly axial disease that is active and <e2>has</e2> insufficient response to NSAIDs , therapy with a bDMARD should be considered , which according to current practice is a TNF inhibitor .	actor-of(e1,e2)
If HbA1c rises to 48 mmol/mol ( 6.5 % ) on lifestyle interventions , consider a DPP-4i , pioglitazone , an SU , an SGLT-2i , and support the person to aim for an HbA1c level of <e1>48</e1> mmol/mol ( 6.5 % ) for people on a DPP-4i , SGLT-2i or pioglitazone or <e2>53</e2> mmol/mol ( 7 % ) for people on an SU .	choice
Patients having radical radiotherapy should be given <e1>CHART</e1> in preference to 60 <e2>Gy</e2> in 30 fractions over six weeks .	other
Do not <e1>offer</e1> a <e2>bisphosphonate</e2> to pregnant women with primary hyperparathyroidism .	acts-on(e1,e2)
Class 1 antiarrhythmic drugs should not be <e1>used</e1> for <e2>treatment</e2> of premature ventricular beats or non sustained VT in patients with previous MI .	modifier(e1,e2)
Offer <e1>metformin</e1> as the initial drug <e2>treatment</e2> for adults with type 2 diabetes .	other
Offer endocrine therapy after breast-conserving surgery for women with ER-positive DCIS if <e1>radiotherapy</e1> is <e2>recommended</e2> but not received .	modifier(e2,e1)
Advise <e1>pregnant</e1> <e2>women</e2> at high risk of pre-eclampsia to take 75-150 mg of aspirin daily from 12 weeks until the birth of the baby .	modifier(e1,e2)
In patients with peripheral arthritis , particularly in those with many swollen joints , structural damage in the presence of inflammation , <e1>high</e1> <e2>ESR/CRP</e2> and/or clinically relevant extra-articular manifestations , csDMARDs should be considered at an early stage , with methotrexate preferred in those with relevant skin involvement .	modifier(e1,e2)
Human papillomavirus vaccination should be <e1>considered</e1> in selected <e2>patients</e2> with AIIRD .	receiver(e2,e1)
Consider budesonide for a first presentation or a single inflammatory exacerbation in a 12-month period for <e1>people</e1> who <e2>have</e2> one or more of distal ileal , ileocaecal or right-sided colonic disease and if conventional glucocorticosteroids are contraindicated , or if the person declines or cannot tolerate them .	actor-of(e1,e2)
Consider a clinical trial as an alternative to second-line chemotherapy for <e1>people</e1> with oesophago-gastric <e2>cancer</e2> .	owner(e1,e2)
If the person is aged <e1>under</e1> 80 <e2>years</e2> with stage 1 hypertension and has diabetes , offer antihypertensive drug treatment .	modifier(e1,e2)
Do not <e1>offer</e1> ACE inhibitor <e2>therapy</e2> if there is a clinical suspicion of haemodynamically significant valve disease until the valve disease has been assessed by a specialist .	acts-on(e1,e2)
If HbA1c rises to 48 mmol/mol ( 6.5 % ) on lifestyle interventions , <e1>offer</e1> <e2>metformin</e2> and support the person to aim for an HbA1c level of 48 mmol/mol ( 6.5 % ) .	acts-on(e1,e2)
Conventional radiography of the SI joints and/or spine may be used for long-term monitoring of structural <e1>damage</e1> , particularly new bone <e2>formation</e2> , in axial SpA .	other
In patients with permanent AF or persistent AF following a rate control strategy and a <e1>resting</e1> heart <e2>rate</e2> > 110 bpm , appropriate rate control therapy should be instituted with an initial target of resting heart rate .	modifier(e1,e2)
Offer an MRA , in addition to an ACE inhibitor ( or ARB ) and beta-blocker , to people who have heart failure with <e1>reduced</e1> ejection <e2>fraction</e2> if they continue to have symptoms of heart failure .	modifier(e1,e2)
Offer bisphosphonates as <e1>adjuvant</e1> <e2>therapy</e2> to postmenopausal women with node-positive invasive breast cancer .	modifier(e1,e2)
In patients undergoing multiple coronary artery bypass grafting , <e1>use</e1> of both internal mammary arteries should be <e2>considered</e2> .	modifier(e2,e1)
Patients with advanced liver disease should be <e1>given</e1> nutritional <e2>support</e2> to minimise malnutrition .	acts-on(e1,e2)
Do not offer a bisphosphonate to pregnant women with <e1>primary</e1> <e2>hyperparathyroidism</e2> .	modifier(e1,e2)
<e1>Consider</e1> a clinical <e2>trial</e2> as an alternative to second-line chemotherapy for people with oesophago-gastric cancer .	acts-on(e1,e2)
Do not <e1>offer</e1> antihypertensive drug <e2>treatment</e2> if the person is with type 1 diabetes .	acts-on(e1,e2)
US with <e1>high-frequency</e1> <e2>colour</e2> or power Doppler is sufficient to detect inflammation and the use of US contrast medium is not needed .	modifier(e1,e2)
In patients with peripheral arthritis and an inadequate response to at least one csDMARD , in whom TNF inhibitors are not appropriate , bDMARDs targeting IL12/23 or <e1>IL17</e1> pathways may be <e2>considered</e2> .	modifier(e2,e1)
A <e1>combination</e1> of digoxin with either a beta-blocker or diltiazem should be considered to <e2>control</e2> heart rate in patients with atrial fibrillation .	actor-of(e1,e2)
<e1>Review</e1> antibiotic <e2>treatment</e2> after 14 days and either stop the antibiotic or continue for a further 14 days if needed , based on an assessment of the person's history , symptoms , clinical examination , urine and blood tests .	acts-on(e1,e2)
Offer an alternative antiplatelet agent to anyone with acute ischaemic stroke who is allergic to or genuinely <e1>intolerant</e1> of <e2>aspirin</e2> .	modifier(e1,e2)
<e1>Vaccination</e1> in patients with AIIRD should ideally be <e2>administered</e2> during stable disease .	acts-on(e2,e1)
For women with a cerebrovascular malformation at <e1>low</e1> <e2>risk</e2> of intracranial bleeding , base decisions on the mode of birth on the woman's preference and obstetric indications .	modifier(e1,e2)
Offer urgent <e1>ultrasound</e1> as first-line <e2>imaging</e2> for children and young people with suspected renal colic .	other
<e1>Treatment</e1> should be <e2>aimed</e2> at reaching a target of sustained remission or low disease activity in every patient .	acts-on(e2,e1)
For people who cannot tolerate aminosalicylates , consider a time-limited course of a <e1>topical</e1> or an oral <e2>corticosteroid</e2> .	modifier(e1,e2)
For <e1>patients</e1> with HCV genotype 1 infection and HIV , who do not achieve an EVR , treatment should be <e2>stopped</e2> .	receiver(e1,e2)
Do not use anticoagulation treatment routinely for the treatment of <e1>acute</e1> <e2>stroke</e2> .	modifier(e1,e2)
<e1>Give</e1> oral <e2>antibiotics</e2> first line if the person can take oral medicines , and the severity of their condition does not require intravenous antibiotics .	acts-on(e1,e2)
Beta-blockers should be used as first <e1>line</e1> <e2>therapy</e2> for the relief of symptoms of stable angina .	modifier(e1,e2)
For people who cannot <e1>tolerate</e1> <e2>aminosalicylates</e2> , consider a time-limited course of an oral corticosteroid .	acts-on(e1,e2)
Sotalol therapy is not recommended for <e1>patients</e1> <e2>following</e2> ACS who do not have sustained ventricular arrhythmias or atrial fibrillation .	actor-of(e1,e2)
<e1>Offer</e1> flexible bronchoscopy to <e2>people</e2> with central lesions on CT if nodal staging does not influence treatment .	receiver(e2,e1)
<e1>Offer</e1> radiotherapy using 60 Gy in 30 fractions with concomitant temozolomide for <e2>people</e2> aged around 70 or under .	receiver(e2,e1)
<e1>Assess</e1> the PR status of all invasive breast cancers using standardised and quality-assured immunohistochemical techniques , and <e2>report</e2> the results quantitatively .	other
In patients with PsA , <e1>NSAIDs</e1> may be <e2>used</e2> to relieve musculoskeletal signs and symptoms .	acts-on(e2,e1)
Use MRI when necessary to assess the <e1>extent</e1> of <e2>disease</e2> , for people with superior sulcus tumours .	other
In patients being considered for active therapy , <e1>pleural</e1> <e2>effusion</e2> should be investigated with pleural aspiration and/or pleural biopsy using image-guided or thoracoscopic biopsy .	modifier(e1,e2)
Perform transthoracic echocardiography to <e1>exclude</e1> important valve <e2>disease</e2> , assess the systolic function of the ventricle , and detect intracardiac shunts .	acts-on(e1,e2)
Offer parathyroid surgery to women who have <e1>primary</e1> <e2>hyperparathyroidism</e2> and are considering pregnancy .	modifier(e1,e2)
Women with platinum resistant relapsed ovarian cancer should be offered <e1>bevacizumab</e1> in combination with <e2>paclitaxel</e2> .	joint
Sotalol therapy is not recommended for patients following ACS who do not have sustained ventricular <e1>arrhythmias</e1> or atrial <e2>fibrillation</e2> .	choice
Gabapentin should be considered for the treatment of <e1>patients</e1> with neuropathic <e2>pain</e2> .	owner(e1,e2)
In surgery for advanced ovarian cancer , the aim should be to achieve <e1>complete</e1> <e2>cytoreduction</e2> .	modifier(e1,e2)
If clinical evaluation or lung function <e1>testing</e1> <e2>indicates</e2> an inadequate response to rhDNase , consider both rhDNase and hypertonic sodium chloride or hypertonic sodium chloride alone .	actor-of(e1,e2)
In <e1>surgery</e1> for advanced ovarian <e2>cancer</e2> , the aim should be to achieve complete cytoreduction .	other
Extensive MRI inflammatory activity , particularly in the spine in patients with ankylosing spondylitis , might be used as a predictor of good <e1>clinical</e1> <e2>response</e2> to anti-TNF-alpha treatment in axial SpA .	modifier(e1,e2)
Consider prostaglandin E1 as an option for <e1>treating</e1> postpartum <e2>haemorrhage</e2> in women with asthma because there is no evidence it worsens asthma .	acts-on(e1,e2)
Amitriptyline should be considered for the treatment of <e1>patients</e1> with <e2>fibromyalgia</e2> and neuropathic pain .	owner(e1,e2)
Olaparib monotherapy should be considered for maintenance treatment after response to platinum for patients with relapsed platinum <e1>sensitive</e1> BRCA mutated ovarian <e2>cancer</e2> .	modifier(e1,e2)
Do not routinely use 24-hour urine collection to <e1>quantify</e1> proteinuria in pregnant <e2>women</e2> .	receiver(e1,e2)
For patients with HCV genotype 1 infection and HIV , who do not <e1>achieve</e1> an <e2>EVR</e2> , treatment should be stopped .	acts-on(e1,e2)
To induce remission in people with a mild-to-moderate first presentation or inflammatory exacerbation of proctitis , offer a topical <e1>aminosalicylate</e1> as first-line <e2>treatment</e2> .	other
Short-term GC should be considered when initiating or <e1>changing</e1> <e2>csDMARDs</e2> , in different dose regimens and routes of administration , but should be tapered as rapidly as clinically feasible .	acts-on(e1,e2)
If the <e1>person</e1> is with stage 2 <e2>diabetes</e2> and symptomatically hyperglycaemic , offer SGLT-2i , pioglitazone or ergocalciferol .	owner(e1,e2)
In hyposplenic/asplenic <e1>patients</e1> with AIIRD <e2>influenza</e2> , pneumococcal , Haemophilus influenzae b and meningococcal C , vaccinations are recommended .	owner(e1,e2)
Do not offer an antibiotic to treat an acute <e1>cough</e1> associated with an upper respiratory tract <e2>infection</e2> in people who are not systemically very unwell or at higher risk of complications .	other
All patients co-infected with <e1>HCV</e1> and <e2>HIV</e2> should be considered for HCV treatment .	joint
Patients with chronic hepatitis <e1>B</e1> and C <e2>co-infection</e2> should be considered for treatment with pegylated IFN and weight based ribavirin .	joint
Women with platinum resistant ovarian cancer should be considered for treatment with <e1>paclitaxel</e1> or single agent pegylated liposomal doxorubicin <e2>hydrochloride</e2> .	choice
Amiodarone may be used when prophylaxis for atrial fibrillation and ventricular arrhythmias is indicated <e1>following</e1> CABG <e2>surgery</e2> .	acts-on(e1,e2)
If the person has stage 2 hypertension , offer <e1>antihypertensive</e1> drug <e2>treatment</e2> .	modifier(e1,e2)
If one TNF-inhibitor therapy has failed , patients may <e1>receive</e1> another <e2>TNF-inhibitor</e2> or an agent with another mode of action .	acts-on(e1,e2)
For preterm <e1>babies</e1> who need invasive ventilation , <e2>use</e2> volume-targeted ventilation in combination with synchronised ventilation as the primary mode of respiratory support .	receiver(e1,e2)
Do not <e1>offer</e1> pre-treatment <e2>stenting</e2> to adults having shockwave lithotripsy for ureteric or renal stones .	acts-on(e1,e2)
If HbA1c <e1>rises</e1> to <e2>58</e2> mmol/mol ( 7.5 % ) , consider triple therapy with metformin and a DPP-4i and an SU , metformin and pioglitazone and an SU , metformin and pioglitazone and an SGLT-2i , metformin and an SU and an SGLT-2i , insulin-based treatment , and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	modifier(e2,e1)
US with high-frequency colour or power Doppler is sufficient to detect inflammation and the use of US contrast <e1>medium</e1> is not <e2>needed</e2> .	modifier(e2,e1)
If a patient is in persistent remission after having tapered GC , one can consider <e1>tapering</e1> <e2>bDMARDs</e2> , especially if this treatment is combined with a csDMARD .	modifier(e1,e2)
Do not offer bisphosphonates for <e1>chronic</e1> <e2>hypercalcaemia</e2> of primary hyperparathyroidism .	modifier(e1,e2)
Offer contrast-enhanced brain MRI for people with stage 3 NSCLC who are having <e1>treatment</e1> with curative <e2>intent</e2> .	other
For people who are at low <e1>risk</e1> of developing a diabetic foot <e2>problem</e2> , continue to carry out annual foot assessments .	other
The routine use of aspirin to reduce perioperative cardiac events in <e1>patients</e1> undergoing non cardiac surgery , including those with known stable <e2>CAD</e2> , is not recommended .	owner(e1,e2)
Monitor for neutropenia in people taking <e1>azathioprine</e1> or <e2>mercaptopurine</e2> even if they have normal TPMT activity .	choice
In patients with peripheral arthritis and an inadequate response to at least one csDMARD , therapy with a <e1>bDMARD</e1> , usually a TNF <e2>inhibitor</e2> , should be commenced .	other
Do not routinely <e1>repeat</e1> PTH <e2>measurement</e2> in primary care .	acts-on(e1,e2)
If the treatment target is not achieved with the first csDMARD strategy , when poor prognostic factors are present , addition of a bDMARD or a <e1>tsDMARD</e1> should be <e2>considered</e2> .	acts-on(e2,e1)
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider dual <e1>therapy</e1> with metformin and a DPP-4i , metformin and pioglitazone , metformin and an SU , <e2>metformin</e2> and an SGLT-2i , and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	other
If the <e1>person</e1> is aged under 80 years with stage 1 hypertension and <e2>has</e2> diabetes , offer antihypertensive drug treatment .	actor-of(e1,e2)
Patients with genotype 1 infection who fail to achieve an EVR at 12 weeks should be <e1>considered</e1> for <e2>cessation</e2> of treatment .	acts-on(e1,e2)
For people with an <e1>acute</e1> <e2>cough</e2> who are identified at a face-to-face clinical examination as at higher risk of complications , consider an immediate antibiotic prescription or a back-up antibiotic prescription .	modifier(e1,e2)
Carboplatin AUC 6 and paclitaxel 80 mg/m2 may be considered for the treatment of first <e1>line</e1> ovarian <e2>cancer</e2> .	modifier(e1,e2)
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider triple therapy with <e1>metformin</e1> and a <e2>DPP-4i</e2> and an SU , metformin and pioglitazone and an SU , metformin and pioglitazone and an SGLT-2i , metformin and an SU and an SGLT-2i , insulin-based treatment , and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	joint
Carboplatin AUC 6 and <e1>paclitaxel</e1> 80 mg/m2 may be <e2>considered</e2> for the treatment of first line ovarian cancer .	modifier(e2,e1)
Offer contrast-enhanced brain CT if the person has <e1>established</e1> cardiovascular <e2>disease</e2> .	acts-on(e1,e2)
If further treatment is needed , stop topical treatments and offer an <e1>oral</e1> <e2>aminosalicylate</e2> and a time-limited course of an oral corticosteroid .	modifier(e1,e2)
Do not use fish oils as a nutritional intervention to <e1>manage</e1> weight <e2>loss</e2> in people with unresectable pancreatic cancer .	acts-on(e1,e2)
In patients with <e1>peripheral</e1> <e2>arthritis</e2> , particularly in those with many swollen joints , structural damage in the presence of inflammation , high ESR/CRP and/or clinically relevant extra-articular manifestations , csDMARDs should be considered at an early stage , with methotrexate preferred in those with relevant skin involvement .	modifier(e1,e2)
Vaccination in patients with AIIRD can be administered during the use of <e1>disease-modifying</e1> antirheumatic <e2>drugs</e2> and tumour necrosis factor alpha blocking agents but should ideally be administered before starting B cell depleting biological therapy .	modifier(e1,e2)
Do not offer dedicated brain imaging to <e1>people</e1> with clinical stage 1 <e2>NSCLC</e2> who have no neurological symptoms and are having treatment with curative intent .	owner(e1,e2)
Combination intravenous <e1>SACT</e1> should be <e2>considered</e2> for patients with SCLC over 70 years of age with performance status 0-2 .	modifier(e2,e1)
Women with platinum resistant relapsed ovarian cancer should be <e1>offered</e1> <e2>bevacizumab</e2> in combination with paclitaxel .	acts-on(e1,e2)
Avoid verapamil , diltiazem and short-acting dihydropyridine agents in people who have heart failure with <e1>reduced</e1> ejection <e2>fraction</e2> .	modifier(e1,e2)
In patients who have recovered from an episode of sustained ventricular tachycardia who are not candidates for an ICD , <e1>amiodarone</e1> or <e2>sotalol</e2> should be considered .	choice
If the <e1>person</e1> is aged under 80 years with stage 1 hypertension and has target organ damage , <e2>offer</e2> antihypertensive drug treatment .	receiver(e1,e2)
In patients with ankylosing spondylitis , initial conventional radiography of the lumbar and cervical spine is recommended to <e1>detect</e1> <e2>syndesmophytes</e2> , which are predictive of development of new syndesmophytes .	acts-on(e1,e2)
Offer a proton pump inhibitor , in addition to aspirin , to anyone with acute ischaemic stroke for whom previous <e1>dyspepsia</e1> associated with <e2>aspirin</e2> is reported .	other
Do not routinely <e1>offer</e1> an <e2>antibiotic</e2> to treat an acute cough associated with acute bronchitis in people who are not systemically very unwell or at higher risk of complications .	acts-on(e1,e2)
Transmyocardial laser revascularisation is not recommended for the <e1>treatment</e1> of stable <e2>angina</e2> .	other
Patients with larger tumours may be <e1>considered</e1> for oncoplastic <e2>surgery</e2> instead of mastectomy .	acts-on(e1,e2)
<e1>Consider</e1> <e2>bisphosphonates</e2> as adjuvant therapy for postmenopausal women with node-negative invasive breast cancer and a high risk of recurrence .	acts-on(e1,e2)
<e1>Offer</e1> endocrine <e2>therapy</e2> after breast-conserving surgery for women with ER-positive DCIS if radiotherapy is recommended but not received .	acts-on(e1,e2)
If dipstick screening is positive , <e1>use</e1> albumin:creatinine ratio or protein:creatinine <e2>ratio</e2> to quantify proteinuria in pregnant women .	acts-on(e1,e2)
In patients who cannot use csDMARDs as comedication , IL-6 pathway inhibitors and tsDMARDs may <e1>have</e1> some <e2>advantages</e2> compared with other bDMARDs .	acts-on(e1,e2)
Consider adjuvant radiotherapy for patients with completely <e1>resected</e1> stage <e2>3B</e2> or 3C melanoma after discussion of the risk of local recurrence and the benefits and risks of radiotherapy including risk of significant adverse effects .	modifier(e1,e2)
<e1>Patients</e1> with AIIRD should <e2>receive</e2> tetanus toxoid vaccination in accordance to recommendations for the general population .	actor-of(e1,e2)
When peripheral SpA is suspected , <e1>US</e1> or MRI may be <e2>used</e2> to detect peripheral enthesitis , which may support the diagnosis of SpA .	modifier(e2,e1)
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider dual <e1>therapy</e1> with a DPP-4i and pioglitazone , a DPP-4i and an SU , <e2>pioglitazone</e2> and an SU , and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	other
<e1>Offer</e1> bisphosphonates as adjuvant therapy to postmenopausal <e2>women</e2> with node-positive invasive breast cancer .	receiver(e2,e1)
Offer a non-steroidal anti-inflammatory drug by any route as first-line treatment for <e1>adults</e1> , <e2>children</e2> and young people with suspected renal colic .	joint
If the <e1>person</e1> is aged under 80 years with stage 1 hypertension and has 10 year cardiovascular risk , <e2>offer</e2> antihypertensive drug treatment .	receiver(e1,e2)
<e1>Anthracycline</e1> taxane based chemotherapy <e2>combinations</e2> should be considered for all patients receiving neoadjuvant chemotherapy .	modifier(e1,e2)
Offer radiotherapy <e1>using</e1> 60 <e2>Gy</e2> in 30 fractions with concomitant temozolomide for people aged around 70 or under .	acts-on(e1,e2)
If a bDMARD or tsDMARD has failed , <e1>treatment</e1> with another bDMARD or a tsDMARD should be <e2>considered</e2> .	acts-on(e2,e1)
Pregabalin is recommended for the treatment of patients with neuropathic pain if other first and second line pharmacological <e1>treatments</e1> have <e2>failed</e2> .	actor-of(e1,e2)
For <e1>people</e1> with an acute <e2>cough</e2> who are identified at a face-to-face clinical examination as at higher risk of complications , consider an immediate antibiotic prescription or a back-up antibiotic prescription .	owner(e1,e2)
Hepatitis A and/or B vaccination is only recommended in <e1>patients</e1> with <e2>AIIRD</e2> at risk .	owner(e1,e2)
<e1>Consider</e1> opioids for <e2>adults</e2> , children and young people with suspected renal colic if both NSAIDs and intravenous paracetamol are contraindicated or are not giving sufficient pain relief .	receiver(e2,e1)
If the person is aged under 80 years with stage 1 hypertension and has <e1>10</e1> year cardiovascular <e2>risk</e2> , offer antihypertensive drug treatment .	modifier(e1,e2)
Consider adjuvant therapy after surgery for people with invasive breast cancer , and ensure that recommendations are recorded at the <e1>multidisciplinary</e1> team <e2>meeting</e2> .	modifier(e1,e2)
In <e1>patients</e1> with axial <e2>SpA</e2> without syndesmophytes in the lumbar spine on conventional radiography , osteoporosis should be assessed by hip DXA and AP-spine DXA .	owner(e1,e2)
Offer contrast-enhanced brain CT to <e1>people</e1> with clinical stage 2 <e2>NSCLC</e2> who are having treatment with curative intent .	owner(e1,e2)
<e1>Treatment</e1> should be <e2>aimed</e2> at reaching the target of remission or , alternatively , minimal/low disease activity , by regular monitoring and appropriate adjustment of therapy .	modifier(e2,e1)
<e1>Patients</e1> with larger <e2>tumours</e2> may be considered for oncoplastic surgery instead of mastectomy .	owner(e1,e2)
Do not <e1>offer</e1> azathioprine , <e2>mercaptopurine</e2> or methotrexate as monotherapy to induce remission .	acts-on(e1,e2)
In patients with syndesmophytes in the lumbar spine on conventional radiography , osteoporosis should be assessed by hip DXA , supplemented by either <e1>spine</e1> <e2>DXA</e2> in lateral projection or possibly QCT of the spine .	modifier(e1,e2)
Local <e1>injections</e1> of glucocorticoids should be <e2>considered</e2> as adjunctive therapy in PsA .	acts-on(e2,e1)
<e1>Offer</e1> an ACE inhibitor and a beta-blocker licensed for heart failure to <e2>people</e2> who have heart failure with reduced ejection fraction .	receiver(e2,e1)
Consider aminosalicylate treatment for a first presentation or a single inflammatory exacerbation in a 12-month period if conventional glucocorticosteroids are contraindicated , or if the person declines or cannot <e1>tolerate</e1> <e2>them</e2> .	acts-on(e1,e2)
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider dual therapy with a DPP-4i and pioglitazone , a DPP-4i and an SU , pioglitazone and an SU , and support the <e1>person</e1> to <e2>aim</e2> for an HbA1c level of 53 mmol/mol ( 7 % ) .	actor-of(e1,e2)
Give a loading <e1>dose</e1> of 20 mg/kg of caffeine <e2>citrate</e2> , followed 24 hours later by a maintenance dosage of 5 mg/kg once daily , increasing up to 20 mg/kg daily if episodes of apnoea persist .	other
<e1>Give</e1> a loading dose of 20 mg/kg of caffeine citrate , <e2>followed</e2> 24 hours later by a maintenance dosage of 5 mg/kg once daily , increasing up to 20 mg/kg daily if episodes of apnoea persist .	other
<e1>Patients</e1> with chronic hepatitis <e2>B</e2> and C co-infection should be considered for treatment with pegylated IFN and weight based ribavirin .	owner(e1,e2)
Adjuvant trastuzumab should be <e1>considered</e1> in all <e2>patients</e2> with HER 2 positive breast cancer who receive adjuvant chemotherapy .	receiver(e2,e1)
Do not <e1>offer</e1> prostaglandin F2 alpha to <e2>women</e2> with asthma because of the risk of bronchospasm .	receiver(e2,e1)
Class 1 antiarrhythmic drugs should not be used for treatment of premature ventricular beats or non sustained VT in <e1>patients</e1> with previous <e2>MI</e2> .	owner(e1,e2)
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider dual therapy with a DPP-4i and pioglitazone , a DPP-4i and an SU , <e1>pioglitazone</e1> and an <e2>SU</e2> , and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	joint
<e1>Offer</e1> metformin as the initial drug treatment for <e2>adults</e2> with type 2 diabetes .	receiver(e2,e1)
<e1>Provide</e1> an accessible <e2>resource</e2> to promote best practice in the management of patients using medium/high-dose GCs to general practitioners .	acts-on(e1,e2)
Offer antihypertensive drug treatment for heart <e1>failure</e1> with treated <e2>hypertension</e2> .	other
Treatment should be aimed at reaching a <e1>target</e1> of sustained <e2>remission</e2> or low disease activity in every patient .	other
Second line systemic anticancer therapy with single agent docetaxel or erlotinib should be considered for <e1>patients</e1> with performance status 0-2 recurrent NSCLC who have been previously <e2>treated</e2> with first line SACT for advanced disease .	receiver(e1,e2)
In hyposplenic/asplenic patients with AIIRD influenza , <e1>pneumococcal</e1> , Haemophilus influenzae <e2>b</e2> and meningococcal C , vaccinations are recommended .	joint
Amiodarone therapy is not recommended for patients following ACS or patients with congestive heart failure who do not <e1>have</e1> sustained ventricular <e2>arrhythmias</e2> or atrial fibrillation .	acts-on(e1,e2)
Do not <e1>offer</e1> <e2>nitrosoureas</e2> concurrently with radiotherapy to people with newly diagnosed grade 3 glioma .	acts-on(e1,e2)
Give oral antibiotics first line if the person can take oral medicines , and the severity of their condition does not require <e1>intravenous</e1> <e2>antibiotics</e2> .	modifier(e1,e2)
Do not offer azathioprine , mercaptopurine or methotrexate as <e1>monotherapy</e1> to <e2>induce</e2> remission .	actor-of(e1,e2)
Monitor the effects of azathioprine , mercaptopurine and methotrexate as <e1>advised</e1> in the British National <e2>Formulary</e2> or British National Formulary for Children .	modifier(e2,e1)
Do not offer antispasmodics to <e1>adults</e1> , <e2>children</e2> and young people with suspected renal colic .	joint
In patients who have recovered from an episode of sustained ventricular tachycardia who are not candidates for an ICD , amiodarone or <e1>sotalol</e1> should be <e2>considered</e2> .	acts-on(e2,e1)
If long-term medium/high-dose GC <e1>therapy</e1> is <e2>anticipated</e2> to be necessary , actively consider GC-sparing therapy .	modifier(e2,e1)
<e1>Offer</e1> systemic combination chemotherapy to <e2>people</e2> with locally advanced pancreatic cancer who are well enough to tolerate it .	receiver(e2,e1)
Digoxin should not be <e1>used</e1> for <e2>prophylaxis</e2> of atrial fibrillation following CABG surgery .	acts-on(e1,e2)
<e1>Use</e1> caffeine citrate routinely in preterm <e2>babies</e2> born at or before 30 weeks , starting it as early as possible and ideally before 3 days of age .	receiver(e2,e1)
Do not <e1>offer</e1> prostaglandin F2 <e2>alpha</e2> to women with asthma because of the risk of bronchospasm .	acts-on(e1,e2)
For <e1>adults</e1> with sudden onset acute vestibular syndrome , a HINTS test should be <e2>performed</e2> if a healthcare professional with training and experience in the use of this test is available .	receiver(e1,e2)
If the patient is already on an ACE inhibitor , the ACE <e1>inhibitor</e1> should be <e2>stopped</e2> for 36 hours before initiating sacubitril / valsartan to minimise the risk of angioedema .	modifier(e2,e1)
If the person is with CKD and vitamin D supplementation is indicated , offer <e1>colecalciferol</e1> or <e2>ergocalciferol</e2> .	choice
Patients with compensated cirrhosis should be considered for <e1>therapy</e1> , unless <e2>contraindicated</e2> .	modifier(e2,e1)
Review antibiotic treatment after 14 days and either stop the antibiotic or continue for a further 14 days if needed , based on an <e1>assessment</e1> of the person's <e2>history</e2> , symptoms , clinical examination , urine and blood tests .	other
Offer a proton pump inhibitor , in addition to aspirin , to anyone with acute ischaemic stroke for whom <e1>previous</e1> <e2>dyspepsia</e2> associated with aspirin is reported .	modifier(e1,e2)
Anthracycline taxane based chemotherapy <e1>combinations</e1> should be <e2>considered</e2> for all patients receiving neoadjuvant chemotherapy .	acts-on(e2,e1)
If the person has severe hypertension , <e1>consider</e1> starting antihypertensive drug <e2>treatment</e2> immediately , without waiting for the results of ABPM or HBPM .	acts-on(e1,e2)
Consider adding intravenous ciclosporin to intravenous corticosteroids or <e1>consider</e1> surgery for <e2>people</e2> who have little or no improvement within 72 hours of starting intravenous corticosteroids or whose symptoms worsen at any time despite corticosteroid treatment .	receiver(e2,e1)
Do not <e1>offer</e1> nitrosoureas <e2>concurrently</e2> with radiotherapy to people with newly diagnosed grade 3 glioma .	modifier(e2,e1)
Consider aminosalicylate treatment for a first presentation or a single inflammatory exacerbation in a 12-month period if conventional glucocorticosteroids are contraindicated , or if the person <e1>declines</e1> or cannot <e2>tolerate</e2> them .	choice
Review intravenous antibiotics by 48 hours and consider stepping down to <e1>oral</e1> <e2>antibiotics</e2> where possible .	modifier(e1,e2)
Do not use synchronised pressure-limited ventilation such as assist control , synchronised intermittent positive pressure ventilation , patient-triggered ventilation , pressure support ventilation or synchronised time-cycled <e1>pressure-limited</e1> <e2>ventilation</e2> .	modifier(e1,e2)
If the person is aged under 80 years with stage 1 hypertension , prescribe metformin and a DPP-4i and support for a target HbA1c <e1>level</e1> of <e2>48</e2> mmol/mol ( 6.5 % ) .	modifier(e2,e1)
A resting ECG should be <e1>performed</e1> in <e2>patients</e2> with suspected cardiac chest pain .	receiver(e2,e1)
<e1>Use</e1> caffeine citrate <e2>routinely</e2> in preterm babies born at or before 30 weeks , starting it as early as possible and ideally before 3 days of age .	modifier(e2,e1)
In patients with permanent AF or persistent AF following a rate control strategy and a resting heart rate > 110 bpm , appropriate rate control therapy should be <e1>instituted</e1> with an initial <e2>target</e2> of resting heart rate .	other
In patients with <e1>suspected</e1> stable <e2>angina</e2> , the exercise tolerance test should not be used routinely as a first line diagnostic tool .	modifier(e1,e2)
<e1>Offer</e1> radical <e2>resection</e2> to people with T1bN0 oesophageal adenocarcinoma if they are fit enough to have surgery .	acts-on(e1,e2)
Give a loading dose of 20 mg/kg of caffeine citrate , <e1>followed</e1> 24 hours later by a maintenance <e2>dosage</e2> of 5 mg/kg once daily , increasing up to 20 mg/kg daily if episodes of apnoea persist .	acts-on(e1,e2)
If the <e1>person</e1> is aged under 80 years with stage 1 hypertension and has diabetes , <e2>offer</e2> antihypertensive drug treatment .	receiver(e1,e2)
BCG vaccination is not <e1>recommended</e1> in <e2>patients</e2> with AIIRD .	receiver(e2,e1)
Second line systemic anticancer <e1>therapy</e1> with single agent <e2>docetaxel</e2> or erlotinib should be considered for patients with performance status 0-2 recurrent NSCLC who have been previously treated with first line SACT for advanced disease .	other
For <e1>people</e1> who cannot <e2>tolerate</e2> aminosalicylates , consider a time-limited course of an oral corticosteroid .	actor-of(e1,e2)
<e1>Consider</e1> oral sodium bicarbonate supplementation for <e2>people</e2> with both a GFR less than 30 ml/min/1.73m2 and a serum bicarbonate concentration of less than 20 mmol/litre .	receiver(e2,e1)
Offer a non-steroidal anti-inflammatory drug by any route as first-line treatment for adults , children and young <e1>people</e1> with suspected renal <e2>colic</e2> .	owner(e1,e2)
Offer radiotherapy using 60 Gy in 30 fractions with concomitant temozolomide for <e1>people</e1> aged around <e2>70</e2> or under .	modifier(e2,e1)
Do not offer platinum-based combination chemotherapy to <e1>obtain</e1> a serum <e2>calcium</e2> for people with extensive-stage disease SCLC if they are fit enough .	acts-on(e1,e2)
If one TNF-inhibitor therapy has failed , patients may receive another TNF-inhibitor or an <e1>agent</e1> with another <e2>mode</e2> of action .	other
Routine <e1>surgery</e1> for limited disease SCLC is not <e2>recommended</e2> .	modifier(e2,e1)
Second line systemic anticancer therapy with single agent docetaxel or <e1>erlotinib</e1> should be <e2>considered</e2> for patients with performance status 0-2 recurrent NSCLC who have been previously treated with first line SACT for advanced disease .	acts-on(e2,e1)
Offer <e1>PET-CT</e1> as the preferred first <e2>test</e2> after CT with a low probability of nodal malignancy , for people with lung cancer who could potentially have treatment with curative intent .	other
<e1>Offer</e1> <e2>bisphosphonates</e2> if indicated for the prevention and treatment of osteoporosis in people with a GFR of 30 ml/min/1.73m2 or more .	acts-on(e1,e2)
In patients with a contraindication to <e1>MTX</e1> , <e2>leflunomide</e2> or sulfasalazine should be considered as part of the treatment strategy .	choice
<e1>Consider</e1> adjuvant <e2>therapy</e2> after surgery for people with invasive breast cancer , and ensure that recommendations are recorded at the multidisciplinary team meeting .	acts-on(e1,e2)
<e1>Start</e1> a trial of a renin-angiotensin system blocking drug as first-line therapy for hypertension in <e2>adults</e2> with type 1 diabetes .	receiver(e2,e1)
Consider alpha blockers for adults , children and <e1>young</e1> <e2>people</e2> with distal ureteric stones less than 10 mm .	modifier(e1,e2)
Consider cinacalcet for <e1>people</e1> with primary <e2>hyperparathyroidism</e2> if surgery has been unsuccessful , is unsuitable or has been declined , and if their albumin-adjusted serum calcium level is either : 2.85 mmol/litre or above with symptoms of hypercalcaemia or 3 mmol/litre or above with or without symptoms of hypercalcaemia .	owner(e1,e2)
Combination intravenous SACT should be <e1>considered</e1> for <e2>patients</e2> with SCLC over 70 years of age with performance status 0-2 .	receiver(e2,e1)
To induce remission in people with a mild-to-moderate first presentation or inflammatory exacerbation of proctitis , <e1>offer</e1> a topical <e2>aminosalicylate</e2> as first-line treatment .	acts-on(e1,e2)
If the person is with <e1>CKD</e1> and <e2>hypertension</e2> and an ACR of 30 mg/mmol or more , offer a low-cost renin-angiotensin-aldosterone system antagonist .	joint
<e1>Women</e1> with platinum sensitive relapsed ovarian <e2>cancer</e2> should be offered treatment with carboplatin combined with either paclitaxel or pegylated liposomal doxorubicin hydrochloride .	owner(e1,e2)
Sotalol therapy is not <e1>recommended</e1> for <e2>patients</e2> following ACS who do not have sustained ventricular arrhythmias or atrial fibrillation .	receiver(e2,e1)
In patients with stable angina requiring percutaneous coronary intervention for in stent restenosis , a drug eluting <e1>balloon</e1> or a second or third generation drug eluting stent should be <e2>considered</e2> .	modifier(e2,e1)
Offer contrast-enhanced brain CT to people with clinical stage 2 NSCLC who are having <e1>treatment</e1> with curative <e2>intent</e2> .	other
Patients with advanced liver disease should be given nutritional <e1>support</e1> to <e2>minimise</e2> malnutrition .	actor-of(e1,e2)
Tricyclic antidepressants should not be <e1>used</e1> for the management of pain in <e2>patients</e2> with chronic low back pain .	receiver(e2,e1)
In patients with a contraindication to MTX , <e1>leflunomide</e1> or <e2>sulfasalazine</e2> should be considered as part of the treatment strategy .	choice
<e1>Advise</e1> pregnant <e2>women</e2> with more than 1 moderate risk factor for pre-eclampsia to take 75-150 mg of aspirin daily from 12 weeks until the birth of the baby .	acts-on(e1,e2)
If clinical evaluation or lung function testing indicates an inadequate response to rhDNase , consider both <e1>rhDNase</e1> and hypertonic sodium <e2>chloride</e2> or hypertonic sodium chloride alone .	joint
If a person is unable to tolerate ABPM , <e1>HBPM</e1> is a suitable alternative to <e2>confirm</e2> the diagnosis of hypertension .	actor-of(e1,e2)
Patients with chronic hepatitis B and C co-infection should be considered for treatment with pegylated IFN and <e1>weight</e1> based <e2>ribavirin</e2> .	modifier(e1,e2)
Blood pressure reduction to <e1>185/110</e1> mmHg or <e2>lower</e2> should be considered in people who are candidates for intravenous thrombolysis .	choice
<e1>Patients</e1> with acute coronary <e2>syndrome</e2> should have continuous cardiac rhythm monitoring .	owner(e1,e2)
Offer either anticoagulants or antiplatelet agents to <e1>people</e1> who <e2>have</e2> stroke secondary to acute arterial dissection .	actor-of(e1,e2)
For people who have had pancreatoduodenectomy and who have a functioning gut , offer early <e1>enteral</e1> <e2>nutrition</e2> rather than parenteral nutrition .	modifier(e1,e2)
Monitor for neutropenia in <e1>people</e1> <e2>taking</e2> azathioprine or mercaptopurine even if they have normal TPMT activity .	actor-of(e1,e2)
Transmyocardial laser revascularisation is not recommended for the treatment of <e1>stable</e1> <e2>angina</e2> .	modifier(e1,e2)
If surgical resection is not appropriate , consider biopsy to obtain a histological and <e1>molecular</e1> <e2>diagnosis</e2> .	modifier(e1,e2)
Keep the requirement for continuing GC treatment under constant review , and <e1>titrate</e1> the <e2>dose</e2> against therapeutic response , risk of undertreatment and development of AEs .	acts-on(e1,e2)
When adequate control of anginal symptoms is not achieved with beta blockade , addition of a calcium channel <e1>blocker</e1> should be <e2>considered</e2> .	acts-on(e2,e1)
In patients with peripheral arthritis and an inadequate response to at least one csDMARD , in whom TNF inhibitors are not appropriate , bDMARDs targeting <e1>IL12/23</e1> or <e2>IL17</e2> pathways may be considered .	choice
Therapy with DMARDs should be started as soon as the <e1>diagnosis</e1> of RA is <e2>made</e2> .	acts-on(e2,e1)
Do not <e1>offer</e1> <e2>azathioprine</e2> or mercaptopurine if TPMT activity is deficient .	acts-on(e1,e2)
Consider measuring anti-CCP antibodies in adults with suspected RA if they are negative for <e1>rheumatoid</e1> <e2>factor</e2> .	modifier(e1,e2)
If the clinic blood pressure is 140/90 mmHg or higher , offer ABPM to confirm the <e1>diagnosis</e1> of <e2>hypertension</e2> .	other
<e1>Maintain</e1> blood <e2>pressure</e2> below 130/80 mmHg by addition of other anti-hypertensive drugs if necessary .	acts-on(e1,e2)
Assess the HER2 <e1>status</e1> of all invasive breast <e2>cancers</e2> using standardised and quality-assured techniques , and report the results quantitatively .	other
Amitriptyline should be <e1>considered</e1> for the <e2>treatment</e2> of patients with fibromyalgia and neuropathic pain .	acts-on(e1,e2)
Patients with CHC who are on a drug treatment programme should be <e1>considered</e1> for <e2>treatment</e2> .	acts-on(e1,e2)
If the person is aged <e1>under</e1> <e2>80</e2> years with stage 1 hypertension and has 10 year cardiovascular risk , offer antihypertensive drug treatment .	modifier(e1,e2)
To induce remission in people with a mild-to-moderate first presentation or inflammatory exacerbation of extensive ulcerative colitis , offer a topical aminosalicylate and a high-dose oral <e1>aminosalicylate</e1> as first-line <e2>treatment</e2> .	other
Verapamil and <e1>diltiazem</e1> may be <e2>used</e2> for prophylaxis of atrial fibrillation following CABG surgery .	acts-on(e2,e1)
Systemic glucocorticoids may be used with caution at the <e1>lowest</e1> effective <e2>dose</e2> .	modifier(e1,e2)
The routine use of <e1>aspirin</e1> to <e2>reduce</e2> perioperative cardiac events in patients undergoing non cardiac surgery , including those with known stable CAD , is not recommended .	actor-of(e1,e2)
Patients with heart failure with <e1>reduced</e1> ejection <e2>fraction</e2> , NYHA class 2-4 , who are intolerant of angiotensin converting enzyme inhibitors should be given an angiotensin receptor blocker .	modifier(e1,e2)
All patients should have appropriate monitoring for clinically <e1>significant</e1> <e2>AEs</e2> .	modifier(e1,e2)
Monitor for neutropenia in people taking azathioprine or mercaptopurine even if they have <e1>normal</e1> TPMT <e2>activity</e2> .	modifier(e1,e2)
All patients with heart failure with reduced ejection fraction , NYHA class 2-4 should be <e1>started</e1> on beta-blocker <e2>therapy</e2> as soon as their condition is stable .	acts-on(e1,e2)
Long term beta-blockers are recommended for <e1>routine</e1> <e2>use</e2> in patients following ACS without contraindications .	modifier(e1,e2)
Offer a mucoactive agent to people with cystic fibrosis who have clinical <e1>evidence</e1> of lung <e2>disease</e2> .	other
Request the oestrogen <e1>receptor</e1> , progesterone <e2>receptor</e2> and human epidermal growth receptor 2 status of all invasive breast cancers simultaneously at the time of initial histopathological diagnosis .	joint
Offer flexible bronchoscopy to <e1>people</e1> with central <e2>lesions</e2> on CT if nodal staging does not influence treatment .	owner(e1,e2)
For patients receiving a protease inhibitor in combination with pegylated IFN and ribavirin therapy , consider ribavirin dose reduction as an alternative to the addition of EPO for <e1>controlling</e1> <e2>anaemia</e2> .	acts-on(e1,e2)
For eligible <e1>people</e1> with stage 3A NSCLC who cannot tolerate or who decline chemoradiotherapy , <e2>consider</e2> radical radiotherapy .	receiver(e1,e2)
Do not routinely use MRI to assess the stage of the primary tumour <e1>(T-stage)</e1> in non-small-cell lung <e2>cancer</e2> .	other
<e1>Offer</e1> a pancreatic protocol CT scan to <e2>people</e2> with pancreatic abnormalities but no jaundice .	receiver(e2,e1)
If remission is not achieved within 4 weeks , consider adding a high-dose <e1>oral</e1> <e2>aminosalicylate</e2> to the topical aminosalicylate or switching to a high-dose oral aminosalicylate and a time-limited course of a topical corticosteroid .	modifier(e1,e2)
Do not <e1>offer</e1> antispasmodics to <e2>adults</e2> , children and young people with suspected renal colic .	receiver(e2,e1)
<e1>Maintain</e1> blood <e2>pressure</e2> below 130/80 mmHg for people with advanced pancreatic cancer .	acts-on(e1,e2)
Offer nutritional assessment and tailored specialist dietetic support to <e1>people</e1> with oesophago-gastric <e2>cancer</e2> before , during and after radical treatments .	owner(e2,e1)
To induce remission in people with a mild-to-moderate first presentation or inflammatory exacerbation of proctosigmoiditis or left-sided ulcerative colitis , <e1>offer</e1> a topical <e2>aminosalicylate</e2> as first-line treatment .	acts-on(e1,e2)
Consider <e1>bisphosphonates</e1> as adjuvant <e2>therapy</e2> for postmenopausal women with node-negative invasive breast cancer and a high risk of recurrence .	other
If the clinic blood <e1>pressure</e1> is <e2>140/90</e2> mmHg or higher , offer ABPM to confirm the diagnosis of hypertension .	modifier(e2,e1)
For people with cystic fibrosis who develop a Haemophilus influenzae infection but do not have clinical evidence of pulmonary infection , <e1>treat</e1> with an appropriate oral <e2>antibiotic</e2> .	acts-on(e1,e2)
<e1>Offer</e1> <e2>PET-CT</e2> as the preferred first test after CT with a low probability of nodal malignancy , for people with lung cancer who could potentially have treatment with curative intent .	acts-on(e1,e2)
Offer a mucoactive agent to people with cystic fibrosis who have <e1>clinical</e1> <e2>evidence</e2> of lung disease .	modifier(e1,e2)
If remission is not achieved within 4 weeks , consider adding a high-dose oral aminosalicylate to the topical aminosalicylate or switching to a high-dose oral <e1>aminosalicylate</e1> and a time-limited <e2>course</e2> of a topical corticosteroid .	joint
Antihypertensives and <e1>statins</e1> may be <e2>used</e2> as in the general population .	acts-on(e2,e1)
If <e1>surgical</e1> <e2>resection</e2> is not appropriate , consider biopsy to obtain a histological and molecular diagnosis .	modifier(e1,e2)
Patients and the patients' treatment teams should receive appropriate , practical <e1>advice</e1> on how to <e2>manage</e2> with GC-induced hypothalamic-pituitary-adrenal axis suppression .	acts-on(e1,e2)
To induce remission in people with a mild-to-moderate first presentation or inflammatory exacerbation of extensive ulcerative colitis , <e1>offer</e1> a topical <e2>aminosalicylate</e2> and a high-dose oral aminosalicylate as first-line treatment .	acts-on(e1,e2)
23-valent polysaccharide pneumococcal vaccination (23-PPV) should be strongly considered for <e1>patients</e1> with <e2>AIIRD</e2> .	owner(e1,e2)
For <e1>people</e1> who are at low risk of developing a diabetic foot problem , <e2>continue</e2> to carry out annual foot assessments .	receiver(e1,e2)
For people with an acute cough who are identified at a face-to-face clinical examination as at higher risk of complications , consider an <e1>immediate</e1> antibiotic <e2>prescription</e2> or a back-up antibiotic prescription .	modifier(e1,e2)
The vaccination <e1>status</e1> should be <e2>assessed</e2> in the initial work-up of patients with AIIRD .	acts-on(e2,e1)
For prolonged treatment , the glucocorticoid dosage should be kept to a minimum and a glucocorticoid <e1>taper</e1> should be <e2>attempted</e2> in case of remission or low disease activity .	acts-on(e2,e1)
In patients with active enthesitis and/or dactylitis and <e1>insufficient</e1> <e2>response</e2> to NSAIDs or local glucocorticoid injections , therapy with a bDMARD should be considered , which according to current practice is a TNF inhibitor .	modifier(e1,e2)
If CT <e1>shows</e1> suspected brain <e2>metastases</e2> , offer contrast-enhanced brain MRI .	acts-on(e1,e2)
Select the appropriate starting dose to achieve therapeutic response , taking into account the <e1>risk</e1> of <e2>undertreatment</e2> .	other
To induce remission in people with a mild-to-moderate first presentation or inflammatory exacerbation of proctosigmoiditis or <e1>left-sided</e1> ulcerative <e2>colitis</e2> , offer a topical aminosalicylate as first-line treatment .	modifier(e1,e2)
Exclude hypoglycaemia in people with <e1>sudden</e1> <e2>onset</e2> of neurological symptoms as the cause of these symptoms .	modifier(e1,e2)
<e1>Offer</e1> antihypertensive drug <e2>treatment</e2> for an annual vaccination against influenza .	acts-on(e1,e2)
Patients who are unfit for combination therapy should be offered single <e1>agent</e1> <e2>carboplatin</e2> .	modifier(e1,e2)
In patients with suspected stable angina , the exercise tolerance test should not be used routinely as a <e1>first</e1> line diagnostic <e2>tool</e2> .	modifier(e1,e2)
Offer contrast-enhanced brain MRI for <e1>people</e1> with stage 3 NSCLC who are <e2>having</e2> treatment with curative intent .	actor-of(e1,e2)
Do not routinely <e1>offer</e1> an antibiotic to treat an acute cough associated with acute bronchitis in <e2>people</e2> who are not systemically very unwell or at higher risk of complications .	receiver(e2,e1)
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider dual therapy with a DPP-4i and pioglitazone , a <e1>DPP-4i</e1> and an <e2>SU</e2> , pioglitazone and an SU , and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	joint
Provide an accessible resource to promote best practice in the management of patients <e1>using</e1> medium/high-dose <e2>GCs</e2> to general practitioners .	acts-on(e1,e2)
Consider prostaglandin E1 as an option for treating postpartum haemorrhage in women with asthma because there is no evidence <e1>it</e1> <e2>worsens</e2> asthma .	actor-of(e1,e2)
Consider thoracic <e1>radiotherapy</e1> with prophylactic cranial <e2>irradiation</e2> for people with extensive-stage disease SCLC .	other
If liver function blood <e1>tests</e1> are <e2>abnormal</e2> , perform a liver ultrasound scan and consider ursodeoxycholic acid treatment .	modifier(e2,e1)
<e1>Patients</e1> with genotype 1 <e2>infection</e2> should be tested for an EVR at 12 weeks .	owner(e1,e2)
In patients with peripheral arthritis and an inadequate response to at least one csDMARD , <e1>therapy</e1> with a <e2>bDMARD</e2> , usually a TNF inhibitor , should be commenced .	other
Aim for a target clinic blood pressure below 140/90 mmHg in people aged under 80 years with <e1>treated</e1> <e2>hypertension</e2> .	modifier(e1,e2)
If a <e1>bDMARD</e1> or <e2>tsDMARD</e2> has failed , treatment with another bDMARD or a tsDMARD should be considered .	choice
Consider aminosalicylate treatment for a first presentation or a single inflammatory exacerbation in a 12-month period if conventional <e1>glucocorticosteroids</e1> are <e2>contraindicated</e2> , or if the person declines or cannot tolerate them .	modifier(e2,e1)
Consider adding azathioprine or mercaptopurine to a conventional <e1>glucocorticosteroid</e1> or <e2>budesonide</e2> to induce remission of Crohn's disease if there are 2 or more inflammatory exacerbations in a 12 month period or the glucocorticosteroid dose cannot be tapered .	choice
Patients undergoing surgical revascularisation of the left <e1>anterior</e1> descending coronary <e2>artery</e2> should receive an internal mammary artery graft .	modifier(e1,e2)
<e1>Start</e1> ACE inhibitor <e2>therapy</e2> at a low dose and titrate upwards at short intervals until the target or maximum tolerated dose is reached .	acts-on(e1,e2)
Women with platinum resistant ovarian cancer should be considered for treatment with paclitaxel or single <e1>agent</e1> pegylated liposomal doxorubicin <e2>hydrochloride</e2> .	modifier(e1,e2)
If remission is not achieved within 4 weeks , consider adding a high-dose oral aminosalicylate to the <e1>topical</e1> <e2>aminosalicylate</e2> or switching to a high-dose oral aminosalicylate and a time-limited course of a topical corticosteroid .	modifier(e1,e2)
Measure parathyroid hormone for <e1>people</e1> whose albumin-adjusted serum calcium <e2>level</e2> is either 2.6 mmol/litre or above on at least 2 separate occasions or 2.5 mmol/litre or above on at least 2 separate occasions and primary hyperparathyroidism is suspected .	owner(e1,e2)
If a person is unable to <e1>tolerate</e1> <e2>ABPM</e2> , HBPM is a suitable alternative to confirm the diagnosis of hypertension .	acts-on(e1,e2)
TC and HDLc should be <e1>used</e1> in CVD risk <e2>assessment</e2> in RA , AS and PsA and lipids should ideally be measured when disease activity is stable or in remission .	other
A combination of <e1>digoxin</e1> with either a <e2>beta-blocker</e2> or diltiazem should be considered to control heart rate in patients with atrial fibrillation .	other
Adjuvant chemotherapy should be considered for all <e1>patients</e1> with breast cancer where <e2>benefit</e2> outweighs risk .	other
MRI of the SI joints and/or the spine may be used to <e1>assess</e1> and <e2>monitor</e2> disease activity in axial SpA , providing additional information on top of clinical and biochemical assessments .	joint
If the <e1>person</e1> is with CKD and hypertension and an ACR of 30 mg/mmol or more , <e2>offer</e2> a low-cost renin-angiotensin-aldosterone system antagonist .	receiver(e1,e2)
In patients with ankylosing spondylitis , initial conventional radiography of the <e1>lumbar</e1> and cervical <e2>spine</e2> is recommended to detect syndesmophytes , which are predictive of development of new syndesmophytes .	joint
<e1>Consider</e1> alpha blockers for <e2>adults</e2> , children and young people with distal ureteric stones less than 10 mm .	receiver(e2,e1)
<e1>Offer</e1> monotherapy with a conventional glucocorticosteroid to induce remission in <e2>people</e2> with a first presentation or a single inflammatory exacerbation of Crohn's disease in a 12-month period .	receiver(e2,e1)
Advise pregnant women at high risk of pre-eclampsia to <e1>take</e1> 75-150 mg of <e2>aspirin</e2> daily from 12 weeks until the birth of the baby .	acts-on(e1,e2)
For patients receiving a protease inhibitor in combination with pegylated IFN and ribavirin therapy , consider ribavirin dose <e1>reduction</e1> as an <e2>alternative</e2> to the addition of EPO for controlling anaemia .	other
Review antibiotic treatment after 14 days and either <e1>stop</e1> the antibiotic or <e2>continue</e2> for a further 14 days if needed , based on an assessment of the person's history , symptoms , clinical examination , urine and blood tests .	choice
Offer flexible bronchoscopy to people with central lesions on CT if nodal <e1>staging</e1> does not <e2>influence</e2> treatment .	actor-of(e1,e2)
MRI may also be used to <e1>predict</e1> <e2>development</e2> of new radiographic syndesmophytes .	acts-on(e1,e2)
<e1>Offer</e1> staging laparoscopy to all <e2>people</e2> with potentially curable gastric cancer .	receiver(e2,e1)
Offer contrast-enhanced brain CT to people with clinical stage 2 NSCLC who are having treatment with <e1>curative</e1> <e2>intent</e2> .	modifier(e1,e2)
<e1>Use</e1> an automated reagent-strip reading device for dipstick screening for proteinuria in pregnant <e2>women</e2> in secondary care settings .	receiver(e2,e1)
In <e1>patients</e1> with a <e2>contraindication</e2> to MTX , leflunomide or sulfasalazine should be considered as part of the treatment strategy .	owner(e1,e2)
Offer an ACE inhibitor and a beta-blocker licensed for heart failure to people who have heart <e1>failure</e1> with reduced ejection <e2>fraction</e2> .	other
<e1>Consider</e1> budesonide for a first presentation or a single inflammatory exacerbation in a 12-month period for <e2>people</e2> who have one or more of distal ileal , ileocaecal or right-sided colonic disease and if conventional glucocorticosteroids are contraindicated , or if the person declines or cannot tolerate them .	receiver(e2,e1)
Patients with <e1>compensated</e1> <e2>cirrhosis</e2> should be considered for therapy , unless contraindicated .	modifier(e1,e2)
Offer an alternative antiplatelet agent to anyone with acute ischaemic stroke who is <e1>allergic</e1> to or genuinely <e2>intolerant</e2> of aspirin .	other
Consider an ARB licensed for heart failure as an alternative to an ACE inhibitor for people who have heart <e1>failure</e1> with reduced ejection <e2>fraction</e2> and intolerable side effects with ACE inhibitors .	other
To induce remission in people with a mild-to-moderate <e1>first</e1> <e2>presentation</e2> or inflammatory exacerbation of extensive ulcerative colitis , offer a topical aminosalicylate and a high-dose oral aminosalicylate as first-line treatment .	modifier(e1,e2)
If the person is aged under 80 years with stage 1 hypertension , <e1>prescribe</e1> <e2>metformin</e2> and a DPP-4i and support for a target HbA1c level of 48 mmol/mol ( 6.5 % ) .	acts-on(e1,e2)
Avoid verapamil , diltiazem and short-acting dihydropyridine agents in people who <e1>have</e1> heart <e2>failure</e2> with reduced ejection fraction .	acts-on(e1,e2)
Offer nutritional assessment and tailored <e1>specialist</e1> dietetic <e2>support</e2> to people with oesophago-gastric cancer before , during and after radical treatments .	modifier(e1,e2)
Do not offer cinacalcet to <e1>pregnant</e1> <e2>women</e2> with primary hyperparathyroidism .	modifier(e1,e2)
If the <e1>person</e1> is with CKD and beta-blocker , <e2>consider</e2> starting antihypertensive drug .	receiver(e1,e2)
<e1>Patients</e1> and the patients' treatment <e2>teams</e2> should receive appropriate , practical advice on how to manage with GC-induced hypothalamic-pituitary-adrenal axis suppression .	joint
Consider a maintenance dosage higher than 20 mg/kg daily if therapeutic efficacy is not achieved , while <e1>ensuring</e1> that a safe plasma <e2>level</e2> is maintained .	acts-on(e1,e2)
To <e1>induce</e1> remission in <e2>people</e2> with a mild-to-moderate first presentation or inflammatory exacerbation of proctosigmoiditis or left-sided ulcerative colitis , offer a topical aminosalicylate as first-line treatment .	receiver(e2,e1)
To induce remission in <e1>people</e1> with a mild-to-moderate first presentation or inflammatory exacerbation of proctitis , <e2>offer</e2> a topical aminosalicylate as first-line treatment .	receiver(e1,e2)
Consider dual therapy with ACE inhibitor and metformin if the person is aged <e1>under</e1> 80 <e2>years</e2> .	modifier(e1,e2)
For people who have had pancreatoduodenectomy and who have a <e1>functioning</e1> <e2>gut</e2> , offer early enteral nutrition rather than parenteral nutrition .	modifier(e1,e2)
If the person is with CKD and beta-blocker , <e1>consider</e1> starting antihypertensive <e2>drug</e2> .	acts-on(e1,e2)
To induce remission in people with a mild-to-moderate first presentation or inflammatory exacerbation of proctitis , offer a topical aminosalicylate as <e1>first-line</e1> <e2>treatment</e2> .	modifier(e1,e2)
In patients with peripheral arthritis and an inadequate response to at least one csDMARD , in whom bDMARDs are not appropriate , a <e1>targeted</e1> synthetic <e2>DMARD</e2> such as a PDE4-inhibitor may be considered .	modifier(e1,e2)
Second <e1>line</e1> systemic anticancer <e2>therapy</e2> with single agent docetaxel or erlotinib should be considered for patients with performance status 0-2 recurrent NSCLC who have been previously treated with first line SACT for advanced disease .	modifier(e1,e2)
Do not offer pre-treatment stenting to adults <e1>having</e1> shockwave <e2>lithotripsy</e2> for ureteric or renal stones .	acts-on(e1,e2)
When peripheral SpA is suspected , US or MRI may be used to detect <e1>peripheral</e1> <e2>enthesitis</e2> , which may support the diagnosis of SpA .	modifier(e1,e2)
If a patient is in persistent remission after <e1>having</e1> tapered <e2>GC</e2> , one can consider tapering bDMARDs , especially if this treatment is combined with a csDMARD .	acts-on(e1,e2)
Consider aminosalicylate treatment for a first presentation or a single inflammatory exacerbation in a 12-month period if conventional glucocorticosteroids are contraindicated , or if the <e1>person</e1> <e2>declines</e2> or cannot tolerate them .	actor-of(e1,e2)
If conventional radiography is negative , <e1>CT</e1> should be <e2>performed</e2> .	modifier(e2,e1)
Calcium channel blocker <e1>therapy</e1> is not <e2>recommended</e2> for reduction in sudden death or all cause mortality in patients following ACS .	modifier(e2,e1)
<e1>Offer</e1> staging <e2>laparoscopy</e2> to all people with potentially curable gastric cancer .	acts-on(e1,e2)
Long term beta-blockers are <e1>recommended</e1> for routine use in <e2>patients</e2> following ACS without contraindications .	receiver(e2,e1)
Sublingual glyceryl trinitrate tablets or spray should be used for the <e1>immediate</e1> <e2>relief</e2> of angina and before performing activities that are known to bring on angina .	modifier(e1,e2)
Maintain blood pressure below 140/90 mmHg for <e1>people</e1> who <e2>have</e2> symptoms of stage 1 hypertension .	actor-of(e1,e2)
MRI of the SI joints and/or the spine may be used to assess and monitor disease activity in <e1>axial</e1> <e2>SpA</e2> , providing additional information on top of clinical and biochemical assessments .	modifier(e1,e2)
Consider measuring anti-CCP antibodies in adults with <e1>suspected</e1> <e2>RA</e2> if they are negative for rheumatoid factor .	modifier(e1,e2)
Patients and the patients' treatment teams should <e1>receive</e1> appropriate , practical <e2>advice</e2> on how to manage with GC-induced hypothalamic-pituitary-adrenal axis suppression .	acts-on(e1,e2)
If the treatment <e1>target</e1> is not <e2>achieved</e2> with the first csDMARD strategy , when poor prognostic factors are present , addition of a bDMARD or a tsDMARD should be considered .	acts-on(e2,e1)
Consider cinacalcet for people with primary hyperparathyroidism if surgery has been unsuccessful , is <e1>unsuitable</e1> or has been <e2>declined</e2> , and if their albumin-adjusted serum calcium level is either : 2.85 mmol/litre or above with symptoms of hypercalcaemia or 3 mmol/litre or above with or without symptoms of hypercalcaemia .	choice
In patients who fail to respond adequately to a bDMARD , <e1>switching</e1> to another bDMARD should be <e2>considered</e2> , including switching between TNF inhibitors .	modifier(e2,e1)
Do not <e1>offer</e1> an antibiotic to <e2>treat</e2> an acute cough associated with an upper respiratory tract infection in people who are not systemically very unwell or at higher risk of complications .	other
CVD risk estimation for patients with RA , AS or PsA should be performed according to national guidelines and the SCORE CVD risk prediction <e1>model</e1> should be <e2>used</e2> if no national guideline is available .	modifier(e2,e1)
If CT shows <e1>suspected</e1> brain <e2>metastases</e2> , offer contrast-enhanced brain MRI .	modifier(e1,e2)
Offer PET-CT as the preferred first test after CT with a low probability of nodal malignancy , for people with lung cancer who could potentially <e1>have</e1> <e2>treatment</e2> with curative intent .	acts-on(e1,e2)
Before starting medium/high-dose GC treatment , <e1>consider</e1> comorbidities <e2>predisposing</e2> to AEs .	acts-on(e1,e2)
If one TNF-inhibitor therapy has failed , patients may receive another <e1>TNF-inhibitor</e1> or an <e2>agent</e2> with another mode of action .	choice
Do not offer an antibiotic to treat an acute cough associated with an upper respiratory tract infection in people who are not systemically very unwell or at higher <e1>risk</e1> of <e2>complications</e2> .	other
A resting ECG should be performed in <e1>patients</e1> with suspected cardiac chest <e2>pain</e2> .	owner(e1,e2)
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider dual therapy with metformin and a DPP-4i , metformin and pioglitazone , metformin and an SU , <e1>metformin</e1> and an <e2>SGLT-2i</e2> , and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	joint
Local injections of glucocorticoids should be considered as <e1>adjunctive</e1> <e2>therapy</e2> in PsA .	modifier(e1,e2)
For people who have had pancreatoduodenectomy and who have a functioning gut , <e1>offer</e1> early enteral <e2>nutrition</e2> rather than parenteral nutrition .	acts-on(e1,e2)
If the person is aged under 80 years with stage 1 hypertension and has established cardiovascular disease , offer <e1>antihypertensive</e1> drug <e2>treatment</e2> .	modifier(e1,e2)
If the <e1>person</e1> is symptomatically <e2>hyperglycaemic</e2> , offer antispasmodics to have HbA1c level of 53 mmol/mol ( 7.5 % ) .	modifier(e2,e1)
In case of major and/or contaminated <e1>wounds</e1> in <e2>patients</e2> who received rituximab within the last 24 weeks , passive immunisation with tetanus immunoglobulins should be administered .	owner(e2,e1)
Do not use anticoagulation <e1>treatment</e1> routinely for the <e2>treatment</e2> of acute stroke .	other
If remission is not achieved within 4 weeks , consider adding a high-dose oral aminosalicylate to the topical aminosalicylate or switching to a high-dose oral aminosalicylate and a time-limited <e1>course</e1> of a topical <e2>corticosteroid</e2> .	other
Women with platinum resistant ovarian cancer should be <e1>considered</e1> for <e2>treatment</e2> with paclitaxel or single agent pegylated liposomal doxorubicin hydrochloride .	acts-on(e1,e2)
All patients co-infected with <e1>HIV</e1> and <e2>HCV</e2> genotype 1 should be considered for treatment with a regimen which includes an HCV protease inhibitor .	joint
US and <e1>MRI</e1> may be <e2>used</e2> to monitor disease activity in peripheral SpA , providing additional information on top of clinical and biochemical assessments .	acts-on(e2,e1)
Duloxetine should be considered for the treatment of patients with diabetic neuropathic pain if other first or <e1>second</e1> line pharmacological <e2>therapies</e2> have failed .	modifier(e1,e2)
If remission is not achieved within 4 weeks , <e1>consider</e1> adding a high-dose oral <e2>aminosalicylate</e2> to the topical aminosalicylate or switching to a high-dose oral aminosalicylate and a time-limited course of a topical corticosteroid .	acts-on(e1,e2)
Patients with AIIRD who plan to travel are recommended to receive their vaccinations according to general rules , except for live <e1>attenuated</e1> <e2>vaccines</e2> which should be avoided whenever possible in immunosuppressed patients with AIIRD .	modifier(e1,e2)
In patients with axial SpA without syndesmophytes in the lumbar <e1>spine</e1> on conventional <e2>radiography</e2> , osteoporosis should be assessed by hip DXA and AP-spine DXA .	other
Amiodarone therapy is not recommended for patients <e1>following</e1> <e2>ACS</e2> or patients with congestive heart failure who do not have sustained ventricular arrhythmias or atrial fibrillation .	acts-on(e1,e2)
Consider aminosalicylate treatment for a first presentation or a single <e1>inflammatory</e1> <e2>exacerbation</e2> in a 12-month period if conventional glucocorticosteroids are contraindicated , or if the person declines or cannot tolerate them .	modifier(e1,e2)
Second line systemic anticancer therapy with single agent <e1>docetaxel</e1> or <e2>erlotinib</e2> should be considered for patients with performance status 0-2 recurrent NSCLC who have been previously treated with first line SACT for advanced disease .	choice
<e1>Consider</e1> enteric-coated <e2>pancreatin</e2> before and after pancreatic cancer resection .	acts-on(e1,e2)
Offer intravenous paracetamol to adults , children and young people with <e1>suspected</e1> renal <e2>colic</e2> if NSAIDs are contraindicated or are not giving sufficient pain relief .	modifier(e1,e2)
Carbamazepine should be <e1>considered</e1> for the <e2>treatment</e2> of patients with neuropathic pain .	other
For women with a cerebrovascular malformation at low risk of intracranial bleeding , manage the second stage of labour based on the woman's preference and <e1>obstetric</e1> <e2>indications</e2> .	modifier(e1,e2)
Hepatitis A and/or B vaccination is only <e1>recommended</e1> in <e2>patients</e2> with AIIRD at risk .	receiver(e2,e1)
If <e1>cytological</e1> or <e2>histological</e2> samples are needed , offer EUS with EUS-guided tissue sampling .	choice
Give oral antibiotics first line if the person can <e1>take</e1> oral <e2>medicines</e2> , and the severity of their condition does not require intravenous antibiotics .	acts-on(e1,e2)
Niraparib monotherapy should be <e1>considered</e1> for maintenance <e2>treatment</e2> after response to platinum for patients with relapsed platinum sensitive non germline BRCA mutated ovarian cancer .	other
In <e1>patients</e1> with peripheral <e2>arthritis</e2> , particularly in those with many swollen joints , structural damage in the presence of inflammation , high ESR/CRP and/or clinically relevant extra-articular manifestations , csDMARDs should be considered at an early stage , with methotrexate preferred in those with relevant skin involvement .	owner(e1,e2)
For people who are at low risk of developing a diabetic foot problem , continue to carry out <e1>annual</e1> foot <e2>assessments</e2> .	modifier(e1,e2)
Class 1 antiarrhythmic drugs should not be used for treatment of premature ventricular beats or non <e1>sustained</e1> <e2>VT</e2> in patients with previous MI .	modifier(e1,e2)
<e1>Offer</e1> standard structural <e2>MRI</e2> as the initial diagnostic test for suspected glioma , unless MRI is contraindicated .	acts-on(e1,e2)
In general , STIR <e1>sequences</e1> are sufficient to <e2>detect</e2> inflammation and the use of contrast medium is not needed .	actor-of(e1,e2)
Do not offer dedicated brain imaging to people with clinical stage 1 NSCLC who have no neurological symptoms and are <e1>having</e1> <e2>treatment</e2> with curative intent .	acts-on(e1,e2)
Consider budesonide for a first presentation or a single inflammatory exacerbation in a 12-month period for people who have one or more of distal <e1>ileal</e1> , <e2>ileocaecal</e2> or right-sided colonic disease and if conventional glucocorticosteroids are contraindicated , or if the person declines or cannot tolerate them .	choice
Offer standard structural <e1>MRI</e1> as the initial diagnostic <e2>test</e2> for suspected glioma , unless MRI is contraindicated .	other
Antihypertensives and statins may be <e1>used</e1> as in the general <e2>population</e2> .	other
For preterm babies who need invasive ventilation but VTV and HFOV are not <e1>available</e1> or not <e2>suitable</e2> , consider synchronised intermittent mandatory ventilation .	choice
<e1>Maintain</e1> blood pressure below 130/80 mmHg or lower for <e2>people</e2> who have heart failure with stage 2 diabetes .	receiver(e2,e1)
Treatment should be aimed at reaching the target of remission or , alternatively , minimal/low disease activity , by regular <e1>monitoring</e1> and appropriate <e2>adjustment</e2> of therapy .	joint
For preterm babies who need invasive ventilation but VTV and <e1>HFOV</e1> are not <e2>available</e2> or not suitable , consider synchronised intermittent mandatory ventilation .	modifier(e1,e2)
In patients with peripheral arthritis , particularly in those with many <e1>swollen</e1> <e2>joints</e2> , structural damage in the presence of inflammation , high ESR/CRP and/or clinically relevant extra-articular manifestations , csDMARDs should be considered at an early stage , with methotrexate preferred in those with relevant skin involvement .	modifier(e1,e2)
If SABR is contraindicated , offer either conventional or <e1>hyperfractionated</e1> <e2>radiotherapy</e2> .	modifier(e1,e2)
<e1>Offer</e1> urgent low-dose non-contrast <e2>CT</e2> to adults with suspected renal colic .	acts-on(e1,e2)
If HbA1c <e1>rises</e1> to <e2>58</e2> mmol/mol ( 7.5 % ) , consider dual therapy with metformin and a DPP-4i , metformin and pioglitazone , metformin and an SU , metformin and an SGLT-2i , and support the person to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	modifier(e2,e1)
<e1>Request</e1> the oestrogen <e2>receptor</e2> , progesterone receptor and human epidermal growth receptor 2 status of all invasive breast cancers simultaneously at the time of initial histopathological diagnosis .	acts-on(e1,e2)
Offer metformin as the initial drug treatment for <e1>adults</e1> with type 2 <e2>diabetes</e2> .	owner(e1,e2)
Consider a bisphosphonate to <e1>reduce</e1> fracture <e2>risk</e2> for people with primary hyperparathyroidism and increased fracture risk .	acts-on(e1,e2)
In patients with <e1>peripheral</e1> <e2>arthritis</e2> and an inadequate response to at least one csDMARD , in whom TNF inhibitors are not appropriate , bDMARDs targeting IL12/23 or IL17 pathways may be considered .	modifier(e1,e2)
Consider endocrine therapy after breast-conserving surgery for women with ER-positive DCIS if <e1>radiotherapy</e1> is not <e2>recommended</e2> .	modifier(e2,e1)
If a patient is in persistent remission after having tapered GC , one can <e1>consider</e1> tapering <e2>bDMARDs</e2> , especially if this treatment is combined with a csDMARD .	acts-on(e1,e2)
If the <e1>person</e1> is aged under 80 <e2>years</e2> with stage 1 hypertension and has diabetes , offer antihypertensive drug treatment .	modifier(e2,e1)
Where appropriate , functional tests , including the exercise tolerance test , should be considered to aid in the risk stratification of patients with <e1>known</e1> <e2>CAD</e2> .	modifier(e1,e2)
Hepatitis A and/or B <e1>vaccination</e1> is only <e2>recommended</e2> in patients with AIIRD at risk .	acts-on(e2,e1)
Offer a non-steroidal anti-inflammatory drug by any route as first-line treatment for adults , children and <e1>young</e1> <e2>people</e2> with suspected renal colic .	modifier(e1,e2)
<e1>Consider</e1> a <e2>bisphosphonate</e2> to reduce fracture risk for people with primary hyperparathyroidism and increased fracture risk .	acts-on(e1,e2)
Class 1 antiarrhythmic drugs should not be used for treatment of <e1>premature</e1> ventricular <e2>beats</e2> or non sustained VT in patients with previous MI .	modifier(e1,e2)
For prolonged treatment , the glucocorticoid <e1>dosage</e1> should be kept to a minimum and a glucocorticoid <e2>taper</e2> should be attempted in case of remission or low disease activity .	joint
Patients with chronic hepatitis B and C co-infection should be <e1>considered</e1> for <e2>treatment</e2> with pegylated IFN and weight based ribavirin .	acts-on(e1,e2)
If remission is not achieved within 4 weeks , consider adding a high-dose oral aminosalicylate to the topical aminosalicylate or switching to a high-dose oral aminosalicylate and a <e1>time-limited</e1> <e2>course</e2> of a topical corticosteroid .	modifier(e1,e2)
Measure parathyroid hormone for people whose albumin-adjusted serum calcium level is either 2.6 mmol/litre or above on at least 2 separate occasions or 2.5 mmol/litre or above on at least 2 separate occasions and primary <e1>hyperparathyroidism</e1> is <e2>suspected</e2> .	modifier(e2,e1)
Do not offer antihypertensive drug treatment if the <e1>person</e1> is with type 1 <e2>diabetes</e2> .	owner(e1,e2)
For patients receiving a protease inhibitor in combination with pegylated IFN and ribavirin therapy , <e1>consider</e1> ribavirin dose <e2>reduction</e2> as an alternative to the addition of EPO for controlling anaemia .	acts-on(e1,e2)
Do not routinely offer an antibiotic to <e1>treat</e1> an acute <e2>cough</e2> associated with acute bronchitis in people who are not systemically very unwell or at higher risk of complications .	acts-on(e1,e2)
In patients with peripheral arthritis , particularly in those with many swollen joints , structural damage in the presence of inflammation , high ESR/CRP and/or clinically <e1>relevant</e1> extra-articular <e2>manifestations</e2> , csDMARDs should be considered at an early stage , with methotrexate preferred in those with relevant skin involvement .	modifier(e1,e2)
<e1>Offer</e1> either anticoagulants or antiplatelet agents to <e2>people</e2> who have stroke secondary to acute arterial dissection .	receiver(e2,e1)
<e1>Keep</e1> the <e2>requirement</e2> for continuing GC treatment under constant review , and titrate the dose against therapeutic response , risk of undertreatment and development of AEs .	acts-on(e1,e2)
Offer either anticoagulants or antiplatelet agents to people who <e1>have</e1> <e2>stroke</e2> secondary to acute arterial dissection .	acts-on(e1,e2)
In patients with axial <e1>SpA</e1> without <e2>syndesmophytes</e2> in the lumbar spine on conventional radiography , osteoporosis should be assessed by hip DXA and AP-spine DXA .	other
Do not routinely offer an antibiotic to treat an <e1>acute</e1> <e2>cough</e2> associated with acute bronchitis in people who are not systemically very unwell or at higher risk of complications .	modifier(e1,e2)
All <e1>patients</e1> <e2>co-infected</e2> with HCV and HIV should be considered for HCV treatment .	modifier(e2,e1)
<e1>Consider</e1> insulin regimen if the <e2>person</e2> is pregnant .	receiver(e2,e1)
Offer antihypertensive drug treatment for heart failure with <e1>treated</e1> <e2>hypertension</e2> .	modifier(e1,e2)
In <e1>patients</e1> undergoing multiple coronary artery bypass grafting , <e2>use</e2> of both internal mammary arteries should be considered .	receiver(e1,e2)
Do not offer azathioprine or mercaptopurine if TPMT <e1>activity</e1> is <e2>deficient</e2> .	modifier(e2,e1)
Routine <e1>surgery</e1> for limited <e2>disease</e2> SCLC is not recommended .	other
If the <e1>person</e1> is with <e2>CKD</e2> and diabetes and an ACR of 3 mg/mmol or more , offer a low-cost renin-angiotensin-aldosterone system antagonist .	owner(e1,e2)
Offer systemic combination chemotherapy to <e1>people</e1> with locally advanced pancreatic cancer who are well enough to <e2>tolerate</e2> it .	actor-of(e1,e2)
<e1>Interpret</e1> proteinuria <e2>measurements</e2> for pregnant women in the context of a full clinical review of symptoms , signs and other investigations for pre-eclampsia .	acts-on(e1,e2)
<e1>Digoxin</e1> should not be <e2>used</e2> for prophylaxis of atrial fibrillation following CABG surgery .	modifier(e2,e1)
<e1>Offer</e1> flexible <e2>bronchoscopy</e2> to people with central lesions on CT if nodal staging does not influence treatment .	acts-on(e1,e2)
If liver function blood tests are abnormal , <e1>perform</e1> a liver ultrasound scan and <e2>consider</e2> ursodeoxycholic acid treatment .	joint
If the person is aged under 80 years with stage 1 hypertension and <e1>has</e1> target organ <e2>damage</e2> , offer antihypertensive drug treatment .	acts-on(e1,e2)
If HbA1c <e1>rises</e1> to 48 mmol/mol ( 6.5 % ) on lifestyle <e2>interventions</e2> , offer metformin and support the person to aim for an HbA1c level of 48 mmol/mol ( 6.5 % ) .	modifier(e2,e1)
If HbA1c rises to 58 mmol/mol ( 7.5 % ) , consider insulin-based treatment and <e1>support</e1> the <e2>person</e2> to aim for an HbA1c level of 53 mmol/mol ( 7 % ) .	acts-on(e1,e2)
<e1>Patients</e1> with left main stem <e2>stenosis</e2> and/or multivessel disease should be considered for revascularisation to improve prognosis .	owner(e1,e2)
<e1>Consider</e1> measuring albumin-adjusted serum calcium for <e2>people</e2> with chronic non-differentiated symptoms .	receiver(e2,e1)
<e1>MRI</e1> of the SI joints and/or the spine may be <e2>used</e2> to assess and monitor disease activity in axial SpA , providing additional information on top of clinical and biochemical assessments .	modifier(e2,e1)
Offer bisphosphonates if indicated for the prevention and <e1>treatment</e1> of <e2>osteoporosis</e2> in people with a GFR of 30 ml/min/1.73m2 or more .	other
Offer platinum-based combination chemotherapy to people with extensive-stage disease SCLC if <e1>they</e1> are fit <e2>enough</e2> .	modifier(e2,e1)
<e1>Maintain</e1> a blood glucose concentration between 4 and 11 mmol/litre in <e2>people</e2> with acute stroke .	receiver(e2,e1)
Extensive MRI inflammatory <e1>activity</e1> , particularly in the spine in patients with ankylosing spondylitis , might be <e2>used</e2> as a predictor of good clinical response to anti-TNF-alpha treatment in axial SpA .	acts-on(e2,e1)
Sotalol therapy is not recommended for <e1>patients</e1> following ACS who do not <e2>have</e2> sustained ventricular arrhythmias or atrial fibrillation .	actor-of(e1,e2)
The routine use of aspirin to <e1>reduce</e1> perioperative cardiac events in <e2>patients</e2> undergoing non cardiac surgery , including those with known stable CAD , is not recommended .	receiver(e2,e1)
Carboplatin <e1>AUC</e1> 6 and <e2>paclitaxel</e2> 80 mg/m2 may be considered for the treatment of first line ovarian cancer .	joint
All patients with chronic HCV infection should be <e1>considered</e1> for antiviral <e2>therapy</e2> .	acts-on(e1,e2)
If ACE inhibitors are not tolerated , <e1>substitute</e1> angiotensin 2 receptor <e2>antagonists</e2> .	acts-on(e1,e2)
Routine initiation of <e1>perioperative</e1> beta-blocker <e2>therapy</e2> to reduce perioperative myocardial infarction in patients undergoing non cardiac surgery is not recommended .	modifier(e1,e2)
<e1>Adjuvant</e1> <e2>trastuzumab</e2> should be considered in all patients with HER 2 positive breast cancer who receive adjuvant chemotherapy .	modifier(e1,e2)
<e1>Conventional</e1> <e2>radiography</e2> of the SI joints and/or spine may be used for long-term monitoring of structural damage , particularly new bone formation , in axial SpA .	modifier(e1,e2)
Erythropoietin is not recommended for patients with heart failure with reduced ejection <e1>fraction</e1> and iron <e2>deficiency</e2> .	joint
Extensive MRI inflammatory activity , particularly in the spine in <e1>patients</e1> with ankylosing <e2>spondylitis</e2> , might be used as a predictor of good clinical response to anti-TNF-alpha treatment in axial SpA .	owner(e1,e2)
MRI may also be used to predict development of <e1>new</e1> radiographic <e2>syndesmophytes</e2> .	modifier(e1,e2)
Exclude hypoglycaemia in <e1>people</e1> with sudden <e2>onset</e2> of neurological symptoms as the cause of these symptoms .	owner(e1,e2)
Patients undergoing surgical <e1>revascularisation</e1> of the left anterior descending coronary <e2>artery</e2> should receive an internal mammary artery graft .	other
For people with cystic fibrosis who <e1>develop</e1> a Haemophilus influenzae <e2>infection</e2> but do not have clinical evidence of pulmonary infection , treat with an appropriate oral antibiotic .	acts-on(e1,e2)
When peripheral SpA is suspected , <e1>US</e1> or <e2>MRI</e2> may be used to detect peripheral enthesitis , which may support the diagnosis of SpA .	choice
If the person is with CKD and hypertension and an ACR of <e1>30</e1> mg/mmol or <e2>more</e2> , offer a low-cost renin-angiotensin-aldosterone system antagonist .	choice
Start a <e1>trial</e1> of a renin-angiotensin system blocking drug as first-line <e2>therapy</e2> for hypertension in adults with type 1 diabetes .	other
